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CRISPR activation screening at single-cell transcriptomic resolution: 
discovering new regulators of zygotic genome activation 
Celia Alda Catalinas 
The maternal-to-zygotic transition in mammals consist of the passing of the developmental 
control from the mother to the embryo and involves two major events: the depletion of maternal 
products and the activation of the zygotic genome. Zygotic genome activation, or ZGA, 
coincides with dramatic epigenetic reprogramming processes and is likely orchestrated by the 
interplay of epigenetic and transcriptional regulators. In this dissertation, I develop a novel 
high-throughput screening method that combines pooled CRISPR activation (CRISPRa) with 
single-cell transcriptomics and apply it to discover new epigenetic and transcriptional 
regulators of ZGA in mouse embryos. 
In chapter 1, I introduce the biological context and latest technological advances related to 
CRISPR and single-cell transcriptomics. In chapter 2, I outline the materials and methods used 
in this dissertation. Chapters 3, 4 and 5 are a description and discussion of the results obtained. 
First, in chapter 3, I optimise the tools necessary to perform a CRISPRa screen with single-cell 
RNA-sequencing read-out. Specifically, I test CRISPRa in mouse embryonic stem cells 
(mESCs) using two well characterised markers of ZGA as targets and, subsequently, I develop 
and validate a method for detecting short guide RNA (sgRNA) molecules in single-cell RNA 
sequencing libraries. 
In chapter 4, I select 230 screen candidates and construct a lentiviral sgRNA library to target 
their promoters by CRISPRa. After transducing this library into mESCs and performing single-
cell RNA-sequencing for approximately 300,000 cells, I assess target gene activation by 
CRISPRa for each candidate gene and investigate different sgRNA features as well as several 
transcriptional and epigenetic parameters in relation to CRISPRa efficiency at the single-cell 
level.    
In chapter 5, I discover 44 screen hits using unsupervised methods to identify latent sources of 
gene expression variation and differential gene expression analysis. Amongst the top hits, I 
identify the DNA binding protein Dppa2, the chromatin remodeller Smarca5 and the 
transcription factor Patz1. I subsequently validate these top hits using both CRISPRa and 
cDNA overexpression in mESCs. By doing this, I uncover new factors that promote a ZGA-
like response in mESCs and are, therefore, strong candidates for ZGA regulation in vivo. 
Further molecular characterisation of Dppa2 and Smarca5 reveals that Smarca5 induces a 
ZGA-like transcriptional signature in mESCs via Dppa2, which in turns acts through the 
zygotic transcription factor Dux. 
Lastly, in chapter 6, I summarise my findings, discuss their relevance in light of the literature 
in the field and propose future directions that arise from my conclusions.  
Altogether, by developing and applying a new method for single-cell transcriptomic profiling 
of CRISPRa-perturbed cells, I provide novel system-level insights into the molecular 
mechanisms that orchestrate ZGA. 
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Chapter 1 Introduction 
Embryonic development in mammals starts with the fertilisation of an oocyte with a sperm, 
giving rise to a one-cell embryo, also called zygote. One of the most intriguing and studied 
aspects of development is how this unique cell is able to give rise to the plethora of cell types 
that constitute a fully-developed organism. Cell-fate decision rely on epigenetic modifications 
and activation of transcriptional programmes that determine cell function (reviewed in Allis & 
Jenuwein 2016). In development, the first transcriptional event is called zygotic genome 
activation (ZGA), and it is a tightly orchestrated and conserved process that is essential for 
continued development (reviewed in Vastenhouw et al. 2019; Eckersley-Maslin, Alda-
Catalinas & Reik 2018). ZGA occurs as part of a wider developmental transition, the maternal-
to-zygotic transition (MZT), in which developmental control is transferred from the mother to 
the embryo. Epigenetic reprogramming occurs hand-in-hand with transcriptional changes 
during the MZT and leads to a change in cellular identities that is essential for subsequent 
development (reviewed in Eckersley-Maslin, Alda-Catalinas & Reik 2018; Jansz & Torres-
Padilla 2019; Ladstatter & Tachibana 2019). Understanding the molecular mechanisms that 
regulate ZGA in the context of the MZT means understanding the first transcriptional event in 
a living organism and therefore constitutes essential knowledge for basic reproductive biology 
and cellular reprogramming, but it is also highly relevant for clinical applications such as 
assisted reproduction and regenerative medicine. 
In this dissertation, I developed a novel screening method using state-of-the-art technologies, 
such as CRISPR and single-cell RNA-sequencing, to uncover novel maternal regulators of 
mouse ZGA. In this chapter, I start by introducing the biological context of ZGA, focusing 
primarily on mouse and human and in the epigenetic remodeling processes that occur as part 
of the MZT. Next, I explain in vitro alternatives to study ZGA in mouse embryonic stem cells. 
In the second half of this introduction, I review the latest technological advances in single-cell 
sequencing, CRISPR, and the power of combining both. 
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1.1 The maternal-to-zygotic transition 
In mammalian embryos, after fertilisation, the very first cellular decisions are made by 
maternally-provided RNA and proteins stored in the cytoplasm of the oocyte and deposited 
into the zygote (reviewed in Lei Li et al. 2013; Schultz 2002; Vastenhouw et al. 2019). The 
MZT involves the depletion of this maternal deposits (reviewed in Walser & Lipshitz 2011), 
activation of the zygotic genome (ZGA) (reviewed in M. T. Lee et al. 2014; Jukam et al. 2017) 
and extensive epigenetic remodeling processes (reviewed in Eckersley-Maslin, Alda-Catalinas 
& Reik 2018; Jansz & Torres-Padilla 2019; Ladstatter & Tachibana 2019). Together, these 
events dramatically remodel the embryonic gene expression landscape and cellular identities, 
and are highly coordinated to ensure a correct developmental progression.  
1.1.1 From oocytes to blastocysts 
1.1.1.1 Oocyte growth and meiotic maturation 
Before fertilisation, oocytes need to acquire meiotic and developmental competence. This 
process goes back to mouse embryonic development day 7.25 (E7.25), when primordial germ 
cells (PGCs) are first detected (Ginsburg et al. 1990). In the latter stages of fetal development, 
at E13.5, PGCs enter meiosis and arrest at the end of prophase I (Figure 1.1). At this stage, 
oocytes are contained within primordial follicles (Figure 1.1), where the surrounding somatic 
cells – the granulosa cells – establish critical signalling connections for oocyte growth 
(reviewed in Rong Li & Albertini 2013). After birth, the pool of primordial follicles constitutes 
the entire store of germ cells available for reproduction and, periodically, a cohort of primordial 
follicles enters into a growth phase (reviewed in Amleh & Dean 2002). During growth, oocytes 
suffer dramatic gene expression changes to ensure storage of organelles and macromolecules 
that will be needed for early stages of embryo development (Pan et al. 2005). Concomitantly, 
granulosa cells proliferate to eventually give rise to pre- or early antral follicles (reviewed in 
Rong Li & Albertini 2013), which grow into antral follicles after puberty with the release of 
follicle-stimulating hormone (FSH) (Kumar et al. 1997) (Figure 1.1).  
 




Figure 1.1– Schematic representation of mouse follicle development 
Mouse follicles develop from primordial germ cells (PGC), which enter meiosis at embryonic day 
13.5 (E13.5). At birth, the pool of primordial follicles constitutes the entire store of germ cells 
available for reproduction and, in these structures, oocytes are surrounded by epithelial cells called 
granulosa cells. Primordial follicles develop first into primary follicles at three days post-birth (P3) 
and into secondary and antral follicles at P7, when they become surrounded by stromal cells called 
theca cells. In antral follicles, granulosa cells are differentiated into cumulus cells that surround the 
oocyte and mural granulosa cells that surround the antrum. The development from secondary to antral 
follicles is induced by follicle-stimulating hormone (FSH), which further drives development of 
antral follicles into preovulatory follicles at P21. Lastly, the luteinizing hormone (LH) surge induces 












Approximately every 4 to 6 days in mouse and 28 days in human, before ovulation, the 
luteinizing hormone (LH) surge induces fully grown germinal vesicle (GV) oocytes to 
complete the first meiotic division, extruding the first polar body, and enter into meiosis II 
(reviewed in Russell & Robker 2007). During this process, oocytes acquire meiotic maturation 
competence in two steps: firstly, by undergoing germinal vesicle breakdown (GVBD) to exit 
prophase I and progress through metaphase I, and secondly, by starting their second meiotic 
division, where they get arrested in metaphase II (MII) (Sorensen & Wassarman 1976; 
Wickramasinghe et al. 1991). Finally, MII oocytes are released from the ovaries during 
ovulation (Figure 1.1), ready to be fertilised by a sperm. 
1.1.1.2 Fertilisation and egg activation 
With fertilisation, oocytes acquire developmental competence. Fertilisation is defined as the 
fusion of the male and female gametes and it involves a series of coordinated, sequential 
molecular events. Following ovulation, the MII oocyte contains an extracellular matrix called 
zona pellucida that is composed of three sulphated glycoproteins, ZP1, ZP2 and ZP3 (reviewed 
in J. P. Evans & Florman 2002). This structure mediates the initial oocyte-sperm recognition 
and is responsible for triggering the sperm acrosome reaction (reviewed in Georgadaki et al. 
2016). Specifically, after capacitation, the sperm recognises and binds primarily to ZP3 
glycoproteins via O-linked oligosaccharide connections (Bleil & Wassarman 1980; Florman & 
Wassarman 1985). This recognition triggers signal transduction events in the sperm that 
include the opening of low voltage-activated calcium channels (Arnoult et al. 1996), which 
eventually results in a sustained calcium influx that drives exocytosis of the acrosome, a single 
secretory granule present in the head of mammalian sperm that is required for fertilisation 
(reviewed in J. P. Evans & Florman 2002). The acrosome reaction allows sperm attachment to 
the oocyte membrane, cell-cell adhesion and membrane fusion of the two gametes mediated by 
multimeric complexes (reviewed in J. P. Evans 1999; Georgadaki et al. 2016). Once both 
gametes have fused, low-frequency oscillations in cytosolic calcium concentration from 
sequestered calcium in the endoplasmic reticulum of the fertilised oocyte induce four events 
that allow the commencement of embryonic development: 1) meiotic resumption with 
extrusion of the second polar body, 2) release of cortical granules that modify the zona 
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pellucida and prevent polyspermy, 3) formation of female and male pronuclei, and 4) the first 
cleavage division of the embryo (reviewed in Schultz & Kopf 1995; Krauchunas & Wolfner 
2013). 
1.1.1.3 Pre-implantation development. Totipotency and pluripotency 
In mice, pre-implantation development lasts four and a half days, spanning from fertilisation 
to implantation into the mother’s uterus (reviewed in Wennekamp et al. 2013). After 
fertilisation, the egg completes meiosis and a one-cell embryo or zygote is formed, containing 
haploid paternal and maternal pronuclei. Then, the DNA is replicated and the two pronuclei 
undergo syngamy to form a diploid one-cell embryo (Zamboni et al. 1972), which enters a 
series of cleavage division that result first in the formation of a two-cell embryo after the first 
mitosis, and eventually, in the formation of a structure called blastocyst. While these cleavage 
divisions occur, two essential processes take place: firstly, the handover of the developmental 
control from the mother to the embryo, which involves the depletion of maternal products and 
the transcriptional activation of the zygotic genome, and secondly, the first two lineage 
decisions in development, where cells commit to the embryo proper or to extra-embryonic 
tissues that are going to give rise to the placenta (reviewed in Leung & Zernicka-Goetz 2015) 
(Figure 1.2).  
During the initial stages of pre-implantation development, the embryo is totipotent, that is, all 
blastomeres or cells that constitute it have the potential to give rise to any cell type, both 
embryonic and extra-embryonic (reviewed in Ishiuchi & Torres-Padilla 2013; Leung & 
Zernicka-Goetz 2015; Zhou & Dean 2015; Dang-Nguyen & Torres-Padilla 2015) (Figure 1.2). 
The exact developmental stage until which the embryo retains this totipotent potential is 
controversial. The most stringent test of totipotency, proposed by Tarkowski in 1959, consists 
on isolating a single blastomere, placing it into an empty zona pellucida, returning this 
construct to the oviduct and monitor developmental progression (TARKOWSKI 1959). These 
early experiments defined totipotency up to the two-cell stage in the mouse embryo. However, 
later on, it was suggested that the failure of four-cell and eight-cell embryo blastomeres to 
perform successfully in this test was due to the limited size of the inner cell mass (ICM) formed 
rather than a restricted developmental potential of cells at these stages (Rossant 1976). In this 
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respect, individual blastomeres from 16-cell stage embryos supported by carrier labelled 
tetraploid blastomeres were able to contribute to embryonic and extra-embryonic lineages 
(TARKOWSKI et al. 2010). More recently, a study examining the developmental potential of 
the blastomeres in two-cell embryos suggested an unequal totipotent potential of the two 
blastomeres (Casser et al. 2017), arising from transcriptomic differences between them (Casser 
et al. 2018). In human embryos, experiments where individual blastomeres were split at the 
four-cell stage and individually cultured in vitro up to 6 days showed that each blastomere 
retained the capacity to form a blastocyst containing a trophectoderm and an ICM (van de 
Velde et al. 2008). However, due to the technical manipulations done to embryos in all these 
studies aiming to define totipotency, its definition remains unclear and continuously under 
revision (Boiani et al. 2019). 
 
 
Figure 1.2– Overview of cleavage divisions and transcriptional changes during pre-implantation 
development  
Following fertilisation, a series of cleavage divisions from the mouse zygote through to the blastocyst 
take place, accompanied by a decline in potency. The early blastocyst is formed by inner cell mass cells 
(ICM) that will give rise to the embryo proper, and extra-embryonic trophectoderm cells, that will give 
rise to the placenta. Maternal mRNA stores (orange line) are depleted during the first hours of 
development while two waves of transcriptional zygotic genome activation (ZGA; green line) occur: 
the first or minor wave predominantly in the male pronucleus (PN) in the zygote, and the second or 
major wave in mid-two-cell to late-two-cell embryos. Approximate cell cycle phases are represented 
by yellow bars for S phase and red bars for M phase. Approximate embryonic days (E) are denoted. 
Image adapted from Eckersley-Maslin, Alda-Catalinas & Reik 2018. 
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With the loss of potency, the first lineages in development are specified at E3.5, when cells are 
segregate into the ICM and the trophectoderm (Figure 1.2), as specified from asymmetric cell 
divisions from the four-cell stage (Johnson & Ziomek 1981; Sutherland et al. 1990; 
Piotrowska-Nitsche et al. 2005).  The cells in the ICM continue differentiating into the epiblast- 
which will constitute the embryo proper-, and the primitive endoderm -another extraembryonic 
tissue-, which are set apart by E4.5 (reviewed in Rossant & Tam 2009). The pre-implantation 
epiblast in the blastocyst has a more restricted developmental potential as it can only give rise 
to embryonic, but not to extraembryonic, tissues; this feature is defined as pluripotency 
(reviewed in De Los Angeles et al. 2015). 
1.1.2 Regulation of maternal gene products 
After fertilisation, the embryo is transcriptionally quiescent and development relies on proteins 
and RNAs provided from the egg cytoplasm (reviewed in Wassarman & Kinloch 1992). While 
the stores deposited from the sperm were traditionally thought to have minimal contribution to 
early embryogenesis (reviewed in Sutovsky & Schatten 2000), recent studies are beginning to 
appreciate the importance of sperm components, such as tRNAs, during early events such as 
ZGA (Sharma et al. 2016). Nevertheless, for the purpose of this dissertation, and given the 
central role of the oocyte deposits for survival of the embryo after fertilisation, I will focus on 
the maternal regulation of early development.  
Approximately 12 hours before ovulation, mouse oocytes become transcriptionally quiescent 
(Clegg & Piko 1983; De Leon et al. 1983). However, before that, as the oocyte is growing 
while arrested in prophase I, it transcribes and accumulates transcripts, most of which are 
immediately translated into proteins that will be deposited into the embryo (De Leon et al. 
1983; Vitale et al. 2007). Other transcripts remain dormant and only become activated later 
during oocyte maturation by cytoplasmic polyadenylation (Racki & Richter 2006). 
Cytoplasmic polyadenylation of dormant transcripts leads to the translation of crucial proteins 
for meiotic maturation and early stages of development, such as the activation of the embryonic 
genome or ZGA, mitotic progression of the embryo throughout cleavage divisions in pre-
implantation development, and establishment of the first lineage decisions. These factors are 
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known as maternal-effect genes (reviewed in Lei Li et al. 2010) and are further reviewed in 
section 1.1.6. 
In mouse early embryos, most deposited maternal transcripts are degraded by the two-cell stage 
(Clegg & Piko 1983) (Figure 1.2), although their corresponding proteins can persist for much 
longer and have functions during the first lineage allocation (Nothias et al. 1996; Y. Gao et al. 
2017). Although some maternal transcripts are degraded during meiotic maturation, the rate is 
slow (Clegg & Piko 1983; De Leon et al. 1983). Fertilisation triggers maternal messenger RNA 
(mRNA) destabilisation of transcripts that encode proteins with roles in specific events during 
meiosis, such as Growth Differentiation Factor 9 (GDF9) (Alizadeh et al. 2005; Su et al. 2007). 
Other transcripts are degraded in a zygotically-directed wave of degradation that follows 
zygotic genome activation after the two-cell stage (Hamatani et al. 2004; reviewed in Svoboda 
et al. 2015). Although less well studied in human embryos, gene expression profiling also 
suggests two waves of maternal transcript clearance (Dobson et al. 2004; P. Zhang et al. 2009; 
Xue et al. 2013). 
As proposed by Vastenhouw et al. in a recent review, this coordinated regulation of maternal 
transcript clearance suggests tight regulation of transcript stabilisation and destabilisation 
mediated by RNA-binding proteins, small non-coding RNAs, RNA modifications and “codon 
optimality” (reviewed in Vastenhouw et al. 2019). The Y-box-binding protein MSY2 was 
found to stabilize maternal transcripts after being phosphorylated by the Cell Division Control 
protein 2 homolog A (CDC2A) kinase upon oocyte maturation (Medvedev et al. 2008; 
Medvedev et al. 2011; J. Yu et al. 2001; J. Yu et al. 2002). The best studied RNA binding 
proteins involved in mRNA destabilisation are the CCCH tandem zing finger protein 36-like 2 
(ZFP36L2) (Ramos et al. 2004) and the B-cell translocating gene 4 (BTG4) (C. Yu, Ji, Sha, et 
al. 2016; Yusheng Liu et al. 2016). Disruption of either of these proteins in mouse oocytes 
impairs development after the one- to -two-cell stage (Ramos et al. 2004; C. Yu, Ji, Sha, et al. 
2016; Yusheng Liu et al. 2016). Small non-coding RNAs play a role in transcript degradation 
during meiotic maturation, specifically, microRNAs (miRNAs) and small interfering RNAs 
(siRNAs) which act in an RNA-induced silencing complex (RISC) that contains Argonaute 
proteins (Murchison et al. 2007; Tang et al. 2007; Kaneda et al. 2009; Lykke-Andersen et al. 
2008). In recent years, it has been discovered that chemical modifications of mRNAs can 
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directly influence post-transcriptional gene regulation (reviewed in Lewis et al. 2017). For 
example, the maternal protein YTH N6-methyladenosine RNA binding protein 2 (YTHDF2), 
which binds N6-methylation of adenosine (m6A) in mRNA, and the mRNA deadenylation 
protein CCR4-NOT transcription complex subunit 6-like (CNOT6L) induce destabilisation of 
mRNAs (Ivanova et al. 2017; Sha et al. 2018). Another form of mRNA modification seen to 
play a role during the MZT in mouse is terminal uridylation in deadenylated mRNAs by the 
terminal uridylyl transferases 4 and 7 (TUT4 and TUT7, respectively) (Morgan et al. 2017; 
Chang et al. 2018). Lastly, in the zebrafish MZT, it was found that transcripts enriched for non-
optimal codons (a codon encoding an amino acid for which an alternative codon has higher 
cognate tRNA abundance) are preferentially degraded (Bazzini et al. 2016; Mishima & Tomari 
2016), a regulation mechanism that has been proposed to be conserved in mice (Bazzini et al. 
2016). 
Importantly, not only RNAs but also maternal proteins are degraded after fertilisation and 
throughout pre-implantation development. This is mediated by ubiquitin-proteasome pathways 
with factors such as Ret Finger Protein-Like 4 (RFPl4) (Suzumori et al. 2003), Ubiquitin-
conjugating enzyme E2 A (UBE2A) (Roest et al. 2004) and E3 ubiquitin-protein ligase 
RNF114 (Y. Yang et al. 2017), and by autophagy (TSUKAMOTO et al. 2008). 
1.1.3 Transcriptional dynamics during zygotic genome activation 
In mouse and human embryos, the initially quiescent zygotic genome becomes activated in two 
transcriptional bursts, namely, the minor wave and the major wave of ZGA (reviewed in 
Schultz 2002; Lei Li et al. 2013; M. T. Lee et al. 2014; Jukam et al. 2017; Eckersley-Maslin, 
Alda-Catalinas & Reik 2018; Vastenhouw et al. 2019) (Figure 1.2). In total, between the two 
waves, approximately 20% of the coding genome is transcribed in mouse during the early days 
of development (Hamatani et al. 2004).  
1.1.3.1 Minor wave of zygotic genome activation 
The first or minor wave occurs predominantly in the male pronucleus of the mouse zygote, in 
the S to G2 cell cycle phases (Figure 1.2) around 10 hours post-fertilisation, and it involves 
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low-level, genome-wide and promiscuous transcription (Ram & Schultz 1993; Bouniol et al. 
1995; Majumder & DePamphilis 1995; Nothias et al. 1996; Aoki et al. 1997; F. Zeng et al. 
2004; Xue et al. 2013; Deng et al. 2014; Abe et al. 2015; S.-J. Park et al. 2015). The number 
of transcripts expressed during this wave has been analysed by single-cell RNA-sequencing 
and varies between approximately 500 and 4000 coding genes, depending on the study (Xue et 
al. 2013; Abe et al. 2015; S.-J. Park et al. 2015; Deng et al. 2014), likely due to slight 
differences in the exact developmental stage analysed, the type of RNA libraries (total RNA or 
poly(A)-capture) and the sequencing depth.  
A few of the transcripts produced during minor ZGA are only transiently transcribed, but the 
majority continue being transcribed in two-cell embryos, during the major wave of ZGA (S.-J. 
Park et al. 2015; Abe et al. 2015). Nevertheless, given the pervasive nature of transcription 
during minor ZGA, it is not only coding transcripts but also intergenic regions, including 
transposable elements (see section 1.1.3.3), that are transcribed even in the absence of core-
promoter elements (Abe et al. 2015) or enhancers (Wiekowski et al. 1991; Majumder & 
DePamphilis 1995), requiring only minimal promoter features (Hamamoto et al. 2014). 
Moreover, it has been proposed that despite this pervasive nature, there is some selectivity 
towards sperm-primed transcripts since more than 300 minor ZGA transcripts are also 
expressed in sperm but not in parthenogenetic embryos (embryos originated from an activated 
MII oocyte in the absence of fertilisation from sperm) (S.-J. Park et al. 2015). 
The function of transcription during minor ZGA is mostly unknown, although it is believed 
that most of the mRNAs produced are not functional due to inefficient 3’ end processing and 
splicing (Abe et al. 2018), and transcription-translation uncoupling in plasmid-borne reporter 
genes in one-cell embryos (Nothias et al. 1996). Importantly, even though the male pronucleus 
supports most of the transcription detected in one-cell embryos (Henery et al. 1995; Aoki et al. 
1997), likely due to the drastic chromatin remodeling that it suffers after fertilisation (see 
section 1.1.4), unspliced transcripts were also detected in parthenogenetic one-cell embryos 
(S.-J. Park et al. 2015; Abe et al. 2015), indicating that ineffective splicing is not exclusive to 
paternal transcripts. Despite the uncertainty in the role of transcription in the one-cell embryo, 
being unclear whether it has a specific function or it is merely a consequence of a relaxed 
chromatin structure (see section 1.1.4), transcription inhibition experiments have effectively 
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shown that promiscuous transcription needs to occur in the embryo before the more regulated 
wave of major ZGA takes place (Abe et al. 2018).  
Although less well characterised, low transcriptional rates occur from the zygote to the four-
cell stage in human embryos, equivalent to a minor wave of ZGA (Xue et al. 2013; L. Yan et 
al. 2013). However, clustering analysis using transcriptomic information show that the one-
cell embryo is transcriptionally distinct from later cleavage stages and from the oocyte, 
suggesting a unique transcriptomic landscape (Xue et al. 2013; L. Yan et al. 2013) that probably 
reflects the presence of maternal products and new zygotic transcription.  
1.1.3.2 Major wave of zygotic genome activation 
The major wave of ZGA occurs at the S to G2 cell-cycle phase of the two-cell stage in mouse 
embryos, after the first cleavage division around 19 hours post fertilisation (Majumder & 
DePamphilis 1995; Aoki et al. 1997; Hamatani et al. 2004; F. Zeng et al. 2004; Xue et al. 2013; 
Deng et al. 2014; S.-J. Park et al. 2015) (Figure 1.2), while it is not until the eight-cell stage 
that a major wave of transcription is detected in the human embryo (Braude et al. 1988; Dobson 
et al. 2004; Vassena et al. 2011; Xue et al. 2013; L. Yan et al. 2013). The major wave of ZGA 
involves a shift in cellular identity from oocyte-like to embryo-like, with the degradation of 
maternal mRNAs and accumulation of novel zygotic transcripts that convey cellular 
totipotency (reviewed in Svoboda et al. 2015; Baker & Pera 2018). 
Similar to minor ZGA, the number of transcripts reported to be involved in major ZGA depends 
on the technology used to detect them (microarray or next-generation sequencing), but, 
regardless, it is known to involve thousands of genes (F. Zeng et al. 2004; F. Zeng & Schultz 
2005; S.-J. Park et al. 2015; Deng et al. 2014; Xue et al. 2013). While most transcripts from 
minor ZGA continue to be transcribed, this wave of transcription in mouse two-cell embryos 
and human eight-cell embryos differs from minor ZGA not only in the volume but also in the 
transcripts produced (Xue et al. 2013; S.-J. Park et al. 2015; Abe et al. 2018). Although most 
of the genes transcribed during major ZGA have unknown functions, this wave also involves 
expression of genes related to transcription regulation, RNA processing, ribosome biogenesis 
and protein translation which are key for later pre-implantation stages (Xue et al. 2013). 
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Furthermore, single-cell sequencing of hybrid zygotes showed the existence of stochastic 
monoallelic expression (Deng et al. 2014).  
Development to the two-cell stage and major ZGA is accompanied by genome-wide 
accumulation of repressive histone marks (Santos et al. 2005). This leads to a transcriptionally 
repressive state (Majumder et al. 1993; Wiekowski et al. 1993) in a transition that is dependent 
on DNA replication (Wiekowski et al. 1991; Majumder et al. 1993; Henery et al. 1995; Forlani 
et al. 1998). Consistently, many genes with unknown functions are only transiently expressed 
during major ZGA (Davis et al. 1996; Xue et al. 2013; S.-J. Park et al. 2015) and their 
expression is enhancer-dependent (Wiekowski et al. 1991; Majumder et al. 1993; Henery et al. 
1995). 
1.1.3.3 Transposable and repeat elements during zygotic genome 
activation 
Transposable elements are mobile and repetitive genomic regions that are able to change their 
location within the genome by transposition. In mammals, they comprise about 70% of the 
genome (Lander et al. 2001; Waterston et al. 2002) and were initially classified as “junk” DNA 
(Ohno 1972). While transposable elements are still regarded as the main danger for genome 
integrity (Doolittle & Sapienza 1980; Orgel & Crick 1980), their function as drivers of genome 
evolution and fundamental regulatory roles has recently begun to be addressed. Transposable 
elements can be classified in two major classes according to their mechanism of transposition: 
class I elements or retrotransposons, which transpose through an RNA intermediate, and class 
II elements or DNA transposons that can directly move from one site in the genome to another 
as DNA molecules (reviewed in García-Pérez et al. 2016) (Figure 1.3). Retrotransposons can 
be further classified into endogenous retroviruses (ERVs), long interspersed elements (LINEs) 
and short interspersed elements (SINEs) (Okamura & Nakai 2008) (Figure 1.3). Approximately 
3% of mammalian genomes are made of DNA transposons, which are no longer mobile in most 
species (Lander et al. 2001; Waterston et al. 2002). On the contrary, retrotransposons can 
constitute up to 40% of a typical mammalian genome and are generally active (Lander et al. 
2001); (reviewed in reviewed in Richardson et al. 2015). During mouse and human pre-
implantation development, retrotransposons are expressed and contribute to cellular identity 
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(X. Lu et al. 2014; Jachowicz et al. 2017) and ZGA (Jachowicz et al. 2017; De Iaco et al. 2017; 
Hendrickson et al. 2017; Whiddon et al. 2017) (reviewed in Rowe & Trono 2011; Rodriguez-
Terrones & Torres-Padilla 2018). 
 
Figure 1.3– Structures of key classes of transposable elements in the mammalian genome  
DNA transposons encode a transposase gene flanked by tandem inverted repeats (IRs). LTR 
retrotransposons or endogenous retroviruses (ERVs) encode the genes Gag and Pol flanked by long 
terminal repeats (LTRs). Two key families of non-LTR retrotransposons are LINE-1 and SINE 
elements. LINE-1 elements contain an internal promoter at their 5’ end, a variable number of open 
reading frames (ORFs) and a 3’ untranslated region (3’ UTR) with a polyadenylation signal and a 
polyA tail. The structure of SINE elements varies for different sub-families, but their 5’ ends are 
generally derived from small cellular RNAs and they encode a polyA tail. Figure adapted from 
García-Pérez et al. 2016. 
 
ERVs contain long terminal repeat (LTR) sequences equally oriented at both ends of the 
retrotransposon, which provide a promoter at the 5’ end and a transcriptional termination and 
polyadenylation signals at the 3’ end (Mager & Stoye 2015) (Figure 1.3). A full-length ERV 
typically encodes two genes: Gag, a polymorphic capsid protein with structural and nucleic 
acid-binding functions, and Pol, which encodes a protease, a reverse transcriptase, an RNAseH 
domain and an integrase (Wicker et al. 2007) (Figure 1.3). ERVs can be autonomous, that is, 
able to encode functional retroviral proteins required for mobilisation, or non-autonomous, 
which rely on retroviral proteins encoded by active ERVs to mobilize (reviewed in García-
Pérez et al. 2016). ERVs are expressed during mouse MZT. For example, mammalian apparent 
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LTRs (MaLRs) are contained in approximately 12% of mouse oocyte transcripts (Peaston et 
al. 2004). Murine ERVs with leucine tRNA primer-binding site (MERVL) elements are 
expressed in one- and two-cell embryos (Kigami 2002; Peaston et al. 2004; Svoboda et al. 
2004; Macfarlan et al. 2012). MERVL elements can be full-length or composed of a solo LTR 
(also known as MT2 elements) (Wicker et al. 2007). There are 656 MERVL full-length copies 
and 37,172 MT2 copies in the C57Bl/6 genome and its transcripts account for nearly 4% of the 
mouse transcriptome at the two-cell stage (Kigami 2002; Peaston et al. 2004; Svoboda et al. 
2004). MERVL elements often function as alternative promoters during ZGA, enabling 
transcription of neighboring genes that results in chimeric transcripts and allows coordinated 
expression during the major wave of activation (Peaston et al. 2004; Y. Huang et al. 2017; 
Macfarlan et al. 2012; Franke et al. 2017). Additionally, MERVL elements can derive non-
coding RNAs (Franke et al. 2017; Karlic et al. 2017) and drive evolution of new protein-coding 
genes during ZGA (Karlic et al. 2017). The human counterpart, HERVL elements, also drive 
ZGA at the eight-cell stage embryo (De Iaco et al. 2017; Hendrickson et al. 2017; Pontis et al. 
2019). Furthermore, through evolution, these elements can form novel binding sites for 
transcription factors, both in mouse and human, providing binding sites for regulators of ZGA 
(Bourque et al. 2008; Kunarso et al. 2010; Imbeault et al. 2017; De Iaco et al. 2017; 
Hendrickson et al. 2017; Whiddon et al. 2017; Pontis et al. 2019).  
LINE elements are autonomous transposable elements that lack LTRs and comprise 
approximately between 10% to 30% of mammalian genomes. L1 elements are the most 
abundant LINE elements in mouse and human (reviewed in Penzkofer et al. 2017). The full-
length elements contain an internal promoter at their 5’ end, a variable number of open reading 
frames (ORFs) and a 3’ untranslated region (3’ UTR) with a polyadenylation signal and a 
polyA tail (Figure 1.3). Young L1 elements are transcribed in one-cell mouse embryos and 
regulate chromatin accessibility during ZGA (Beraldi et al. 2006; Fadloun et al. 2013; 
Jachowicz et al. 2017; Percharde et al. 2018), specifically, they repress the zygotic transcription 
factor DUX, allowing exit from the two-cell stage (Percharde et al. 2018) (see sections 1.1.4.2 
and 1.1.6.4-1.1.6.5).  
SINE elements are non-autonomous transposable elements that rely on the enzymatic 
machinery of LINE elements for their transposition (reviewed in Richardson et al. 2015). Most 
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SINE elements have a 5’ end derived from small cellular RNAs transcribed by polymerase III, 
a central sequence of diverse origin and a 3’ tail related to the 3’ end of a LINE (Figure 1.3). 
While their functional role, if any, during ZGA is unknown, the B2 subfamily of SINE elements 
is transcribed in mouse zygotes during the minor wave of ZGA (Vasseur et al. 1985). 
Besides transposable elements, there are other repetitive elements in the genome whose 
transcription is active during ZGA. This is the case for major satellites, pericentric 
heterochromatin repeats with AT-rich long repetitive domains (Wong & Rattner 1988; Joseph 
et al. 1989). Major satellites are actively transcribed in two-cell embryos, where they play a 
role in pericentromeric heterochromatin organisation (Probst et al. 2010; Casanova et al. 2013) 
(see section 1.1.4.2). 
1.1.4 Epigenetic dynamics during the maternal-to zygotic transition 
The term “epigenetics” has been given multiple definitions since it was first coined by 
Waddington in 1942. Here, I use “epigenetics” to refer to “the layer of information that exists 
beyond that encoded in the DNA sequence itself, thereby making the genome function 
distinctively in different cell types” (reviewed in Greally 2018). Epigenetic regulation is critical 
for normal development and its deregulation can be associated with various diseases (reviewed 
in Portela & Esteller 2010; Reik et al. 2003). The epigenome is extensively remodeled during 
the MZT, by changes in global DNA methylation, histone post-translational modifications 
(PTMs), local chromatin remodeling and higher-order chromatin architecture (reviewed in 
Eckersley-Maslin, Alda-Catalinas & Reik 2018; Jansz & Torres-Padilla 2019; Ladstatter & 
Tachibana 2019). Epigenetic remodeling, together with the associated changes in the gene 
expression landscape, changes cellular identity and confers totipotency to the embryo 
(reviewed in Ishiuchi & Torres-Padilla 2013; Ladstatter & Tachibana 2019). 
1.1.4.1 Global DNA demethylation 
DNA methylation is a covalent modification of the DNA itself by which a methyl group is 
added to the 5-carbon of the cytosine base (5mC) (Holliday & Pugh 1975; Razin & Riggs 1980) 
(Figure 1.4). In the mammalian genome, 5mC is mostly found in cytosine residues of CpG 
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dinucleotides (Bird et al. 1985), although non-CpG methylation is also present at low levels, 
mostly in the CpA context (Bird 2002). Approximately 60% to 80% of all CpG sites in the 
mammalian genome are methylated, with the notable exception of regions rich in the CpG 
dinucleotide, known as CpG islands, which are mostly unmethylated and found in promoters 
of active genes, particularly housekeeping and developmental genes (Bird 2002). CpG 
methylation at gene promoters has long been associated to transcriptional repression (Razin & 
Riggs 1980) via different mechanisms such as recruitment of histone post-translational 
modifications or by preventing the binding of transcription factors (reviewed in Klose & Bird 
2006). DNA methylation is established and maintained by DNA methyltransferases (DNMTs). 
Specifically, the maintenance DNMT1, together with its interacting partner E3 ubiquitin-
protein ligase UHRF1, methylate the unmodified nascent DNA strand opposite to a previously 
methylated position after DNA replication (reviewed in Bestor 2000; E Li et al. 1992) (Figure 
1.4). The de novo methyltransferases DNMT3A and DNMT3B, regulated by the catalytically 
inactive isoform DNMT3L, establish new DNA methylation patterns (reviewed in Bestor 
2000); (Okano et al. 1999; Barau et al. 2016) (Figure 1.4). Removal of DNA methylation can 
occur either passively by dilution through impaired maintenance upon DNA replication, or 
actively via DNA repair pathways and/or oxidation reactions catalysed by the ten-eleven 
translocation (TET) enzymes (reviewed in H. Wu & Yi Zhang 2014) (Figure 1.4).  
During mammalian development, the genome undergoes two waves of global DNA 
demethylation: during the establishment of PGCs and in the zygote after fertilisation (reviewed 
in H. J. Lee et al. 2014) (Figure 1.5). Regulation of DNA methylation in these two critical 
processes plays a major role in genome regulation, genome stability, X chromosome 
inactivation, transposon silencing and genomic imprinting (Reik & Walter 2001; reviewed in 
Greenberg & Bourc'his 2019). Genomic imprinting refers to the epigenetic phenomenon driven 
by DNA methylation in which certain genes are solely expressed from either the paternal or 
maternal allele and retain their DNA methylation status (parental imprints) during epigenetic 
reprogramming in the early embryo (Figure 1.5). For the purpose of this dissertation, I next 
review the DNA methylation dynamics that occurs after fertilisation and through pre-
implantation development. 
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Figure 1.4.– DNA methylation and demethylation machinery  
Unmodified cytosines are de novo methylated by the DNA methyltransferase enzymes DNMT3A/B 
regulated by the co-factor DNMT3L. DNMT1, together with UHRF1, maintains DNA methylation 
patterns across DNA replication. TET enzymes (TET1/2/3) oxidise 5-methylcytosine (5mC) to 5-
hydroxymethylcytosine (5hmC), 5’ formylcytosine (5fC) and 5-carboxycytosine (5caC). 5fC and 
5caC can be excised by thymine-DNA glycosylase (TDG), leaving an abasic site that triggers base-
excision repair (BER) mechanisms. DNA demethylation can also occur through passive dilution of 
5mC, 5hmC, 5fC or 5caC. Figure modified from H. Wu & Yi Zhang 2014. 
 
DNA methylation reprogramming in the zygote erases the epigenetic “memory” inherited from 
the parents, with the notable exception of parental imprints, and allows re-establishment of 
developmental totipotency (reviewed in H. J. Lee et al. 2014). This process occurs differentially 
in the maternal and paternal genome (Figure 1.5), as demonstrated both by 
immunofluorescence-based and genome-wide analysis (Oswald et al. 2000; Mayer et al. 2000; 
Wossidlo et al. 2010; Wossidlo et al. 2011; Smith et al. 2012; L. Wang et al. 2014; F. Guo et 
al. 2014; Smith et al. 2014; Peat et al. 2014; Santos et al. 2013; Amouroux et al. 2016; Petrussa 




Figure 1.5– Overview of CpG methylation dynamics during mouse development  
In primordial germ cells (PGCs), reprogramming is necessary to erase the DNA methylation pattern 
originated in the epiblast, from which they are derived at E7.25, to reset parental imprints in a gender-
specific manner, and to gain developmental potency. Concomitant with proliferation and migration 
towards the genital ridge, PGCs undergo a wave of DNA demethylation from E7.25 to E12.5 (black 
line, top panel). After sex determination, new DNA methylation patterns are established in the germ 
cell precursors in a sex-specific manner (blue and red lines, top panel). Following fertilisation, a new 
wave of DNA demethylation takes place differentially in the paternal and maternal genome 
throughout pre-implantation development. Paternal DNA methylation (5mC, blue solid line, top and 
bottom panel) is rapidly lost by mechanisms of active demethylation. Paternal 5-hydroxymethylation 
(5hmC, blue dashed line, bottom panel) increases rapidly after fertilisation, while de novo DNA 
methylation also occurs (*,  bottom panel). Maternal DNA methylation (red solid line, top and bottom 
panel) is lost by passive dilution following DNA replication during cleavage divisions. This wave of 
DNA demethylation after fertilisation does not affect parental imprints (imprinted genomic 
differentially methylated regions, gDMRs, green dashed line, top panel). After implantation of the 
blastocyst into the mother’s uterus, DNA methylation patterns are re-established associated with 
lineage determination. In the bottom panel, approximate cell cycle phases are represented by yellow 
bars for S phase and red bars for M phase. Approximate embryonic days (E) are denoted. Image 
adapted from Smallwood & Kelsey 2012 (top panel) and Eckersley-Maslin, Alda-Catalinas & Reik 
2018 (bottom panel). 
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CpG methylation is established in mouse oocytes by the DNMT3A/DNMT3L complex in 
around 40% of CpG sites (Smallwood et al. 2011; Kobayashi et al. 2012). Interestingly, and 
unlike the genome of sperm and somatic cells, the oocyte is hypomethylated in transcriptionally 
inert regions (Smallwood et al. 2011; Kobayashi et al. 2012) (reviewed in Stewart et al. 2016), 
a feature that is maintained, at least in part, by STELLA (also known as DPPA3 or PGC7) and 
is essential for development after fertilisation and ZGA (Y. Li et al. 2018). DNA methylation 
in the maternal genome is passively lost in a replication-dependent manner upon fertilisation 
and during pre-implantation development (Rougier et al. 1998) (Figure 1.5), predominantly by 
nuclear exclusion of DNMT1 in the female pronucleus (Howell et al. 2001; Mahadevan et al. 
2017) and cytoplasmic localisation of UHRF1 (Maenohara et al. 2017). However, low levels 
of active maternal DNA demethylation were also recently observed in zygotes (F. Guo et al. 
2014; Shen et al. 2014). 
Mouse sperm presents high levels of DNA methylation, around 90% of CpGs, also established 
by the DNMT3A/DNMT3L complex (Erkek et al. 2013). After fertilisation, the male 
pronucleus rapidly demethylates by mechanisms of active demethylation (Figure 1.5), through 
oxidation of 5mC to 5-hydroxymethylation (5hmC), 5-formylmethylation (5fC) and 5-
carboxymethylation (5caC), as demonstrated by immunofluorescence (T.-P. Gu et al. 2011; 
Inoue & Yi Zhang 2011; Iqbal et al. 2011; Santos et al. 2013; Wossidlo et al. 2011). This 
oxidation is partly driven by TET3, the only TET enzyme expressed one-cell embryos and 
whose knock-down or maternal knock-out (KO) inhibits DNA demethylation in the male 
pronucleus (T.-P. Gu et al. 2011; Wossidlo et al. 2011; Inoue et al. 2012; Peat et al. 2014; F. 
Guo et al. 2014; Inoue et al. 2015; Tsukada et al. 2015). Moreover, TET3-mediated 
demethylation is also responsible for the transcriptional activation of transposable elements 
(Inoue et al. 2012). However, recent studies have shown that 5hmC and 5fC only rise in the 
late pronuclear stages of the male genome (Santos et al. 2013; Amouroux et al. 2016; Zhu et 
al. 2017) (Figure 1.5), suggesting that active demethylation involves other mechanisms other 
than TET3 which are currently unknown. Consequently, it has been suggested that TET3 also 
has a role in counteracting the de novo DNA methylation observed in zygotes (Amouroux et 
al. 2016) (Figure 1.5). Other machinery that might contribute to the demethylation of the male 
pronucleus is the maternal factor gonad-specific expression gene (GSE), whose depletion 
20 Introduction 
 
reduces the loss of 5mC and gain of 5hmC in the paternal genome (Hatanaka et al. 2013). 
Additionally, base-excision repair (BER) mechanisms contribute to paternal DNA 
demethylation by replacing modified cytosines with unmodified ones (Wossidlo et al. 2010; 
Hajkova et al. 2010; Wossidlo et al. 2011; Santos et al. 2013; Ladstatter & Tachibana-
Konwalski 2016) (Figure 1.4). How these different mechanisms act together to rapidly 
demethylate the paternal pronucleus is an active area of research. For example, it was shown 
that TET3-mediated demethylation generates DNA lesions in the paternal pronucleus that are 
repaired by a cohesin-dependent mechanism, preventing activation of a mitotic checkpoint and 
allowing cleavage divisions to proceed (Ladstatter & Tachibana-Konwalski 2016). 
The maternal genome and paternal imprints are protected from TET3-mediated demethylation 
by preferential binding of STELLA to dimethylated histone H3 at Lysine 9 (H3K9me2) 
(Hajkova et al. 2010; Nakamura et al. 2012), which is not found in the paternal pronucleus 
(Santos et al. 2005). Other recently proposed candidates to establish the asymmetry in active 
DNA demethylation between the paternal and maternal pronuclei are the H3K9 
methyltransferases euchromatic histone lysine methyltransferase 2 (EHMT2, also known as 
G9a) and SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) (T.-B. Zeng et 
al. 2019). Imprinted regions are also maintained by the cooperative action of zinc-finger protein 
57 (ZFP57) and KRAB-associated protein-1 (KAP1), which are able to recruit DNMT1 to these 
loci, ultimately driving maintenance of methylation (Xiajun Li et al. 2008; Quenneville et al. 
2011). 
In human embryos, the major wave of DNA demethylation is completed by the two-cell stage, 
which is surprisingly earlier than what is observed in mouse embryos. However, and consistent 
with the mouse model, the paternal genome demethylates much faster than the maternal 
pronuclei (H. Guo et al. 2014). Nevertheless, the mechanistic insights of how differential DNA 
methylation is regulated between the two parental genomes at this stage remains unknown. 
1.1.4.2 Chromatin remodeling 
Chromatin refers to the molecular organisation of DNA and proteins in the nucleus of a cell 
(Flemming, 1882). The basic structural unit of the eukaryotic chromatin is the nucleosome 
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(Figure 1.6). Each nucleosome contains eight histone proteins (2 copies of H2A, H2B, H3 and 
H4) and approximately 147 base pairs (bp) of DNA, which, via another histone protein, H1, 
can be packed into different levels of structural organisation (reviewed in D. E. Olins & A. L. 
Olins 2003). Nucleosome composition and histone post-translational modifications (PTMs) 
determine the degree of chromatin compaction, which subsequently influences transcriptional 
activity through alterations in transcriptional factor binding and affinity of enzymatic 
machinery (reviewed in Venkatesh & Workman 2015; Allis & Jenuwein 2016; Lawrence et al. 
2016; Harr et al. 2016) (Figure 1.6). According to the level of compaction, mammalian 
genomes are largely organised in two distinct chromatin states: euchromatin, a state generally 
permissive for gene activation, and heterochromatin, which is largely gene poor and 
transcriptionally silenced (reviewed in Grewal & Elgin 2002). During mammalian MZT, the 
chromatin landscape is highly remodelled via changes in histone PTMs, local chromatin 
accessibility and higher-order genome organisation (Figure 1.7), which together with the 
reprogramming of DNA methylation after fertilisation, set a new epigenetic landscape in the 
early embryo (reviewed in Eckersley-Maslin, Alda-Catalinas & Reik 2018; Jansz & Torres-
Padilla 2019; Ladstatter & Tachibana 2019). 
1.1.4.2.1 Global dynamics of histone post-translational modifications 
In mammals, inactive genes are generally marked by methylation of histone H3 lysine 9 
(H3K9), histone H3 lysine 27 (H3K27) and histone H4 lysine 20 (H4K20), albeit active genes 
are marked with high levels of acetylation and methylation of histone H3 lysine 4 (H3K4), 
histone H3 lysine 36 (H3K36) and histone H3 lysine 79 (H3K79) (reviewed in Kouzarides 
2007) (Figure 1.6). Trimethylation of H3K4 (H3K4me3) is usually found in promoter regions 
whereas trimethylation of H3K36 (H3K36me3) is found in gene bodies of actively transcribed 
genes (Liang et al. 2004). Many genes important for development are termed “poised” because 
they present co-occurrence of the activating H3K4me3 and the repressing trimethylation of 
H3K27 (H3K27me3) marks at their promoters, a feature that is called bivalent chromatin and 
allows rapid gene expression upon lineage specification (Bernstein et al. 2006; Azuara et al. 
2006). Additionally, monomethylation of H3K4 (H3K4me1) and acetylation of H3K27 
(H3K27ac) mark cell type specific enhancers (Rada-Iglesias et al. 2011), while a subset of 
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enhancers has also been found to be marked by acetylation of histone H3 lysine 122 (H3K122 
ac) and lack of H3K27ac (Pradeepa et al. 2016). 
 
Figure 1.6– Chromatin organisation in the mammalian genome 
In mammals, DNA is associated with histone proteins to form chromatin. The basic structural units 
of chromatin are nucleosomes, which can be found into more or less compacted chromatin based on 
DNA and histone post-translational modifications. Chromatin can also organise into higher-order 
structures such as lamina-associated domains (LADs). The transcriptional state of chromatin can be 
inactive (off) or active (on) as determined by DNA methylation and histone post-translational 
modifications, which in turn determine accessibility to DNA binding proteins such as transcription 
factors (TF) and RNA polymerase II (RNAPII). DNA methylation, trimethylation of histone H3 
lysine 9 (H3K9me3) and trimethylation of histone H3 lysine 27 (H3K27me3) are generally associated 
with transcriptional repression, whereas trimethylation of histone H3 lysine 4 (H3K4me3) and 
trimethylation of histone H3 lysine 36 (H3K36me3) are generally associated with active 
transcription. Image adapted from Zhou, Goren & Bernstein 2011.  
1.1 The maternal-to-zygotic transition 23 
 
 
Figure 1.7– Chromatin remodeling during the MZT  
The pattern of different chromatin features from oocytes to two-cell embryos is shown. The 
chromatin marks H3K4me3 (blue), H3K27me3 (purple) and H3K27ac (green) have been profiled by 
Chromatin Immunoprecipitation-sequencing (ChIP-seq). H3K4me3 (blue), a mark associated with 
transcriptional activity, is present in MII oocytes as broad domains, non-overlapping with similarly 
broad domains found for the H3K27me3 mark (purple), associated with transcriptional repression. 
These broad peaks of both H3K4me3 and H3K27me3 are maintained in zygotes and early two-cell 
embryos but disappear after the major wave of ZGA (dashed vertical line). After ZGA, canonical 
peaks of H3K4me3 are established. H3K27me3 is also present in a canonical peak structure in 
oocytes, but these disappear after ZGA. H3K27ac (green), associated with open chromatin, is 
gradually gained after ZGA. The local chromatin structure (pink) has been measured by Assay for 
Transposable Accessible Chromatin followed by sequencing (ATAC-seq) and by DNaseI 
hypersensitivity sequencing (DHS) in several stages after fertilisation, assays that revealed large 
domains of accessible chromatin covering MERVL elements before the major wave of ZGA. From 
the late two-cell embryo, after ZGA, the number of accessible regions increases both at transcription 
start sites (TSS) and at transcription end sites (TES). Higher order chromatin structure has been 
measured by chromatin conformation capture-based (Hi-C) approaches showing compartments and 
topologically associating domains (TADs) disordered in MII oocytes, zygotes and early two-cell 
embryos. After ZGA, compartments are established and subsequently, TADs. Pink dashed lines 
represent disordered or unstructured features and solid pink lines represent established features. n/a: 
data not available. Image from Eckersley-Maslin, Alda-Catalinas & Reik 2018. 
 
While histone PTMs in early mammalian development have traditionally been studied by 
immunofluorescence (reviewed in Burton & Torres-Padilla 2010), the recent development of 
low-input chromatin immunoprecipitation followed by sequencing (ChIP-seq) techniques has 
allowed genome-wide profiling of H3K4me3, H3K27me3 and H3K27ac during mouse MZT 
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and pre-implantation development (Dahl et al. 2016; Xiaoyu Liu et al. 2016; B. Zhang et al. 
2016; Hanna et al. 2018) (Figure 1.7). Additionally, using CUT&RUN technique (Skene & 
Henikoff 2017), H3K4me3 and H3K27me3 has also been profiled in human embryos (Xia et 
al. 2019) 
In mouse MII oocytes, H3K4me3 is present in large blocks spanning more than 10 kilobases 
(kb) that cover approximately 22% of the genome (Figure 1.7), a unique pattern very distinct 
from the sharp peaks typically present at transcription start sites (TSS) in somatic cells (Dahl 
et al. 2016; Xiaoyu Liu et al. 2016; B. Zhang et al. 2016; Hanna et al. 2018). These blocks of 
H3K4me3 are gradually established during oogenesis and anti-correlate with DNA methylation 
(Smallwood et al. 2011; Dahl et al. 2016; B. Zhang et al. 2016; Hanna et al. 2018), in fact, 
depletion of the de novo DNA methyltransferases DNMT3A and DNMT3B showed that DNA 
methylation protects regions from acquiring H3K4me3 blocks (Hanna et al. 2018). 
Interestingly, even though H3K4me3 domains are not broadly associated with gene promoters 
in oocytes, the promoters of genes expressed during the major wave of ZGA are pre-marked 
by H3K4me3 both in oocytes and in sperm (Dahl et al. 2016). Upon fertilisation, these broad 
domains are maintained in the maternal, but not in the paternal, pronucleus of the zygote and 
early two-cell embryos, but from the late two-cell embryo, they are depleted and classical sharp 
peaks are established (Dahl et al. 2016; Xiaoyu Liu et al. 2016; B. Zhang et al. 2016; Lepikhov 
& Walter 2004) (Figure 1.7). These parental-specific differences likely reflect the genome-
wide replacement of sperm-derived protamines with histones upon fertilisation (Nonchev & 
Tsanev 1990). From the late two-cell stage, promoter H3K4me3 correlates with transcription, 
suggesting that H3K4me3 specifies permissive promoters of either recently transcribed genes 
or genes poised for activation (B. Zhang et al. 2016). Concomitant with the loss of H3K4me3 
levels from oocytes to two-cell embryos, H3K27ac increases markedly from the oocyte to the 
eight-cell embryo (Figure 1.7), especially in major ZGA gene TSS-containing domains 
previously marked by the broad H3K4me3 in oocytes (Dahl et al. 2016). Strikingly, in human 
GV and metaphase I (MI) oocytes, H3K4me3 is present in canonical promoter peak patterns 
rather than in broad domains, a landscape that is maintained until the four-cell stage before 
ZGA (Xia et al. 2019). Similar to mouse embryos, approximately half of the promoters marked 
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with H3K4me3 in pre-ZGA stages retain this mark and become activated during ZGA in eight-
cell stage embryos (Xia et al. 2019). 
H3K27me3 is also present as broad domains in mouse MII oocytes (Figure 1.7) in regions 
depleted of transcription, H3K4me3 and DNA methylation (H. Zheng et al. 2016). These broad 
distal domains of H3K27me3 are present in two-cell embryos during ZGA and also in the ICM 
of E3.5 blastocysts (Figure 1.7) and persist until the post-implantation embryo, where they are 
converted to canonical H3K27me3 peaks marking bivalent promoters (Xiaoyu Liu et al. 2016; 
H. Zheng et al. 2016). Overall, bivalent promoters are infrequent and unstable in early embryos 
compared to embryonic stem cells (ESCs) and post-implantation embryos (Xiaoyu Liu et al. 
2016). However, H3K27me3 is also found in oocytes with a canonical peak pattern in 
promoters of Hox genes and other developmentally-relevant genes (H. Zheng et al. 2016) 
(Figure 1.7). There are also promoter-distal H3K27me3 peaks in oocytes that are inherited by 
the zygote (Figure 1.7) whereas promoter-associated peaks at developmental genes disappear 
before major ZGA (H. Zheng et al. 2016). In contrast, most H3K27me3 sperm-derived peaks 
are lost in zygotes following fertilisation (H. Zheng et al. 2016), consistent with 
immunostainings showing H3K27me3 detection in the maternal but not in the paternal 
pronucleus (Burton & Torres-Padilla 2010). De novo paternal-specific H3K27me3 peaks are 
then established in late pre-implantation stages and throughout post-implantation in genes that 
remain silent (H. Zheng et al. 2016). Similarly, in human oocytes, H3K27me3 is present both 
in canonical peak promoters of developmental genes and also in partially-methylated domains, 
but unlike mouse maternal H3K27me3, human embryos at the time of ZGA are nearly depleted 
of this histone mark (Xia et al. 2019). 
As explained above, DNA demethylation mechanisms are drastically different in the maternal 
and paternal genome (see section 1.1.4.1). This might be explained by the different chromatin 
environments of the two pronuclei given by the differences observed in histone variants and 
histone PTMs, including lysine methylation marks in histones H3 and H4 and histone H4 
acetylation (reviewed in Burton & Torres-Padilla 2010; Zhou & Dean 2015). 
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1.1.4.2.2 Local chromatin dynamics 
The chromatin accessibility landscape has also been profiled from mouse zygotes throughout 
pre-implantation using both Assay for Transposable Accessible Chromatin followed by 
sequencing (ATAC-seq) (J. Wu et al. 2016) and DNaseI hypersensitivity (DHS) mapping (F. 
Lu et al. 2016; Inoue et al. 2017) (Figure 1.7).  ATAC-seq relies on the use of a hyperactive 
Tn5 transposase to label open chromatin regions (Buenrostro et al. 2013), whereas DHS 
mapping or DNase-seq identifies open chromatin sites as those sensitive to DNaseI cleavage 
(Crawford et al. 2006). In zygotes, while DHS mapping showed peaks mostly located at gene 
promoters (F. Lu et al. 2016; Inoue et al. 2017), ATAC-seq revealed a weak and noisy profile 
where large domains of open chromatin were covering genes expressed during the minor wave 
of ZGA, including MERVL elements (J. Wu et al. 2016) (Figure 1.7), consistent with the 
pervasive transcription observed at this stage (see section 1.1.3.1). Following major ZGA, at 
the late two-cell stage, ATAC-seq showed peaks of accessible chromatin at TSSs and 
transcription end sites (TES) (J. Wu et al. 2016), the functional relevance of which is unclear. 
After the MZT is completed, from the eight-cell stage onwards, the overall landscape of 
chromatin becomes more accessible (J. Wu et al. 2016), with a drastic increase of DHS peaks 
gained at the eight-cell stage (Figure 1.7) at promoters, intragenic and intergenetic regions (F. 
Lu et al. 2016). This increase in chromatin accessibility correlates with an increase in 
transcriptional activity (F. Lu et al. 2016), however, accessible promoters are also found in 
inactive genes that become activated at later developmental stages, suggesting these promoters 
are primed for activation (F. Lu et al. 2016). Similarly, in human embryos, promoter 
accessibility correlates with major ZGA and, overall, there is a global increase in accessible 
regions during cleavage stages (L. Gao et al. 2018; Lin Li et al. 2018). 
Marked differences have been found in chromatin accessibility between the paternal and the 
maternal genome. After fertilisation, the paternal genome experiences the most extensive 
reprogramming since the highly packaged chromatin in protamines of the sperm needs to be 
replaced with maternal histones (Nonchev & Tsanev 1990; van der Heijden et al. 2005; Torres-
Padilla et al. 2006). Despite this exchange and the drastic differences in the DNA methylation 
and histone PTMs landscapes between the two pronuclei after fertilisation (see sections 1.1.4.1 
and 1.1.4.2.1), the local chromatin structure, as analysed by DHS mapping, does not present 
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major differences between the paternal and maternal genome (F. Lu et al. 2016). Interestingly 
though, DHS parental-specific peaks have been found to be priming genes in the zygote that 
are later on allelically expressed at the time of major ZGA (Inoue et al. 2017). Furthermore, 
paternal-specific DHS-marked genes have been found to be marked with H3K27me3 in the 
corresponding maternal allele in zygotes (Inoue et al. 2017). Later on, after the two-cell stage, 
the DHS profiles are similar between parental alleles, except imprinted genes that present a 
differential chromatin accessibility profile before becoming expressed (F. Lu et al. 2016). On 
the contrary, in human embryos, the chromatin accessibility, as measured by the single-cell 
multi-omics approach “chromatin overall omic-scale landscape sequencing” (scCOOL-seq) is 
higher in the paternal than in the maternal genome from mid-zygotic stages to the four-cell 
stage (Lin Li et al. 2018), likely reflecting a paternal-specific minor wave of ZGA. 
1.1.4.2.3 High-order chromatin architecture 
Traditionally, nuclear sub-structures, such as the nucleolus, nuclear envelope and lamina, 
promyelocytic leukemia and Cajal bodies, nuclear speckles, euchromatin and heterochromatin, 
and chromosome territories have been studied with microscopy-based techniques in pre-
implantation mouse embryos (reviewed in Borsos & Torres-Padilla 2016). A marked difference 
in early embryos compared to somatic cells is the organisation of major satellite repeats, which 
comprise pericentromeric heterochromatin, around nucleolar precursor bodies (NPBs) (Probst 
et al. 2007), whose localisation is critical for the establishment of repressive heterochromatin 
and further development (Jachowicz et al. 2013). Of special interest as well is the recent 
development of high-resolution maps of genomic interactions with the nuclear lamina (Borsos 
et al. 2019), a fibrillar network in the inner nuclear membrane (Figure 1.6), using the DNA 
adenine methyltransferase identification (DamID) technique (van Steensel et al. 2001). These 
maps revealed that lamina-associated domains (LADs) are not inherited from the oocyte but 
rather established de novo after fertilisation in a parental-specific and DNA replication-
independent manner, with fewer genome-nuclear lamina contacts in the maternal than in the 
paternal genome at the zygote stage (Borsos et al. 2019). Interestingly, ectopic expression of 
the lysine-specific demethylase 5B (KDM5B, also known as JARID1B or PLU-1), which 
demethylates H3K4, inhibited paternal LAD formation in zygotes, suggesting that LAD 
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establishment may be dependent on H3K4me3 remodeling. LADs AT content changes 
substantially from zygotes to two-cell embryos (Borsos et al. 2019), possibly as a result of 
major genome reorganisation at the time of ZGA. At this stage, maternal genome-nuclear 
lamina contacts are reinforced whereas paternal genome-nuclear lamina contacts are 
rearranged (Borsos et al. 2019). After the eight-cell stage, parental-specific differences 
disappear and LADs become more strongly associated with reduced chromatin accessibility 
sites (Borsos et al. 2019). 
Recent advances in low-input chromatin conformation captured-based (Hi-C) techniques have 
allowed the development of multi-hierarchical chromatin structure maps in early mouse 
embryos, describing the remodeling and establishment of loops, topologically associating 
domains (TADs) and compartments during the MZT (Du et al. 2017; Flyamer et al. 2017; 
Gassler et al. 2017; Ke et al. 2017). Loops are three-dimensional (3D) structures formed by 
close contact of two distal genomic regions. TADs refer to regions of approximately 400-500 
kilobase (kb) in length that present high contact frequency and contain loci that are more likely 
to interact with each other than across TAD boundaries. TADs further organize into spatially 
segregated regions of approximately 5 mega-bases termed A and B compartments that 
correspond, respectively, to transcriptionally active and inactive regions in the genome 
(reviewed in Dekker et al. 2013; Bonev & Cavalli 2016). Oocyte maturation involves a 
transition from active to inactive transcription (Clegg & Piko 1983; De Leon et al. 1983), which 
is coupled with considerable chromatin rearrangements and condensation from a non-
surrounded nucleolus to a surrounded nucleolus morphology in GV oocytes, contributing to 
the acquisition of developmental competence (Zuccotti et al. 1995). Single-nucleus Hi-C 
revealed a decline in the strength of TADs and compartments during this transition (Flyamer 
et al. 2017). In MII oocytes, TADs and compartments were not detected (Ke et al. 2017; Du et 
al. 2017) (Figure 1.7). TADs and loops start being established after fertilisation in the zygote, 
although with weak strength (Flyamer et al. 2017; Gassler et al. 2017) (Figure 1.7). Following 
the major wave of ZGA in the late two-cell embryo, TADs become more pronounced and 
insulation around TAD boundaries is already detected but only clearly defined from the eight-
cell stage onwards (Du et al. 2017; Gassler et al. 2017; Ke et al. 2017) (Figure 1.7), suggesting 
a gradual shift towards a somatic-like chromatin state. This reinforcement of TADs and TAD 
1.1 The maternal-to-zygotic transition 29 
 
boundaries after ZGA has been proposed to be regulated by MERVL expression (Kruse et al. 
2019). Consistently, HERVL elements also shape TADs in human ESCs (Yanxiao Zhang et al. 
2019). Interestingly, genome-nuclear lamina interactions precede TAD establishment in the 
zygote (Borsos et al. 2019), indicating that LADs arrangement may direct higher-order 
chromatin topology. A and B compartments are weak and disorganised in zygotes and early 
two-cell embryos (Du et al. 2017; Flyamer et al. 2017; Gassler et al. 2017; Ke et al. 2017) and 
only detected after ZGA through to the formation of the ICM (Du et al. 2017) (Figure 1.7). 
After fertilisation, the chromatin of the two parental genomes is structurally distinct. The 
compartment strength in the maternal genome is weaker than in the paternal genome (Du et al. 
2017; Flyamer et al. 2017; Ke et al. 2017), consistent with the respective organisation seen in 
mature gametes, since sperm has a very structured chromatin organisation with high frequency 
of extra-long-range and inter-chromosome interactions (Ke et al. 2017; Jung et al. 2017). 
Interestingly though, TADs and loop strengths are similar between the two pronuclei (Du et al. 
2017; Flyamer et al. 2017; Gassler et al. 2017; Ke et al. 2017) but fewer distal interactions are 
found in the paternal genome (Du et al. 2017). This allelic differences in TAD formation are 
regulated by cohesin and associated proteins (Gassler et al. 2017).  
1.1.5 Interplay between epigenetic remodeling and transcriptional 
activation during the maternal-to-zygotic transition 
All these recent transcriptional and epigenetic maps of oocytes and early embryos have shed 
light into the events occurring during the MZT. However, a consensus model of the functional 
relationships and temporal coupling between DNA demethylation, chromatin remodeling and 
transcriptional changes has not been established yet. For example, MERVL elements are one 
of the first transcripts expressed in embryos (Kigami 2002; Peaston et al. 2004; Svoboda et al. 
2004; Macfarlan et al. 2012) and they also become hypomethylated following fertilisation (L. 
Wang et al. 2014). LINE-1, MERVL and SINE B2 elements, expressed at the time of major 
ZGA, show an open chromatin accessibility state and are strongly enriched in H3K4me3 at this 
developmental time point (Percharde et al. 2018; J. Wu et al. 2016). In fact, overall, 
transposable elements are present in accessible distal regions of mouse two-cell embryos and 
marked by H3K27ac (J. Wu et al. 2016), and, in early human embryos, SVA and HERV-K 
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transposons harbor distal DHS sites and are highly expressed (L. Gao et al. 2018; J. Wu et al. 
2018). These data suggests that transposable elements may function not only as alternative 
promoters during ZGA (Peaston et al. 2004) but also as enhancer elements over long distances. 
Additionally, even though promoter chromatin accessibility is normally correlated with gene 
expression, accessible promoters are also found in inactive genes that become activated at later 
developmental stages, indicating these promoters are primed for activation and suggesting 
chromatin remodeling precedes ZGA (F. Lu et al. 2016) 
These observations illustrate that whether transcriptional activity helps chromatin and DNA 
demethylation reprogramming or it is a consequence of these epigenetic changes remains 
unclear. Several studies using a combination of chemical inhibitors and gene depletion 
strategies have aimed to uncover such hierarchy of events. Treating zygotes or two-cell 
embryos with a-amanitin blocks transcription and results in developmental arrest, however, it 
does not prevent H3K27me3 remodeling in both parental genomes or TAD formation (H. 
Zheng et al. 2016; Ke et al. 2017; Du et al. 2017), indicating that chromatin reorganisation does 
not require ZGA. On the other hand, knock-down of the lysine-specific demehylases 5A and 
5B (KDM5A and KDM5B), responsible for remodeling the broad H3K4me3 domains, resulted 
in downregulation of many ZGA genes (Dahl et al. 2016). Consistently, loss of H3K4me3 
results in reduced paternal pronuclear ZGA (Aoshima et al. 2015) and histone hyperacetylation 
by trapoxin treatment enhances transcription in 2-cell embryos (Aoki et al. 1997), suggesting 
that chromatin changes influence transcriptional activation. However, blocking transcription in 
late zygotes or early 2-cell embryos impedes removal of the broad H3K4me3 domains and 
establishment of canonical H3K4me3 peaks (B. Zhang et al. 2016) and it also reduces 
chromatin accessibility and nucleosome-depleted regions at the time of ZGA (J. Wu et al. 2016; 
F. Guo et al. 2017), suggesting local chromatin changes require transcriptional activity. 
Moreover, TET3 KO or knock-down embryos undergo zygotic transcription (Inoue et al. 2012; 
Peat et al. 2014; Shen et al. 2014) at an increased rate (Tsukada et al. 2015), and the genes that 
are normally demethylated in the paternal pronucleus and then transcribed in two-cell embryos 
are independent on TET3-mediated demethylation (Peat et al. 2014). 
Altogether, these experiments show that the epigenetic and transcriptional changes during the 
MZT are closely interconnected, but the exact functional interdependencies require further 
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investigation. Identifying the epigenetic and transcriptional regulators of this developmental 
transition and their mechanism of action can help towards the understanding of the precise 
relationships between DNA demethylation, chromatin remodeling and transcriptional 
activation, and this is, precisely, the aim of my dissertation. 
1.1.6 Maternal regulators of the maternal-to-zygotic transition 
The extensive chromatin remodeling and transcriptional changes that occur after fertilisation 
and during early embryogenesis need to be tightly regulated to ensure a correct developmental 
progression. Maternal effect genes (MEGs) are defined as genes whose function is essential for 
embryonic development and whose disruption in the oocyte before fertilisation causes 
developmental defects in the embryo (reviewed in K.-H. Kim & K.-A. Lee 2014; Lei Li et al. 
2010). A number of them have been described in mice to date, including proteins from the 
subcortical maternal complex (Tong et al. 2000; Esposito et al. 2007; Yurttas et al. 2008; Lei 
Li et al. 2008; P. Zheng & Dean 2009; Tashiro et al. 2010; X.-J. Yu et al. 2014; Mahadevan et 
al. 2017); proteases such as GRANZYME G (Tsai et al. 2010); structural molecules such as b-
CATENIN (de Vries et al. 2004) or FORMIN 2 (Leader et al. 2002); ubiquitylation-related 
enzymes (Roest et al. 2004; Sekiguchi et al. 2006; C. Yu et al. 2013; Mtango et al. 2012; 
Maenohara et al. 2017); cell cycle regulators such as CYCLIN A2 (Hara et al. 2005); DNA 
damage repair proteins such as the mismatch repair endonuclease PSM2 (Gurtu et al. 2002), 
breast carcinoma amplified sequence 2 (BCAS2) (Q. Xu et al. 2015) or RAD9 checkpoint 
clamp component A (RAD9A) (L. Huang et al. 2019); pluripotency factors such as POU5F1 
(Foygel et al. 2008) or SOX2 (Pan & Schultz 2011); autophagy-related proteins such as ATG5 
(TSUKAMOTO et al. 2008) or DDB1-cullin-4-associated factors 2 and 13 (DCAF2 and 
DCAF13) (Y.-W. Xu et al. 2017; Yang Liu et al. 2019); methionine adenosyltransferase such 
as MAT2A (Sun et al. 2018); and proteins involved in post-transcriptional mRNA stability and 
degradation (Lykke-Andersen et al. 2008; Murchison et al. 2007; Tang et al. 2007; J. Chen et 
al. 2011; Sousa Martins et al. 2016; Mak et al. 2018; K. Lin et al. 2018).  
Several of these MEGs have been directly implicated in essential processes of the MZT, such 
as maternal transcript degradation and ZGA (reviewed in Lei Li et al. 2010; Eckersley-Maslin, 
Alda-Catalinas & Reik 2018; Vastenhouw et al. 2019). However, a vast majority of the MEGs 
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with direct roles in ZGA are epigenetic and transcription factors (reviewed in Eckersley-
Maslin, Alda-Catalinas & Reik 2018), which are the subject of study of this dissertation and, 
therefore, I review them in detail in the following sections. 
1.1.6.1 DNA methylation machinery 
In mouse embryos, many of the DNA methylation machinery enzymes are MEGs, consistent 
with the global loss of DNA methylation that occurs after fertilisation (see section 1.1.4.1) 
(reviewed in K.-H. Kim & K.-A. Lee 2014). These include the oocyte-specific isoform of 
DNMT1 (DNMT1o) (Howell et al. 2001), UHRF1 (Sharif et al. 2007; Maenohara et al. 2017), 
DNMT3A (Okano et al. 1999; Kaneda et al. 2004), DNMT3B (Okano et al. 1999), DNMT3L 
(Bourc'his et al. 2001), TET3 (T.-P. Gu et al. 2011) and GSE (Hatanaka et al. 2013).  
Maternal conditional KO embryos of Dnmt1o and zygotic KO embryos of Dnmt1 die during 
post-implantation stages due to defects in imprinting maintenance (E Li et al. 1992; Howell et 
al. 2001). The effect of maternal conditional KO of Uhrf1 is more pronounced and, although 
oocytes present a normal phenotype, the majority of derived embryos die before the blastocyst 
stage with reduced levels of DNA methylation, particularly at the imprinting control regions 
(Maenohara et al. 2017). In contrast, zygotic KO embryos of Uhrf1 exhibit similar 
developmental arrest and gestational lethality to Dnmt1 KO embryos (Sharif et al. 2007), 
highlighting the importance of the maternal pools of UHRF1 to early embryogenesis. While 
zygotic Dnmt3a KO embryos survive to birth although with prominent developmental defects 
that result in their death a few weeks after (Okano et al. 1999), embryos derived from 
conditional maternal KO females die in utero and lack methylation and allele-specific 
expression at maternally imprinted loci (Kaneda et al. 2004). This phenotype of conditional 
Dnmt3a KO embryos is almost indistinguishable from that of Dnmt3l zygotic KO embryos 
(Bourc'his et al. 2001). The zygotic KO of Dnmt3b leads to demethylation at pericentric 
satellite DNA and severe developmental phenotypes which result in embryonic lethality from 
mid-gestation (Okano et al. 1999). Maternal conditional KO females for Tet3 present reduced 
fecundity and their offspring show significantly compromised development (T.-P. Gu et al. 
2011; Shen et al 2014; Inoue et al. 2015). Lastly, antisense RNA knock-down of GSE in 
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oocytes does not affect early developmental progression but derived embryos present notorious 
impairments in active DNA demethylation in the paternal pronucleus (Hatanaka et al. 2013). 
Altogether, these studies reflect that maternal mutations in DNA methylation machinery 
enzymes typically cause defects at late post-implantation stages, predominantly due to 
imprinting misregulation, and do not normally impede ZGA, therefore suggesting that 
transcription in early embryos can occur even when DNA methylation is misregulated. 
1.1.6.2 Chromatin remodellers 
Eukaryotic chromatin can be remodelled by factors that use ATP hydrolysis to enhance 
nucleosome accessibility (reviewed in Vignali et al. 2000). This family of chromatin 
remodelers can be subdivided into three groups based on their biochemical properties and 
sequence similarity of their catalytic ATPase subunits: the SWItch/Sucrose Non-fermentable 
nucleosome remodeling (SWI/SNF) complex, the Imitation SWI (ISWI) complex and the Mi-
2 nucleosome remodeling deacetylase (Mi-2/NuRD) complex (Boyer et al. 2000). One of the 
first epigenetic modifiers identified in mice as MEG and shown to activate zygotic transcription 
at the two-cell stage is one of the ATPase subunits of the SWI/SNF complex, namely SWI/SNF 
related, matrix associated, active dependent regulator of chromatin, subfamily A, member 4 
(SMARCA4, also known as BRG1) (Bultman et al. 2006). Despite normal germ-cell 
development and fertilisation, oocyte-conditional deletions lead to embryonic arrest at the two-
cell stage and impaired ZGA (Bultman et al. 2006). Interestingly, maternal mutation of the 
SMARCA4-interacting partner dual bromodomain and WD repeat domain containing 1 
(BRWD1) results in meiotic maturation defects, and in vitro fertilisation (IVF) of oocytes that 
are able to reach the MII stage leads to developmental arrest at the pronuclear stage in zygotes 
(Philipps et al. 2008). These studies suggest that SMARCA4 and BRWD1 act together to 
regulate the MZT and highlight the importance of chromatin remodeling for efficient 
reprogramming to totipotency after fertilisation. Recently, the role of SMARCA4 during the 
MZT has also been linked to the transcriptional co-activator mediator complex 13 (MED13), 
whose zygotic knock-down or conditional maternal KO induces ZGA defects (Miao et al. 
2018). The catalytic subunit of the ISWI complex, SMARCA5, has also been implicated in the 
regulation of early embryogenesis since both zygotic RNAi knock-down and KO lead to pre-
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implantation developmental defects due to cell arrest in both the ICM and the trophectoderm 
(Stopka & Skoultchi 2011; Torres-Padilla & Zernicka-Goetz 2006), possibly due to ZGA 
impairments since it localises to sites of active transcription in early embryos (Torres-Padilla 
& Zernicka-Goetz 2006).  
The polycomb group proteins are evolutionally conserved chromatin-modifying factors which 
canonically catalyse H3K27me3 and are critical regulators of gene expression 
(Schuettengruber et al. 2017). The polycomb repressive complexes 1 and 2 (PRC1 and PRC2) 
have roles during mouse MZT (Posfai et al. 2012; Erhardt et al. 2003). Interestingly, despite 
the canonical repressive function of polycomb complexes, Ring1/Rnf2 (members of PRC1) 
conditional KO oocytes show defects in meiotic maturation, and derived embryos do not 
develop beyond the two-cell stage due to defective replication and ZGA (Posfai et al. 2012). 
Maternal conditional deletion of the enhancer of zeste homolog 2 (EZH2), a component of 
PRC2, disrupts histone H3 methylation in the early zygote and causes severe growth retardation 
of neonates (Erhardt et al. 2003). This late phenotype of Ezh2-maternal deficient embryos is 
likely due to embryonic rescue from the paternal allele from the four-cell stage, as complete 
Ezh2-null mice show early embryonic lethality  (O’Carroll et al. 2001). 
Another factor that extensively remodels the chromatin landscape in early embryos is the 
chaperone nucleoplasmin 2 (NPM2), whose deletion causes female infertility due to loss of 
heterochromatin and deacetylated histone H3 around nucleoli in oocytes and early embryos, 
leading to pre-implantation developmental arrest (Burns et al. 2003; La Fuente et al. 2004). 
The CCCTC-binding factor (CTCF) is key in the 3D organisation of the nuclear space 
(reviewed in Ong & Corces 2014) and, consistent with the major high-order genome 
reorganisation that occurs upon fertilisation (see section 1.1.4.2.3), maternal depletion of CTCF 
via RNAi knock-down causes meiotic defects in oocytes and mitotic defects in derived 
embryos that are accompanied by transcriptional activation defects during ZGA (Wan et al. 
2008). Lastly, ectopic expression of the uncharacterised protein zygote arrest 1-like (ZAR1L) 
leads to two-cell-stage arrest, likely due to abnormal levels of H3K4me2/3 and H3K9me2/3 
and downregulation of other chromatin modifiers (Hu et al. 2010), consistent with the MEG 
role of its closely related factor ZAR1 (Xuemei Wu et al. 2003). 
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1.1.6.3 Histone-modifying enzymes 
In recent years, the key role of a number of histone-modifying enzymes during the MZT has 
been uncovered (reviewed in Eckersley-Maslin, Alda-Catalinas & Reik 2018) (Figure 1.8). 
This is in fact not surprising given the extensive remodeling of histone PTMs (see section 
1.1.4.2.2).  
In oocytes, the lysine-lysine N-methyltransferase 2B (KMT2B, also known as MLL2) is the 
enzyme responsible for the establishment of the broad H3K4me3 domains during oogenesis 
(Hanna et al. 2018) and is necessary for proper ZGA (Andreu-Vieyra et al. 2010; Dahl et al. 
2016) (Figure 1.8). KMT2C and KMT2D (also known as MLL3 and MLL4, respectively) were 
discovered as ZGA regulators through a screen of histone lysine-to-methionine (K-M) mutants 
essential for early embryonic development (Aoshima et al. 2015). Overexpression of H3.3 
K4M and K36M mutants in MII oocytes resulted in decreased embryo survival to the blastocyst 
stage, whereas overexpression of these mutants in zygotes did not interfere with development, 
suggesting essential remodeling of these histone PTMs during the MZT. These defects are 
likely due to a decrease in transcription at later pronuclear stages in H3.3 K4M mutants, as 
shown by EU incorporation assays, indicating that remodeling of H3K4 methylation is 
necessary for minor ZGA (Aoshima et al. 2015). Consistently, knock-down of 
KMT2C/KMT2D in GV oocytes, but not in fertilised zygotes, phenocopied overexpression of 
H3.3 K4M mutants and resulted in decreased levels of H3K4me1 and H3K27ac (Figure 1.8), 
together with reduced transcription in the paternal pronucleus during the minor wave of ZGA 
(Aoshima et al. 2015). Regarding the phenotype of K36M mutants, the H3K36me3 
methyltransferase enzyme SET domain containing 2 (SETD2) is a crucial regulator of the 
oocyte epigenome and its maternal deficiency results in loss of H3K36me3, failure to establish 
the correct DNA methylome, invasion of H3K4me3 and H3K27me3 into H3K36me3 regions, 
aberrant deposit of H3K4me3 at imprinting control regions and one-cell stage developmental 
arrest in derived embryos (Q. Xu et al. 2019). The role of SETD2 is likely regulated by the 
mRNA processing and export factor IWS1 that interacts with the histone H3/H4 chaperone and 
transcription elongation factor SUPT6 to recruit SETD2 via the AKT signalling pathway 
(Oqani et al. 2019). Accordingly, knock-down of both ISWI and SUPT6 in zygotes arrests 
embryos at the two-cell stage and leads to aberrant H3K36me3 at the time of ZGA (Oqani et 
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al. 2019). Recently, another H3K4 methyltransferase, the histone-lysine N-methyltransferase 
SETD1B, was reported to regulate oogenesis and early epigenetic reprogramming in the 
embryo, although at earlier stages than KMT2C and KMT2D (Brici et al. 2017) (Figure 1.8). 
 
Figure 1.8– Regulation of the MZT by histone-modifying enzymes  
Histone-lysine N-methyltransferase 2B (KMT2B) establishes the broad histone H3K4me3 domains 
in MII oocytes, which are subsequently removed by the lysine-specific demethylase 5A (KDM5A; 
also known as JARID1A) and KDM5B (also known as JARID1B) in two-cell embryos, leading to 
the formation of the canonical peaks of H3K4me3 distribution. SET domain containing 1B 
(SETD1B) also catalyses H3K4me3 in MII oocytes, but there is no experimental evidence that it 
establishes the broad H3K4me3 domains (dashed arrow). The methyltransferase SETDB1 catalyses 
H3K9me2 and H3K9me3 deposition in MII oocytes. H3K9me3 is removed by the H3K4me3-specific 
and H3K9me3-specific demethylase KDM1A (also known as LSD1). In zygotes, KMT5C catalyses 
H4K20me3 at the maternal pronucleus; in the paternal pronucleus, KMT2C and KMT2D catalyse 
the H3K4me1 and support acetylation of H3K27ac enrichment. Methyltransferase-like 23 
(METTL23) catalyses the asymmetric dimethylation of histone H3 arginine 17 (H3R17me2a) and 
has a role in active DNA demethylation of the paternal pronucleus by recruiting the gonad-specific 
expression gene–ten-eleven translocation 3 (GSE–TET3) complex. Colours represent the role of the 
enzyme: yellow represents a role of transcription during oocyte development; green represents a role 
of transcription during minor ZGA; blue represents a role of transcription during major ZGA; and 
pink represents DNA (de)methylation proteins. Image and legend adapted from Eckersley-Maslin, 
Alda-Catalinas & Reik 2018. 
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This was observed via depletion of maternal stores of SETD1B that led to female infertility 
due to oocyte transcriptional misregulation, zona pellucida irregularities, meiotic defects and 
fertilisation impairments with polyspermy and one-cell stage arrest (Brici et al. 2017). This 
phenotype suggests that SETD1B might be involved in establishing and/or remodeling the 
broad H3K4me3 domains together with KMT2B (Figure 1.8), but further functional studies are 
required to confirm this hypothesis. 
Following fertilisation, histone methyltransferases also play a critical role during the 
protamine-histone exchange of the paternal pronucleus and during heterochromatin formation. 
The enzyme methyltransferase-like 23 (METTL23) catalyses asymmetric dimethylation of 
histone H3 arginine 17 (H3R17me2a), a histone modification that together with the histone cell 
cycle regulator (HIRA) has been shown to be critical for incorporation of the histone variant 
H3.3 in the male pronucleus after fertilisation (Santenard et al. 2010; Akiyama et al. 2011; 
Inoue & Yi Zhang 2014; C.-J. Lin et al. 2014; Nashun et al. 2015; Hatanaka et al. 2017). 
Furthermore, METTL23 also acts during the wave of active DNA methylation of the paternal 
pronucleus by recruiting the GSE-TET3 complex (Hatanaka et al. 2017) (Figure 1.8). 
Regarding heterochromatin formation, the constitutive heterochromatin mark H4K20me3 is 
specifically found after fertilisation in the maternal pronucleus, localizing around the ring-like 
structures of NPBs (Probst et al. 2007; Wongtawan et al. 2011), and it is catalysed by KMT5C 
(also known as SUV420H2) (Figure 1.8), amongst other enzymes. Accordingly, 
overexpression of KMT5C in zygotes increases H4K20me3 accumulation in the maternal 
pronucleus and reduces transcriptional activity during ZGA, leading to developmental arrest at 
the one- to two-cell stages (Eid et al. 2016). H3K9 methylation silences transposable elements 
in pericentric repeats (Bannister et al. 2001) and is specifically enriched in the maternal 
pronucleus (Santos et al. 2005; Hajkova et al. 2010; Nakamura et al. 2012). Maternal KO of 
the methyltransferase Setdb1, which catalyses H3K9me2/3 (Figure 1.8) and protects the 
maternal pronucleus from active DNA demethylation (T.-B. Zeng et al. 2019), induces meiotic 
impairments, DNA damage, derepression of retrotransposons and degeneration of derived 
embryos before the morula stage (J. Kim et al. 2016). Similarly, maternal deletion of EHMT2 
(also known as G9a), which together with SETDB1 is also responsible for the H3K9me2 
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asymmetry between pronuclei after fertilisation (T.-B. Zeng et al. 2019), reduces the 
developmental rate to blastocysts (Au Yeung et al. 2019). 
Histone demethylases are also crucial in remodeling histone PTMs during the MZT. The 
lysine-specific demethylases responsible for removing the broad H3K4me3 domains 
established in oocytes and remodel them to a canonical peak structure after fertilisation are 
KDM5A and KDM5B (also known as JARID1A and JARID1B, respectively) (Dahl et al. 2016; 
Xiaoyu Liu et al. 2016; B. Zhang et al. 2016) (Figure 1.8). Consequently, ectopic expression 
of KDM5B, but not KDM5A, leads to reduced levels of H3K4me3 and reactivation of 
transcription in surrounded nucleolus GV oocytes (B. Zhang et al. 2016), whereas KDM5A 
and KDM5B morpholino-mediated knock-down in zygotes downregulates the expression of 
many major ZGA genes at the two-cell stage and impairs pre-implantation development (Dahl 
et al. 2016; B. Zhang et al. 2016), likely due to failure to remodel the broad H3K4me3 domains. 
Therefore, KDM5A and KDM5B have a role both in oocyte transcription and ZGA (Figure 
1.8). Another lysine demethylase critical for ZGA is KDM1A (also known as LSD1), whose 
depletion in maternal stores arrests derived embryos at the one- to two-cell stages (Ancelin et 
al. 2016; Wasson et al. 2016). This demethylase acts on H3K4me3 and H3K9me3 (Figure 1.8) 
and, in agreement, two-cell embryos derived from KDM1A maternal mutants show increased 
levels of these histone PTMs, increased amounts of maternal transcripts and LINE-1 elements 
and fail to undergo ZGA (Ancelin et al. 2016; Wasson et al. 2016). This phenotype suggests 
that KDM1A helps remodeling the broad H3K4me3 domains and H3K9me3 upon fertilisation 
(Figure 1.8).  
The repressive histone modification H3K27me3 is regulated by the H3K27me2/3-specific 
demethylases KDM6A and KDM6B (also known as UTX and JMJD3, respectively), whose 
functions are contrasting during pre-implantation development (L. Yang et al. 2016). For 
example, KDM6B knock-down in MII oocytes improves the developmental efficiency of 
parthenogenetic embryos, whereas KDM6A knock-down compromises development to the 
blastocyst stage; double maternal knock-down of KDM6A and KDM6B significantly reduces 
developmental rates (L. Yang et al. 2016). Consistent with these observations, ectopic 
expression of KDM6A improves the efficiency of somatic cell nuclear transfer (SCNT) 
whereas knock-down of KDM6B facilitates ZGA in these embryos, as measured with a 
1.1 The maternal-to-zygotic transition 39 
 
MERVL reporter (L. Yang et al. 2018). These studies suggest that KDM6A and KDM6B 
demethylases are tightly regulated to remodel H3K27me3 during the MZT, although the exact 
mechanism of action remains unknown.  
1.1.6.4 Transcription factors and DNA binding proteins 
During ZGA, a number of maternal transcription factors bind gene promoters and activate 
transcription in the zygote and two-cell embryo. Amongst the first identified is the transcription 
intermediary factor 1a (TIF1a), that translocates to the nucleus during mid-to-late pronuclear 
stages in the zygote and localises with other maternal chromatin remodellers, such as 
SMARCA4 and SMARCA5, to regulate RNA polymerase II localisation and transcription in 
the zygote, as shown by staining of 5-bromouridine-5′-triphosphate incorporation (Torres-
Padilla & Zernicka-Goetz 2006).  
Another recently discovered critical regulator is the nuclear transcription factor Y subunit-a 
(NFYA), that was identified via motif enrichment analysis of open DHS sites in two-cell 
embryos (F. Lu et al. 2016) and its role is conserved in zebrafish (Stanney et al. 2019). NFYA 
partly contributes to ZGA given that knock-down in GV oocytes leads to downregulation of 
approximately 15% of two-cell activated genes in derived embryos, as measured by RNA-
sequencing, but also results in embryonic arrest at the morula stage and reduced chromatin 
openness at gene promoters in two-cell embryos (F. Lu et al. 2016).  
STELLA is a key regulator of the oocyte DNA methylation landscape and it protects against 
active DNA demethylation in the maternal pronucleus after fertilisation (Hajkova et al. 2010; 
Nakamura et al. 2012; Y. Li et al. 2018). Interestingly, several studies also show its role as a 
MEG (Payer et al. 2003; Bortvin et al. 2004) by regulating chromatin remodeling and major 
ZGA (Arakawa et al. 2015; Y. Huang et al. 2017; Y. Li et al. 2018). Stella-null oocytes show 
excessive levels of DNA methylation genome-wide, which is inherited by the zygote and 
maintained in two-cell embryos (Y. Li et al. 2018). Additionally, Stella-/- embryos show 
impaired chromocenter formation due to failure to undergo reverse transcription of major 
satellites and H3.3 incorporation (Arakawa et al. 2015). In fact, death-associated protein 6 
(DAXX), responsible for H3.3 incorporation in pericentromeric regions, is reduced in Stella-/- 
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zygotes causing these defects, as demonstrated by rescue experiments (Arakawa et al. 2015). 
Recent single-cell and single-embryo RNA-sequencing studies suggest that this phenotype is 
linked to failure to transcribe ZGA genes, including MERVL elements, and to downregulate 
maternal transcripts (Y. Huang et al. 2017; Y. Li et al. 2018).  
Highlighting the importance of tight regulation of degradation of maternal transcripts 
concomitantly with ZGA was the recent discovery of the transcriptional co-activator yes-
associated protein 1 (YAP1) as a critical regulator of the MZT (C. Yu, Ji, Dang, et al. 2016). 
YAP1 protein accumulates in oocytes and contributes to the degradation of up to approximately 
80% of maternal transcripts and to the activation of around 700 ZGA genes (C. Yu, Ji, Dang, 
et al. 2016). Consequently, depletion of maternal stores leads to a prolonged two- to four-cell 
stage transition and reduced pre-implantation developmental rates (C. Yu, Ji, Dang, et al. 
2016). 
The homologs Dux (mouse) and DUX4 (human) multicopy retrogenes encode double-
homeodomain proteins and are conserved throughout placental mammals (Leidenroth et al. 
2012). Three companion studies recently uncovered a role for DUX/DUX4 during ZGA in both 
species (De Iaco et al. 2017; Hendrickson et al. 2017; Whiddon et al. 2017). Dux/Dux4 
transcripts are detected at the onset of zygotic transcription (De Iaco et al. 2017; Hendrickson 
et al. 2017) (Figure 1.9) and their identification came through two different observations: 1) 
DUX4/DUX activates an early embryonic two-cell-like gene signature in human 
facioscapulohumeral muscular dystrophy cells (FSHD) and in mouse myoblast, respectively 
(De Iaco et al. 2017; Hendrickson et al. 2017; Whiddon et al. 2017) (Figure 1.9); and 2) motif 
analysis of cleavage-stage specific genes, as defined from transcriptome analysis of human 
oocytes and pre-implantation embryos, showed enrichment of DUX4 motif binding in the TSS 
(Hendrickson et al. 2017). Furthermore, in mouse and human ESCs, DUX induces activation 
of ZGA-like transcripts and retrotransposons, including MERVL elements (De Iaco et al. 2017; 
Hendrickson et al. 2017) (Figure 1.9). ChIP-seq analysis showed that up to 20% of DUX-
induced genes and ∼50% of MERVL elements are directly bound by DUX (Hendrickson et al. 
2017). Strikingly, DUX is a potent inductor of the rare two-cell-like (2C-like) subpopulation 
within mouse ESCs (mESCs) (see section 1.2), as analysed using a MERVL LTR reporter (De 
Iaco et al. 2017; Hendrickson et al. 2017) (Figure 1.9). Additionally, transcriptional analysis in 
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two-cell embryos showed that absence of zygotic DUX leads to failure to activate ZGA-
specific targets, including MERVL elements (De Iaco et al. 2017).  
 
Figure 1.9– DUX/DUX4 as a regulator ZGA  
DUX/DUX4 is a multicopy retrogene, conserved in human and mouse, that regulates ZGA or 
embryonic genome activation (EGA) at the two-cell stage in mouse and at the four-cell stage in 
human. It is first expressed in the zygote or one-cell embryo, where it binds to promoters (Prom) and 
LTR elements associated to ZGA or cleavage-stage genes, leading to chromatin opening and 
transcriptional activation of these transcripts. In vitro, it induces the 2C-like subpopulation in mouse 
embryonic stem cells (mESCs) and leads to apoptosis in both mouse and human myoblasts. Image 
from Iturbide & Torres-Padilla 2017.  
 
Interestingly, despite these exciting results that suggested that DUX was the master regulator 
of ZGA, recent studies have shown that Dux maternal and zygotic KO mouse embryos can 
survive after birth (Iaco et al. 2019; Z. Chen & Yi Zhang 2019), and DUX4 siRNA-mediated 
know-down in human embryos leads to transcriptome miregulation but embryos do not arrest 
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(Vuoristo et al. 2019). These latest studies indicate that DUX is a non-essential synchronizer 
of ZGA. Consistently, DUX/DUX4 have not been detected as proteins in the oocyte, which 
suggests that there should be other maternal stores in the oocyte prior to fertilisation that allow 
Dux transcription during the minor wave of ZGA. 
Maternal regulators of ZGA are less well characterised in human embryos due to the ethical 
restrictions to manipulate them. Besides DUX4, another transcription factor that was recently 
identified by motif enrichment analysis of gene promoters activated during human ZGA is 
pleomorphic adenoma gene 1 (PLAG1), which binds to SINE Alu elements in human and SINE 
B1 elements in mouse (Madissoon et al. 2019). Maternal deletion of PLAG1 in mouse oocytes 
leads to transcriptional misregulation and an extended two-cell stage (Madissoon et al. 2019). 
Motif analysis of open regions in chromatin accessibility maps can also help shed light into the 
potential regulators of human ZGA (J. Wu et al. 2016; Lin Li et al. 2018; L. Gao et al. 2018). 
In these regards, the pluripotency factor OCT4 is enriched in DHS sites at the time of ZGA in 
humans, but not in mice, and consistently, siRNA knock-down in human, but not in mouse, 
zygotes leads to downregulation of ZGA genes at the eight-cell stage (L. Gao et al. 2018). 
Other candidate factors implicated in human ZGA are PRD-like homeobox genes (Töhönen et 
al. 2015; Jouhilahti et al. 2016), but their functional role remains to be probed. Recently, 
Krüppel-like factors (KLFs) have recently been shown to activate the expression of 
evolutionally-recent transposable elements during human ZGA, whose expression remodels 
the chromatin landscape and is subsequently repressed by Krüppel-associated box (KRAB)-
containing zinc finger proteins (KZFPs) in a timely manner (Pontis et al. 2019). 
Notably, none of these transcription factors seem to be the master regulator of mouse ZGA. 
While oocytes accumulate STELLA and YAP1 proteins that are inherited after fertilisation 
(Payer et al. 2003; Bortvin et al. 2004; C. Yu, Ji, Dang, et al. 2016), they only activate a subset 
of ZGA transcripts (C. Yu, Ji, Dang, et al. 2016; Y. Huang et al. 2017; Y. Li et al. 2018). 
Although promising to be a pioneer transcription factor during ZGA, Dux/DUX4 is only 
expressed from the zygotic genome (De Iaco et al. 2017; Hendrickson et al. 2017) (Figure 1.9), 
mouse KO females have viable offspring (Iaco et al. 2019; Z. Chen & Yi Zhang 2019) and 
human knock-down embryos do not arrest (Vuoristo et al. 2019). Therefore, all these studies 
suggest that ZGA is regulated by a complex network of redundant regulatory loops and factors. 
1.1 The maternal-to-zygotic transition 43 
 
Consequently, systematic studies, such as the one presented in this dissertation, are needed to 
improve our understanding of ZGA and its regulation. Recently, using the in vitro 2C-like 
mESC subpopulation, three independent studies, including one described in chapter 5 of this 
dissertation, identified the Developmental Pluripotency-Associated proteins 2 and 4 (DPPA2 
and DPPA4) as critical regulators of ZGA via regulation of the expression of Dux (Eckersley-
Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et al. 2019) (see section 1.2.3). Although 
DPPA2 overexpressing mESCs show contribution to extraembryonic tissues in chimeric 
embryos, highlighting the increased developmental potential of these cells (Y.-L. Yan et al. 
2019), functional in vivo studies of DPPA2 and DPPA4 are still missing. Maternal depletion 
of these proteins and analysis of transcription in derived embryos is needed to assess how 
critical they are in regulating ZGA. 
1.1.6.5 Non-coding RNAs 
Importantly, not only proteins but also non-coding RNAs play a role in the MZT (reviewed in 
Eckersley-Maslin, Alda-Catalinas & Reik 2018; Svoboda 2017) (Figure 1.10). The microRNA 
family miR-125 is a negative regulator of ZGA that controls the expression of the maternal-
effect genes homeobox SEBOX and Lin-28 homolog A (LIN28A) (K.-H. Kim et al. 2016) 
(Figure 1.10). Injection of miR-125 family member mimics in GV oocytes causes embryonic 
arrest at the two-cell stage while inhibitors of this microRNA family enhance ZGA (K.-H. Kim 
et al. 2016).   
Interestingly, parental diet is important for MERVL activation and ZGA. This was 
demonstrated by a study showing that protein restriction increases the levels of GCC 5’ 
fragments of glycine tRNAs in mouse sperm, which are inherited into the embryo after 
fertilisation and repress MERVL elements during the major wave of activation in two-cell 
embryos (Sharma et al. 2016) (Figure 1.10).  
As described in section 1.1.3.3, LINE-1 elements regulate chromatin accessibility in early 
embryos (Figure 1.10), since prolonging its activation beyond the two-cell stage leads to an 
increase in DNaseI sensitivity and, in agreement, premature silencing reduces it (Jachowicz et 
al. 2017). Consistently, sustained expression of LINE-1 elements beyond the two-cell stage, as 
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well as their repression immediately after fertilisation, impairs development to the blastocyst 
(Beraldi et al. 2006; Jachowicz et al. 2017), suggesting that this tight window of LINE-1 
expression is critical for proper development. Interestingly, injection of the LINE-1 transcript 
in two-cell embryos has no effect on blastocyst development, indicating that it is the act of 
LINE-1 transcription itself rather than the products of transcription that regulate chromatin 
remodeling (Jachowicz et al. 2017). LINE-1 expression is linked to Dux silencing and exit from 
the two-cell stage (Percharde et al. 2018). In the in vitro 2C-like subpopulation, LINE-1 
transcripts provide a nuclear RNA scaffold that recruits Nucleolin and KAP1, subsequently 
repressing Dux (Percharde et al. 2018), however, whether this mechanism also applies to early 
embryos remains unknown. 
 
Figure 1.10– Regulation of the MZT by non-coding RNAs  
Members of the microRNA miR-125 family are expressed in MII oocytes and suppress the expression 
of maternal-effect genes (MEGs), including SEBOX and protein lin-28 homologue A (LIN28A), 
consequently repressing transcription during the major wave of ZGA in two-cell embryos. The 5′ 
fragments of tRNA-Gly-GCC (tRF- Gly-GCC) are inherited by the zygote from the sperm under 
certain dietary conditions and negatively regulate the expression of MERVL in two-cell embryos.  
LINE-1 repeats are expressed from the zygote up to four- cell embryos and regulate chromatin 
accessibility. The long non-coding RNA LincGET is expressed in two-cell and four-cell embryos, 
similarly to promoter-associated non-coding RNA with interleukin-17d (pancIl17d), which promotes 
the expression of interleukin-17d from the four-cell stage. Image and legend adapted from Eckersley-
Maslin, Alda-Catalinas & Reik 2018. 
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Lastly, the long non-coding RNA (lncRNAs) LincGET is expressed in two-cell and four-cell 
embryos (Figure 1.10) and its depletion compromises development beyond the two-cell stage, 
likely due to impairments in RNA splicing and MAP kinase (MAPK) signalling (Jiaqiang 
Wang et al. 2016). The associated non-coding RNA with interleukin-17d (pancIl17d) is a 
lncRNA highly expressed at the time of ZGA that promoters Il17-d expression in four-cell 
embryos (Hamazaki et al. 2015) (Figure 1.10); its knock-down in zygotes reduces the 
developmental rate to blastocysts through apoptosis-mediated mechanisms (Hamazaki et al. 
2015). 
1.2 Mouse embryonic stem cells to study zygotic genome 
activation 
Mouse embryonic stem cells (mESCs) can be isolated from the ICM of early blastocysts and 
cultured in vitro, serving as an invaluable tool for mechanistic studies in developmental biology 
(M. J. Evans & Kaufman 1981; G. R. Martin 1981). When cultured in serum-containing media 
with Leukaemia Inhibitory Factor (LIF), mESC have self-renewal capacity and are pluripotent 
(Figure 1.11). Under these culture conditions, mESCs are heterogeneous both at the 
transcriptional and epigenetic level (reviewed in De Los Angeles et al. 2015; H. J. Lee et al. 
2014; Torres-Padilla & Chambers 2014). Recently, a rare and transient sub-population within 
mESC was identified to have totipotent-like properties (Morgani et al. 2013; Macfarlan et al. 
2012; Choi et al. 2017; Y.-L. Yan et al. 2019) and express transcripts normally restricted to 
two-cell stage embryos, such as MERVL (Macfarlan et al. 2012) and the zinc finger and SCAN 
domain containing-4 (ZSCAN4) gene cluster (Zalzman et al. 2010), amongst others (Bošković 
et al. 2014; Ishiuchi et al. 2015; Akiyama et al. 2015; Eckersley-Maslin et al. 2016; Rodriguez-
Terrones et al. 2018) (Figure 1.11). These cells are termed two-cell-like cells (2C-like cells) 
and represent an in vitro approach to mimic totipotency and ZGA, both from a transcriptional 
and epigenetic point of view (Macfarlan et al. 2012; Zalzman et al. 2010; Bošković et al. 2014; 
Ishiuchi et al. 2015; Akiyama et al. 2015; Eckersley-Maslin et al. 2016; Dan et al. 2017; 




Figure 1.11– Features of totipotent-like and pluripotent mESCs  
2-cell (2C)-like cells can be used as an in vitro approximation of the 2-cell embryo and are a transient 
sub-population naturally present in mESC cultures, which derived from the inner cell mass (ICM) of 
blastocysts. While mESCs are pluripotent, 2C-like cells present totipotent-like features reminiscent 
of zygotes and 2-cell embryos, such as the capacity to yield placental tissue. Pluripotent mESCs have 
the capacity to self-renew and a pluripotent state can be induced experimentally; however, 2C-like 
cells in culture cycle in and out of this totipotent-like state and whether totipotency can be induced 
in vitro remains controversial. Some pluripotency factors, such as OCT4, are not present in 2C-like 
cells, although the transcript is expressed (*). Pre-implantation mouse embryos are characterised by 
low global DNA methylation levels, which are asymmetric in the zygote and two-cell embryo 
according to the parental origin; in vitro, cycling through the 2C-like state involves DNA 
demethylation, which is restored after the cells exit this transient state, except in imprinted regions. 
Nucleolus precursor bodies are observed in zygotes and 2-cell embryos but these disappear after the 
4-cell stage and are replaced by chromocenters, which are observed in mESCs but not in the 2C-like 
sub-population. Retrotransposons are particularly expressed in early embryos after fertilisation and 
in 2C-like cells. Arrows indicate the transitions between the two stages: zygote and two-cell embryos 
develop into blastocysts and 2C-like cells within mESC cultures cycle in and out of this state. Image 
from Ishiuchi & Torres-Padilla 2013. 
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1.2.1 Transcriptional features of 2C-like cells: MERVL and Zscan4 
2C-like cells can be identified in culture with reporters for MERVL and ZSCAN4 (Macfarlan 
et al. 2012; Zalzman et al. 2010; Ishiuchi et al. 2015; Eckersley-Maslin et al. 2016; Rodriguez-
Terrones et al. 2018). MERVL is an LTR retrotransposon described in detail in section 1.1.3.3 
of this introduction. Approximately 1% of mESC express MERVL (Macfarlan et al. 2012) 
(Figure 1.11). In these cells, the MERVL MT2 promoter drives expression of hundreds of 
chimeric uncharacterised transcripts that are organised into tight genomic clusters (Macfarlan 
et al. 2012; Eckersley-Maslin et al. 2016; Choi et al. 2017; Rodriguez-Terrones et al. 2018), 
suggesting that MERVL induces coordinated and rapid regulation of these genes. In fact, 2C-
like specific genes tend to be close to MERVL MT2 elements (Eckersley-Maslin et al. 2016; 
X. Fu et al. 2019). 
The Zscan4 gene cluster includes six genes (Zscan4a, Zscan4b, Zscan4c, Zscan4d, Zscan4e 
and Zscan4f) and three pseudogenes (Zscan4-ps1, Zscan4-ps2 and Zscan4-ps3) whose 
expression peaks at the late 2C-stage in mouse embryos (Falco et al. 2007; Ishiguro, Nakatake, 
et al. 2016), although recent reports suggest they are also expressed in adult testes and ovaries 
(Ishiguro, Nakatake, et al. 2016; Ishiguro, Monti, et al. 2016). Around 5% of mESCs express 
ZSCAN4 at a given time (Zalzman et al. 2010; Falco et al. 2007). Transient cycling of mESCs 
through a ZSCAN4+ state has been shown to promote telomere extension, accounting for a role 
of this gene cluster in genomic stability (Zalzman et al. 2010) and maintenance of 
developmental potency in long-term cultures (Hirata et al. 2012; Amano et al. 2013).  
Approximately 1-2% of mESCs express both MERVL and ZSCAN4 (Eckersley-Maslin et al. 
2016) together with hundreds of genes expressed in the two-cell embryo at the time of ZGA 
(Macfarlan et al. 2012; Bošković et al. 2014; Ishiuchi et al. 2015; Akiyama et al. 2015; 
Eckersley-Maslin et al. 2016; Rodriguez-Terrones et al. 2018). Importantly, the 2C-like sub-
population labelled by these two reporters exist in all stages of the cell cycle, similar to mESCs, 
although with a prolonged G2/M phase (Storm et al. 2014, Eckersley-Maslin et al. 2016). While 
all MERVL+ cells present high expression of ZSCAN4, not all ZSCAN4+ cells express 
MERVL (Eckersley-Maslin et al. 2016; Rodriguez-Terrones et al. 2018). Single-cell 
transcriptomics analysis suggest that this single ZSCAN4+ population likely represents an 
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intermediate stage in the induction of two-cell embryo transcripts (Eckersley-Maslin et al. 
2016; Rodriguez-Terrones et al. 2018). Nevertheless, the functional relationship between 
MERVL and ZSCAN4 expression remains unclear. Recently, ChIP-seq analysis showed that 
ZSCAN4 binds to enhancers and MT2 elements, recruits chromatin remodellers such as BRG1 
and, consequently, enhances MERVL expression and associated ZGA transcripts by promoting 
H3K4me1, H3K27ac and H3K14ac deposition on MT2 (W. Zhang et al. 2019). The role of 
ZSCAN4 in enhancing rather than directly regulating ZGA-like expression was also previously 
proposed in a model in which DPPA2 and DPPA4 regulate DUX expression, which in turns 
activates ZSCAN4 that helps enhancing the 2C-like state (Eckersley-Maslin et al. 2019). 
Furthermore, pluripotency proteins such as OCT4 or SOX2 are absent in 2C-like cells, whereas 
the mRNA transcripts are still present (Macfarlan et al. 2012; Ishiuchi et al. 2015; Eckersley-
Maslin et al. 2016; Choi et al. 2017; Rodriguez-Terrones et al. 2018) (Figure 1.11). Notably, 
this downregulation of pluripotency proteins is unrelated to differentiation (Rodriguez-
Terrones et al. 2018).  
Interestingly, both MERVL and ZSCAN4 transiently activate the expression of genes 
expressed in the two-cell embryo during intermediate-to-late stages of induced pluripotent stem 
cell reprogramming and its overexpression can increase reprogramming efficiency (Hirata et 
al. 2012; Jiang et al. 2013; Friedli et al. 2014; Y.-W. Kwon et al. 2015; Eckersley-Maslin et al. 
2016; T. Zhao et al. 2018), suggesting that cellular reprogramming to pluripotency requires 
transient passage through a totipotent-like state.  
1.2.2 Epigenetic features of 2C-like cells 
Importantly, in addition to the transcriptome, the chromatin and the DNA methylation 
landscape of 2C-like cells also resembles that of the two-cell mouse embryo (Figure 1.11). 
Similar to the protein downregulation observed for pluripotency factors, the DNA methylation 
machinery, such as DNMT1, UHRF1, DNMT3A and DNMT3B is downregulated at the protein 
level in 2C-like cells (Eckersley-Maslin et al. 2016; Dan et al. 2017), leading to a global loss 
of DNA methylation genome-wide reminiscent to the early embryo, as measured by mass 
spectrometry and bisulfite sequencing (Eckersley-Maslin et al. 2016) (Figure 1.11). This 
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coincides with an increase in 5-hydroxymethylation (Eckersley-Maslin et al. 2016). Strikingly, 
after exiting the transient 2C-like state, cells recover the expression of DNA methyltransferases 
and restore their DNA methylation levels, except at imprinted regions (Eckersley-Maslin et al. 
2016) (Figure 1.11). Mechanistically, ZSCAN4 proteins expressed in 2C-like cells recruit the 
DNA methylation maintenance proteins UHRF1 and DNMT1 and target their degradation 
through the E3 ubiquitin ligase activity of UHRF1 (Dan et al. 2017). Importantly, DNA 
methylation analysis of Dnmt1 KO mESCs revealed that the entry in the 2C-like state and 
expression of MERVL- and ZSCAN4-regulated transcripts is not a consequence of the global 
DNA demethylation but rather DNA demethylation occurs subsequently to MERVL/ZSCAN4- 
transcriptional network activation (Eckersley-Maslin et al. 2016). 
ATAC-seq analysis of the 2C-like subpopulation showed that these cells, similar to the two-
cell embryo, have a globally decondensed chromatin, with accessibility especially pronounced 
at promoters of ZGA-like genes and MERVL elements (Eckersley-Maslin et al. 2016). 
Consistently, these cells lack chromocenters (Ishiuchi et al. 2015) (Figure 1.11) and their 
chromatin mobility, as measured by fluorescent recovery after photobleaching (FRAP) of the 
histones H3.1 and H2A, is higher than in the bulk of mESCs and similar to that observed in 
two-cell embryos (Bošković et al. 2014; Ishiuchi et al. 2015). This can be further induced by 
downregulation of the Chromatin-Assembly Factor 1 (CAF-1), which increases the 2C-like 
subpopulation (see section 1.2.3, Figure 1.11) and leads to higher H3.1 mobility and dispersed 
chromocenters (Ishiuchi et al. 2015). In agreement with an increased chromatin accessibility, 
histone acetylation is also increased in 2C-like cells (Macfarlan et al. 2012; Ishiuchi et al. 2015; 
Akiyama et al. 2015), leading to derepression of heterochromatin and transcriptional activation 
of major satellite repeats in pericentromeric chromatin (Ishiuchi et al. 2015; Akiyama et al. 
2015), a feature reminiscent of zygotes and two-cell embryos (Probst et al. 2010; Santenard et 
al. 2010). In fact, treating mESCs with the histone deacetylase inhibitor sodium butyrate 
induces the 2C-like subpopulation (Dan et al. 2015). At the higher-order chromatin structure, 
recent Hi-C analysis of CAF-1 knock-down-induced 2C-like cells have shown that these cells 
present an increased 3D structural plasticity, with less long-range contacts, reduced strength in 
TADs and loops and an overall decreased compartment strength (Kruse et al. 2019). 
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1.2.3 Regulators of 2C-like cells 
Given the transcriptional and epigenetic similarities between 2C-like mESCs and two-cell 
embryos, these cells can be used as proxy to mimic ZGA in vitro. Consequently, a number of 
studies have aimed to identify factors which, upon deletion or overexpression, increase the 2C-
like subpopulation (Figure 1.12).  
 
Figure 1.12– Regulators of 2C-like cells  
Identified repressors (left) and inducers (right) of MERVL expression and/or the 2C-like 
subpopulation in mESCs. CAF-1: chromatin-assembly factor 1 (CAF-1); KDM1A (also known as 
LSD1): lysine demethylase 1A; KAP1 (also known as TRIM28): KRAB-associated protein-1; 
hnRNP K: heterogeneous nuclear ribonucleoprotein K; HP1: heterochromatin protein-1; EHMT2 
(also known as G9a): histone-lysine N-methyltransferase 2; RYBP: RING1 and YY1-binding 
protein; CHD5: chromodomain helicase DNA binding protein-5; PRC1.6: polycomb complex 1.6;  
EP400 (also known as TIP60): E1A-binding protein p400; PIAS4: SUMO2 E3 ligase; MYC: MYC 
proto-oncogene, BHLH transcription factor; DNMT1: DNA methyltransferase-1; GATA2/3: GATA-
binding factor 2/3; TBX3: T-box transcripton factor-3; DUX: double homeobox; DPPA2/4: 
developmental pluripotency-associated proteins 2/4; IRF1: interferon regulator factor-1; EYA1: 
transcriptional coactivator and phosphatase-1; SP110: SP110 nuclear body protein; TRP63: tumour 
protein 63; BAHD1: bromo adjacent homology domain containing-1; USP3: ubiquitin specific 
peptidase-3; TOX3: TOX high mobility group box family member-3 (TOX3); HDAC9: histone 
deacetylase-9 (HDAC9); ZSCAN4C: zinc finger and SCAN domain containing-4C. 
GADD45A/B/G: growth arrest and DNA damage-inducible proteins-45A/B/G. Cell schematics from 
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As mentioned above, interfering with epigenetic factors, such CAF-1, can increase the 2C-like 
subpopulation (Figure 1.12), as labelled by a MERVL reporter, 10- to 30-fold with a 
subsequent increase of ZGA-like transcripts, including MERVL and Zscan4 (Ishiuchi et al. 
2015). Interestingly, SCNT embryos derived from CAF-1 knock-down mESCs showed higher 
reprogrammability, suggesting an increased developmental potency of these cells (Ishiuchi et 
al. 2015).  Knock-down of other repressive chromatin complexes also results in an expansion 
of MERVL-expressing mESCs (reviewed in Schlesinger & Goff 2015). For example, KDM1A 
(also known as LSD1), whose function is critical in the early embryo (Ancelin et al. 2016; 
Wasson et al. 2016), is a key repressor of endogenous retroviruses in mESCs, specifically, it 
regulates a subset of ZGA genes whose expression is controlled by a MERVL LTR promoter 
(Macfarlan et al. 2011) (Figure 1.12). This function of KDM1A is likely exerted via chromatin 
regulation of a number of repressive histone PTMs, such as hypomethylation of H3K4, 
hypoacetylation of H3K27 and dimethylation of H3K9 at ERVs (Macfarlan et al. 2011). 
Consequently, Kdm1a mutant mESCs express high levels of ZGA genes and show higher 
contribution to extra-embryonic tissues in embryoid-body differentiation assays (Macfarlan et 
al. 2011). KAP1 (also known as TRIM28), is a repressor that acts by recruiting SETDB1, 
heterochromatin protein-1 (HP1) and the NuRD complex (Sripathy et al. 2006) (Figure 1.12). 
Similar to KDM1A, Kap1 deletion in mESCs leads to upregulation of ERVs, specifically 
intracisternal A-type particles (IAPs) and MERVL elements, possibly due to misregulation of 
H3K9 methylation and H4 acetylation (Rowe et al. 2010; Maksakova et al. 2013). This 
phenotype is similar to that observed in KO cells of SETDB1/KAP1 binding partner 
Heterogeneous Nuclear Ribonucleoprotein K (hnRNP K) (Thompson et al. 2015) (Figure 
1.12). Deletion of HP1 and the H3K9 methyltransferase EHMT2 or G9a, also leads to 
deregulation of MERVL elements and associated ZGA genes (Maksakova et al. 2013) (Figure 
1.12), consistent with their role in the early embryo (T.-B. Zeng et al. 2019; Au Yeung et al. 
2019). The PRC1 protein RING1 has functions during meiotic maturation, mitotic cleavage 
divisions and ZGA (Posfai et al. 2012). In vitro, the RING1 and YY1-binding protein (RYBP) 
binds to RING1A and RING1B to assist PRC localisation to their targets (Garcia et al. 1999). 
Interestingly, and possibly due to its interaction with RING1, Rybp deletion in mESCs induces 
the expression of MERVL and two-cell stage specific genes (Hisada et al. 2012) (Figure 1.12). 
Consistent with the remodeling of H3K27me3 during the MZT, dysregulation of this histone 
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modification in mESC after interfering with the Chromodomain Helicase DNA binding 
protein-5 (CHD5) also leads to MERVL derepression (M. Hayashi et al. 2015) (Figure 1.12). 
Although it remains to be determined how many of these MERVL regulators act directly in the 
activation of a 2C-like transcriptional program, these studies highlight that the mechanism of 
epigenetic ZGA regulation can be faithfully recapitulated in an in vitro system such as mESCs, 
facilitating functional studies that are, otherwise, inaccessible in the early embryo. In fact, 
recently, a systematic screen of chromatin regulators whose siRNA knock-down increases the 
2C-like subpopulation identified the non-canonical PRC1 complex PRC1.6 and the E1A-
binding protein p400 (EP400) / histone acetyltransferase Tip60 (TIP60) complex as repressors 
of the emergence of 2C-like cells in mESC cultures (Rodriguez-Terrones et al. 2018) (Figure 
1.12). 
Interestingly, non-coding RNAs regulate the MERVL-driven transcriptional network not only 
in early embryos (see section 1.1.6.5) but also in mESCs. The microRNA miR-34a represses 
MERVL and associated ZGA transcript expression, partially via repression of the GATA-
binding factor 2 (GATA2) (Choi et al. 2017) (Figure 1.12). As a result, mESCs deficient of 
miR-34a show an increased cell fate potential, with extraembryonic contribution in mESC-
derived teratomas, embryoid-bodies and chimeric embryos (Choi et al. 2017). Notably, not 
only GATA2 (Choi et al. 2017), but also GATA3 (Eckersley-Maslin et al. 2019) are inductors 
of the 2C-like subpopulation (Figure 1.12), consistent with a role for GATA factors in cell fate 
potency (C. Zhang et al. 2007).  
In contrast to all these negative regulators of 2C-like cells and MERVL expression, very few 
positive inductors have been identified to date. One example is the T-box transcription factor-
3 (TBX3) (Dan et al. 2013) (Figure 1.12). TBX3 ectopic expression decreases the levels of 
DNMT3B and increases TET2, which results in reduced binding of DNMT3B to subtelomeres 
and subsequently leads to reduced DNA methylation and derepression of genes at 
subtelomeres, including ZSCAN4 (Dan et al. 2013).  
Most notably, the transcription factor DUX was identified as a potent regulator of 2C-like cells 
and ZGA in embryos (De Iaco et al. 2017; Hendrickson et al. 2017; Whiddon et al. 2017) (see 
section 1.1.6.4) (Figures 1.9 and 1.12). However, recent in vivo evidence shows that lack of 
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maternal and/or zygotic DUX/DUX4 does not heavily compromise development in mouse or 
human (Iaco et al. 2019; Z. Chen & Yi Zhang 2019; Vuoristo et al. 2019) and suggests 
redundancy in ZGA regulation. Consequently, recent studies have aimed to identify maternal 
regulators of DUX, some of them in a systematic screening manner. This is the case for one of 
the studies that identified DPPA2 and DPPA4 as critical regulators of ZGA-like transcription 
in 2C-like cells (Eckersley-Maslin et al. 2019) (Figure 1.12). This candidate-based screen 
identified another ten chromatin and epigenetic factors that increase the 2C-like subpopulation, 
as measured by a MERVL reporter and by bulk RNA-sequencing analysis of ZGA transcripts, 
including Dux (Eckersley-Maslin et al. 2019). These included Interferon Regulator Factor-1 
(IRF1), EYA transcriptional coactivator and phosphatase-1 (EYA1), SP110 nuclear body 
protein (SP110), GATA3, Tumour Protein-63 (TRP63), Bromo Adjacent Homology Domain 
containing-1 (BAHD1), Ubiquitin Specific Peptidase-3 (USP3), TOX high mobility group box 
family member-3 (TOX3), Histone Deacetylase-9 (HDAC9) and ZSCAN4C (Eckersley-
Maslin et al. 2019) (Figure 1.12).  
Dppa2 and/or Dppa4 KO mESC completely abrogate the 2C-like subpopulation and 
expression of MERVL, ZSCAN4 and other ZGA genes and associated retrotransposons, such 
as LINE-1 (Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et al. 2019). As 
expanded in chapter 5 of this dissertation, DPPA2 and DPPA4 require DUX to initiate 2C-like 
transcription, suggesting they are upstream regulators (Eckersley-Maslin et al. 2019; De Iaco 
et al. 2019). Interestingly, it was recently proposed that DPPA2 expression is regulated by 
sumoylation, specifically, by the SUMO2 E3 ligase PIAS4, whose knock-down induces the 
2C-like subpopulation and ZGA-like expression (Figure 1.12), indicating that the sumoylated 
form of DPPA2 is unable to trigger transcription of Dux and ZGA (Y.-L. Yan et al. 2019). 
Other recently identified regulators of DUX expression and 2C-like cells are the Growth Arrest 
and DNA Damage-inducible proteins-45 (GADD45) (Schule et al. 2019) (Figure 1.12). Triple 
KO of GADD45A/B/G results in downregulation of 2C-like genes, which can be rescued by 
DUX overexpression (Schule et al. 2019). 
Further to the candidate-based screen performed by Eckersley-Maslin et al. (Eckersley-Maslin 
et al. 2019), recent genome-wide Clustered Regularly Interspaced Short Palindromic Repeat 
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(CRISPR)-based screens (see sections 1.4 and 1.5) have further attempted to uncover the 
regulation of ZGA in vitro in 2C-like cells. In fact, an independent identification of DPPA2 
came through a genome-wide CRISPR-inhibition screen of PIAS4 knock-down mESCs using 
a ZSCAN4C reporter (Y.-L. Yan et al. 2019). A similar screen design, but using a CRISPR KO 
approach on a DUX-induced 2C-like subpopulation labeled with a MERVL reporter, was 
performed by Fu and colleagues (X. Fu et al. 2019), leading to the identification of both positive 
and negative regulators of the 2C-like subpopulation, including MYC Proto-Oncogene, BHLH 
Transcription Factor (MYC) and DNMT1 as repressors of Dux transcription and 2C-like 
expression (X. Fu et al. 2019) (Figure 1.12). 
Despite all these efforts to understand ZGA regulation, a comprehensive understanding is still 
missing. This is partly due to the reliance on single or double MERVL and ZSCAN4 reporters 
to identify ZGA-like cells in vitro. The recent advances on sequencing technologies, especially 
at the single-cell level, promise to serve as a powerful tool to identify ZGA signatures in 
mESCs that go beyond MERVL and ZSCAN4. The combination of these technologies with 
genetic perturbation strategies in mESCs constitutes an unprecedented approach for a 
systematic study of the regulation of ZGA.  
1.3 Single-cell RNA-sequencing technologies 
In recent years, the development of single-cell RNA-sequencing (scRNA-seq) has not only 
enabled the dissection of variable and heterogenous cell populations, but also the 
transcriptional profiling of lowly-abundant and rare cell types, which are of special relevance 
in early development (reviewed in Serena Liu & Trapnell 2016; Hadjantonakis & Arias 2016; 
Svensson et al. 2018). Initially, plate-based technologies, including methods such as CEL-seq 
(Hashimshony et al. 2012; Hashimshony et al. 2016), Quartz-seq (Sasagawa et al. 2013), 
Smart-seq2 (Picelli et al. 2013; Picelli et al. 2014), MARS-seq (Jaitin et al. 2014), MATQ-seq 
(Sheng et al. 2017), and others (Tang et al. 2009; Tang et al. 2010; Islam et al. 2011; Ramsköld 
et al. 2012; Islam et al. 2012; X. Fan et al. 2015; Chapman et al. 2015; Vitak et al. 2017; Cao 
et al. 2017) were developed. These methods are characterised by high transcript detection level 
and coverage, low bias, high accuracy, but low throughput (reviewed in X.-T. Huang et al. 
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2018; Birnbaum 2018). However, recent development of combinatorial indexing strategies has 
allowed increased throughput of plate-based technologies (Vitak et al. 2017; Cao et al. 2017; 
Rosenberg et al. 2018). Current international efforts aim to profile transcriptionally every cell 
type of multi-cellular developing and adult organisms, out of which, of special interest, are 
mouse and human (Pijuan-Sala et al. 2019; Cao et al. 2019; Behjati et al. 2018; Vento-Tormo 
et al. 2018; Schaum et al. 2018; Regev et al. 2017). To this end, high-throughput scRNA-seq 
strategies were subsequently developed using droplet-based technologies, which allow 
profiling the transcriptome of thousands of individual cells at the same time by individually 
encapsulating them in nanoliter-sized aqueous droplets, each associated with a barcode that 
gives cell identify (Streets et al. 2014; Macosko et al. 2015; Klein et al. 2015; H. C. Fan et al. 
2015; Bose et al. 2015; G. X. Y. Zheng et al. 2017; Zilionis et al. 2017; Gierahn et al. 2017). 
In this dissertation, I use droplet-based scRNA-seq technologies to probe candidate maternal 
regulators of ZGA. Therefore, in the following sections I revise, firstly, how scRNA-seq has 
been used to profile the transcriptome of early embryos and 2C-like cells and secondly, how 
droplet-based technologies can be used to profile the transcriptome of thousands of cells in a 
cost- and time-effective manner. 
1.3.1.1 Single-cell RNA-sequencing profiling of early embryos 
The development of single-cell technologies was a major advancement for developmental 
biology due to the limited number of cells available for analysis and the cell-to-cell 
heterogeneity that drives crucial decisions in the embryo (reviewed in Hadjantonakis & Arias 
2016). Most scRNA-seq methods rely on the use of oligo(d)T adaptors to capture mRNAs via 
their polyadenylated tail at the 3’end and are therefore not suitable to study non-coding 
transcription. Using these methods, the coding transcriptome of both mouse and human pre-
implantation development has been profiled at single-cell resolution (Tang et al. 2011; Xue et 
al. 2013; L. Yan et al. 2013; Deng et al. 2014; Biase et al. 2014; Blakeley et al. 2015; Boroviak 
et al. 2018), giving unprecedented insights into the MZT, ZGA and first lineage decisions. 
Polyadenylated lncRNAs have also been recently profiled using these datasets both in mouse 
and human pre-implantation development (K. Zhang et al. 2014; Hamazaki et al. 2015; Lv et 
al. 2015; Qiu et al. 2016). Interestingly, plate-base polyA-capture scRNA-seq technologies 
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have enable mapping the emergence of the transient and cycling sub-population of 2C-like 
cells in mESC cultures (Eckersley-Maslin et al. 2016; Rodriguez-Terrones et al. 2018; X. Fu 
et al. 2019) (see section 1.2). 
However, recent technological advances have made possible the capture of the whole 
transcriptome from a single-cell (Sheng et al. 2017; T. Hayashi et al. 2018; Verboom et al. 
2019) and, specifically, the small non-coding transcriptome (Faridani et al. 2016). Similar low-
input methods have been applied to a pool of embryos, although not to single cells, to profile 
early embryogenesis (S.-J. Park et al. 2015; Abe et al. 2015), including circular RNAs (X. Fan 
et al. 2015). Profiling the MZT at single-cell resolution without a bias for polyadenylated 
transcripts will be of particular importance given the post-transcriptional regulation of maternal 
transcripts via cytoplasmic polyadenylation (Paynton & Bachvarova 1994; Racki & Richter 
2006). 
Given the relatively low number of cells in pre-implantation mouse and human embryos, plate-
based technologies are preferentially used to map these stages and achieve high transcript 
coverage without the need to profile thousands of cells. However, deciphering the wide variety 
of cell types in later post-implantation stages requires high-throughput methods, such as 
droplet-based technologies, which have been recently used to generate maps of early mouse 
gastrulation and organogenesis (Pijuan-Sala et al. 2019; Cao et al. 2019) and of the human 
maternal-fetal interface in first trimester pregnancies (Vento-Tormo et al. 2018). 
Unfortunately, these scRNA-seq methods lose important spatial information. To overcome this 
limitation, recent efforts have aimed to adapt traditional in situ hybridisation-based techniques 
to measure both the abundance and the localisation of hundreds of transcripts in single cells 
(Lubeck et al. 2014; K. H. Chen et al. 2015; Moffitt et al. 2016; Moffitt & Zhuang 2016; Salmen 
et al. 2018; Eng et al. 2019; Rodriques et al. 2019), and, excitingly, these have begun to be 
applied to early embryos (Peng et al. 2019).  
The epigenome is now also accessible at single-cell resolution (reviewed in Kelsey et al. 2017), 
providing much of our current understanding of the molecular events of the MZT (reviewed in 
Eckersley-Maslin, Alda-Catalinas & Reik 2018). Most notably, multi-omics single-cell 
sequencing, including simultaneous profiling of DNA methylation and transcription 
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(Angermueller et al. 2016), DNA methylation and chromatin accessibility (F. Guo et al. 2017; 
Lin Li et al. 2018) and DNA methylation, chromatin accessibility and transcription (Clark et 
al. 2018; Argelaguet et al. 2019) has just begun to provide unprecedented insights into the 
coordination and interdependencies of the transcriptome and the epigenome in early mouse and 
human embryos.  
1.3.1.2 Droplet-based technologies for high-throughput scRNA-seq 
In this dissertation, I use scRNA-seq to profile the transcriptome of hundreds of thousands of 
mESCs where the expression of hundreds of maternal epigenetic and transcription factors was 
induced using CRISPR technology. As described in chapters 3 to 5 of this dissertation, multiple 
single cells had to be sequenced per CRISPR perturbation to achieve statistical power, and 
therefore, a high-throughput droplet-based method was required. 
One of the first attempts to prepare cDNA from single-cells using microfluidic technology 
came from Streets and colleagues (Streets et al. 2014) and consisted on an adaptation of the 
first plate-based scRNA-seq protocol (Tang et al. 2009) using a microfluidic platform for 
single-cell manipulation, which improved detection sensitivity and measurement precision 
(Streets et al. 2014). Consistently, implementation of the widely-used Smart-seq2 protocol 
(Picelli et al. 2013; Picelli et al. 2014) to the commercially available microfluidic platform 
Fluidigm C1 improved mRNA capture efficiency (Islam et al. 2014). After these initial proof 
of concept studies, two protocols, Drop-seq and inDrop, showed effective and specific mRNA 
capture using beads coated with cell-specific barcodes containing oligo(d)T primers and unique 
molecular identifiers (UMIs) dispensed into microfluidics droplets (Macosko et al. 2015; Klein 
et al. 2015; Zilionis et al. 2017). These protocols can routinely sequence tens of thousands of 
cells in a cost-effective manner, but the number of mRNAs captured per cell is considerably 
reduced compared to plate-based methods (Ziegenhain et al. 2017). Additionally, the cell 
capture rates in Drop-seq and inDrop is only 10%, making these protocols unsuitable to profile 
rare cell populations or samples where the material is limited (Macosko et al. 2015; Klein et 
al. 2015; Zilionis et al. 2017). Two years later, a commercially available solution, 10X 
Genomics Chromium, was made available to profile the 3’ transcriptome at single-cell 
resolution (G. X. Y. Zheng et al. 2017).  Although the cost per cell is slightly higher than in 
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Drop-seq or InDrop, 10X Genomics single-cell sequencing is highly convenient for several 
reasons: 1) it uses a commercial droplet device, avoiding the need to set up manually a 
sophisticated microfluidic platform; 2) the capture rate is between 50% to 65%, depending on 
the cell type; 3) the process of encapsulating cells into droplets is incredibly fast, with up to 
80,000 cells processed in less than 10 minutes, making it time-effective and reducing the time 
between sample preparation and droplet formation, thereby preserving cell quality; and 4) it is 
highly scalable as up to 8 different samples with up to 10,000 cells each can be run in parallel. 
Consequently, 10X Genomics scRNA-seq is the current method of choice for many 
laboratories world-wide (reviewed in Birnbaum 2018). In parallel, Seq-Well technology was 
released, consisting on a portable platform where capture beads and single cells are captured 
and sealed in an array of subnanoliter wells using a semipermeable membrane (Gierahn et al. 
2017). Although Seq-Well was shown to preserve high cell quality, commercially available 
options have taken over given the simpler experimental set-up. Despite 10X Genomics, which 
has recently released a 5’ capture method (https://www.10xgenomics.com), all these described 
droplet-based approaches rely on transcript capture with oligo(d)T-coated beads, making them 
unsuitable to study non-coding or nascent transcription. 
In this dissertation, I am interested in detecting the well-defined ZGA-like signature in mESC 
upon inducing perturbations with CRISPR technology and therefore, I can trade sensitivity in 
transcript detection with throughput and use a method that allows profiling hundreds of 
thousands of cells in a cost- and time-effective manner. For these reasons, the method of choice 
was 10X Genomics 3’ scRNA-seq. In this protocol, 10X barcoded gel beads are loaded into a 
microfluidics system (called Chromium controller) that encapsulates cells with barcodes in oil 
droplets or gel beads-in-emulsion (GEMs) (Figure 1.13). Each bead is coated with many oligos, 
each comprising a partial Illumina read 1 (R1) adaptor used for library preparation, a 16-
nucleotide 10X cell barcode unique in each bead, a 10-nucleotide UMI and an oligo(d)T to 
capture the polyadenylated tail of mRNAs (Figure 1.13). After passing through the Chromium 
controller, a suspension of single cells encapsulated in oil droplets with beads is collected and 
after cell lysis, reverse transcription and oil removal, a single tube containing cell- and 
transcript-barcoded cDNA is obtained (Figure 1.13). Lastly, barcoded cDNA is processed via 
a standard scRNA-seq library preparation protocol (see Materials and Methods) and 
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Figure 1.13– Work-flow of 10X Genomics scRNA-seq droplet formation and transcriptional 
analysis 
Up to 750,000 different 10X barcoded gel beads are loaded into a microfluidics system (or Chromium 
controller) together with cells, enzymes (or reagents) and oil. Each cell is encapsulated with a 10X 
barcoded bead in gel bead-in-emulsions (GEMs). Each bead is coated with many oligos, each 
comprising a 22-nucleotide partial Illumina Read 1 (R1) adaptor used for library preparation, a 16-
nucleotide 10X cell barcode unique in each bead, a 10-nucleotide unique molecular identifier (UMI) 
and an oligo(d)T (poly(dT)VN) to capture the polyadenylated tail of mRNAs. After passing through 
the Chromium controller, a suspension of single cells encapsulated in oil droplets with beads is 
collected and, after cell lysis, reverse transcription (RT) and oil removal, a single tube containing 
cell- and transcript-barcoded cDNA is obtained. Lastly, barcoded cDNA is processed via a standard 
scRNA-seq library preparation protocol and downstream analysis allows transcriptional profiling of 
thousands of genes in individual cells. Image adapted from (https://www.10xgenomics.com). 
60 Introduction 
 
1.4 CRISPR as a tool for genome editing 
In the early 1990s, Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) arrays 
were discovered by three independent groups in bacteria and archea (Ishino et al. 1987; 
Hermans et al. 1991; Mojica et al. 1993) and later proposed to serve as an adaptive immune 
system against foreign nucleic acids, including viruses and plasmids (Mojica et al. 2005; 
Barrangou et al. 2007) (Figure 1.14). In 2002, CRISPR-associated (Cas) genes were discovered 
as RNA-guided DNA endonucleases associated with the clustered repeats (Jansen et al. 2002). 
In contrast to type I CRISPR systems, type-II systems require only one Cas protein called Cas9 
(Makarova et al. 2015; Heler et al. 2015; Wei et al. 2015). In naturally occurring type II-
CRISPR systems in bacteria and archea, the invading nucleic acid sequence is incorporated 
into the host bacterial genome between an array of CRISPR sequences, and these CRISPR 
repeat arrays are transcribed and processed into CRISPR RNAs (crRNAs) (Brouns et al. 2008) 
(Figure 1.14). Between the CRISPR arrays, short stretches of conserved DNA, called 
protospacer adjacent motifs (PAMs), are crucial for the defence mechanism (Bolotin et al. 
2005; Mojica et al. 2009) (Figure 1.14). In Streptococcus pyogenes, PAM motifs have the form 
of “NGG”, where “N” denotes any nucleotide and “G” denotes guanine (Makarova et al. 2015). 
Trans-activating crRNA molecules (tracrRNAs) are required to generate mature crRNAs and 
to bridge them with Cas9 proteins (Deltcheva et al. 2011; Jinek et al. 2012). When a new 
foreign nucleic acid enters the cell, the crRNA/Cas9 complexes scans the foreign genome for 
the presence of PAM and, if the adjacent region to it matches the spacer of the crRNA, Cas9 
catalyses a double-strand break that halts the infection (Garneau et al. 2010; Jinek et al. 2012; 
Gasiunas et al. 2012) (Figure 1.14). 
It was not until 2012 that these seminal discoveries led to the proposal that CRISPR/Cas9 
systems could be used as a tool for genome editing. This was based on biochemical in vitro 
studies that showed that Cas9 could be reprogrammed to target any genomic site of interest 
that was adjacent to a PAM and induce a double strand break by using a crRNA sequence 
complementary to the target site of interest (Jinek et al. 2012; Gasiunas et al. 2012). 
Furthermore, one of these reports showed that the crRNA and the tracrRNA molecules could 
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be fused together to create a single, synthetic 20-nucleotide guide RNA (sgRNA) that guides 
and targets Cas9 to the site of interest (Gasiunas et al. 2012).  
 
 
Figure 1.14– CRISPR/Cas adaptive immune mechanism in bacteria and archea 
Bacteria and archea use CRISPR/Cas as an adaptive immune system against foreign nucleic acids, 
such as invading viruses. First, in a process called adaptation, the invader DNA is acquired and 
incorporated into the host CRISPR locus near a sequence called leader. The CRISPR locus contains 
copies of a short direct repeat sequence (black) in between the invader-derived sequences (multiple 
colours). The invading sequence selected for integration into the CRISPR locus are called protospacer 
(red) and are located adjacent to protospacer adjacent motifs (PAMs, white). Transcription of the 
CRISPR locus generates multiple crRNAs in a process called crRNA biogenesis, where mature 
crRNAs retain the repeat sequence (black) adjacent to the invader-derived guide sequence (multiple 
colours). When a new invading sequence comes in contact with the hosts, crRNAs, associated to Cas 
proteins, recognise the foreign nucleic acid via base-pairing and the Cas protein cleaves in the region 
of hybridisation, a process called invader silencing. In this process, PAMs are critical for recognition 




A year later, two independent studies reported that CRISPR/Cas9 from S. pyogenes and S. 
thermophilus could be expressed in mouse and human cells to cleave a target site in a 
programmable manner and that it could induce homology-directed repair (Cong et al. 2013; 
Mali, Yang, et al. 2013). Therefore, since it only requires a 20-nucleotide sgRNA 
complementary to a region of interest containing a PAM and expression of Cas9, CRISPR is 
an incredibly useful tool for genome editing. Consequently, since 2013, CRISPR has been 
installed in the scientific community as a powerful tool for genome editing used by multiple 
laboratories world-wide with a plethora of applications, from the generation of transgenic 
animals, to lineage molecular recording and even the first clinical applications (reviewed in 
Pickar-Oliver & Gersbach 2019). 
1.4.1 Endogenous transcriptional activation using CRISPR: CRISPRa 
Multiple CRISPR applications rely on the inactivation of the catalytic activity of Cas9 to render 
a dead Cas9 (dCas9), by introducing two mutations (D10A and H841A in S. pyogenes) in the 
nuclease domains HNH and RuvC1 (Jinek et al. 2012; Gasiunas et al. 2012; Qi et al. 2013; 
Konermann et al. 2013; Mali, Aach, et al. 2013). The use of a dCas9 repurposes CRISPR to a 
sequence-specific RNA-guided platform that can be used to activate or inhibit transcriptional 
activity (CRISPR-activation or CRISPRa and CRISPR-inhibition or CRISPRi, respectively) 
(Mali, Aach, et al. 2013; Gilbert et al. 2013; A. W. Cheng et al. 2013; Perez-Pinera et al. 2013; 
Maeder et al. 2013; Larson et al. 2013; Gilbert et al. 2014; Tanenbaum et al. 2014; Konermann 
et al. 2015; Chakraborty et al. 2014; Chavez et al. 2015; Zalatan et al. 2015; Chavez et al. 2016; 
Rajagopal et al. 2016), alter the epigenetic state of a gene or genomic element by DNA 
methylation or histone modifications (Hilton et al. 2015; Kearns et al. 2015; Polstein et al. 
2015; Thakore et al. 2015; Vojta et al. 2016; Choudhury et al. 2016; D. Y. Kwon et al. 2017), 
edit specific nucleotides (Thakore et al. 2015; Hess et al. 2016; Y. Ma et al. 2016) or image 
genomic regions in living cells (Tanenbaum et al. 2014; reviewed in B. Chen et al. 2016), 
amongst other applications, simply by fusing dCas9 to different functional domains and 
designing sgRNAs to target the genomic region of interest (reviewed in Sander & Joung 2014; 
Adli 2018; Doench 2018) (Figure 1.15). 
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Figure 1.15– CRISPR applications 
Cas9, in its wild-type form, can be used for gene editing by generating double DNA breaks (top left 
panel). A catalytically-inactive or dead Cas9 (dCas9) can fused to different domains for multiple 
purposes: to regulate gene expression, either by activating or repressing it, when fused to different 
trans-effectors (second top panel from left); to edit epigenetic marks, such as DNA methylation (me), 
when fused to epigenetic modifiers (third top panel from left); to image chromatin when fused either 
directly or via MS2 loops to fluorescent proteins (FP) (top and bottom right panels); or to edit 
chromatin topology when fused to proteins that dimerise (third bottom panel from left). A nickase 
Cas9 (nCas9) can be used to edit DNA bases in the absence of double DNA breaks when fused to 
“apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like” (APOBEC) and “uracil DNA-
glycolyase inhibitor” (UGI) (bottom left panel). Lastly, Cas13 can be used for RNA-targeting 
strategies (second bottom panel from left). Pol II: polymerase II. Image from Adli 2018 
 
In this dissertation, I use CRISPRa to induce the endogenous transcription of candidate 
maternal ZGA regulators in mESCs and assess the transcriptional consequences. CRISPRa can 
be achieved by fusing dCas9 to different trans-activation domains and designing sgRNAs 
against the region upstream of the gene TSS (or gene promoter) (Chavez et al. 2016). 
Recruiting trans-activation domains to gene promoters via dCas9 leads to the recruitment of 
polymerases that activate transcription (Gilbert et al. 2013). In eukaryotic cells, the first 
generation of CRISPRa methods, used to induce endogenous gene activation, consisted on 
fusing dCas9 to the transcription activation domain tetrameric VP16 (also called VP64) or to 
the nuclear factor NF-kappa-b p65 subunit (p65) (Gilbert et al. 2013). VP16 is a transcription 
factor from the herpex simplex virus involved in the expression of viral genes by interacting 
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with numerous host factors to recruit RNA polymerase II and binding histone modifiers that 
allow transcriptional activation (Tumbar et al. 1999). In CRISPRa applications, VP16 domain 
is commonly found fused to dCas9 in four copies for enhanced activity, and this is referred to 
as VP64. The activation domain p65, from the NF-kappa-b signalling pathway, is involved in 
innate and adaptive immune responses and interacts with members of the basal transcription 
complex, such as TATA-binding protein and Transcription factor II b, making it a potent 
transcription inducer (van Essen et al. 2009). VP64 fusion to dCas9 is more efficient than p65 
fusion (Gilbert et al. 2013) and, therefore, the first generation of CRISPRa methods used 
dCas9-VP64 fusion (Figure 1.16). Although this first generation of activators has been used in 
a number of studies, showing that it can activate both silent and already active genes, the fold 
change achieved compared to basal gene expression is very modest (Mali, Aach, et al. 2013; 
Gilbert et al. 2013; A. W. Cheng et al. 2013; Perez-Pinera et al. 2013; Maeder et al. 2013). The 
observation that using multiple sgRNAs to recruit additional activators enhanced target gene 
activation (A. W. Cheng et al. 2013; Maeder et al. 2013) led to the development of the second 
generation of activators (reviewed in La Russa & Qi 2015). 
One of the second generation CRISPRa methods is SunTag, developed by two independent 
groups (Gilbert et al. 2014; Tanenbaum et al. 2014). In SunTag CRISPRa system, dCas9 is 
fused to a tandem array of peptides to recruit many copies of the VP64 effector, which in turn 
is fused to a single-chain variable fragment (scFv) that recognises the peptide array (Figure 
1.16). This method can lead to an increase of up to 50-fold in the protein levels of the targeted 
gene (Tanenbaum et al. 2014).  
Another potent CRISPRa strategy consists on employing multiple different activators fused to 
dCas9 in tandem, namely VP64, p65 and Replication and Transcription activator (RTa) 
(Chavez et al. 2015). RTa is an immediate-early murine gammaherpesviruses gene product 
found to activate viral lytic genes by binding to RTa-responsive elements in the promoter 
regions of target genes (Buisson et al. 1989). This method, known as VPR, has been 
successfully applied in human, mouse, Drosophila melanogaster and Saccharomyces 
cerevisiae cells to activate target genes and upregulate their mRNAs from 5- to 300-fold using 
multiple different sgRNAs per target (Chavez et al. 2015).  
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Figure 1.16– CRISPRa strategies 
Transcriptional activation of endogenous loci (CRISPRa) can be achieved by tethering dead Cas9 
(dCas9) with different trans-activation domains. Different methods have been developed: fusion of 
dCas9 to VP64 (top left); SunTag, in which multiple copies of VP64 are recruited by interaction 
between single-chain variable fragments (scFv, fused to VP64) with a peptide array (fused to dCas9) 
(top middle); VPR, in which dCas9 is fused to VP64, p65 and RTa (top right); SAM, in which dCas9 
is fused to VP64 and MCP-p65-HSF1 fusions are recruited via MS2 loops in the scaffold sequence 
of the sgRNA (bottom left); or epigenome editing methods such as dCas9 fusion to the histone 
acetyltransferase p300 (bottom right). VP64: tetrameric VP16 transcription activation domain; RTa: 
replication and transcription activator; SAM: synergistic activator mediator; HSF1: heat shock factor-
1 protein; MCP: MS2 coat protein; ac: acetylation. Image from Lo & Qi 2017. 
 
Interestingly, a third CRISPRa approach called synergistic activator mediator (SAM) can 
achieve similar or even higher levels of target gene upregulation than SunTag and VPR using 
a single sgRNA (Konermann et al. 2015). This strategy also uses three different trans-
activators, however, the synergistic effect is achieved by using two different fusion proteins: 
1) dCas9-VP64 and 2) p65 fused together with heat shock factor-1 protein (HSF1) to the MS2 
RNA binding protein (also known as MCP or MS2 coat protein) (Konermann et al. 2015) 
(Figure 1.16). HSF1 is a transcription factor and the major mediator of the heat shock response, 
by inducing transcription of heat shock proteins in response to environmental stress (reviewed 
in Dayalan Naidu & Dinkova-Kostova 2017). To allow recruitment of p65 and HSF1 to the 
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dCas9-VP64/sgRNA complex at the promoter of the gene of interest, the scaffold sequence of 
the sgRNA is modified to include two MS2 loops (Figure 1.16). MS2 RNA binding proteins 
bind to MS2 loops as dimers, therefore, further to VP64, four additional copies of activation 
modules are recruited to the targeted promoter, leading to mRNA fold changes from two- to 
multiple-thousand-fold, depending on basal gene expression levels of the targeted gene 
(Konermann et al. 2015).  
Lastly, fusion of the histone acetyltransferase p300 to dCas9 can be used to induce endogenous 
gene transcription via deposition of H3K27ac by designing sgRNAs against enhancers, instead 
of promoters, creating an epigenome editing platform that can be used to upregulate gene 
expression via indirect mechanisms (Hilton et al. 2015) (Figure 1.16). However, this strategy 
requires detailed knowledge of the regulation of cell-type specific enhancers and, therefore, it 
is less adaptable than previously described strategies. 
A recent study comparing SunTag, VPR and SAM CRISPRa systems across several human, 
mouse and fly cell lines showed that SAM is the most potent and consistent in inducing target 
gene activation, while maintaining high specificity (Chavez et al. 2016). Consequently, in this 
dissertation, I decided to employ SAM as a robust method for CRISPRa screening.  
CRISPRa has a number of advantages over traditional cDNA overexpression techniques. 
Firstly, the levels of gene expression achieved are more physiologically-relevant by CRISPRa 
(Chavez et al. 2015; Sanson et al. 2018; J. Yang et al. 2019). Secondly, it does not require 
cloning of the cDNA of interest, making it amenable for transcriptional upregulation of any 
gene, regardless of its size. Thirdly, it can be multiplexed and highly scalable, allowing 
simultaneous activation of multiple genes in a single pooled experiment, making it very 
suitable for screening purposes (Konermann et al. 2015; Joung et al. 2017; Horlbeck et al. 2016; 
Sanson et al. 2018). 
1.4.2 Pooled genetic screens using CRISPR 
Genetic screening refers to the assessment of multiple gene functions in a systematic way. 
Pooled screening means the simultaneous testing of thousands of individual perturbations in a 
single batch, and contrasts to arrayed screening in which each perturbation is tested 
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individually in a single well (Figure 1.17). Pooled screening has multiple advantages over 
arrayed screening: the set-up is simpler as it does not require automation or specialised 
equipment for liquid handling, they are high-throughput allowing comprehensive profiling of 
genome-wide libraries, and they are cost-effective. However, pooled screening also has some 
disadvantages, such as the requirement of high number of cells, the biosafety considerations 
for viral preparation and the dependency on next-generation sequencing (NGS) (reviewed in J. 
Yao & Dai 2018). 
 
Figure 1.17– Pooled and arrayed CRISPR screening strategies 
Pooled CRISPR screens can be done by delivering a lentiviral sgRNA library into cells and, after 
applying some sort of selection, changes in sgRNA abundance amongst bulk populations of cells are 
assayed by next-generation sequencing analysis on the extracted DNA (a). In contrast, arrayed 
CRISPR screens support complex read-outs, such as transcriptional cellular signatures, but require 
assaying each perturbation separately, making them low-throughput and labour-intensive (b). Pooled 
CRISPR screening with single-cell read-out, using methods such as CROP-seq, combines the 
advantages of a) and b), allowing pooled lentiviral delivery and complex analysis of each perturbation 
by single-cell RNA-sequencing, where the transcriptome of each cell is profiled individually along 
with the expressed sgRNA (c). Image from Datlinger et al. 2017. 
 
Before the discovery of CRISPR as a tool for genome editing, mammalian genetic screening 
was routinely carried out with RNAi technology, where phenotypes were interpreted after loss-
of-function perturbations. However, the rate of off-target effects mediated by RNAi are 
relatively high and the gene suppression achieved is often insufficient to allow observation of 
KO phenotypes (reviewed in Mohr & Perrimon 2012). Over the last years, the simplicity and 
specificity of CRISPR for genome editing has led to an explosion in the application of CRISPR 
for genetic pooled screening. In short, a library of sgRNAs (genome-wide or targeted to a set 
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of genes or genomic features of interests) is delivered to cells and, after some sort of selection, 
the perturbations that cause the phenotype of interest are analysed by NGS of the genomic 
DNA to quantify the abundance of each perturbation (Gasperini et al. 2016; reviewed in 
Doench 2018) (Figure 1.17). In these multiplexed CRISPR screenings, replication-inactivated 
lentiviruses are often the delivery method of choice for sgRNA libraries (Figure 1.17), since 
they are stably integrated into the host genome, can infect both dividing and non-dividing cells 
and are relatively easy to produce and manipulate to control the number of integrations per cell 
(reviewed in Lino et al. 2018). 
CRISPR screens can be classified based on the type of perturbations introduced. CRISPR 
screening was first performed in mammalian cells by introducing Cas9-mediated loss-of 
function mutations via double-strand DNA breaks in coding regions of the genes of interest 
(Shalem et al. 2014; T. Wang et al. 2014; Koike-Yusa et al. 2014) (Figure 1.15). These are 
called CRISPR KO screens and are widely used both in genome-wide and targeted screens in 
an ample variety of systems (reviewed in Doench 2018). Loss-of-function screening can also 
be performed using CRISPRi, which is carried out by directing dCas9 alone to the region 
around the TSS of the genes of interest (Qi et al. 2013; Gilbert et al. 2013) or fused to the 
transcriptional repressor KRAB (Gilbert et al. 2013; Gilbert et al. 2014; Horlbeck et al. 2016; 
Radzisheuskaya et al. 2016; Sanson et al. 2018) (Figure 1.15). Interestingly, gain-of-function 
screens can also be performed using second generation CRISPRa systems (Figure 1.16). One 
of the first genome-wide CRISPRa screens was performed using the SunTag system (Gilbert 
et al. 2014). By using a tiling sgRNA library, the authors found that optimal CRISPRa 
efficiency was achieved with sgRNAs targeted 50 to 400 bp upstream of the TSS regardless of 
basal gene expression levels (Gilbert et al. 2014). Consequently, they designed a genome-wide 
library using this targeting rule and screened for genes that affect cell growth after activation 
in the human K562 cell line (Gilbert et al. 2014). Interestingly, the same screen design using 
CRISPRi rendered different results: CRISPRi hits were limited to expressed genes whereas 
CRISPRa hits included genes across a broad range of endogenous expression levels (Gilbert et 
al. 2014), therefore highlighting the power of CRISPRa for screening gene function regardless 
of the basal expression state of genes. The study that first reported the development of 
CRISPRa SAM technology (Konermann et al. 2015) showed optimal activation efficiency with 
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sgRNAs targeted 200 bp upstream of the gene’s TSS as well as successful multiplex gene 
activation using this system. A genome-scale screen using a SAM lentiviral library containing 
3 sgRNAs per gene, targeted 200 bp upstream of the TSS, was successful in identifying gain-
of-function perturbations that conferred resistance to a small molecule inhibitor in a melanoma 
cell line (Konermann et al. 2015). More recently, further optimised genome-wide and targeted 
CRISPRa libraries have been constructed (Horlbeck et al. 2016; Sanson et al. 2018) based on 
two observations: 1) CRISPR/Cas9 is influenced by nucleosome occupancy (Horlbeck, 
Witkowsky, et al. 2016; Horlbeck et al. 2016), and 2) functional TSS annotation with the 
FANTOM database (Forrest et al. 2014), which identifies TSSs using Cap Analysis of Gene 
Expression (CAGE), is more accurate for functional sgRNA design than RefSeq or Ensembl 
annotations, in both CRISPRi and CRISPRa applications (Radzisheuskaya et al. 2016; 
Horlbeck et al. 2016; Sanson et al. 2018). 
Based on their read-out, pooled CRISPR screens can be divided into viability screens, screens 
based on flow-cytometry read-outs and screens based on single-cell read-outs (reviewed in 
Doench 2018). Viability screens rely on affecting cell fitness, so that perturbations that affect 
it are depleted or enriched by the end of the screen. This type of screens is widely used in cancer 
biology to identify dependencies of tumour cells on a particular mutation, and are often 
combined with drug screening to unravel mutations that confer resistance. CRISPR screening 
can be combined with flow cytometry to separate cells of interest based on fluorescent reporters 
incorporated in the cells or stained with fluorescent antibodies. However, one of the critical 
premises of pooled CRISPR screening is maintaining adequate representation of the library at 
all steps and, therefore, one of the main drawbacks of CRISPR screening based on flow-
cytometry read-outs is the extensive hours of sort time required, especially for large-scale or 
genome-wide screens. In these two types of screens, the populations of cells separated based 
on survival or expression of fluorescent markers are subsequently analysed by NGS on the 
extracted DNA. This way, sgRNAs constitute a unique barcode that can be used to unravel 
enriched or depleted perturbations compared to sgRNA non-targeting controls and associated 
with the phenotype of interest (Figure 1.17). The third type of CRISPR screens, those based on 
single-cell read-outs, are significantly different from the other two and were recently made 
possible thanks to the combination of CRISPR technology with single-cell sequencing 
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(reviewed in Doench 2018; J. Yao & Dai 2018) (Figure 1.17). In this case, analysis of the whole 
transcriptome or epigenetic state of each single cell is used to understand the phenotype caused 
by each perturbation. While CRISPR KO and CRISPRi screens based on single-cell read-outs 
have been previously performed, in this dissertation, I developed for the first time a 
combination of pooled CRISPRa screening with scRNA-seq read-out to probe maternal 
epigenetic and transcription factors as regulators of ZGA. Therefore, single-cell read-out-based 
screens are reviewed in detail in the following section 1.5. 
1.5 CRISPR screening at single-cell resolution 
Until recently, complex CRISPR screening molecular read-outs, such as transcriptional or 
epigenetic profiling, were limited to arrayed screens (Tan & S. E. Martin 2016) (Figure 1.17), 
making them very labour-intensive and low-throughput in the number of perturbations that 
could be tested in one experiment. Combining pooled CRISPR screening with complex read-
outs is not straight forward, since it implies being able to identify the perturbation introduced 
in every cell that renders the observed transcriptional and/or epigenetic changes (Figure 1.17). 
Even though single-cell sequencing presented itself as the obvious method to analyse these 
read-outs, an important limitation became apparent: sgRNAs are often transcribed from a U6 
promoter which is bound by polymerase III (Pol III), leading to a non- 3’ polyadenylated 
transcript (H. Ma et al. 2014). As reviewed earlier in section 1.3, most scRNA-seq methods 
rely on the capture of 3’ polyadenylated transcripts. Since 2016, a number of methods have 
overcome this limitation and shown that it is possible to combine CRISPR screening with 
single-cell-based read-outs, namely CROP-seq (Datlinger et al. 2017), Perturb-seq (Dixit et al. 
2016; Adamson et al. 2016; Replogle et al. 2018; Rubin et al. 2019) and CRISP-seq (Jaitin et 
al. 2016). These methods not only allow performing high-throughput pooled CRISPR 
screenings with complex interrogation of gene function but also permit disentangling cell-to-
cell heterogeneities (Figure 1.17). 
CROP-seq implements a smart cloning strategy that allows simultaneous analysis of the whole 
transcriptome and detection of the sgRNA expressed in each cell (Datlinger et al. 2017) (Figure 
1.17). The strategy consists on incorporating the sgRNA transcript expressed in each cell within 
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a polymerase II (Pol II) transcript that can be capture in scRNA-seq libraries (Figure 1.18). For 
that, the authors took advantage of the replication mechanism of lentiviruses and incorporated 
the U6 Pol III promoter and sgRNA cassette within the 3’LTR, at the same position of the 400 
bp deletion that makes lentivirus self-inactivating, and just before the 3’ LTR polyadenylation 
signal (Figure 1.18). Upstream of the 3’ LTR, contained within the lentiviral integration site, a 
Pol II promoter drives expression of an antibiotic-resistance cassette used for selection of 
transduced cells (Figure 1.18). Upon lentiviral reverse transcription and integration into the 
host genome, the U6-sgRNA cassette is copied to the 5’ LTR (Figure 1.18). Functional sgRNAs 
are then expressed in the host cell from the U6 promoter but also, the U6-sgRNA cassette is 
contained within the Pol II polyadenylated transcript, making it detectable by scRNA-seq 
approaches (Figure 1.18). Using this strategy, sgRNA expression can be assigned to every 
single-cell and downstream transcriptional changes induced by each perturbation can be 
determined (Figure 1.17). Interestingly, CROP-seq has been used to probe not only genes but 
also enhancer elements, as demonstrated recently (Gasperini et al. 2019). 
 
Figure 1.18– Schematic representation of CROP-seq strategy 
The CROPseq-Guide-Puro was derived from the LentiGuide-Puro by moving the hU6-sgRNA 
cassette within the 3’ LTR. After lentiviral integration and transcription from the host genome, the 
sgRNA is contained within a polyadenylated Pol II transcript detectable by single-cell RNA-
sequencing (scRNA-seq), while a functional sgRNA Pol III transcript is also produced. Image from 
Datlinger et al. 2017. 
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In contrast, Perturb-seq (Dixit et al. 2016; Adamson et al. 2016) and CRISP-seq (Jaitin et al. 
2016) methods do not detect the sgRNA sequence itself by scRNA-seq but rather an associated 
polyadenylated barcode previously incorporated in the sgRNA libraries. Using a very similar 
strategy, Mosaic-seq was used to systematically study the function of enhancer elements (S. 
Xie et al. 2017). Although these methods have been shown to be highly scalable, a critical 
drawback has been pointed out in screens performed during the last year: uncoupling of the 
sgRNA-barcode pairs can occur during lentiviral packaging of pooled libraries, leading to 
inaccurate sgRNA-cell assignments after scRNA-seq (Hill et al. 2018; S. Xie et al. 2018; 
Adamson et al. 2018; Feldman et al. 2018). Even though alternatives have been proposed to 
reduce this uncoupling, including arrayed packaging of lentiviral libraries (Adamson et al. 
2018; Feldman et al. 2018), they come with a substantial reduction in throughput and 
scalability, making CROP-seq a more suitable strategy for high-throughput pooled CRISPR 
screening (Hill et al. 2018). However, the disruption of the 3’ LTR used in CROP-seq implies 
that only one sgRNA can be cloned per lentiviral vector (Datlinger et al. 2017), making this 
option unsuitable for multiple sgRNA delivery in a single cell, unless a high multiplicity-of-
infection (MOI) is used for random combinatorial integrations of sgRNAs into cells. 
Nevertheless, the experimental design presented in this dissertation only required one 
perturbation introduced per cell and, therefore, I opted to adapt CROP-seq for pooled CRISPR 
screening. 
Last year, an alternative strategy was proposed to combine the best features of CROP-seq and 
Perturb-seq/CRISP-seq methods to capture directly the non-polyadenylated sgRNA sequence 
in 10X Genomics scRNA-seq libraries (Replogle et al. 2018). For that, this method, called 
direct-capture Perturb-seq, requires the incorporation of custom sequences in the stem loop or 
at the 3’ end of the sgRNA scaffold sequence in the sgRNA libraries. Importantly, these 
modifications in the sgRNA sequence do not compromise sgRNA activity (Replogle et al. 
2018). At the time of scRNA-seq, 10X beads are not only coated with oligo(d)T adaptors but 
also with specialised barcodes that recognize the modified sgRNA scaffold and consequently, 
capture both mRNAs and sgRNA transcripts (Replogle et al. 2018). Since this method is 
commercially available, it is likely to become the method of choice for pooled CRISPR 
scRNA-seq screening.  
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Most scRNA-seq-based CRISPR screens performed to date have employed loss-of function 
perturbations through CRISPR KO (Datlinger et al. 2017; Jaitin et al. 2016; Dixit et al. 2016) 
or CRISPRi (Adamson et al. 2016; S. Xie et al. 2017; Replogle et al. 2018; Genga et al. 2019; 
Gasperini et al. 2019) to screen different biological functions of genes (Datlinger et al. 2017; 
Jaitin et al. 2016; Dixit et al. 2016; Adamson et al. 2016; Replogle et al. 2018; Genga et al. 
2019) and enhancers (S. Xie et al. 2017; Gasperini et al. 2019). Therefore, these approaches 
can only be used to interrogate genes that are already expressed or enhancers that are already 
active in the cellular system under study. Recently, two months before the deposition of this 
dissertation, CRISPRa has been combined with scRNA-seq read-out using Perturb-seq to 
generate genetic interaction maps of cell fitness in human cell lines (Norman et al. 2019). 
However, the combination of CRISPRa with single-cell read-outs as a screening tool is 
presented for the first time in this dissertation. 
Excitingly, not only the transcriptome but also epigenetic features, such as chromatin 
accessibility measured by ATAC-seq, can also now be combined with pooled CRISPR 
screening at single-cell resolution (Rubin et al. 2019). Even though the scalability of these 
methods is still limited and genome-scale screens are not feasible due to the single-cell 
sequencing costs, these methods promise great advents in the understanding of mammalian 
gene function.  

 
Chapter 2 Materials and Methods 
2.1 Cloning 
2.1.1 Vectors 
The following vectors were used in this dissertation: 
Table 2.1 – Vectors used, providers and short description 




It expresses the human immunodeficiency virus (HIV) 
VSV-G envelope was used for lentiviral packaging 
together with psPAX2 and a lentiviral vector 




It expresses the HIV genes gag, pol, rev, and tat and 
was used for lentiviral packaging together with 
pMD2.G and a lentiviral vector expressing the 





Third generation lentiviral vector that expresses the 
fusion dCas9-VP64 and was used to generate SAM 






Third generation lentiviral vector that expresses the 
fusion MS2-p65-HSF1 and was used to generate SAM 
mESCs (section 3.2.1). 







Third generation lentiviral backbone for sgRNA 
cloning containing a scaffold sequence with MS2 
loops at the tetraloop and stemloop-2, and an 
elongation factor-1 alpha (EF1α)-puromycin 
resistance marker. It also contains BsmBI sites for 
insertion of a sgRNA spacer sequence. It was used in 












Gateway plasmid used to clone in the PCR products of 
the cDNA sequences used for experiments described 
in sections 5.2.3, 5.2.4 and Appendix J. 
pIG400 In-house built  
Gateway pDEST vector containing a CAG promoter 
and an in-frame C-terminal eGFP coding sequence 
linked to a blasticidin resistance marker by an internal 
ribosome entry site (IRES) sequence. It was used to 
express GFP fusion proteins after transferring the 
relevant cDNA sequence from pDONR221 by 
Gateway cloning, in the experiments described in 
sections 5.2.3, 5.2.4 and Appendix J. Full sequence 
provided in Appendix B. 
 
2.1.2 Synthesis of CROP-sgRNA-MS2 lentiviral construct 
The CROP-sgRNA-MS2 lentiviral vector was synthesised by VectorBuilder using the design 
of the CROPseq-Guide-Puro (Addgene, 86708) (Datlinger et al. 2017) with the following 
modifications: 1) the sgRNA scaffold sequence contains two MS2 loops, as in the 
sgRNA(MS2)_puro backbone (Addgene, 73795),  that allow recruitment of MS2-p65-HSF1 in 
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SAM22 mESCs; and 2) a fluorescent mCherry marker was included downstream of the EF1α 
promoter and linked through T2A to a puromycin resistance cassette, allowing assessment of 
the MOI by flow cytometry and antibiotic selection of the cells (Figure 3.27). This vector’s 
sequence is provided in Appendix A. 
2.1.3 Cloning of individual sgRNAs 
For individual sgRNA cloning, two oligos were synthesised per sgRNA (Sigma Aldrich), one 
containing the spacer or target sequence with a “CACCG” flank at the 5’ end and the other one 
synthesised as the reverse complementary sequence to the target sequence and flanked by 
“AAAC” at the 5’ end and by a “C” at the 3’ end. Each oligo pair was annealed using T4 
Polynucleotide Kinase (PNK) enzyme (NEB, M0201S) and then cloned into the 
sgRNA(MS2)_puro backbone (Addgene 73795) or into the in-house built CROP-sgRNA-MS2 
backbone (Figure 3.27) by a Golden Gate reaction using BsmBI enzyme (Thermo Fisher      
Scientific, ER0451) and T7 ligase (NEB, M0318S). The product from the Golden Gate reaction 
was transformed into Stbl3 competent cells (Thermo Fisher Scientific, C737303). Between 2 
to 3 colonies were picked per sgRNA and verified by Sanger sequencing. All sgRNA target 
sequences used in this dissertation were design in Joung et al. 2017 and sequences are provided 
in Appendix C. 
2.1.4 Cloning of the 475 sgRNA pooled library  
For cloning the 475 sgRNA pooled library into the CROP-sgRNA-MS2 backbone, first, oligos 
containing the sgRNA target sequence with a 5’ end 26 base-pair (bp) flanking region 
complementary to the U6 promoter (TATCTTGTGGAAAGGACGAAACACCG) and a 3’ end 
35 bp flanking region complementary to the sgRNA scaffold sequence 
(GTTTAAGAGCTAGGCCAACATGAGGATCACCCATG) were synthesised by Twist 
Bioscience. This oligo library was then amplified and cloned into the CROP-sgRNA-MS2 
vector using Gibson assembly, as previously described in Joung et al. 2017, by VectorBuilder. 
Library coverage was estimated to be >11,000 folds by colony count of diluted transformations. 
150 bp paired-end sequencing was performed on Illumina HiSeq4000 to analyse sgRNA 
representation in the library. The target sgRNA sequences synthesised and cloned into the 
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CROP-sgRNA-MS2 lentiviral backbone and the number of sequencing reads for each sgRNA 
in the final pooled plasmid library are provided in Appendix C. 
2.1.5 Cloning of cDNA-eGFP constructs  
Sequence-verified cDNA sequences lacking stop codons (Appendix D) were polymerase chain 
reaction (PCR) amplified from plasmids purchased from Thermo Fisher Scientific using 
forward primers containing an AttB1 sequence (GGGGACAAGTTTGTACAAAAAAGCAG 
GCTTCACC) followed by the 22 5’end bases of the cDNA of interest, and reverse primers 
containing an AttB2 sequence (GGGGACCACTTTGTACAAGAAAGCTGGGTC) followed 
by the 24 complementary bases to the 3’ end of the cDNA sequence (Table 2.2). The PCR was 
performed with Phusion High-Fidelity DNA Polymerase (NEB, M0530S) or LongAmp Tap 
DNA Polymerase (NEB, M0323), following manufacturer’s instructions. The PCR product 
was then cloned into pDONR221 vector (Thermo Fisher Scientific, 12536017) using a 
Gateway BP clonase II enzyme (Thermo Fisher Scientific, 11789020), following 
manufacturer’s instructions. A Gateway LR II clonase reaction (Thermo Fisher Scientific, 
11791100) was then used to transfer the cDNA sequences into an in-house built pDEST vector 
(pIG400) containing a CAG promoter and an in-frame C-terminal eGFP coding sequence 
linked to a blasticidin resistance marker by an IRES sequence (full plasmid sequence provided 
in Appendix B). Expression plasmids were sequence verified by Sanger Sequencing prior to 
use. 
Table 2.2 – Primer sequences for PCR amplification of cDNA sequences 
Gene 
Forward primer (5’ flanking 
GGGGACAAGTTTGTACAAAAA
AGCAGGCTTCACC) 
Reverse primer (5’ flanking 
GGGGACCACTTTGTACAAGAAA
GCTGGGTC) 
Dppa2  ATGTCATACTTCGGCCTGGAGA CTACGGCGGCATATTTGGGGGTAG 
Smarca5 ATGTCGTCCGCGGTGGAGCCTC TAGTTTCAGCTTCTTTTTTCTTCC 
Patz1 ATGGAGCGGGTCAACGACGCTT CTTCCCTTCAGGCCCCATGGGCTG 
Carhsp1 ATGTCATCTGAGCCTCCTCCAC GTTGCTGATGACGTGCCCAGACCA 
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2.2 Cell culture 
2.2.1 Culture of mouse embryonic stem cells (mESCs) 
All mouse embryonic stem cells (mESCs) used in this dissertation were grown under 
serum/LIF conditions: DMEM (Gibco, 11995-040), 15% fetal bovine serum (FBS), 1 U/mL 
penicillin - 1 mg/mL streptomycin (Gibco, 15140-122), 0.1 mM nonessential amino acids 
(Gibco, 11140-050), 4 mM GlutaMAX (Gibco, 35050-061), 50 µM β-mercaptoethanol (Gibco, 
31350-010), and 103 U/mL LIF (Stem Cell Institute, Cambridge). mESCs were cultured on 
tissue culture plates coated with immortalised mouse embryonic fibroblast (MEFs) or with 
0.1% gelatin, and maintained in an incubator at 37 ̊C with 5% CO2 humidified atmosphere. 
Media was refreshed every day and the cells passaged every other day with Trypsin EDTA 
(Thermo Fisher Scientific, 25200056). 
2.2.2 Culture of HEK293T 
HEK293T cells were grown in D10 media: DMEM (Gibco, 11995-040), 10% FBS, 1 U/mL 
penicillin - 1 mg/mL streptomycin (Gibco, 15140-122). HEK293T cells were cultured on T175 
tissue culture flasks or 100 mm tissue culture plates and maintained in an incubator at 37 ̊C in 
5% CO2 humidified atmosphere. Media was refreshed every other day and the cells passaged 
every three days with Trypsin EDTA (Thermo Fisher Scientific, 25200056). 
2.2.3 Lentiviral packaging  
2.2.3.1 Individual lentiviruses  
Individual lentiviruses were packaged for experiments in chapter 3 and validation experiments 
in chapter 5 (section 5.2.3) and Appendix J. First, 3.5 million HEK293T cells were seeded into 
100 mm tissue culture plates 24 hours before transfection. The day after, they were 
cotransfected with 3.5 µg of pMD2.G (Addgene, 12259), 6.5 µg of psPAX2 (Addgene, 12260) 
and 10 µg of the lentiviral vector of interest: dCas9-VP64_Blast (Addgene, 61425), MS2-p65-
HSF1_Hygro (Addgene, 61426), sgRNA(MS2)_puro (Addgene, 73795) cloned with an 
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individual sgRNA, or CROP-sgRNA-MS2 cloned with an individual sgRNA. A single-tube 
reaction mix was prepared for each transfection containing the three lentiviral plasmids and 60 
µl of TransIT Reagent (Mirus Bio, 2700) diluted in 1.5 mL of Opti-MEM (Gibco, 31985), 
which was subsequently added drop-wise into the cells cultured in 8.5 mL of fresh media, 
following manufacturer’s instructions. 48 hours later, 10 mL of viral supernatant were 
harvested by filtering through a 0.45 µm filter (Sartorius, 16533). For sgRNA-expressing 
lentivirus from the CROP-sgRNA-MS2 backbone, the 10 mL of viral supernatant were 
concentrated to 800 µL with LentiX Concentrator (Takara, 631231), following manufacturer’s 
instructions, due to the lower viral titer (Datlinger et al. 2017). Before transduction, 
supernatants were supplemented with 8 µg/mL polybrene (Millpore, TR-1003-G) 
2.2.3.2 Pooled sgRNA lentiviral library 
VectorBuilder packaged into lentivirus the 475 sgRNA pooled library cloned into the CROP-
sgRNA-MS2 lentiviral vector. Briefly, the plasmid library was co-transfected with their 
proprietary envelop plasmid encoding VSV-G and packaging plasmids encoding Gag, Pol and 
Rev into HEK293T packaging cells. After a short incubation period, the supernatant was 
collected, followed by removal of cell debris by centrifugation, filtration and polyethylene 
glycol (PEG) concentration of the viral particles. To measure lentiviral titer, HEK293T cells 
were transduced with lentivirus diluted from the stock. Then, a quantitative reverse 
transcription PCR (qPCR)-based approach was used to quantify the average number of 
integration events of the proviral genome per host genome to estimate titer in the original viral 
stock. From the titer provided, I then performed the titration on SAM22 mESCs as described 
in the result section 4.2.2. 
2.2.4 Lentiviral transduction and generation of cell lines 
2.2.4.1 Generation of SAM7 and SAM22 mESCs 
SAM7 and SAM22 mESCs were generated by lentiviral transduction of lenti dCas9-
VP64_Blast (Addgene, 61425) and lenti MS2-p65-HSF1_Hygro (Addgene, 61426) into E14 
mESCs, followed by antibiotic selection and manual subcloning. Briefly, 1.5 million E14 
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mESCs were seeded into 100 mm tissue culture plates and, the day after, they were 
supplemented with 5 mL of a 1:1 lentiviral mixture of dCas9-VP64 and MS2-p65-HSF1 (5 mL 
out of the 20 mL combined viral mixture, see section 2.2.3.1). 24 hours later, cells were washed 
with phosphate-buffered saline (PBS) and subsequently cultured in mESC media supplemented 
with 20 µg/mL blasticidin (InvivoGen, ant-bl-05) and 200 µg/mL hygromycin (InvivoGen, ant-
hg-1). After 10 days of antibiotic selection, 18 individual colonies were picked manually and 
expanded to 24-well plates before DNA isolation (see section 2.3).  
2.2.4.2 Generation of sgRNA-expressing cell lines from the sgRNA 
(MS2)_puro backbone 
Lentiviral transduction of sgRNAs expressed from the sgRNA(MS2)_puro backbone was 
performed on SAM22 mESCs previously cultured for at least 5 days in mESC culture media 
containing 20 µg/mL blasticidin (InvivoGen, ant-bl-05) and 200 µg/mL hygromycin 
(InvivoGen, ant-hg-1) to ensure expression of dCas9-VP64 and MS2-p65-HSF1. After 
collection of the corresponding lentiviral supernatant in 10 mL (see section 2.2.3.1), 1.5 million 
SAM22 mESCs were supplemented with 1 mL of lentivirus diluted in 9 mL of mESC media, 
without blasticidin or hygromycin, and seeded in 100 mm tissue culture plates. 24 hours after 
transduction, the cells were re-infected with 1 mL of lentivirus diluted in 9 mL of regular mESC 
culture media. 24 hours later, cells were washed with PBS and media was replaced to mESC 
media containing 1 µg/mL puromycin. After 6-15 days of antibiotic selection and culture, cells 
were frozen down or harvested for RNA isolation, western-blotting, immunofluorescence 
analysis or 10X Genomics scRNA-seq.  
2.2.4.3 Generation of sgRNA-expressing cell lines from the CROP-
sgRNA-MS2 backbone 
Lentiviral transduction of sgRNAs expressed from the CROP-sgRNA-MS2 backbone was 
performed on SAM22 mESCs previously cultured for at least 5 days in mESC culture media 
containing 20 µg/mL blasticidin (InvivoGen, ant-bl-05) and 200 µg/mL hygromycin 
(InvivoGen, ant-hg-1) to ensure expression of dCas9-VP64 and MS2-p65-HSF1. After 
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collection and concentration of the corresponding lentiviral supernatant to 800 µL (see section 
2.2.3.1), 120,000 SAM22 mESCs were supplemented with all the volume of the concentrated 
lentivirus and seeded in one well of a 24-well plate. 24 hours later, cells were washed with PBS 
and media was replaced to regular mESC culture media. Two days later, media was replaced 
to 1 µg/mL puromycin-containing mESC media and cells were cultured for an extra 7 days 
before being frozen down or harvested for RNA isolation, immunofluorescence analysis or 
10X Genomics scRNA-seq. 
2.2.4.4 Transduction of the pooled sgRNA lentiviral library 
Detailed description of the number of SAM22 mESCs and lentiviral volumes used for 
transduction of the pooled 475 sgRNA lentiviral library is provided in the result section 4.2.2. 
The transduction was performed by direct supplementation of the lentiviral supernatant into 
the cells. 
2.2.5 Other cell lines used 
Dppa2 knock-out (KO) mESCs were previously described in Eckersley-Maslin et al. 2019 and 
Smarca5 (Snf2h) KO mESCs in Barisic et al. 2019. 
2.3 DNA isolation and genomic PCR 
DNA from clones of E14 mESCs transduced with dCas9-VP64 and MS2-p65-HSF1 (see 
section 2.2.4.1) was isolated using AllPrep DNA/RNA mini Kit (Qiagen, 80004). Clones were 
screened for dCas9-VP64 and MS2-p65-HSF1 genomic insertion by PCR using DreamTaq 
DNA Polymerase (Thermo Fisher Scientific, P0701) and primers provided in Table 2.3. The 
resulting PCR products were run in a 1% agarose gel with HyperLadder IV (Biolane, BIO-
33029) (Figure 3.3). 
 
 




Table 2.3 – Primer sequences for genomic PCR of dCas9-VP64 and MS2-p65-HSF1 







2.4 RNA isolation, cDNA synthesis and quantitative reverse 
transcription PCR (qPCR) 
RNA was isolated using RNeasy Mini kit (Qiagen, 74104), RNAasy Micro kit (Qiagen, 74004) 
or AllPrep DNA/RNA mini Kit (Qiagen, 80004) and treated with DNaseI (Thermo Fisher 
Scientific, EN0521) following manufacturer’s instructions. cDNA was synthesised from 0.5-2 
µg of DNAaseI-treated RNA using RevertAid First-Strand cDNA Synthesis Kit (Thermo 
Fisher Scientific, K1622), and diluted 1:10 prior to qPCR. qPCRs were performed in two 
technical replicates using Brilliant III SYBR master mix (Agilent Technologies, 600882) and 
a CFX384 Touch Real-Time PCR Detection System machine (BioRad). Relative levels of 
transcript expression were quantified by the comparative CT method with normalisation to 
Gapdh levels. Primer sequences are provided in Table 2.4. 
Table 2.4 – Primer sequences for qPCR 
Transcript Forward primer  Reverse primer  
sgRNA  
GTTTTAGAGCTAGGCCAACATGA 
(amplify sgRNA scaffold sequence) 
TGGCCAAGTTGATAACGGACT 
(amplify sgRNA scaffold sequence) 
Gapdh GGTGGTGAAGCAGGCATCT CGGCATCGAAGGTGGAAGA 
MERVL  CTTCCATTCACAGCTGCGA GTGCTTCGCATACAGTGCAG 
Zscan4  AGTCTGACTGATGGTGCT GGCCTTGTTGCAGATTGCT 
84 Materials and Methods 
 
(amplify all isoforms) (amplify all isoforms) 
Gm4014 TGTCATGGGCCCAGGTTTAC AGTACACGGTGCGTTCCTTT 
Tcstv3 GGTTTTCGCCAGAAGTGAGA GGAGCTGACAGAAGATCCC 
Gm8994 ACGAGATGCCCATGAACCTG TGGGTCATTTACACGTGCATTA 
Zfp352 CCAGGACCCTGCAATACACA TACAGGTTGTCTCCTGTGTGC 








Dux AGGCCCTGCTATCAACTTTCAAGA CTGAGACCCCCATTCGCTTG 
Pou5f1 GACCGCCCCAATGCCGTGAA TGGTCTGGCTGAACACCTTTCCA 
Nanog CCTCGCCATCACACTGACATGAGT GCAGGTCTTCAGAGGAAGGGCG 
Smarca5 ACGGTACAAAGCACCCTTTCA CTGAGGGGAGTTTCGGATGC 





Tmem92 GGTTCTTGGTCATCCTGGCAT TCCAAGGAGGTGACCCAAATG 
Mreg CCGCTGGTCAGTGGTAACAA  TCCTATCGTCATCCGCCTCT  
Obox6 ATGTCCGCAAGAGTCCCAAG CCCTGGAAACCAGCTCTCAC 
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2.5 Western-blotting 
Total cell extracts were prepared in a detergent buffer (10 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, 10 mM KCl, 0.5% NP-40) containing a protease inhibitor cocktail (Sigma, P2714) and 
incubated at 4°C for 20 minutes, followed by centrifugation (12,000 × g, 10 minutes). Protein 
concentration was quantified with Bio-Rad Protein Assay Dye Reagent (Bio-Rad, 5000006). 
50 µg of protein were resolved in 4-12% SDS-PAGE gels (Expedon, NBT41212) and blotted 
on polyvinylidene difluoride (PVDF) membranes. Membranes were blocked in 3% milk in 
0.01% Tween20 in PBS and incubated overnight at 4°C with primary antibodies diluted in this 
same blocking buffer. Primary antibodies and dilutions used were: 1:1000 rabbit anti-ZSCAN4 
(Millipore, 2793611), 1:1000 mouse anti-β-ACTIN (Abcam, ab6276), 1:500 mouse anti-
DPPA2 (Millipore MAB4356), 1:1000 rabbit anti-OCT4 (Abcam, ab19857), 1:1000 rabbit  
anti-NANOG (Abcam, ab80891) and 1:5000 mouse anti-HSP90 (Abcam, ab13492). After 
washing with 0.01% Tween20 in PBS for 45 minutes (3 washes of 15 minutes each), 
Horseradish peroxidase (HRP)-conjugated secondary antibodies diluted 1:3000 in blocking 
buffer were incubated for 1 hour and subsequently washed with 0.01% Tween20 in PBS for 1 
hour (4 washes of 15 minutes each). Secondary antibodies used were: HRP-conjugated anti-
mouse (Santa Cruz Biotechnology, sc-2005) and HRP-conjugated anti-rabbit (Santa Cruz 
Biotechnology, sc-2004). Detection was carried out with enhanced chemiluminescence (ECL) 
reaction (GE Healthcare, RPN2209) using standard X-ray films. Band intensities were 
quantified using ImageJ software.  
2.6 Immunofluorescence and imaging 
2.6.1 Immunofluorescence and imaging on mESCs 
mESCs were grown on 0.1% gelatin-coated glass coverslips in regular culture conditions and 
then fixed with 4% paraformaldehyde (PFA) (Polysciences, Inc., 18814) for 20 minutes and 
permabilised with 0.5% TritonX-100 in PBS for 30 minutes at room temperature. After 
blocking for 1 hour in 3% bovine serum albumin (BSA) in 0.05% Tween20 in PBS (BS buffer), 
corresponding primary antibodies diluted in BS were incubated either 1 hour at room 
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temperature or overnight at 4°C. Primary antibodies and dilutions used were: 1:200 rabbit anti-
ZSCAN4 (Millipore, 2793611) and 1:250 rabbit anti-DPPA3 (STELLA) (Abcam, ab19878). 
After three 10-minutes washes with BS, the secondary antibody donkey anti-rabbit IgG Alexa 
Fluor (AF)-conjugated 488 (Invitrogen, A21206) diluted 1:1000 in BS was incubated for 30 
minutes at room temperature and washed four times, 15 minutes each, with 0.05% Tween20 in 
PBS. DNA was then counterstained with 5 µg/mL DAPI in PBS and coverslips mounted in 
ProLong Gold Antidade mounting media (Invitrogen, P36934). Single optical sections were 
captured with a Zeiss LSM780 microscope (63x oil-immersion objective) and the images 
pseudo-coloured using Fiji or Adobe Photoshop. For visualisation, images were corrected for 
brightness and contrast, within the recommendations for scientific data. Fluorescence semi-
quantification analysis was performed with Volocity 6.3 (Improvision). 
2.6.2 Immunofluorescence and imaging on embryos 
All mice used in this study were C57BL/6 and were bred and maintained in the Babraham 
Institute Biological Support Unit. All procedures were covered by a project license to Wolf 
Reik under the Animal Scientific Procedures Act 1986, and are locally regulated by the 
Babraham Institute Animal Welfare, Experimentation, and Ethics Committee.  
Embryos were collected from females after superovulation and mating to males. Zygotes were 
collected on the day of plugging and two-cell embryos one day after plugging in M2 media 
(Sigma-Aldrich, MR-015P-5F) containing hyaluronidase (Sigma, H2126). Subsequently, 
embryos were washed in M2 droplets to remove the cumulus cells, fixated with 4% PFA 
(Polysciences, Inc., 18814) for 10 minutes, permeabilised with 0.5% TritonX-100 in PBS for 
1 hour and blocked with BS for another hour. Then, primary antibodies were diluted in BS and 
incubated for 1 hour, followed by 1-hour wash in BS. Next, secondary antibodies diluted in BS 
were incubated for 45 minutes, followed by 30-minutes to 1-hour wash in 0.05% Tween20 in 
PBS. DNA was then counterstained with 5 µg/mL DAPI in PBS and embryos mounted in fibrin 
clots. All incubations were performed at room temperature. Primary antibodies and dilutions 
used were: rabbit 1:100 anti-SMARCA5 (SNF2H) (Abcam, ab72499) and 1:200 mouse anti-
DPPA2 (Millipore, mab4356). Secondary antibodies used were anti-rabbit AF-conjugated 568 
and anti-mouse AF-conjugated 488 (Molecular Probes) and diluted 1:1000. Single optical 
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sections were captured with a Zeiss LSM780 microscope (63x oil-immersion objective) and 
the images pseudo-coloured using ImageJ2. For visualisation, images were corrected for 
brightness and contrast, within the recommendations for scientific data. Fluorescence co-
localisation analysis was performed with Volocity 6.3 (Improvision) in 10 zygotes and 10 two-
cell embryos. Pearson correlation coefficient between SMARCA5 and DPPA2 signals were 
calculated in the area corresponding to the pronuclei or nuclei. The pronuclei in zygotes and 
nuclei of each blastomere in two-cell embryos were measured separately, with values 
comparable within the same embryo. 
2.7 Flow cytometry and fluorescence-activated cell sorting 
(FACS) 
For the 10X Genomics scRNA-seq experiment presented in section 3.2.3 with E14, and 
SAM22 mESCs transduced with MERVL and Zscan4 sgRNAs, 8,000 live single-cells from 
each condition were fluorescence-activated cell sorted (FACS) from a DAPI- population using 
a BD FACSAria III Cell Sorter into 1.5 mL collection tubes (Eppendorf, 0030120086) 
containing 29 µL of 0.1% FBS in PBS. For MOI calculation after transduction of the pooled 
sgRNA lentiviral library (Figures 4.7 and 4.9), mCherry expression was analysed by flow-
cytometry on BD LSR Fortessa from a DAPI- population. For single-cell NOMe, methylation 
and transcription-sequencing (scNMT-seq) analysis of Dppa3 CRISPRa, 44 live SAM22 
mESCs stably transduced with the Dppa3 sgRNA 379 (Appendix C) and 44 live SAM22 
mESCs stably transduced with the non-targeting sgRNA 462 (Appendix C) were single-cell 
FACS sorted for DAPI- on a BD Influx High-Speed Cell Sorter each into a well of a 96-well 
plate (Eppendorf, 0030129512) containing a GpC methyltransferase mix (see section 2.10). 
For screen cDNA validations (section 5.2.3 and Appendix J) and mechanistic experiments of 
Dppa2 and Smarca5 (section 5.2.4), 200,000-500,000 DAPI-/eGFP+ cells were FACS sorted 
on a BD Influx High-Speed Cell Sorter Sorter into 1.5 mL collection tubes (Eppendorf, 
0030120086) and tdTomato fluorescence was also recorded for Dppa2 WT and KO mESCs 
(Eckersley-Maslin et al. 2019) (Figure 5.33) and analysed using FlowJo v10. 
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2.8 Bulk RNA-sequencing 
2.8.1 Preparation of libraries and sequencing 
All bulk RNA-sequencing libraries were prepared from 1 µg of DNaseI-treated RNA using 
Sanger Institute Illumina bespoke pipelines. E14, SAM7 and SAM22 mESC libraries (section 
3.2.1) were opposite strand-specific total RNA libraries (ribozero) and sequenced at 100 bp 
paired-end on the Illumina HiSeq2500 Rapid Run platform. MERVL LTR and Zscan4 
CRISPRa libraries (section 3.2.2) were opposite strand-specific total RNA libraries (ribozero) 
and sequenced at 50 bp single-end on the Illumina HiSeq2500 Rapid Run platform. Dppa2, 
Smarca5, Patz1 and Carhsp1 CRISPRa and cDNA overexpression libraries (section 5.2.3), as 
well as those presented in Appendix J, were opposite strand-specific polyA RNA libraries and 
sequenced at 50 bp single-end on Illumina HiSeq4000. 
2.8.2 Data processing and analysis 
For processing of all bulk RNA-sequencing data, raw FastQ files were trimmed with Trim 
Galore (v0.4.1-v0.6.1, default parameters) and mapped to the mouse mm10 genome assembly 
using TopHat2 (v2.0.12) (D. Kim et al. 2013) or Hisat2 (v2.0.5) (D. Kim et al. 2015), as guided 
by known splice sites taken from Ensembl v70-v96. Hits were filtered to remove mappings 
with MAPQ scores <20. For alignments to dCas9-VP64 and MS2-p65-HSF1 exogenous 
transcripts in E14, SAM7 and SAM22 data (Figure 3.4), two artificial chromosomes were 
constructed with the sequences between both LTRs for each lentiviral plasmid (Figure 3.2) and 
reads were mapped as described for mm10 genome assembly.  
Data were quantified at mRNA level using the RNA-sequencing quantification pipeline in 
SeqMonk software (www.bioinformatics.babraham.ac.uk/projects/seqmonk/) with strand-
specific quantification using mRNA probes. For dCas9-VP64 and MS2-p65-HSF1 
quantification, the reads mapping to the two artificial chromosomes were integrated to the 
mm10 genome assembly to quantify their expression in relation to the whole transcriptome 
(Figure 3.4). Differential gene expression analysis were done with different parameters for the 
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different datasets, as specified in each figure caption, using EdgeR, DESeq2 and/or and 
intensity difference filters. 
For alignments to repetitive regions in the genome, artificial repeat genomes were constructed 
from repeat annotations downloaded from the UCSC table browser (RepeatMasker, mm10). 
Sequences of the list of repeat element instances were stitched together separated by ‘NNNNN’ 
to create repeat-specific genomes. Trimmed reads from each sample were aligned against all 
individual repeat genomes using Bowtie2 (v1.0.1-v2.3.3, default parameters) (Langmead & 
Salzberg 2012). Values reported are cumulative reads mapping to a specific repeat group as 
percentage of the total read count (Figures 3.10 and 5.23) 
2.9 10X Genomics single-cell RNA-sequencing (scRNA-seq) 
2.9.1 Library preparation and sequencing 
2.9.1.1 Sample and 10X Genomics V2 library preparation 
The sample preparation to obtain a single cell suspension to be loaded into the 10X Genomics 
Chromium controller was optimised over the course of this dissertation. Briefly, in the first 
experiment to analyse CRISPRa of MERVL LTR and Zscan4 (section 3.2.3), cells were 
washed with PBS, trypsinised as usual, spin down, resuspended in PBS, passed through a 50 
µm cell strainer (Thermo Fisher Scientific, NC9667434) and FACS sorted with a DAPI 
live/dead staining to collect the appropriate number of live cells (see section 2.7). This sample 
preparation procedure resulted in low cell capture rate (24.5-29.5%) in the 10X libraries (Figure 
3.19) with a prominent population of low-quality cells (Figure 3.20). Subsequently, the sample 
preparation procedure was optimised, resulting in the following protocol which rendered a 
capture efficiency of 71% (Figure 4.11) and good quality of most of the cells captured (Figure 
4.12): cells in culture in 150 mm plates were washed twice with PBS and trypsinised for 2 
minutes with 3 mL of Trypsin EDTA (Thermo Fisher Scientific, 25200056); then 5 mL of 
mESC media were added to the plate and a single cell suspension was obtained by gently 
pipetting up and down 10-15 times; next, an extra 17 mL of media were added to obtain a final 
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volume of 25 mL cell suspension which were spin down (300 × g, 3 minutes) and the resulting 
pellet resuspended in 1 mL of 0.1% FBS in PBS; this cell suspension was then passed twice 
through 50 µm cell strainers (Thermo Fisher Scientific, NC9667434) and diluted in a total of 
5 mL of 0.1% FBS in PBS; cells were then counted in three biological replicates and two 
technical replicates in a NucleoCounter NC-3000 (Chemometec) using a viability dye; only 
samples with > 90% viability were taken forward; lastly, the counted cell suspension was spin 
down (300 × g, 3 minutes) and resuspended in the appropriate volume to obtain a sample 
concentration of 600 cells / µL, from which 34 µL were loaded in each lane of the 10X 
Genomics Chromium controller chip to aim to recover 10,000 cells per lane. 
In the CRISPRa experiment of MERVL LTR and Zscan4 (section 3.2.3), a 8,000-cell 
suspension from each the following samples were loaded each in a lane of the 10X Genomics 
Chromium Controller chip: E14 mESCs, SAM22 mESCs, SAM22 mESCs transduced with the 
non-targeting sgRNA control 1, SAM22 mESCs transduced with the MERVL LTR sgRNAs 1 
and 3 individually and pooled at the time of sequencing, and SAM22 mESCs transduced with 
the Zscan4 sgRNAs 1 and 3 individually and pooled at the time of sequencing (see Appendix 
C for sgRNA sequences). sgRNAs for this experiment were cloned in the sgRNA(MS2)_puro 
backbone. Droplet formation in the sample of untransduced SAM22 mESCs failed (data not 
shown) and was not carried forward.  
In the CRISPRa experiment from section 3.2.4 using MERVL sgRNA 1, Zscan4 sgRNA 1, 
Dppa4 sgRNAs 1 and 2, Kdm5b sgRNAs 1 and 2, Dux sgRNAs 1 and 2 and Dppa3 sgRNAs 
1 and 2 (see Appendix C for sgRNA sequences), SAM22 mESCs were individually transduced 
with lentiviruses encoding each of these sgRNAs cloned in the CROP-sgRNA-MS2 backbone 
and pooled at equal ratios at the time of sequencing. A 10,000-cell suspension of the pool of 
cells was loaded in one lane of the 10X Genomics Chromium Controller chip.  
In the CRISPRa screen experiment of SAM22 mESCs transduced with the pooled 475 sgRNA 
lentiviral library (chapters 4 and 5), each transduction replicate was loaded across a full 10X 
Chromium Controller chip (8 lanes), with 20,000 cells per lane. In all 10X Genomics scRNA-
seq experiments, libraries were prepared using the 10X V2 Single Cell 3′ Solution kit (10X 
Genomics) following manufacturer’s instructions. 
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2.9.1.2 Amplicon sgRNA libraries 
All amplicon sgRNA PCRs were performed on full length cDNA samples obtained during the 
library preparation protocol of 10X Genomics V2 scRNA-seq libraries, as previously described 
(Hill et al. 2018). Briefly, 10 ng of full length 10X cDNA were used as starting material and 
each round of PCR amplification, using with the primers described in Table 2.5 and Figure 
3.31, was monitored by KAPA SYBR (Kapa Biosystems, KR0389) to avoid overcycling. The 
PCR products obtained after each PCR round were cleaned-up with 1X AMPure XP beads 
(Beckman Coulter, A63881) and eluted in 20 µL. The second and third rounds of PCR were 
done with 1 µL of a 1:25 dilution of the PCR product from the first and second rounds, 
respectively. In the pilot test described in chapter 3 (section 3.2.4), the number of cycles for 
each round of amplification are detailed in Figure 3.32. In the CRISPRa screen experiment of 
SAM22 mESCs transduced with the pooled 475 sgRNA lentiviral library, 11 cycles were used 
in PCR 1, 17 cycles in PCR 2 and 11 cycles in PCR 3. The final amplicon libraries were 
analysed on a bioanalyzer instrument (Aligent), as shown in Figure 3.33, and multiplexed 
before sequencing. 
Table 2.5– Primer sequences for amplicon sgRNA libraries 
PCR 
round 
Forward primer  Reverse primer  
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2.9.1.3 Sequencing 
In the MERVL LTR and Zscan4 CRISPRa experiment (section 3.2.3), each 10X library was 
sequenced on an Illumina HiSeq4000 lane with 75 cycles for read 1, 75 cycles for read 2 and 
8 cycles for i7 sample index. 1,956 E14 mESCs, 2,045 SAM22 mESCs transduced with the 
non-targeting sgRNA control 1, 2,233 SAM22 mESCs transduced with the MERVL LTR 
sgRNAs 1 and 3 and 2,362 SAM22 mESCs transduced with the Zscan4 sgRNAs 1 and 3 were 
captured, based on number of cell barcodes detected, before quality control, with a total of 
21,371 genes detected in the dataset. 
In the CRISPRa experiment from section 3.2.4, the 10X library was sequenced on an Illumina 
HiSeq4000 lane with 26 cycles for read 1, 98 cycles for read 2 and 8 cycles for i7 sample index. 
A total of 3,644 cells were captured based on number of cell barcodes detected, with a total of 
19,571 genes detected, before quality control processing. The amplicon sgRNA library was 
sequenced in a lane of the Illumina Hiseq2500 Rapid Run platform, with 27 cycles for read 1, 
267 cycles for read 2 and 8 cycles for i7 sample index.  
In the CRISPRa screen experiment of SAM22 mESCs transduced with the pooled 475 sgRNA 
lentiviral library (chapters 4 and 5), each 10X library was sequenced on an Illumina HiSeq4000 
lane with 26 cycles for read 1, 98 cycles for read 2 and 8 cycles for i7 sample index. A total of 
114,866 cells were captured for replicate 1, 118,646 cells for replicate 2 and 107,591cells for 
replicate 3, based on number of cell barcodes detected, which, after merging transduction 
replicates, resulted in a dataset of 341,103 cells with a total of 23,760 genes detected before 
quality control processing. The amplicon sgRNA libraries were sequenced across two lanes of 
the Illumina Hiseq2500 Rapid Run, with 27 cycles for read 1, 267 cycles for read 2 and 8 cycles 
for i7 sample index. 
2.9.2 Data processing and analysis 
2.9.2.1 Pilot test in section 3.2.3 
10X Genomics scRNA-seq data was processed with the default CellRanger v2.1 pipeline (G. 
X. Y. Zheng et al. 2017) for mapping to the mm10 mouse genome assembly. Gene counts were 
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further analysed with scanpy (Wolf et al. 2018). To keep only high-quality data and discard 
potential cell doublets, the following criteria was used to filter cells out: cells with less than 
15,000 and more than 40,000 UMI counts; cells with less than 4,000 and more than 6,500 
detected genes; and cells with more than 5% of UMI reads coming from mitochondrial genes 
(Figure 3.20). After this quality control, 1,138 E14 mESCs, 687 SAM22 mESCs transduced 
with the non-targeting sgRNA control 1, 1,227 SAM22 mESCs transduced with the MERVL 
LTR sgRNAs 1 and 3, and 899 SAM22 mESCs transduced with the Zscan4 sgRNAs 1 and 3 
were retained for analysis.  
A gene was considered for downstream analysis if it was detected (UMI count >0) in at least 
10 cells that passed the quality control filter across the full dataset. The final dataset consisted 
of 16,498 genes across 3,951 cells. The number of UMIs for each cell and gene were adjusted 
by the library size in each cell, dividing by the total number of UMIs per cell. Gene expression 
levels were obtained as loge-transformed adjusted UMI counts, scaled by a factor of 10,000. 
Quantification of MERVL repeat elements was done as described in section 2.9.2.3.5. 
Differentially expressed genes were estimated with EdgeR, false discovery rate (FDR) <5% 
(Figure 3.26). 
2.9.2.2 Pilot test in section 3.2.4 
In this test, the whole-transcriptome standard 10X V2 libraries were constructed and sequenced 
as described in section 2.9.1, but they were not formally processed or analysed. This 
experiment was primarily used to test and optimise the protocol to perform amplicon sgRNA 
libraries. In these libraries, the potential sgRNA sequence (nucleotides 24-43 of the read) was 
compared to the collection of 11 possible sgRNAs and the number of barcodes recovered 
associated with a sgRNA was calculated (Figure 3.34). 
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2.9.2.3 Pooled screen with 475 sgRNAs 
2.9.2.3.1 Data processing, quality control and gene expression 
quantification 
10X Genomics scRNA-seq data was processed with the default CellRanger v2.1 pipeline (G. 
X. Y. Zheng et al. 2017) for mapping to the mm10 mouse genome assembly. Gene counts were 
further analysed with scanpy (Wolf et al. 2018). To keep only high-quality data and discard 
potential cell doublets, the following criteria was used to filter cells out: cells with less than 
4,000 and more than 20,000 UMI counts; cells with less than 1,600 and more than 5,000 
detected genes; and cells with more than 5% of UMI reads coming from mitochondrial genes 
(Figure 4.12). After filtering, 109,061 cells were retained from replicate 1, 118,646 cells from 
replicate 2 and 107,591 cells from replicate 3. Next, cells were assigned a sgRNA using the 
amplicon sgRNA libraries (see section 2.9.2.3.2) and cells that were not uniquely assigned to 
one sgRNA were discarded for downstream analysis. This resulted in 71,047 cells in replicate 
1, 71,188 cells in replicate 2 and 61,729 cells in replicate 3, which corresponds to 203,894 cells 
in total across all replicate sets (Figure 4.13).  
A gene was considered for downstream analysis if it was detected (UMI count >0) in at least 
10 out of the 203,894 cells that passed quality control filtering. The final dataset after quality 
control consisted of 20,690 genes. The number of UMIs for each cell and gene were adjusted 
by the library size in each cell, dividing by the total number of UMIs per cell. Gene expression 
levels were obtained as loge-transformed adjusted UMI counts, scaled by a factor of 10,000.  
For principal component analysis (PCA) (Figures 4.17, 5.2 and 5.4), 965 highly variable genes 
were selected (Appendices E and F), as implemented in scanpy (Wolf et al. 2018) with 
minimum mean of 0.01, maximum mean of 5 and minimum dispersion of 0.5. Uniform 
Manifold Approximation and Projection (UMAP) (Figure 4.17) was also performed on the 965 
highly variable genes, as implemented in scanpy (Wolf et al. 2018), with a spread of 3.0. 
For mapping dCas9-VP64 and MS2-p65-HSF1 transcripts, reads discarded by CellRanger 
pipeline for not aligning to the mm10 mouse genome assembly were mapped to an artificial 
genome assembly containing the integration sequences between the 3’ and 5’ LTR of the 
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corresponding lentiviral vectors (Figure 3.2), using BWA (version 0.7.17-r1188, default 
parameters) (Heng Li & Durbin 2009). Reads sharing a UMI and a cell barcode were then 
collapsed to estimate the number of transcript reads per cell (Figure 4.21). 
2.9.2.3.2 Assignment of sgRNAs to cells 
Using the amplicon sgRNA libraries, the potential sgRNA sequence (nucleotides 24-43 of the 
read) was compared to the collection of 475 designed sgRNAs. By taking only exact matches 
to the white list of sgRNAs, most of the 475 sgRNA sequences were recovered (470-474, 
variable from one library to another) and 16% of reads on average (15.3%-16.8% for different 
libraries) were left unassigned to a sgRNA. To correct for PCR and sequencing errors, a 
minimum edit distance (Levenshtein distance – 4 edits) was allowed between any two 
sequences of the designed sgRNAs as well as the CROP-sgRNA-MS2 vector sequence 
surrounding the potential sgRNA in the read. For the reads left unassigned to a sgRNA at this 
stage, if there was a sgRNA sequence within Levenshtein distance of 1 or 2 and if the 23 
nucleotides upstream and 23 nucleotides downstream matched the CROP-sgRNA-MS2 vector 
sequence with up to 4 edits each, the respective sgRNA was assigned to the read. After this 
correction procedure, approximately 2% of amplicon reads were left unassigned. Cell barcodes 
detected in the amplicon libraries were then matched with barcodes detected in the regular 10X 
Genomics scRNA-seq libraries. Out of the 317,847 cells that passed quality control across the 
three transduction replicates in the regular 10X libraries, 249,767 cell barcodes were captured 
in the amplicon sgRNA libraries (85,993 in replicate 1, 86,671 in replicate 2 and 77,103 in 
replicate 3). A sgRNA was assigned to a cell if more than 90% of all the amplicon reads 
containing the sgRNA had the same cell barcode, with a standard error of binomial proportion 
of less than 10% (e.g. more than 8 reads if all the barcodes are associated with the same sgRNA, 
13 reads of the same sgRNA if there were more than one sgRNA for a cell barcode, etc.). Table 
2.6 illustrates cell numbers and percentages for each assignment in each transduction replicate 
(see also Figure 4.13):  
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Table 2.6– Assignment of sgRNA to cells in CRISPRa scRNAseq screen 




85,933 No sgRNA 397 0.46 
85,933 Unique sgRNA 71,047 82.62 
85,933 Two sgRNAs 3,028 3.52 
85,933 Multiple sgRNAs 11,521 13.40 
2 
86,671 No sgRNA 400 0.46 
86,671 Unique sgRNA 71,118 82.14 
86,671 Two sgRNAs 3,210 3.70 
86,671 Multiple sgRNAs 11,873 13.70 
3 
77,103 No sgRNA 381 0.49 
77,103 Unique sgRNA 61,729 80.06 
77,103 Two sgRNAs 3,084 4.00 
77,103 Multiple sgRNAs 11,909 15.45 
 
2.9.2.3.3 Target gene activation 
In chapter 4, section 4.2.4, to call activated (higher target gene expression than the basal level 
in non-targeting sgRNA controls) and not-activated (equal or lower target gene expression than 
the basal level in non-targeting sgRNA controls) cells for each targeting sgRNA, an empirical 
p-value was obtained for the expression the corresponding target gene in every cell transduced 
with such sgRNA after calculating the percentage of cells with a non-targeting sgRNA control 
that had the same or higher target gene expression. These empirical p-values were then adjusted 
using Benjamini-Hochberg multiple testing correction. Cells with an FDR of >10% were called 
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not-activated for the target gene and cells with an FDR of <10% were called activated for the 
target gene (Figure 4.18 and Appendix C).  
2.9.2.3.4 sgRNA off-target effects estimation 
To estimate off-target effects for each targeting sgRNA, the sgRNA sequence followed by an 
NRG PAM (where N can be any nucleotide and R can be A or G), was mapped to the mm10 
mouse genome using BWA (version 0.7.17-r1188) (Heng Li & Durbin 2009) with the 
following parameters: bwa aln -n 5 -l 10 -k 5, which means a maximum of 5 mismatches, a 
seed length of 10 and a maximum difference of 5 nucleotides in the seed; and bwa samse -n 
100, to obtain and report up to 100 alignments per sgRNA. After interpreting the results, 
sgRNAs were classified in Appendix C as not having or potentially having off-target effects 
(multi-mapping). Only 9 out of 458 targeting sgRNAs (excluding MERVL LTR sgRNAs) 
mapped to multiple regions of the genome with up to 5 mismatches. 
2.9.2.3.5 Quantification of repeat elements 
All occurrences in the genome of repeat sequences from 12 repeat families (LINE-1, LINE-2, 
ERV1, ERVK, MERVL, Major satellites, Minor satellites, Ribosomal RNA, SINE Alu B1, 
SINE B2, SINE B4, Telomeric repeats), with each respective genomic locations were 
downloaded from the UCSC table browser (RepeatMasker, mm10, Nov 2018), concatenated 
and treated as a reference genome to map the reads discarded by CellRanger pipeline, due to 
mapping to multiple regions, using SAMtools (Heng Li et al. 2009) and BWA (version 0.7.17-
r1188, default parameters) (Heng Li & Durbin 2009). The following number of reads were 
discarded by CellRanger pipeline in each transduction replicate: 253,330,874 reads in replicate 
1, 276,401,843 reads in replicate 2 and 242,863,617 reads in replicate 3, out of which 
38,792,331 (15.31%) in replicate 1, 37,285,351 (13.49%) in replicate 2 and 25,837,444 
(10.64%) mapped to repeat elements. LINE-2 elements and minor satellite repeats were 
discarded for downstream analysis due to inefficient mapping (Table 2.7). Reads sharing a 
UMI and a cell barcode were then collapsed in order to get an estimate of the number of 
molecules for each repeat family in every cell (Figure 5.6). 
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Table 2.7– Number of mapped scRNA-seq reads to each repeat family 







Major Satellites 305,524 
Minor Satellites 3 
Ribosomal RNA 
(rRNA) 773 
SINE Alu B1 398,331 
SINE B2 4,583,807 
SINE B4 464,024 







Major Satellites 318,816 
Minor Satellites 2 
Ribosomal RNA 
(rRNA) 846 
SINE Alu B1 457,910 
SINE B2 5,341,151 
SINE B4 533,479 
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Major Satellites 173,969 
Minor Satellites 4 
Ribosomal RNA 
(rRNA) 551 
SINE Alu B1 370,782 
SINE B2 4,226,418 
SINE B4 427,651 
Telomeric repeats 394 
 
2.9.2.3.6 Multi-omics factor analysis (MOFA) model 
A hierarchical Bayesian model, as implemented in an extension of multi-omics factor analysis 
(MOFA) (Argelaguet et al. unpublished), was trained on two views: first, the set of 965 highly 
variable protein-coding genes used for PCA and UMAP (see section 2.9.2.3.1), and second, 
the expression levels of eight repeat families (LINE-1, ERV1, ERVK, MERVL, Major 
satellites, SINE Alu B1, SINE B2 and SINE B4). Ribosomal RNA (rRNA) and telomeric 
repeats were excluded from the model due to low detection rate (Figure 5.6). The sgRNA-cell 
assignment was provided to the model in order to take advantage of group-wise sparsity of the 
model (Figure 5.5). Upon interpreting the first five factors using their top loadings of variance 
explained (Appendices G and H, Figures 5.7-5.9), factor 3 was interpreted as a ZGA-like factor 
due to its top loadings (both protein-coding genes and MERVL repeat) being associated to 
ZGA. 
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2.9.2.3.7 Identification of screen hits 
MOFA factor 3 was used to reconstruct the expression dataset for each group of cells (grouped 
by sgRNA expression) to calculate the variance explained by factor 3 for each group. Average 
fraction of expression variance for protein-coding genes and repeat elements was then used to 
rank the 460 targeting sgRNAs (Appendix C), with higher percent of variance explained being 
attributed to sgRNAs with more potency to induce a ZGA-like transcriptional signature. For 
hit calling, the average and one standard deviation of the fraction of expression variance 
explained by MOFA factor 3 for cells expressing the fifteen different non-targeting sgRNA 
controls was estimated as a background rate, and sgRNAs ranking higher than the standard 
deviation above the mean were considered hits (Figure 5.10, Appendix C). Higher fraction of 
expression variance explained by MOFA factor 3 correlated with higher factor 3 values and 
hence higher expression of ZGA-like transcripts (Figures 5.11 and 5.12).  
2.9.2.3.8 Differential gene expression analysis 
First, for every targeting sgRNA, differential gene expression was assessed between targeted 
and non-targeted cells transcriptome-wide using a generalised linear model (glm), as 
implemented in EdgeR, fitted for every gene and a likelihood ratio test to estimate the effect of 
the targeting sgRNA on the gene’s level of expression (Robinson et al. 2010). Using an FDR 
<10%, few genes were found to be differentially expressed (Appendix C). Consequently, an 
FDR <100% was applied to rank the top 400 upregulated genes by their FDR in cells expressing 
each targeting sgRNA compared to non-targeting sgRNA controls. Then, the rank was 
intersected with a list of known ZGA genes (as described in Appendix I) to assess the 
enrichment of known ZGA transcripts amongst the differentially expressed genes by each 
sgRNA (Figure 5.15, Appendix C). 
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2.10 Single-cell NOMe, methylation and transcription-sequencing 
(scNMT-seq) 
2.10.1  Preparation of libraries and sequencing 
scNMT-seq libraries for Dppa3 CRISPRa were generated as described in Clark et al. 2018. 
Briefly, 44 live SAM22 mESCs stably transduced with the Dppa3 sgRNA 379 (Appendix C) 
and 44 live SAM22 mESCs stably transduced with the non-targeting sgRNA 462 (Appendix 
C) were single-cell FACS sorted for DAPI- (see section 2.7) into a GpC methyltransferase-
containing mix (M.CviPI, NEB), which was used to label open chromatin by incubation at 
37°C for 15 minutes. Subsequently, the RNA and DNA were physically separated using 
oligo(d)T-conjugated beads. Then, the RNA was processed on the one hand to obtain the 
transcriptome information, and the DNA was bisulfite-treated and libraries processed on the 
other hand to obtain chromatin accessibility and DNA methylation information, as described 
in Clark et al. 2018. Additionally, eight negative controls were included for quality checks: 
four containing the GpC methylase mix without a cell and four containing a cell and reaction 
mix but without the GpC enzyme. The multiplexed scRNA-seq libraries were sequenced at 75 
bp paired-end on the Illumina NextSeq500 MidOutput and the multiplexed single-cell bisulfite 
and NOMe libraries were sequenced at 100 bp paired-end on the Illumina HiSeq2500 Rapid 
Run platform.  
2.10.2  Data processing, quality control and quantifications 
Raw FastQ files of scRNA-seq data were trimmed with Trim Galore (v0.4.1-v0.6.1, default 
parameters) and mapped to the mouse mm10 genome assembly using Hisat2 (v2.0.5) (D. Kim 
et al. 2015) with the options –dta –sp1000,1000 –no-mixed –no-discordant. Single-cell bisulfite 
and NOMe libraries were trimmed with Trim Galore (v0.6.1, default parameters) and mapped 
to the mouse mm10 genome assembly using Bismark (v0.20.1) (F. Krueger & Andrews 2011) 
with the –NOMe option. 
For scRNA-seq quality control, cells with less than 3,500 genes were discarded, resulting in a 
dataset of 59 single-cell transcriptomes, 38 expressing the Dppa3 sgRNA 379 and 21 
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expressing the non-targeting sgRNA control 462 (Figure 4.37). Gene expression was quantified 
at mRNA level based on Ensembl v96 using the RNA-sequencing quantification pipeline in 
SeqMonk software (www.bioinformatics.babraham.ac.uk/projects/seqmonk/). 
For chromatin accessibility analysis, cells with less than 5,000,000 GpC sites covered were 
discarded, resulting in 58 cells that passed this quality control in the dataset, 27 expressing the 
Dppa3 sgRNA 379 and 31 expressing the non-targeting sgRNA control 462. Percentage global 
accessibility for each cell was calculated as the percentage of methylated GpCs over total GpCs 
in 10 kilobases windows that had a minimum of 10 GpC sites (Figure 4.38). 
For DNA methylation analysis, cells with less than 500,000 CpG sites covered were discarded, 
resulting in 59 cells that passed this quality control in the dataset, 27 expressing the Dppa3 
sgRNA 379 and 32 expressing the non-targeting sgRNA control 462. Percentage methylation 
for each cell was calculated as the percentage of methylated CpGs over total CpGs in 10 
kilobases windows that had a minimum of 10 CpG sites (Figure 4.40). 
In the correlation analysis between Dppa3 promoter accessibility and Dppa3 expression, only 
cells that passed quality control criteria for both omics and had at least 10 GpC sites covered 
in the Dppa3 promoter region (1.5 kilobases upstream and 0.5 kilobases downstream of the 
Dppa3 TSS) were analysed, resulting in a total of 21 cells, 11 expressing the Dppa3 sgRNA 
379 and 10 expressing the non-targeting sgRNA control 462 (Figure 4.39). Percentage 
chromatin accessibility in the Dppa3 promoter was calculated as the percentage of methylated 
GpCs over total GpCs. In the correlation analysis between Dppa3 promoter DNA methylation 
and Dppa3 expression, only cells that passed quality control criteria for both omics were 
analysed, resulting in a total of 30 cells, 17 expressing the Dppa3 sgRNA 379 and 13 expressing 
the non-targeting sgRNA control 462 (Figure 4.41). Percentage DNA methylation in the Dppa3 
promoter was calculated as the percent of methylated CpG over total CpG, without a thereshold 
for a minimum number of observations. 
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2.11 Data processing and analysis of published sequencing 
datasets 
The RNA-sequencing datasets from Xue et al. 2013, Eckersley-Maslin et al. 2019, Rulands et 
al. 2018, Deng et al. 2014 and Barisic et al. 2019 were processed and quantified as described 
in section 2.8.2. Transcriptional variability between single cells from Rulands et al. 2018 was 
quantified as follows: highly variable genes were calculated considering the over-dispersion 
observed in scRNA-seq data (Brennecke et al. 2013); a score of variability per gene was 
calculated by fitting the squared coefficient of variation as a function of the mean normalised 
counts and then calculating the distance to a rolling average (window size=100); to minimize 
the bias due to lowly expressed genes, only genes with a mean greater than 10 were used.  
For processing of ATAC-sequencing (King et al. 2018; Dongwei Li et al. 2017), DNase-
sequencing (ENCODE) and ChIP-sequencing (Hernandez et al. 2018; Bilodeau et al. 2009; 
Neri et al. 2017) data, raw FastQ files were trimmed with Trim Galore (v0.6.1, default 
parameters) and mapped to the mouse mm10 genome assembly using Bowtie2 (v2.3.3, default 
parameters) (Langmead & Salzberg 2012). Hits were filtered to remove mappings with MAPQ 
scores <20. Log2 normalised read counts were quantified over promoters defined as the region 
1 kilobase upstream of the gene TSS. 
For processing of whole-genome bisulfite sequencing libraries from Ficz et al. 2013, Habibi et 
al. 2013, Milagre et al. 2017 and Berrens et al. 2017, raw FastQ files were trimmed with Trim 
Galore (v0.6.1, default parameters) and mapped to the mouse mm10 genome assembly using 
Bismark (v0.20.1, default parameters) (F. Krueger & Andrews 2011). CpG methylation calls 
were extracted and analysed using SeqMonk software 
(www.bioinformatics.babraham.ac.uk/projects/seqmonk/). Methylation over promoters, 
defined as the region 1 kilobase upstream of the gene TSS, was calculated as the percentage of 
methylated CpGs over total CpGs considering only CpG sites covered by at least 10 reads and 
only promoters with at least 10 CpGs covered.  
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2.12 Other software and data representation 
For screen candidate selection in section 4.2.1, mouse proteins associated with nucleic acid 
binding and transcription factor activities were extracted from the PANTHER 
(http://pantherdb.org) (Mi et al. 2019) protein classes PC00171 and PC00218. Motif 
enrichment and discovery analysis on the promoters of activated and not-activated genes, as 
described in section 4.2.4, was performed using AME and DREME tools from the MEME suite 
(http://meme-suite.org/index.html) (Bailey et al. 2009). Gene ontology analysis for gene 
loadings of PCA components (Appendix F) and MOFA factors (Appendix H), as described in 
section 5.2.1, was performed with Gorilla (http://cbl-gorilla.cs.technion.ac.il) (Eden et al. 
2009). Graphs and illustrations were generated with RStudio, SeqMonk, GraphPad Prism, 
Microsoft Excel and Illustrator software.  
2.13 Sequencing data availability 
The following sequencing data has been deposited in GEO (GSE135622): bulk RNA-
sequencing of SAM22 and E14 mESCs; scRNA-seq of E14 and CRISPRa of MERVL LTRs 
and Zscan4; scRNA-seq of CRISPRa screen data; and bulk RNA-sequencing of CRISPRa and 
cDNA overexpression of Dppa2, Smarca5, Patz1 and Carhsp1. 
 
Chapter 3 Development of CRISPR activation at 
single-cell RNA-sequencing resolution 
3.1 Background and summary 
The aim of my thesis is to comprehensively understand the regulation of ZGA, a crucial 
transcriptional event that occurs early after fertilisation (reviewed in Eckersley-Maslin, Alda-
Catalinas & Reik 2018; Svoboda 2017; Jukam et al. 2017; Yartseva & Giraldez 2015). 
However, screening in early mouse embryos is not feasible at a high-throughput level due to 
the scarcity of material, maternal stores of proteins and complex manipulation techniques 
required. Recent studies have shown that a major ZGA-like state can be mimicked in mouse 
embryonic stem cells (mESCs) (Macfarlan et al. 2012; Zalzman et al. 2010; Bošković et al. 
2014; Ishiuchi et al. 2015; Akiyama et al. 2015; Eckersley-Maslin et al. 2016; Rodriguez-
Terrones et al. 2018). These cells are termed 2C-like cells as they partially resemble the two-
cell embryo. Consequently, they represent an ideal system for in vitro screening and have been 
previously used to identify regulators of ZGA (Rodriguez-Terrones et al. 2018; Eckersley-
Maslin et al. 2019; X. Fu et al. 2019; Y.-L. Yan et al. 2019).  
Most of the regulators of 2C-like cells identified to date are repressors of this state (Macfarlan 
et al. 2011; Rowe et al. 2010; Macfarlan et al. 2012; Ishiuchi et al. 2015; Percharde et al. 2018; 
Rodriguez-Terrones et al. 2018; Choi et al. 2017; Maksakova et al. 2013; Storm et al. 2014; 
Schoorlemmer et al. 2014; Hisada et al. 2012; X. Fu et al. 2019; Y.-L. Yan et al. 2019) (see 
section 1.2.3) and, therefore, cannot explain how ZGA is triggered in the embryo. The 
identification of positive inducers of ZGA is more relevant given the transcriptionally inactive 
state prior to ZGA. During the course of this dissertation, DUX was reported as positive crucial 
regulator of ZGA in mouse and human ESCs (Hendrickson et al. 2017; De Iaco et al. 2017; 
Whiddon et al. 2017). However, Dux is only expressed at the onset of ZGA (Hendrickson et 
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al. 2017; De Iaco et al. 2017), which raises the question of what are the maternally-deposited 
proteins that activate Dux. Furthermore, recent studies have shown that mouse and human 
embryos that lack maternal and/or zygotic Dux are not heavily compromised (Iaco et al. 2019; 
Z. Chen & Yi Zhang 2019; Vuoristo et al. 2019), indicating that DUX is a non-essential 
synchronizer of ZGA and suggesting redundancy in the regulation of ZGA.  
All of these positive and negative regulators were identified using reporter constructs of two 
well-characterised ZGA transcripts: MERVL (Kigami 2002; Peaston et al. 2004; Svoboda et 
al. 2004; Macfarlan et al. 2012) and Zscan4 gene cluster (Falco et al. 2007; Ishiguro, Nakatake, 
et al. 2016; Zalzman et al. 2010). Even though the single and double positive populations of 
mESCs for these reporters recapitulate well the two-cell embryo at the time of major ZGA, 
their transcriptome and epigenome are not identical (reviewed in Ishiuchi & Torres-Padilla 
2013; Eckersley-Maslin, Alda-Catalinas & Reik 2018). Consequently, the use of whole 
transcriptome read-out in a mESC screen could benefit from potentially identifying regulators 
that trigger a wider ZGA response than the one observed in 2C-like cells. Moreover, such a 
screen design requires a method to overexpress those potential ZGA regulators in a high-
throughput manner, reasoning that their upregulation could induce a ZGA signature. On the 
contrary, screening by knocking-out or downregulating the expression of candidates would 
only identify repressors of the 2C-like state, which might act in vivo by repressing ZGA 
transcripts after the two-cell stage, but could not identify regulators that trigger ZGA. 
CRISPRa is a potent tool for selective transcriptional activation of endogenous genes. Using 
sgRNAs targeted upstream of TSSs together with a catalytically-inactive Cas9 (or dead Cas9, 
dCas9) and transcriptional co-activators, RNA polymerases can be recruited to gene promoters 
and activate or increase transcription of the endogenous locus (Mali, Aach, et al. 2013; Gilbert 
et al. 2013; A. W. Cheng et al. 2013; Perez-Pinera et al. 2013; Maeder et al. 2013; Gilbert et 
al. 2014; Tanenbaum et al. 2014; Konermann et al. 2015; Chakraborty et al. 2014; Chavez et 
al. 2015; Chavez et al. 2016; Rajagopal et al. 2016, see section 1.4.1). The CRISPRa 
“synergistic activator mediator” (SAM) uses three trans-activators to induce robust 
transcription: on the one hand, the tetrameric VP16 transcription activation domain (or VP64) 
is fused to dCas9; on the other hand, the nuclear factor NF-kappa-b p65 subunit (p65) is fused 
together with the heat shock factor-1 protein (HSF1) to the RNA binding protein MS2 (Figure 
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3.1). The MS2-p65-HSF1 fusion protein is recruited to the sgRNA-dCas9-VP64 complex 
through MS2 loops introduced in the sgRNA scaffold sequence (Konermann et al. 2015) 
(Figure 3.1). 
 
Figure 3.1– Schematic of CRISPRa SAM method 
Schematic showing the components and function of CRISPRa method SAM. The sgRNA (grey) is 
targeted upstream of the TSS of the gene of interest and its scaffold contains two MS2 loops (red); 
the catalytically-inactive or dead Cas9 (dCas9) (yellow) is fused to the trans-activation domain VP64 
(green) and the MS2 RNA binding protein (orange) to the trans-activators p65 and HSF1 (yellow and 
orange). MS2 RNA binding proteins bind to MS2 loops as dimers and therefore, four copies of p65-
HSF1 are recruited to the dCas9-VP64/sgRNA complex. Recruitment of these three components to 
the promoter region of a gene (or upstream of the TSS- depicted by an arrow) induces recruitment of 
polymerase II (Pol II) and, consequently, transcriptional gene activation. Image from Joung et al. 
2017. 
 
Pooling multiple sgRNAs targeting different genes into a single lentiviral library that can be 
transduced at low MOI into cells allows the introduction of multiple perturbations in a single 
pooled experiment while having a unique perturbation in every cell (Gilbert et al. 2014; 
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Konermann et al. 2015; Horlbeck et al. 2016; Sanson et al. 2018, see section 1.4.2). 
Transcriptomic analysis of single cells can consequently allow the identification of the sgRNA 
expressed in every cell while having a complex functional interrogation of the targeted gene 
(see section 1.5). Although CRISPR KO and CRISPRi have been previously combined with 
single-cell transcriptomic analysis (Jaitin et al. 2016; Dixit et al. 2016; Adamson et al. 2016; 
Datlinger et al. 2017; S. Xie et al. 2017; Replogle et al. 2018; Genga et al. 2019; Gasperini et 
al. 2019), CRISPRa screens have been limited to simpler read-outs.  
In this chapter, I generated, optimised and characterised the tools necessary to perform a 
CRISPRa screen at single-cell transcriptomic resolution in mESCs. This characterisation was 
done with the aim of subsequently applying the method to target multiple maternal epigenetic 
and transcriptional regulators and uncover new factors that induce a ZGA-like signature in 
mESCs. First, I generated a clonal mESC line expressing dCas9-VP64 and MS2-p65-HSF1. 
Next, I tested CRISPRa in mESCs by targeting MERVL and the gene cluster Zscan4. I initially 
tested and characterised the system using qPCR, bulk RNA-sequencing, western-blot and 
immunofluorescence, and then performed scRNA-seq experiments using the 10X Genomics 
platform. These tests revealed that CRISPRa works effectively in mESCs and that targeting 
MERVL and Zscan4 induces a ZGA-like signature that can be detected both by bulk and single-
cell RNA-sequencing measurements. Lastly, I envisaged and validated a strategy to 
simultaneously capture sgRNA sequence information together with the whole transcriptome in 
single-cells by scRNA-seq.  
3.2 Results 
3.2.1 Generation of a clonal mouse embryonic stem cell line for CRISPR 
activation 
In order to generate a stable mESC line expressing the CRISPRa SAM components, dCas9-
VP64 and MS2-p65-HSF1 (Figure 3.2), I transduced lentiviral constructs expressing these two 
fusion proteins into E14 mESCs. After two weeks of selection with the antibiotics blasticidin 
and hygromycin, which were respectively cloned in the integration sites of the corresponding 
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lentiviral constructs, I manually picked 18 individual colonies, expanded and harvested them 
for DNA and RNA isolation (see Materials and Methods). I also harvested a non-clonal 
population by pooling the remnant colonies that were not picked.  
Using genomic DNA, I performed a PCR with primers specific for dCas9-VP64 and MS2-p65-
HSF1 (see Materials and Methods). After running the resulting PCR products in an agarose 
gel, I observed that most clones were positive for both integrations, while the non-clonal 
population was positive for MS2-p65-HSF1 but very weak for dCas9-VP64 integration (Figure 
3.3), suggesting that clonal selection improves stable integration of exogenous inserts.  
 
Figure 3.2– Schematic representation of dCas9-VP64 and MS2-p65-HSF1 lentiviral 
constructs 
The integration site of both dCas9-VP64 (top panel) and MS2-p65-HSF1 (bottom panel) lentiviral 
constructs contains a retroviral psi packaging element, a rev response element (RRE), a central 
polypurine tract (cPPT) and a Pol II elongation factor-1 alpha (EF1α) promoter. In the case of the 
dCas9-VP64 construct (top panel), EF1α drives the expression of a catalytically inactive or dead 
Cas9 (dCas9) linked to the trans-activation domain VP64 via a nuclear localisation signal (NLS); a 
P2A self-cleaving peptide is placed between the dCas9-VP64 fusion and the antibiotic selection 
marker blasticidin, followed by a Woodchuck hepatitis virus posttranscriptional regulatory element 
(WPRE). In the MS2-p65-HSF1 construct (bottom panel), EF1α drives the expression of the RNA 
binding protein MS2 linked to the trans-activation domains p65 (nuclear factor NF-kappa-b p65 
subunit) and HSF1 (heat shock factor-1) via an NLS; a P2A self-cleaving peptide is placed between 
the MS2-p65-HSF1 fusion and the antibiotic selection marker hygromycin, followed by WPRE. 
cPPT






dCas9-VP64 lentiviral expression vector
cPPT






MS2-p65-HSF1 lentiviral expression vector
HSF1
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Figure 3.3– Genomic integrations of SAM embryonic stem cell clones  
Agarose gel electrophoresis showing the PCR products of dCas9-VP64 (top panel) and MS2-p65-
HSF1 (bottom panel) after specific amplification from genomic DNA of the SAM mESCs clones. 
The expected band size for a clone expressing dCas9-VP64 is 275bp and for MS2-p65-HSF1 is 672 
bp. The input material for PCR positive controls (+) was plasmid DNA of dCas9-VP64 construct (top 
panel) or MS2-p65-HSF1 construct (bottom panel). The PCR negative controls (-) included all PCR 
reagents but DNA. The ladder is HyperLadder IV (Biolane, BIO-33029). Dotted boxes highlight 
clones 7 and 22 that were picked for further characterisation. NC: non clonal. 
 
 
To further characterise the transcriptome of these cell lines and confirm expression of dCas9-
VP64 and MS2-p65-HSF1, I selected clones SAM7 and SAM22 for RNA-sequencing analysis 
and compared their transcriptomics to the parental cell line E14. Both clones showed high 
expression of dCas9-VP64 and MS2-p65-HSF1 and presented a largely unchanged 
transcriptome compared to E14 mESCs (Figure 3.4). Clone SAM7 had 13 differentially 
expressed genes (DEGs) and clone SAM22 showed 5 DEGs; these transcriptomic changes are 
probably not due to the expression of dCas9-VP64 and MS2-p65-HSF1 but rather reflect the 
expected variation generated during cell culture as well as technical variation of library 
preparation and sequencing, since two different cultures and RNA-sequencing libraries of E14 
mESCs sequenced at the same time showed a similar number of DEGs (Figure 3.4). In 
conclusion, expression of SAM CRISPRa machinery has minimal effects on gene expression. 
Due to the lower number of DEGs, I selected clone SAM22 to carry all further experiments 
presented in this dissertation. 
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Figure 3.4– Transcriptome of SAM clones 7 and 22 
Scatterplots showing normalised gene expression in log2 reads per million (RPM) of SAM7 clone 
against its parental cell line E14 (top left panel), SAM22 clone against E14 (top right panel) and two 
replicates of E14s (bottom panel) analysed by RNA-sequencing, highlighting dCas9-VP64 and MS2-
p65-HSF1 transcripts in black and differentially expressed genes (DEGs) in blue. The transcriptome 
analysis was done with two replicates of SAM7, two replicates of SAM22 and three replicates of 
E14. DEGs were determined using DESeq2 (FDR<5%), EdgeR (FDR<5%) and intensity difference 
filter (FDR<5%), with the high-confidence DEGs defined as the intersection between the three 
statistical tests and a log2 fold change >2. 
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3.2.2 CRISPR activation of MERVL and Zscan4 
I next chose to target the endogenous retrovirus MERVL and the gene cluster Zscan4 to test 
and optimise my CRISPRa system in mESCs. These transcripts are specifically expressed in 
mouse two-cell embryos at the time of ZGA and in 2C-like cells (Macfarlan et al. 2012; 
Zalzman et al. 2010; Eckersley-Maslin et al. 2016). As previously described in Konermann et 
al. 2015, I designed sgRNAs to target the 200 bp window upstream of the gene TSS for optimal 
CRISPRa efficiency. I designed and cloned into the sgRNA(MS2)_puro backbone two 
sgRNAs targeting MERVL long terminal repeats (LTRs) (MERVL sgRNA 1 and MERVL 
sgRNA 3) and two targeting Zscan4 cluster promoters (Zscan4 sgRNA 1 and Zscan4 sgRNA 
3) as well as a non-targeting sgRNA (see Materials and Methods and Appendix C for sgRNA 
sequences). Given the high sequence similarity of the genes within the Zscan4 cluster 
(Zscan4b, Zscan4c, Zscan4d, Zscan4e, Zscan4f), a single sgRNA can target more than one 
gene within the cluster, specifically, Zscan4 sgRNA 1 targeted the 200 bp upstream window 
of the TSSs of Zscan4b, Zscan4c, Zscan4d and Zscan4f whereas Zscan4 sgRNA 3 targeted the 
promoters of Zscan4c and Zscan4f (see Appendix C). 
After transducing individually each sgRNA into SAM22 mESCs in triplicate and selecting the 
cells with puromycin, I analysed target gene activation by qPCR six days after transduction. 
Importantly, the qPCR primers used for Zscan4 were designed to amplify all transcripts in the 
cluster. This experiment demonstrates that all four sgRNAs induced at least a 3-fold 
upregulation of their target loci compared to a non-targeting control (Figure 3.5). 
Unsurprisingly, sgRNAs targeted to MERVL LTRs also induced Zscan4 activation and vice 
versa, suggesting that both belong to the same transcriptional network and are inter-regulated.  
In order to prove this observation and to check whether RNA upregulation translated into an 
increase in protein levels, I extracted protein from these samples and analysed ZSCAN4 
expression by western-blot. ZSCAN4 protein was highly increased in SAM22 mESCs 
transduced with Zscan4 promoter-targeted sgRNAs and also, to a lesser extent, with a MERVL 
LTR-targeted sgRNA (Figure 3.6). Immunofluorescence analysis of ZSCAN4 protein 
confirmed these observations, showing that ZSCAN4 was only expressed in a small percentage 
of cells at basal levels in the non-targeting sgRNA control, in agreement with previous studies 
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(Zalzman et al. 2010; Eckersley-Maslin et al. 2016), and CRISPRa induced expression in a 
larger number of cells (Figure 3.7). It is however interesting to note that not all cells transduced 
with Zscan4 or MERVL sgRNAs, and selected with puromycin for sgRNA expression, showed 
ZSCAN4 protein expression, which raises some questions that are discussed later on in this 
chapter (see section 3.3). Nevertheless, I can conclude that the CRISPRa SAM method in 




Figure 3.5– MERVL and Zscan4 expression induced by CRISPRa, analysed by qPCR 
Analysis of MERVL (blue) and Zscan4 (red) relative RNA levels by qPCR in SAM22 mESCs 
transduced with a non-targeting sgRNA control, with sgRNAs targeted to MERVL LTR elements 
(MERVL sgRNA 1 and MERVL sgRNA 3) or with sgRNAs targeted to the promoters of the Zscan4 
cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3). RNA was harvested 6 days post-sgRNA 
transduction and puromycin selection. The experiment was performed in triplicate and the qPCR run 
in two technical replicates. Data is shown as mean plus standard deviation. Statistically significant 
differences to non-targeting control are reported (homoscedastic two-tailed t-test: ****: p-value < 









Figure 3.6– Western-blot of ZSCAN4 after CRISPRa of Zscan4 and MERVL  
Western-blot showing ZSCAN4 protein (~65KDa) levels in SAM22 mESCs transduced with a non-
targeting sgRNA control, Zscan4 sgRNA 1, Zscan4 sgRNA 3 and MERVL sgRNA 1. An 
uncharacterised ZSCAN4 band was also observed at ~ 72KDa. β-ACTIN antibody was used as a 
loading control. Protein extracts were harvested 15 days after sgRNA transduction and puromycin 
selection. The experiment was done once. Quantification of the ~57 KDa Zscan4 bands corrected by 
the intensity of the corresponding β-actin band and normalised to the non-targeting control is shown 
in the bottom panel. 
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Figure 3.7– Immunofluorescence of ZSCAN4 after CRISPRa of Zscan4 and MERVL 
Representative images of SAM22 mESCs transduced with a non-targeting sgRNA control, Zscan4 
sgRNA 1 and MERVL sgRNA 1, and stained for ZSCAN4 protein (green) and DNA stained with 
DAPI (blue). The cells were seeded on coverslips 15 days after sgRNA transduction and puromycin 
selection and cultured for an extra day before fixation. Images show a single Z-plane. Scale bar = 20 
µm. 
 
2C-like mESCs are characterised transcriptionally by the activation of a network of genes 
driven by MERVL LTR elements, similarly to ZGA in two-cell embryos (Kigami 2002; 
Peaston et al. 2004; Macfarlan et al. 2012; Y. Huang et al. 2017; Ishiuchi et al. 2015; Eckersley-
Maslin et al. 2016). To investigate whether Zscan4 and MERVL LTR CRISPR-activated cells 
resembled a 2C-like or ZGA-like state, I initially analysed the expression of a panel of ZGA 
markers by qPCR, showing that both MERVL-LTR and Zscan4 sgRNAs induced activation of 
these markers, whereas the pluripotency genes Pou5f1 (also known as Oct4) and Nanog did 
not show any significant change (Figure 3.8).  
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Figure 3.8– ZGA markers, Pou5f1 and Nanog expression after CRISPRa of MERVL and 
Zscan4, analysed by qPCR 
Analysis of relative mRNA levels of a panel of ZGA markers (green-blue), Pou5f1 (Oct4) (dark 
orange) and Nanog (light orange) by qPCR in SAM22 mESCs transduced with a non-targeting 
sgRNA control, with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and MERVL 
sgRNA 3) or with sgRNAs targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and 
Zscan4 sgRNA 3). RNA was harvested 6 days post-sgRNA transduction and puromycin selection. 
The experiment was performed in triplicate and the qPCR run in two technical replicates. Data is 
shown as mean plus standard deviation. Statistically significant differences to non-targeting control 
were assessed by homoscedastic two-tailed t-test. For figure simplicity, */**/***/**** are not 
depicted; all transcripts except Pou5f1 and Nanog were significantly upregulated in the four 
experimental conditions compared to the non-targeting control, with a p-value < 0.05.  
 
To achieve a more comprehensive understanding of the transcriptional changes triggered by 
MERVL and Zscan4 CRISPRa, I performed RNA-sequencing analysis on SAM22 mESCs 
transduced with MERVL LTR or Zscan4 sgRNAs. I first interrogated target gene activation 
and observed that all genes within the Zscan4 cluster were activated upon transduction with 
both MERVL LTR and Zscan4 sgRNAs (Figure 3.9). Interestingly, some sgRNAs were more 
efficient than others, in particular, Zscan4 sgRNA 1 induced a strong upregulation of Zscan4b, 
Zscan4c, Zscan4d, Zscan4f and, to a lesser extent of Zscan4e. This is consistent with the design 
of the sgRNA (Appendix C) and with the results observed for ZGA marker upregulation by 
qPCR, where Zscan4 sgRNA 1 was a slightly stronger inductor than Zscan4 sgRNA 3 (Figures 
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Figure 3.9– Heatmap of Zscan4 genes expression after CRISPRa of MERVL and Zscan4, 
analysed by RNA-sequencing 
Heatmap showing transcript normalised expression, scaled per transcript, of Zscan4f, Zscan4c, 
Zscan4d, Zscan4e and Zscan4b in SAM22 mESCs transduced with a non-targeting sgRNA control, 
with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and MERVL sgRNA 3) or with 
sgRNAs targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3), 
analysed by RNA-sequencing. RNA was harvested 6 days post-sgRNA transduction and puromycin 
selection. The experiment was performed in triplicate.  
 
In order to analyse MERVL target upregulation by RNA-sequencing, the data was re-mapped 
to a custom-built repeat genome, allowing analysis of different repeat element families. As 
expected from the qPCR results, the four sgRNAs induced strong upregulation of MERVL 
elements (Figure 3.10). Interestingly, MERVL sgRNA 3, the strongest sgRNA for MERVL 
activation as indicated by qPCR analysis (Figure 3.5 and 3.8), as well as the strongest Zscan4 
sgRNA (Zscan4 sgRNA 1), also upregulated LINE-1 elements (Figure 3.10). This is consistent 
with previous studies showing that LINE-1 expression is activated during ZGA (Beraldi et al. 
2006; Jachowicz et al. 2017; Percharde et al. 2018; Eckersley-Maslin et al. 2019; De Iaco et al. 
2019). Other repeat families, such as ERV1, MaLR or SINE B2, were significantly upregulated 
by one or more sgRNAs compared to the non-targeting sgRNA control, however, the absolute 
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change in the percentage of total sequencing reads was very small (Figure 3.10), making it 
difficult to draw any conclusions on the biological significance. 
 
Figure 3.10– Expression repeat families after CRISPRa of MERVL and Zscan4, analysed by 
RNA-sequencing 
Expression of different repeat families analysed by RNA-sequencing and plotted as percentage of 
total reads in the library, in SAM22 mESCs transduced with a non-targeting sgRNA control (black), 
with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1- blue, and MERVL sgRNA 3- 
light blue) or with sgRNAs targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1- red 
and Zscan4 sgRNA 3- brown). RNA was harvested 6 days post-sgRNA transduction and puromycin 
selection. The experiment was performed in triplicate. Data is shown as mean plus standard deviation. 
Statistically significant differences to non-targeting sgRNA control are reported (homoscedastic two-
tailed t-test, ****: p-value < 0.0001, ***: p-value <0.001, **: p-value <0.01, * p-value <0.5, absence 
of starts: not significant). 
 
Given that MERVL LTR elements can act as functional promoters driving the expression of 
hundreds of chimeric transcripts (Macfarlan et al. 2012; Y. Huang et al. 2017; Franke et al. 
2017), I analysed transcriptional activation of 10 kilobase (kb) probes downstream of MERVL 
LTR elements. Read quantification of these probes showed that transcription was increased 
downstream of MERVL LTR elements in cells targeted with MERVL LTR and Zscan4 
sgRNAs (Figure 3.11), reinforcing the idea that ZSCAN4- and MERVL-driven transcriptional 
programs are directly inter-regulated. 




Figure 3.11– Transcription downstream of MERVL LTR elements after CRISPRa of MERVL 
and Zscan4, analysed by RNA-sequencing 
Top panel: Normalised quantification of transcription in 10kb probes downstream of MERVL LTR 
elements genome-wide, analysed by RNA-sequencing in SAM22 mESCs transduced with a non-
targeting sgRNA control, with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and 
MERVL sgRNA 3) or with sgRNAs targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 
1 and Zscan4 sgRNA 3). RNA was harvested 6 days post-sgRNA transduction and puromycin 
selection. The experiment was performed in triplicate. Data is shown as mean plus and minus 
standard error.  
Bottom panel: Representative example of a 10kb probe downstream of a MERVL LTR element in 
chr7:1082594-10830581, showing raw reads (blue) and quantification in log2 reads per million 
(RPM) (green-to-red bars) in SAM22 mESCs transduced with a non-targeting sgRNA control, with 
sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and MERVL sgRNA 3) or with 
sgRNAs targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3). 
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I also studied ZGA-like gene expression in these RNA-sequencing libraries to try to 
recapitulate the results seen by qPCR; specifically, I analysed the expression of transcripts in 
the MERVL/ZSCAN4-driven network, described in Eckersley-Maslin et al. 2016, and of 
transcripts deregulated upon Dux induction in mESCs, as described in Hendrickson et al. 2017. 
DUX overexpression in mESCs has been shown to upregulate a ZGA-like transcriptional 
signature (Hendrickson et al. 2017; De Iaco et al. 2017). In both cases, most of these ZGA-like 
transcripts were upregulated upon CRISPRa of MERVL LTRs and Zscan4 (Figure 3.12). 
Consistent with my previous results, MERVL sgRNA 3 and Zscan4 sgRNA 1 induced higher 
expression of these transcripts compared to the other two sgRNAs.  
Furthermore, the DEGs upon MERVL and Zscan4 activation showed a peak of expression in 
two-cell embryos, when ZGA occurs, corroborating that MERVL and Zscan4 CRISPRa 
induces a ZGA-like transcriptional signature (Figure 3.13). I can therefore conclude that the 
CRISPRa SAM method that I have established in mESCs works effectively to induce 
endogenous target gene activation and the expected downstream transcriptional changes. 
Despite the robustness of the results described above, I further validated CRISPRa target 
specificity and downstream network activation by comparing it to a more traditional method 
of gene overexpression, cDNA transfection. Using published RNA-sequencing data of 
ZSCAN4C transient overexpression (Eckersley-Maslin et al. 2019), I used principal 
component analysis (PCA) (Pearson 2010) on the whole transcriptome to understand how 
similar were the responses triggered by CRISPRa and cDNA overexpression of the same target. 
For transient ZSCAN4C overexpression, E14 mESCs were transfected with ZSCAN4C-eGFP 
and sorted for eGFP-/+ 48 hours later. While principal component 1 (PC1) (48.75% of variation 
in the data) separated the different datasets by experiment (ZSCAN4C cDNA overexpression 
and MERVL/Zscan4 CRISPRa), interestingly, PC2 (16.3% of variation in the data) sorted 
datasets by control (non-targeting sgRNA and ZSCAN4C-GFP-) and experimental conditions 
(MERVL/Zscan4 CRISPR-activated cells and ZSCAN4C-GFP+ cells) (Figure 3.14). This 
implies that, after taking experimental conditions into consideration, CRISPRa of endogenous 
targets promoted a similar transcriptional response to cDNA overexpression.  




Figure 3.12– Heatmaps of ZGA-like gene expression after CRISPRa of MERVL and Zscan4, 
analysed by RNA-sequencing 
Heatmaps showing transcript normalised expression, scaled per transcript, of differentially expressed 
genes (DEGs) in MERVL+/ZSCAN4+ cells (as defined in Eckersley-Maslin et al. 2016) (top panel), 
and of DEGs upon Dux doxycycline induction (analysed from Hendrickson et al. 2017) (bottom 
panel), in SAM22 mESCs transduced with a non-targeting sgRNA control, with sgRNAs targeted to 
MERVL LTR elements (MERVL sgRNA 1 and MERVL sgRNA 3) or with sgRNAs targeted to the 
promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3), analysed by RNA-
sequencing. RNA was harvested 6 days post-sgRNA transduction and puromycin selection. The 
experiment was performed in triplicate.  










Figure 3.13– Expression of differentially expressed genes after CRISPRa of MERVL and 
Zscan4 in pre-implantation development, analysed by RNA-sequencing  
Box-whisker plots showing normalised expression in log2 reads per million (RPM) of differentially 
expressed genes (DEGs) between MERVL sgRNAs and non-targeting sgRNA control (blue), and 
between Zscan4 sgRNAs and non-targeting control (red), as well as the expression of a random set 
of expressed genes in the MERVL and Zscan4 CRISPRa dataset, in mouse oocytes and pre-
implantation development (data analysed from Xue et al. 2013). DEGs were determined using 
DESeq2 (FDR<5%), EdgeR (FDR<5%) and intensity difference filter (FDR<5%), with the high-
confidence DEGs defined as the intersection between the three statistical tests. The DEGs by MERVL 
sgRNA 1 were merged to the DEGs by MERVL sgRNA 3 and the DEGs by Zscan4 sgRNA 1 merged 
to the DEGs by Zscan4 sgRNA 3 for this analysis. The number of DEGs in each case is depicted in 
brackets. NT: non-targeting.  
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Figure 3.14– Principal component analysis of MERVL and Zscan4 CRISPRa and ZSCAN4C 
cDNA overexpression 
Principal component 1 (PC1) and principal component 2 (PC2) on RNA-sequencing quantified read 
counts for all transcripts in SAM22 mESCs transduced with a non-targeting sgRNA control (black 
square), with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 – blue square, and 
MERVL sgRNA 3 - light blue square) or with sgRNAs targeted to the promoters of the Zscan4 cluster 
(Zscan4 sgRNA 1- red square, and Zscan4 sgRNA 3- brown square) and E14s mESCs transiently 
transfected for 48h with ZSCAN4C-eGFP and sorted for eGFP-/+ (ZSCAN4C-GFP--black triangle,  
ZSCAN4C-GFP+- green triangle). The CRISPRa experiment was performed in triplicate. 
ZSCAN4C-GFP- and ZSCAN4C-GFP+ data analysed from Eckersley-Maslin et al. 2019. 
 
The largely different expression levels of the target gene achieved with both methods (Figure 
3.15), as well as the differences in timing (6 days for CRISPRa and 2 days for cDNA 
overexpression), might also account for some of the variation explained by PC1. To further 
understand the differences between CRISPRa and cDNA overexpression, I looked at the 
overlap between the DEGs of Zscan4 CRISPRa, MERVL LTR CRISPRa and ZSCAN4C 
cDNA overexpression. Consistent with the results presented above, the transcriptome of 
MERVL LTR CRISPR-activated cells is very similar to Zscan4 CRISPRa (Figure 3.16). 
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However, comparison with cDNA overexpression revealed that out of the 494 DEGs between 
ZSCAN4C-GFP– and ZSCAN4C-GFP+, only 32.4% (160/494) were commonly deregulated 
upon CRISPRa of Zscan4 and/or MERVL LTRs compared to a non-targeting sgRNA control 
(Figure 3.16). Intriguingly, 56.4% (102/181) of the DEGs upon CRISPRa of MERVL LTR and 
40.7% (154/378) of the DEGs in Zscan4 CRISPR-activated cells were also deregulated in 
ZSCAN4C cDNA-overexpressing cells (Figure 3.16). Therefore, a higher proportion of the 
transcriptional changes triggered by CRISPRa was shared with the changes observed by cDNA 
overexpression than vice versa. This could mean that the artificial levels of mRNA and protein 
expression resulting from cDNA overexpression leads to transcriptional changes that do not 
completely reflect the physiological role of the gene of interest.  
 
 
Figure 3.15– Zscan4c normalised expression after CRISPRa or cDNA overexpression  
Fold change expression of Zscan4c normalised to corresponding control (non-targeting sgRNA for 
CRISPRa samples and ZSCAN4-GFP- for ZSCAN4-GFP+) in SAM22 mESCs transduced with 
sgRNAs targeted to MERVL LTR elements (MERVL sgRNA_1 – blue, and MERVL sgRNA_3 -
light blue) or with sgRNAs targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA_1- red, 
and Zscan4 sgRNA_3 - brown) and E14s mESCs transiently transfected for 48h with ZSCAN4-eGFP 
and sorted for eGFP+ (green). The experiment was performed in triplicate and analysed by RNA-
sequencing. ZSCAN4C-GFP- and ZSCAN4C-GFP+ data analysed from Eckersley-Maslin et al. 2019. 
Data is shown as mean plus standard deviation. 
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Figure 3.16– Venn diagram of differentially expressed genes by CRISPRa and cDNA 
overexpression 
Venn diagram showing the overlap of the differentially expressed genes (DEGs) in 1) ZSCAN4C-GFP+ 
cells compared to ZSCAN4C-GFP- (green), 2) MERVL sgRNA 1 and 3 cells compared to non-targeting 
sgRNA control (blue), and 3) Zscan4 sgRNA 1 and 3 cells compared to non-targeting sgRNA control 
(pink), as analysed by RNA-sequencing. DEGs were determined using DESeq2 (FDR<5%), EdgeR 
(FDR<5%) and intensity difference filter (FDR<5%), with the high-confidence DEGs defined as the 
intersection between the three statistical tests. The DEGs by MERVL sgRNA 1 were merged to the 
DEGs by MERVL sgRNA 3 and the DEGs by Zscan4 sgRNA 1 merged to the DEGs by Zscan4 sgRNA 
3 for this analysis. The experiment was performed in triplicate. ZSCAN4C-GFP- and ZSCAN4C-GFP+ 
data analysed from Eckersley-Maslin et al. 2019. 
 
Lastly, I assessed the duration of endogenous target gene activation and downstream changes 
induced by CRISPRa SAM by performing a time-course experiment in which RNA samples 
were harvested 6, 9, 11, 13 and 15 days post-sgRNA transduction into SAM22 mESCs. 
Puromycin selection was maintained throughout the duration of the experiment. Analysis by 
qPCR showed that MERVL and Zscan4 transcriptional activation did not significantly change 
after six days of culture and could be maintained up to 15 days (Figure 3.17). Similarly, the 
expression of three ZGA markers (Gm4014, Tcstv3 and Gm4340/Gm2123), but not of the 
pluripotency markers Pou5f1 (also known as Oct4) and Nanog, was induced to a greater or 
lesser extent up to 15 days of culture (Figure 3.18). 





Figure 3.17– Time-course analysis of MERVL and Zscan4 expression induced by CRISPRa, 
analysed by qPCR 
Analysis of MERVL (blue) and Zscan4 (red) relative RNA levels by qPCR in SAM22 mESCs 
transduced with a non-targeting sgRNA control (lighter colours), with sgRNAs targeted to MERVL 
LTR elements (MERVL sgRNA 1 and MERVL sgRNA 3) or with sgRNAs targeted to the promoters 
of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3) and cultured for 6, 9, 11, 13 or 15 
days after sgRNA transduction with puromycin selection. The experiment was performed in triplicate 
and the qPCR run in two technical replicates. Data is shown as mean plus standard deviation. 
Statistically significant differences to non-targeting controls are reported (homoscedastic two-tailed 
t-test, ****: p-value < 0.0001, ***: p-value <0.001, **: p-value <0.01, * p-value <0.5, absence of 
starts: not significant). A dashed line at y = 1 is used to indicate that any condition above it shows 
transcript upregulation compared to non-targeting control. 
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Figure 3.18– Time course analysis of ZGA markers, Pou5f1 and Nanog expression after 
CRISPRa of MERVL and Zscan4, analysed by qPCR 
Analysis of relative mRNA levels of a panel of ZGA markers (Gm4014- green, Tcstv3- dark blue, 
Gm3230/Gm2123- light blue), Pou5f1 (Oct4) (dark orange) and Nanog (light orange) by qPCR in 
SAM22 mESCs transduced with a non-targeting sgRNA control (lighter colours), with sgRNAs 
targeted to MERVL LTR elements (MERVL sgRNA 1 and MERVL sgRNA 3) or with sgRNAs 
targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3) and 
cultured for 6, 9, 11, 13 or 15 days after sgRNA transduction with puromycin selection. The 
experiment was performed in triplicate and the qPCR run in two technical replicates. Data is shown 
as mean plus standard deviation. Statistically significant differences to non-targeting controls were 
assessed by homoscedastic two-tailed t-test. For figure simplicity, */**/***/**** are not depicted; 
all transcripts except Pou5f1 and Nanog were significantly upregulated in all experimental 
conditions compared to the corresponding non-targeting sgRNA control, with a p-value < 0.05. A 
dashed line at y = 1 is used to indicate that any condition above it shows transcript upregulation 
compared to non-targeting control. 
 
 
3.2.3 ZGA-like signature detection by single-cell RNA-sequencing  
With the aim to combine CRISPRa with a scRNA-seq read-out to ultimately perform a pooled 
screen, I next assessed whether the target gene activation observed by bulk measurements 
(qPCR and RNA-sequencing), as well as the downstream changes, could be detected in 
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scRNA-seq libraries. I used the single-cell 3’ solution from 10X Genomics that captures 3’ 
polyadenylated transcripts and allows the transcriptome of thousands of single cells to be 
sequenced at a low cost per cell (see chapters 1 and 2). 
SAM22 mESCs were transduced with each of the same sgRNAs previously described: a non-
targeting sgRNA, MERVL sgRNA 1, MERVL sgRNA 3, Zscan4 sgRNA 1 and Zscan4 sgRNA 
3. Six days post-transduction and puromycin selection, the cells transduced with MERVL 
sgRNA 1 and MERVL sgRNA 3 were pooled together, and the cells transduced with Zscan4 
sgRNA 1 and Zscan4 sgRNA 3 were pooled together in a second pool. 8,000 single cells from 
each condition, as well as control E14 and untransduced SAM22 mESCs, were FACS-sorted 
for live cells, based on the absence of DAPI staining, and 10X scRNA-seq libraries were 
prepared (see Materials and Methods). Droplet formation in the sample of untransduced 
SAM22 mESCs failed (data not shown) and was not carried forward. For the other four samples 
(E14, SAM22 + non-targeting control, SAM22 + MERVL sgRNAs and SAM22 + Zscan4 
sgRNAs), between 1,956 and 2,362 single cells were recovered for each library according to 
detected cellular barcodes, yielding a capture efficiency of 24.5-29.5% (Figure 3.19). 
 
Figure 3.19– Number of cells captured in 10X Genomics scRNA-seq libraries 
Number of cells captured in 10X Genomics scRNA-seq libraries of E14 mESCs (grey), SAM22 
mESCs transduced with a non-targeting sgRNA control (blue), SAM22 mESCs transduced with 
sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and MERVL sgRNA 3) (pink) and 
SAM22 mESCs transduced with sgRNAs targeted to the promoters of the Zscan4 cluster (Zscan4 
sgRNA 1 and Zscan4 sgRNA 3) (orange). 
3.2 Results 129 
 
The distribution of number of UMI reads and number of genes detected for every cell suggested 
a population of low-quality cells in the four libraries, with less than 15,000 UMI reads and 
4,000 detected genes and more than 5% of reads coming from mitochondrial genes (Figure 
3.20), likely indicative of sub-optimal sample preparation (see Materials and Methods). These 
cells were removed for downstream analysis to keep only high-quality input.  
 
Figure 3.20– Quality control and filtering of 10X Genomics scRNA-seq libraries 
Histograms showing number of unique molecular identifier (UMIs) (top left panel), number of genes 
detected (top right panel) and percentage of reads from mitochondrial genes (bottom left panel) in 
10X Genomics scRNA-seq libraries of E14 mESCs, SAM22 mESCs transduced with a non-targeting 
sgRNA control, SAM22 mESCs transduced with sgRNAs targeted to MERVL LTR elements 
(MERVL sgRNA 1 and MERVL sgRNA 3) and SAM22 mESCs transduced with sgRNAs targeted 
to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3). As indicated with 
red vertical lines, cells with more than 15,000 and less than 40,000 UMIs (top left panel), more than 
4,000 and less than 6,500 genes (top right panel) and less than 5% of mitochondrial reads (bottom 
panel) were retained as high-quality cells. Within the high-quality cells for every sample, the 
proportion of cells in each phase of the cell cycle was analysed (bottom right panel) as described in 
Satija et al. 2015. 
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Within the high-quality cells, cell cycle analysis (as described in Satija et al. 2015) showed that 
MERVL and Zscan4 CRISPR-activated cells exist in all stages of the cell cycle, although with 
a prolonged G2/M phase (Figure 3.20), as previously described for 2C-like cells (Storm et al. 
2014, Eckersley-Maslin et al. 2016). Next, I assessed target gene activation in every cell by 
analysing MERVL and Zscan4 cluster expression. These key markers of ZGA were expressed 
in 1.93% and 1.23% of untransduced E14 mESCs respectively, consistent with previous studies 
(Macfarlan et al. 2012; Zalzman et al. 2010) (Figures 3.21, 3.22). Upon transduction with a 
non-targeting sgRNA control, the population of cells expressing MERVL and Zscan4 increased 
to 3.49% and 18.63%, respectively, indicating that lentiviral transduction of mESCs slightly 
increased the expression of these markers (Figures 3.21, 3.22). Notably, and consistent with 
my previous results, 10.43% of cells transduced with MERVL LTR sgRNAs and 52.8% of 
cells transduced with Zscan4 sgRNAs activated their respective targets (Figures 3.21, 3.22). 
Strikingly, MERVL CRISPRa induced Zscan4 expression and vice versa, consistent with my 
previous qPCR and bulk RNA-sequencing results (Figures 3.5, 3.6, 3.7, 3.9, 3.10, 3.11, 3.17). 
 
Figure 3.21– MERVL expression after CRISPRa of MERVL and Zscan4, analysed by 10X 
Genomics scRNA-seq 
Dot plot (top panel) and density representation (bottom panel) of MERVL normalised expression in 
each single cell (in loge(number of UMIs for MERVL / sum (number of total UMI in a cell) *10,000 
+ 1)) in E14 mESCs (grey), SAM22 mESCs transduced with a non-targeting sgRNA control (blue), 
SAM22 mESCs transduced with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and 
MERVL sgRNA 3) (pink) and SAM22 mESCs transduced with sgRNAs targeted to the promoters 
of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3) (orange), analysed by 10X Genomics 
scRNA-seq. Reported percentages of cells expressing MERVL are calculated as the proportion of 
cells above the vertical black line out the total number of cells in each sample. 





Figure 3.22– Zscan4 expression after CRISPRa of MERVL and Zscan4, analysed by 10X 
Genomics scRNA-seq 
Dot plot (top panel) and density representation (bottom panel) of Zscan4 (all genes) normalised 
expression in each single cell (in loge(number of UMIs for Zscan4b/c/d/e/f / sum (number of total 
UMIs in a cell) *10,000 + 1)) in E14 mESCs (grey), SAM22 mESCs transduced with a non-targeting 
sgRNA control (blue), SAM22 mESCs transduced with sgRNAs targeted to MERVL LTR elements 
(MERVL sgRNA 1 and MERVL sgRNA 3) (pink) and SAM22 mESCs transduced with sgRNAs 
targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3) (orange), 
analysed by 10X Genomics scRNA-seq. Reported percentages of cells expressing Zscan4 are 




This scRNA-seq experiment also revealed that not all cells selected for sgRNA expression 
activated their targets, consistent with the immunofluorescence results for ZSCAN4 (Figure 
3.7). Reassuringly, nearly all cells in all conditions had high expression of the pluripotency 
marker Pou5f1 (also known as Oct4) (Figure 3.23), consistent with previous reports showing 
that 2C-like cells lack OCT4 protein but the mRNA is not downregulated (Macfarlan et al. 
2012; Ishiuchi et al. 2015; Eckersley-Maslin et al. 2016; Choi et al. 2017; Rodriguez-Terrones 
et al. 2018). 
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Figure 3.23– Pou5f1 expression after CRISPRa of MERVL and Zscan4, analysed by 10X 
Genomics scRNA-seq 
Dot plot (top panel) and density representation (bottom panel) of Pou5f1 (Oct4) normalised 
expression in each single cell (in loge(number of UMIs for Pou5f1 / sum (number of total UMsI in a 
cell) *10,000 + 1)) in E14 mESCs (grey), SAM22 mESCs transduced with a non-targeting sgRNA 
control (blue), SAM22 mESCs transduced with sgRNAs targeted to MERVL LTR elements 
(MERVL sgRNA 1 and MERVL sgRNA 3) (pink) and SAM22 mESCs transduced with sgRNAs 
targeted to the promoters of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3) (orange), 
analysed by 10X Genomics scRNA-seq. Reported percentages of cells expressing Pou5f1 are 




Similar to bulk RNA-sequencing analysis, I then looked at the expression of the 
MERVL/ZSCAN4-driven network described in Eckersley-Maslin et al. 2016 (Figure 3.24) and 
of the transcripts induced upon DUX overexpression (Hendrickson et al. 2017) (Figure 3.25). 
Between 2% and 2.46% of untransduced E14 mESCs expressed these ZGA transcripts, 
consistent with previous studies (Macfarlan et al. 2012; Zalzman et al. 2010; Eckersley-Maslin 
et al. 2016; Hendrickson et al. 2017; De Iaco et al. 2017; Eckersley-Maslin et al. 2019). This 
proportion was very slightly increased upon transduction of SAM22 mESCs with a non-
targeting sgRNA control (Figures 3.24, 3.25), an observation that has also been made in the 
Reik laboratory when mESCs are transiently transfected with GFP (Eckersley-Maslin, M., 
personal communication). Upon CRISPRa of MERVL LTRs or Zscan4, the proportion of cells 
expressing these ZGA-like transcripts increased to 6%-10% (Figure 3.24, 3.25), regardless of 
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the target gene activation state in each individual cell. These results confirm that a ZGA-like 
signature can be detected by scRNA-seq and validates my approach of using CRISPRa in 





Figure 3.24– MERVL/ZSCAN4 network expression after CRISPRa of MERVL and Zscan4, 
analysed by 10X Genomics scRNA-seq 
Dot plot (top panel) and density representation (bottom panel) of the expression of differentially 
expressed genes (DEGs) in MERVL+/ZSCAN4+ cells (as defined in Eckersley-Maslin et al. 2016) in 
each single cell (in loge(number of UMIs / sum (number of total UMsI in a cell) *10,000 + 1)) in E14 
mESCs (grey), SAM22 mESCs transduced with a non-targeting sgRNA control (blue), SAM22 
mESCs transduced with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and 
MERVL sgRNA 3) (pink) and SAM22 mESCs transduced with sgRNAs targeted to the promoters 
of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3) (orange), analysed by 10X Genomics 
scRNA-seq. Reported percentages of cells expressing the indicated transcripts are calculated as the 








Figure 3.25– Expression of DUX-regulated genes after CRISPRa of MERVL and Zscan4, 
analysed by 10X Genomics scRNA-seq 
Dot plot (top panel) and density representation (bottom panel) of the expression of differentially 
expressed genes (DEGs) upon Dux doxycycline induction (analysed from Hendrickson et al. 2017) 
in each single cell (in loge(number of UMIs / sum (number of total UMsI in a cell) *10,000 + 1)) in 
E14 mESCs (grey), SAM22 mESCs transduced with a non-targeting sgRNA control (blue), SAM22 
mESCs transduced with sgRNAs targeted to MERVL LTR elements (MERVL sgRNA 1 and 
MERVL sgRNA 3) (pink) and SAM22 mESCs transduced with sgRNAs targeted to the promoters 
of the Zscan4 cluster (Zscan4 sgRNA 1 and Zscan4 sgRNA 3) (orange), analysed by 10X Genomics 
scRNA-seq. Reported percentages of cells expressing the indicated transcripts are calculated as the 
proportion of cells above the vertical black line out the total number of cells in each sample. 
 
 
Contrary to what I observed in bulk RNA-sequencing analysis (Figure 3.13), the DEGs upon 
MERVL LTR and Zscan4 CRISPRa, as analysed by scRNA-seq, did not show a clear peak of 
expression in two-cell embryos (Figure 3.26). This is probably due to the less stringent 
differential gene expression analysis applied to scRNA-seq data (only EdgeR FDR<5% versus 
DESeq2 FDR<5%, EdgeR FDR<5% and intensity difference FDR<5% in bulk RNA-
sequencing data), since filtering for the top 100 differentially upregulated genes showed a 
similar pattern of expression in pre-implantation embryos to that observed by bulk RNA-
sequencing (Figure 3.13, 3.26). 





Figure 3.26– Expression of differentially expressed genes after CRISPRa of MERVL and 
Zscan4 in pre-implantation development, analysed by scRNA-seq  
Box-whisker plots showing normalised expression in log2 reads per million (RPM) of differentially 
expressed genes (DEGs) between MERVL sgRNAs and non-targeting sgRNA control (blue, top), 
and between Zscan4 sgRNAs and non-targeting sgRNA control (red, top), as well as the top 100 
upregulated (up) DEGs between MERVL sgRNAs and non-targeting sgRNA control (blue, bottom), 
and the top 100 upregulated DEGs between Zscan4 sgRNAs and non-targeting sgRNA control (red, 
bottom), in mouse oocytes and pre-implantation development (data analysed from Xue et al. 2013). 
DEGs were determined using EdgeR (FDR<5%). The number of analysed genes in each case is 
depicted in brackets. NT: non-targeting 
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Notwithstanding the power of combining CRISPR with scRNA-seq, the maximum number of 
candidate genes screened in previous studies is 100 (Jaitin et al. 2016; Dixit et al. 2016; 
Adamson et al. 2016; Datlinger et al. 2017; S. Xie et al. 2017), which means that the high 
sequencing costs are an important limitation. Therefore, determining the minimum number of 
cells required to be sequenced to be able to detect a specific transcriptional signature is crucial 
to define the number of genes that can be screened. These estimations are highly dependent on 
the biological context under investigation and on the prominence of the transcriptional 
signature triggered. This pilot scRNA-seq experiment allowed such power estimation to be 
made in order to determine the minimum number of cells required to be sequenced per sgRNA 
in the pooled screen to detect a ZGA-like signature in a potential positive hit. I applied a 
qualitative two-tailed Fisher’s exact test and calculated the sample size necessary to detect a 
ZGA-like signature with an adjusted p-value < 0.0005 and a power of 0.8, considering that the 
percentage of cells that expressed ZGA-like transcripts was 2.62% in cells transduced with a 
non-targeting sgRNA control and 10.02% in cells transduced with a positive inductor (e.g. 
MERVL LTR sgRNAs) (Figure 3.24). The test returned a sample size of 367 cells required to 
be screened per sgRNA to detect a positive hit with an actual adjusted p-value < 0.00032. 
3.2.4 Capturing sgRNA sequence information by single-cell RNA-
sequencing 
Having optimised CRISPRa with scRNA-seq read-out, I next envisaged a strategy to capture 
and sequence the sgRNA transduced in each cell by scRNA-seq. This would allow a 
multiplexed screen to be performed where a pooled sgRNA library would be transduced into 
SAM22 mESCs and, after antibiotic selection and expansion, scRNA-seq could be used to infer 
the sgRNA transduced in every cell, consequently the target gene activated and, ultimately, the 
transcriptional changes triggered by the activation or upregulation of that gene. 
Most droplet-based scRNA-seq technologies, including 10X Genomics 3’sequencing, rely on 
transcripts being polyadenylated at their 3’ end for capture with oligo(d)T adaptors (X. Zhang 
et al. 2019), which ensures capturing mRNAs but makes these methods unsuitable to study 
non-coding transcription (see section 1.3). sgRNAs are often transcribed from a U6 promoter 
which is bound by polymerase III (Pol III), leading to a non- 3’ polyadenylated transcript (H. 
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Ma et al. 2014). Recent studies have described ways to overcome this limitation and capture 
sgRNA sequences in scRNA-seq libraries (Jaitin et al. 2016; Dixit et al. 2016; Adamson et al. 
2016; Datlinger et al. 2017; Replogle et al. 2018). CROP-seq allows simultaneous analysis of 
the transcriptome and the sgRNA transduced into each cell by incorporating the sgRNA 
transcript within a polymerase II (Pol II) transcript (Datlinger et al. 2017) (Figure 1.18). The 
strategy consists on designing a lentiviral vector that contains the U6 Pol III promoter and 
sgRNA cassette within the 3’LTR, at the same position of the deletion that makes lentivirus 
self-inactivating and just before the 3’ LTR polyadenylation signal. Upstream of the 3’ LTR, 
contained within the lentiviral integration site, a Pol II promoter would drive expression of an 
antibiotic-resistance cassette. Upon lentiviral reverse transcription and integration into the host 
genome, the U6-sgRNA cassette would be copied to the 5’ LTR. Functional sgRNAs would be 
expressed from the U6 promoter but also, the U6-sgRNA cassette would be contained within 
the Pol II polyadenylated transcript, making it detectable by scRNA-seq approaches (Figure 
1.18). 
In order to adapt the CROP-seq strategy to the CRISPRa SAM system, a lentiviral vector was 
re-synthesize from the CROP-seq backbone with the following modifications: 1) the sgRNA 
scaffold sequence contains two MS2 loops to allow recruitment of MS2-p65-HSF1 in SAM22 
mESCs, same as in the sgRNA(MS2)_puro backbone used in sections 3.2.2 and 3.2.3; and 2) 
a fluorescent mCherry marker was included downstream of the Pol II EF1α promoter and 
linked through the self-cleaving peptide T2A to the puromycin resistant cassette to allow 
assessment of the MOI by flow cytometry. I refer to this construct as CROP-sgRNA-MS2 
(Figure 3.27, Appendix A). 
To validate this construct for its use in scRNA-seq experiments, I transduced SAM22 mESCs 
with a non-targeting sgRNA control cloned in either the lentiviral vector sgRNA(MS2)_puro 
or in the lentiviral construct CROP-sgRNA-MS2. I first had to optimise the lentiviral 
transduction protocol for sgRNAs cloned into the CROP-sgRNA-MS2 construct, given its 
lower titer, compared to the sgRNA(MS2)_puro vector (see Materials and Methods, Datlinger 
et al. 2017). Part of the optimisation included culturing cells with puromycin selection up to 9 
days post-transduction before harvesting for analysis, a timepoint where CRISPRa worked 
effectively with the sgRNA(MS2)_puro backbone (Figure 3.17 and 3.18). After puromycin 
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selection, I harvested RNA and synthesised cDNA using oligo(d)T adaptors so that only 
polyadenylated RNA molecules would go through the first strand synthesis of cDNA, a method 
that recapitulates cDNA synthesis in 10X Genomics 3’ scRNA-seq library preparation. To test 
whether the sgRNA transcribed from the CROP-sgRNA-MS2 construct was polyadenylated, I 
performed a qPCR on the cDNA synthesised with oligo(d)T adaptors using primers that bound 
the scaffold sequence of the sgRNA. As expected, the qPCR amplified the sgRNA produced 
from the CROP-sgRNA-MS2 lentiviral construct but not the sgRNA transcribed from the 
sgRNA(MS2)_puro construct (Figure 3.28), validating my adaptation of the CROP-seq 




Figure 3.27– Schematic representation of CROP-sgRNA-MS2 construct 
The integration site of the CROP-sgRNA-MS2 construct contains a Pol II EF1α promoter driving the 
expression of mCherry and puromycin, linked through the self-cleaving peptide T2A, and of the 
Woodchuck hepatitis virus posttranscriptional regulatory element (WPRE). Contained within the 3’ 
LTR are the U6 promoter, the target sgRNA sequence and the scaffold sgRNA sequence with two 
MS2 loops. Upon reverse transcription and lentiviral integration into SAM22 mESCs, two transcripts 
are produced from this construct: a functional sgRNA Pol III transcript that drives target gene 
activation and a polyadenylated Pol II transcript containing mCherry, T2A, puromycin, WPRE, U6 
promoter and the sgRNA sequence. 
 
 













PolIII sgRNA transcript for target gene activation
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Figure 3.28– sgRNA capture with oligo(d)T adaptors  
Analysis of polyadenylated sgRNA expression by qPCR in SAM22 mESCs untransduced, transduced 
with a non-targeting sgRNA cloned in the sgRNA(MS2)_puro lentiviral construct or with a non-
targeting sgRNA cloned in the CROP-sgRNA-MS2 lentiviral construct. SAM22 mESCs were 
cultured for 9 days with puromycin selection after sgRNA transduction. cDNA was synthesised from 
DNaseI-treated RNA using oligo(d)T primers. Primers used for qPCR analysis bound to the scaffold 
sequence of the sgRNA. The experiment was performed twice and the qPCR run in two technical 
replicates. Data is shown as mean plus and minus standard deviation with individual data points 
shown. Statistically significant differences to untransduced SAM22 mESCs were assessed by 
homoscedastic two-tailed t-test. ns: non-significant, **: p-value <0.01.  
 
Although the CROP-seq vector had been shown to work effectively for CRISPR KO (Datlinger 
et al. 2017), I tested whether promoter-targeted sgRNAs cloned into the CROP-sgRNA-MS2 
construct could induce effective target gene activation. To that end, I cloned Zscan4 sgRNA 1 
and MERVL sgRNA 1 into this new construct as positive controls, since they worked before 
for inducing target gene activation in the sgRNA(MS2)_puro backbone. I also tested sgRNAs 
for Dppa4, Kdm5b, Dux and Dppa3, as they have been implicated in ZGA regulation 
(Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Dahl et al. 2016; B. Zhang et al. 2016; 
Hendrickson et al. 2017; De Iaco et al. 2017; Whiddon et al. 2017; Arakawa et al. 2015; Y. 
Huang et al. 2017; Payer et al. 2003; Bortvin et al. 2004; Y. Li et al. 2018) and, therefore, were 























































cDNA synthesized with oligo(d)T adaptors
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2, I observed at least a 2-fold increase in the expression of the target gene compared to a non-
targeting sgRNA control by qPCR (Figure 3.29), confirming that insertion of the U6-sgRNA 
cassette within the 3’ LTR does not interfere with sgRNA function.  
 
Figure 3.29– Expression of target genes after CRISPRa with CROP-sgRNA-MS2 construct, 
analysed by qPCR 
Analysis of relative RNA levels of target genes (MERVL, Zscan4, Dppa4, Kdm5b, Dux and Dppa3) 
by qPCR in SAM22 mESCs after CRISPRa. Expression was normalised to average expression in 
two non-targeting sgRNA controls. Bars show relative expression of the gene targeted by the sgRNA 
indicated in the x axis. SAM22 mESCs were transduced with two non-targeting sgRNA controls 
(non-targeting 1 and non-targeting 2), with MERVL LTR sgRNA 1 (blue), with Zscan4 sgRNA 1 
(red), with Dppa4 sgRNA 1 (brown), with Dppa4 sgRNA 2 (orange), with Kdm5b sgRNA 1 (dark 
purple), with Kdm5b sgRNA 2 (light purple), with Dux sgRNA 1 (dark green), with Dux sgRNA 2 
(light green), with Dppa3 sgRNA 1 (dark pink) or with Dppa3 sgRNA 2 (light pink), all cloned into 
the CROP-sgRNA-MS2 construct. RNA was harvested 9 days post-sgRNA transduction and 
puromycin selection. The experiment was performed once and the qPCR run in two technical 
replicates. A dashed line at y = 1 is used to indicate that any sgRNA above it showed target transcript 
upregulation compared to non-targeting control. 
 
This experiment also showed that the effectiveness of CRISPRa varies significantly from one 
target gene to another and does not necessarily correlate with the basal expression of the target 
gene, since MERVL, Zscan4 and Dux are expressed in 1-5% of mESCs (Macfarlan et al. 2012; 
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(Figures 3.7, 3.21 and 3.22 for Zscan4 and MERVL), Dppa3 is expressed in 20-30% of mESCs 
(K. Hayashi et al. 2008) and Dppa4 and Kdm5b are highly expressed to similar levels of the 
pluripotency marker Oct4 (Bortvin et al. 2003; L. Xie et al. 2011). 
Importantly, I showed previously that RNA upregulation by CRISPRa translated into protein 
overexpression (Figure 3.6 and 3.7). CRISPRa mediated by sgRNAs expressed from the 
CROP-sgRNA-MS2 construct also translated into protein overexpression, as shown by 
immunofluorescence of DPPA3 in cells transduced with the corresponding targeting sgRNA 
(Figure 3.30). Similar to what was observed for ZSCAN4 protein expression, Dppa3 CRISPRa 
did not induce protein upregulation in all the cells selected for the expression of the sgRNA. 
The reasons why sgRNA expression might induce target upregulation in some cells but not in 
others are discussed in section 3.3 of this chapter and further in chapter 4 of this dissertation. 
 
Figure 3.30– Immunofluorescence of DPPA3 after CRISPRa with CROP-sgRNA-MS2 
construct 
Left panel: Representative images of SAM22 mESCs transduced with a non-targeting sgRNA 
control, or with Dppa3 sgRNA 1, both cloned into the CROP-sgRNA-MS2 construct, and stained for 
DPPA3 protein (green) and DNA stained with DAPI (blue). The cells were seeded on coverslips 15 
days after sgRNA transduction and puromycin selection and cultured for an extra day before fixation. 
Images show a single Z-plane. Scale bar = 10 µm. 
Right panel: Box-whisker plots showing quantification of DPPA3 protein as mean fluorescence 
intensity in SAM22 mESCs transduced with a non-targeting sgRNA control (grey), or with Dppa3 
sgRNA 1 (pink). A total of 190 cells were quantified in the non-targeting sgRNA control condition 
and 107 cells in the Dppa3 sgRNA 1 condition. Differences between the two groups were statistically 
significant (Mann-Whitney test: **** p-value <0.0001). 
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Having validated the CROP-sgRNA-MS2 construct for sgRNA capture with oligo(d)T 
adaptors and for effective target gene activation, I performed a pilot scRNA-seq experiment to 
test sgRNA detection. A major limitation of the CROP-seq strategy is that sgRNA detection in 
a single cell is highly dependent on cell sequencing coverage and, therefore, many cells with 
an undetected sgRNA have to be discarded for downstream analysis (Datlinger et al. 2017). In 
order to overcome this limitation, Hills and colleagues developed a strategy to increase the 
proportion of cells assigned to a sgRNA in 10X Genomics 3’ scRNA-seq libraries to 94% (Hill 
et al. 2018). The method consists on performing a PCR enrichment for barcoded cDNA 
fragments that contain a sgRNA, using three rounds of amplification (Figure 3.31): in the first 
round, the forward primer binds the U6 promoter which is upstream of the sgRNA, and the 
reverse primer binds half of the Read 1 Nextera adaptor incorporated during droplet formation 
and which is adjacent to the 10X cell barcode; in a second PCR, the forward oligo primes on 
the U6 promoter and adds the Nextera read 2 primer while the reverse oligo primes Nextera 
read 1 and adds the Illumina P5 adaptor; in the third and last round, a P7 Illumina adaptor and 
a sample index are incorporated with the forward primer, using the same reverse primer as in 
the second PCR (see Materials and Methods for more details). These cell-barcoded and sample-
indexed sgRNA amplicon libraries can then be sequenced on top of the standard whole 
transcriptome 10X scRNA-seq libraries to obtain information of the sgRNA expressed in each 
cell for a high proportion of the cells. 
Using the eleven CRISPRa SAM22 cell lines generated above with CROP-sgRNA-MS2 
transductions (Figure 3.29, and two non-targeting sgRNA controls), I merged them at equal 
ratios and ran them through 10X Genomics 3’ scRNA-seq droplet formation. After cDNA 
amplification, I used 10 ng of 10X Genomics barcoded cDNA to perform enrichment PCRs for 
sgRNA amplicons, following Hills et al. protocol (Hill et al. 2018) (see Materials and 
Methods). A crucial aspect of this protocol is to monitor PCR amplifications by qPCR to reduce 
the rate of chimeras that otherwise introduce noise in sgRNA-cell assignments. As a control, I 
used cDNA from two previous 10X Genomics 3’ scRNA-seq libraries of cells transduced with 
sgRNA(MS2)_puro constructs, whose insertion leads to non- 3’polyadenylated sgRNA 
transcripts which are not captured during droplet formation with oligo(d)T adaptors. To limit 
transcript chimera formation, I stopped the PCR reactions at 13 cycles in PCR 1, 12 cycles in 
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PCR 2 and 10 cycles in PCR 3, before a steady-state of amplification was reached (Figure 
3.32). Analysis of these libraries on a bioanalyzer instrument confirmed specific amplification 
of ~500 bp amplicons (Figure 3.33). 
 
Figure 3.31– Schematic representation of enrichment PCRs to generate barcoded sgRNA 
amplicons from 10X Genomics cDNA 
After 10X Genomics 3’ scRNA-seq droplet formation, cDNA amplification leads to the formation of 
fragments (top) that contain a standard Nextera Read 1 adaptor (black), a 10X cell barcode (green), 
a unique molecular identifier (UMI, red), a poly(d)T sequence (blue), and the 3’ end of a transcript, 
here illustrated as a U6-sgRNA sequence (yellow and purple, respectively) transcribed from the EF1α 
Pol II promoter in the CROP-sgRNA-MS2 integration. After three rounds of nested PCR 
amplification, an Illumina P5 adaptor (dark blue) is incorporated at one end of the fragment adjacent 
to Nextera Read 1 (black, left), and a Nextera Read 2 primer (black, right), an i7 sample index (grey) 
and an Illumina P7 adaptor (orange) are incorporated at the other end, generating cell-barcoded and 
sample-indexed sgRNA amplicons ready to be sequenced in an Illumina sequencer (bottom). Picture 
adapted from 10X Genomics website 
 
 
Figure 3.32– qPCR monitoring of sgRNA enrichment PCRs 
Relative fluorescent units (RFU, y axis) vs number of qPCR cycles (x axis) in each of the three rounds 
of nested PCRs on barcoded sgRNAs using 10X Genomics cDNA of SAM22 mESCs transduced 
with CROP-sgRNA-MS2 constructs or with sgRNA(MS2)_puro lentivirus. qPCR was performed 
with KAPA SYBR and the reactions were stopped before reaching a steady-state of amplification. 




Figure 3.33– Bioanalyzer traces of sgRNA enrichment libraries 
Bioanalyzer electropherogram showing fluorescence units (FU, y axis) vs migration time in seconds 
(s, x axis) of sgRNA amplicon libraries of SAM22 mESCs transduced with sgRNA(MS2)_puro 
constructs (left, control) or with CROP-sgRNA-MS2 lentiviruses (right). Numbers above 
electropherogram peaks indicate the size in bp of detected fragments, including a lower molecular 
weight marker of 35 bp (green) and a higher molecular weight marker of 10,380 bp (purple). Only 
sgRNA amplicon libraries from cells transduced with CROP-sgRNA-MS2 constructs generate 
amplicons of ~500 bp (right).  
 
Strikingly, after sequencing this CROP-sgRNA-MS2 amplicon sgRNA libraries, 96.45% of 
the cell barcodes captured could be assigned to expression of a unique sgRNA (Figure 3.34), 
which is consistent with the percentage reported in Hills et al. 2018 and represents a significant 
improvement in comparison to the assignment ratio achieved without sgRNA enrichment 
(Datlinger et al. 2017). With these results, I can conclude that CROP-seq adaptation to the 
SAM CRISPRa system combined with barcoded sgRNA amplicon libraries is a reliable method 
to perform a high-throughput pooled CRISPRa screen at scRNA-seq resolution.  
 
Figure 3.34– Pie chart of sgRNA-cell assignment from amplicon libraries 
Pie chart showing the percentage of 10X cell barcodes from SAM22 mESCs transduced with CROP-
sgRNA-MS2 constructs that could be assigned to expression of a unique sgRNA (blue) as well as the 
percentage of these cells where a sgRNA could not be detected (grey), after sequencing of sgRNA 
amplicon libraries. 
Cell barcodes assigned 
to a unique sgRNA
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3.3 Conclusions and discussion 
In the results presented in this chapter, I first generated mESC lines expressing constitutively 
the CRISPRa SAM machinery dCas9-VP64 and MS2-p65-HSF1 (Figures 3.2-3.4). 
Subsequently, I tested the CRISPRa SAM system established in mESCs using MERVL LTRs 
and Zscan4 genes as targets, and validated their activation as well as the induction of the 
expected downstream transcriptional changes by qPCR, western-blot, immunofluorescence 
and bulk RNA-sequencing (Figures 3.5-3.13). Moreover, I compared the changes induced by 
Zscan4 upregulation by either CRISPRa or cDNA overexpression (Figures 3.14-3.16) and also 
assessed the duration of the transcriptional changes induced by CRISPRa in a time-course 
experiment (Figures 3.17 and 3.18). Next, I translated the findings from transcriptomic bulk 
experiments to an scRNA-seq read-out (Figures 3.19-3.26), establishing guidelines and 
performing calculations critical for subsequent chapters in this dissertation. Lastly, I envisaged 
a strategy for highly efficient capture of sgRNA sequence information in scRNA-seq 
experiments where the pool of transduced cells contains information of multiple sgRNAs 
(Figures 3.27-3.34). Altogether, the experiments described in this chapter set the basis of my 
dissertation and allowed me to develop an efficient method to do pooled CRISPRa screening 
at single-cell resolution. In this discussion section, I put these results in context, highlight their 
relevance in relation to published literature, speculate alternative interpretations and propose 
further experiments and/or analysis that could help towards a better understanding of the 
mechanisms regulating CRISPRa in mESCs as well as the MERVL- and ZSCAN4-mediated 
transcriptional signature in ZGA and 2C-like cells. 
Transgenes integrated by lentiviral transfer can be silenced by epigenetic mechanisms (Pfeifer 
et al. 2002; S. Yao et al. 2004; Herbst et al. 2012). Therefore, it was crucial to generate a mESC 
line expressing dCas9-VP64 and MS2-p65-HSF1, to be used in subsequent experiments, where 
the expression of the transgenes was stable. To this end, I generated clonal mESC lines by 
antibiotic selection and manual colony picking (see Materials and Methods). Whereas dCas9-
VP64 integration was more variable across clones, the integration of MS2-p65-HSF1 was 
efficient in most of the clones tested (Figure 3.3), likely reflecting a higher titer of the lentiviral 
preparation used for transduction. Moreover, the genomic DNA PCR band for dCas9-VP64 
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integration in the non-clonal population was very weak (Figure 3.3), consistent with the more 
variable integration observed across clones and highlighting the importance of generating 
clonal cell lines. However, in addition to confirming integration and expression of the 
transgenes, it was crucial to select clones with an unaltered transcriptome for subsequent 
transcriptomic analysis after transduction with sgRNAs that induce target activation of 
endogenous loci. RNA-sequencing analysis of two of the clones, SAM7 and SAM22, 
confirmed high expression of the transgenes and showed that the rest of the transcriptome was 
largely unchanged (Figure 3.4). These results indicate that the random lentiviral integration of 
both transgenes and their expression did not interfere with gene expression, and are consistent 
with previous studies showing that dCas9 by itself does not induce transcriptomic changes 
(Gilbert et al. 2013; Qi et al. 2013).  
MERVL and Zscan4 are key markers of ZGA and 2C-like cells (Kigami 2002; Peaston et al. 
2004; Svoboda et al. 2004; Falco et al. 2007; Zalzman et al. 2010; Macfarlan et al. 2012; 
Ishiuchi et al. 2015; Ishiguro, Nakatake, et al. 2016; Eckersley-Maslin et al. 2016; Rodriguez-
Terrones et al. 2018). Therefore, I selected them as targets to optimise my CRISPRa SAM 
system in SAM22 mESCs, reasoning that if CRISPR-activating them induced a ZGA-like 
signature, then I could use pooled CRISPRa to screen for multiple regulators. Transduction of 
two different sgRNAs for each of these targets into SAM22 mESCs led to efficient target gene 
activation, as analysed by qPCR, immunofluorescence, bulk and single-cell RNA-sequencing 
(Figures 3.5-3.7, 3.9-3.11, 3.17, 3.21 and 3.22). From these experiments, a key advantage of 
using CRISPRa over cDNA overexpression became apparent: using a single sgRNA, repetitive 
elements or multiple genes within a highly similar cluster could be activated at the same time 
(Figures 3.9-3.11).  
As expected, ZGA-like transcription was triggered both by MERVL LTR and Zscan4 
CRISPRa, as seen by qPCR (Figures 3.8 and 3.18), bulk RNA-sequencing (Figures 3.12 and 
3.13) and scRNA-seq (Figures 3.24-3.26). Interestingly, higher sgRNA efficiency, measured 
by activation of the target gene (Figures 3.5, 3.9, 3.10, 3.11 and 3.17), also translated into 
higher upregulation of the downstream targets (Figures 3.8, 3.12, 3.18), indicating that ZGA-
like transcription is dependent on the dose of MERVL and Zscan4 expression.  
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ZSCAN4C cDNA overexpression in mESCs was done in the Reik laboratory while I was doing 
these experiments (Eckersley-Maslin et al. 2019) and very recently also published by another 
group (W. Zhang et al. 2019). Both studies showed that ZSCAN4C induces ZGA-like 
expression, same as I observed with CRISPRa of the Zscan4 gene cluster. However, I showed 
for the first time MERVL LTR activation (Figures 3.10, 3.21), which triggered transcription 
downstream of them (Figure 3.11), including the expression of ZGA genes (Figures 3.8, 3.12, 
3.13, 3.18, 3.24-3.26). While this was expected, since these repetitive elements can act as 
functional promoters to drive the expression of hundreds of chimeric ZGA transcripts 
(Macfarlan et al. 2012; Y. Huang et al. 2017; Franke et al. 2017), genetic manipulation of these 
elements had not been done before. Furthermore, it revealed a previously unknown inter-
regulatory link between Zscan4 and MERVL, seen consistently in all experiments shown in 
this chapter (Figures 3.5-3.7, 3.9-3.11, 3.16, 3.17, 3.21 and 3.22). While it is known that both 
factors belong to the same transcriptional network in the two-cell embryo and they label the 
same 2C-like subpopulation within mESCs (Kigami 2002; Zalzman et al. 2010; Falco et al. 
2007; Macfarlan et al. 2012; Eckersley-Maslin et al. 2016), how they regulate each other has 
only started to be addressed. ZSCAN4C has been proposed  to enhance rather than drive ZGA-
like expression in mESCs (Eckersley-Maslin et al. 2019) by direct binding to MERVL LTRs 
(or MT2 elements), subsequent recruitment of chromatin modifiers and H3K4me1, H3K27ac 
and H3K14ac deposition on MERVL LTRs that eventually leads to MERVL LTR activation 
and MERVL expression (W. Zhang et al. 2019). However, my results also show that MERVL 
LTR activation induces Zscan4 expression (Figures 3.5-3.7, 3.9-3.11, 3.16, 3.17, 3.21 and 
3.22). MERVL LTR elements are present within the Zscan4 cluster but in opposite orientation 
to the Zscan4 genes, making unlikely direct activation of Zscan4 expression through MERVL 
LTR elements acting as promoters. It is possible to think of three different mechanisms of how 
MERVL LTR CRISPRa induces Zscan4 expression: 1) MERVL LTR CRISPRa recruits 
chromatin modifications, similar to what direct binding of ZSCAN4C would do (W. Zhang et 
al. 2019), and subsequently, activated MERVL elements act as enhancers of ZGA transcription, 
including the Zscan4 cluster; 2) as seen in my RNA-sequencing results (Figure 3.11), MERVL 
LTR CRISPRa induces transcription of the genomic regions downstream of these elements, 
which could result in the upregulation of a direct activator of Zscan4; and 3) MERVL LTR 
CRISPRa provides new transcription factor binding sites (Jichang Wang et al. 2014), which, 
148 Development of CRISPR activation at single-cell RNA-sequencing resolution 
 
indirectly, activates Zscan4 expression. While beyond the scope of this dissertation, these 
remain open questions that could be further investigated using this potent tool to activate 
endogenous transcription of MERVL repeats.  For example, MERVL LTR CRISPRa in Zscan4 
KO mESCs (W. Zhang et al. 2019) followed by transcriptome analysis would unravel whether 
either or both of them are necessary to induce the expression of ZGA genes.  
Importantly, I also showed by qPCR that expression of the key pluripotency genes Oct4 and 
Nanog was not affected after induction of a ZGA-like signature by MERVL LTR or Zscan4 
CRISPRa (Figures 3.8 and 3.18). This is consistent with previous reports showing that protein 
levels of OCT4 are downregulated in 2C-like cells without alterations at the mRNA level 
(Macfarlan et al. 2012; Ishiuchi et al. 2015; Eckersley-Maslin et al. 2016; Rodriguez-Terrones 
et al. 2018).  
Despite Zscan4c CRISPRa and cDNA overexpression inducing both a ZGA-like 
transcriptional response, I analysed in more detail the similarities and differences triggered by 
both methods. PCA clustered CRISPRa and cDNA overexpression samples together and apart 
from controls, confirming the overall transcriptomic similarities (Figure 3.14). However, 
differential gene expression analysis showed that, despite a considerable overlap, there were 
differences in the responses induced by each method (Figure 3.16). Consistent with the qPCR 
results showing that higher Zscan4 CRISPRa leads to higher fold changes in the downstream 
targets (Figures 3.5, 3.8-3.12, 3.17 and 3.18), it is quite likely that the big differences in 
Zscan4c expression levels achieved by CRISPRa and cDNA overexpression (Figure 3.15) 
explain the transcriptomic differences. In other words, the transcriptional responses might be 
very similar but, if ZGA-like expression is dependent on the dose of ZSCAN4, there might be 
some genes that passed the threshold to be called differentially expressed with one method but 
not the other. In fact, other recent studies comparing cDNA overexpression and CRISPRa 
showed that downstream responses might be different due to target gene dose effects (Chavez 
et al. 2015; Sanson et al. 2018; J. Yang et al. 2019). Since CRISPRa triggers transcriptional 
activation of the endogenous locus, the expression changes of the gene target are possibly more 
physiologically-relevant than the acute overexpression induced with cDNA transfections. For 
example, the dosage of OCT4 achieved by either overexpression method influences stem cell 
reprogramming (J. Yang et al. 2019) and, consistently, CRISPRa has been successfully used 
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for cellular reprogramming and the study of cellular transitions (Chakraborty et al. 2014; Black 
et al. 2016; Peng Liu et al. 2018; Weltner et al. 2018; J. Yang et al. 2019). Importantly, there 
are other technical differences in the application of both methods: 1) for CRISPRa SAM, I 
harvested cell samples for transcriptomic or protein analysis 6-15 days after sgRNA 
transduction, whereas ZSCAN4C cDNA overexpression was done over the course of 48 hours; 
2) for CRISPRa SAM, transduced cells were selected with antibiotics for expression of the 
sgRNA, whereas cDNA-eGFP transfected samples from Eckersley-Maslin et al. 2019 were 
eGFP+/- FACS-sorted before RNA-sequencing analysis. Altogether, the gene dose, the timing 
and other technical aspects might contribute to the differences seen by Zscan4 CRISPRa and 
cDNA overexpression, which, yet, are remarkably similar in the induction of ZGA transcript 
expression, confirming CRISPRa target specificity.  Additionally, CRISPRa presents two extra 
advantages over cDNA overexpression which are critical in this dissertation: 1) as it does not 
require cloning of genes, it is highly scalable and allows activation of genes that are, otherwise, 
difficult to clone or transfect into cells, and 2) by using pooled lentiviral libraries of sgRNAs, 
many different genes, or other genomic features such as repeat elements (Figures 3.5, 3.10, 
3.11, 3.17 and 3.21), can be simultaneously activated within a single pooled experiment, 
making it a very suitable tool for screening purposes (Konermann et al. 2015; Joung et al. 2017; 
Horlbeck et al. 2016; Sanson et al. 2018). 
To further address the timing effects of the CRISPRa SAM system that I established in mESCs, 
I performed a time-course experiment, harvesting samples for qPCR analysis 6-15 days after 
sgRNA transduction into SAM22 cells (Figures 3.17 and 3.18). The earliest time point of 6 
days was selected because this was the minimum time needed to transduce sgRNA-expressing 
lentiviruses into cells and select them effectively with puromycin (see Materials and Methods). 
Notably, I showed that longer culture of cells, while maintaining puromycin selection, did not 
affect target gene activation (Figure 3.17) or the expected downstream transcriptional response 
(Figure 3.18). These results became critical later on with the use of the CROP-sgRNA-MS2 
backbone, whose lentiviral titer is reduced compared to the sgRNA(MS2)_puro vector 
(Datlinger et al. 2017) and, therefore, longer culture times were required for effective lentiviral 
transduction and antibiotic selection (see Materials and Methods). However, these experiments 
also raised other questions: how stable are the changes triggered by CRISPRa? does CRISPRa 
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SAM targeting change the epigenetic state of the targeted promoter? and, if that is the case, are 
those changes reversible? A study using a doxycyline-inducible CRISPRa system to target the 
Nanog locus in human ESCs showed that Nanog activation could be reverted upon doxycycline 
withdrawal (J. Guo et al. 2017). Nevertheless, larger studies using different cellular systems 
and different target genes are needed to confirm this observation. 
An important observation made in this chapter, using both immunofluorescence and scRNA-
seq, was that not all cells selected with antibiotics for sgRNA expression showed target gene 
upregulation at the RNA (Figures 3.21, 3.22) or protein level (Figures 3.7, 3.31). For example, 
at the RNA level, approximately 10% of the cells transduced with MERVL LTR sgRNAs 
activated MERVL expression (Figure 3.21), and 50% of the cells transduced with Zscan4 
sgRNAs activated their targets (Figure 3.22). Two alternative hypotheses could explain these 
observations: 1) antibiotic resistance was acquired by cells that silenced the sgRNA lentiviral 
construct or were not transduced and, therefore, lack of target gene activation in those cells was 
due to lack of sgRNA expression; or 2) there was heterogeneity at the single-cell level in the 
chromatin organisation and/or DNA methylation state of the target gene promoters that allowed 
the sgRNA to activate transcription in some cells but not in others. The first option seems 
unlikely given the high percentage of cells that did not activate the target, which is likely too 
high to be explained by acquisition of antibiotic resistance. However, this possibility could be 
addressed by analysing expression of the sgRNA at the single-cell level in scRNA-seq libraries. 
This could not be done in the MERVL and Zscan4 CRISPRa experiments presented in this 
chapter since the scRNA-seq libraries were performed on cells transduced with the 
sgRNA(MS2)_puro construct, which produces a sgRNA transcript that is not captured by the 
oligo(d)T-conjugated beads in 10X Genomics 3’ scRNA-seq libraries. It will be addressed in 
the following chapter with cells transduced with CROP-sgRNA-MS2 lentiviruses. The second 
hypothesis is also tested in chapter 4, using scNMT-seq (single-cell NOMe, methylation and 
transcription-sequencing) (Clark et al. 2018), a technique that allows profiling chromatin 
accessibility, DNA methylation and transcription from the same single cell. 
On a more technical aspect, the cell capture efficiency obtained in the scRNA-seq libraries 
presented in this chapter was considerably low (approximately 25-30%, depending on the 
sample), probably due to the quality of the sample preparation, reflected in a population of 
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“low-quality” cells (Figure 3.20). The sample preparation procedure was improved upon in 
subsequent experiments (see Materials and Methods). 
More importantly, this scRNA-seq experiment allowed a power calculation to be made using 
the percentage of cells that activated a ZGA-like signature upon MERVL and Zscan4 
activation. While these calculations are critical to design the multiplexed pooled screen (see 
chapter 4), it is essential to keep in mind that not all regulators of ZGA might act via the 
MERVL/Zscan4-regulated transcriptional pathway and, therefore, more or less cells than the 
367 calculated per sgRNA might be needed to detect a screen hit with enough statistical power. 
In the last result section of this chapter, I decided to use CROP-seq (Datlinger et al. 2017) as a 
strategy to capture sgRNA sequence information in scRNA-seq libraries over the published 
alternative Perturb-seq or CRISP-seq strategies (Jaitin et al. 2016; Dixit et al. 2016; Adamson 
et al. 2016). Whereas CROP-seq uses a clever cloning strategy to read directly the sgRNA 
sequence from a polyadenylated transcript by exploiting the replication cycle of lentivirus into 
the host genome (Datlinger et al. 2017) (Figure 1.18), Perturb-seq- and CRISP-seq-based 
approaches use expression vectors to co-express polyadenylated barcodes alongside the non-
polyadenylated sgRNAs; these barcodes can be detected by scRNA-seq and used to assign 
sgRNA expression to each individual cell (Jaitin et al. 2016; Dixit et al. 2016; Adamson et al. 
2016). However, since Pertub-seq/CRISP-seq was published, it has been shown that this 
strategy often leads to inaccurate sgRNA-cell assignment in up to 50% of the cells due to 
uncoupling of the sgRNA-barcode pairs during lentiviral packaging of pooled libraries (Hill et 
al. 2018; S. Xie et al. 2018; Adamson et al. 2018; Feldman et al. 2018). This could be overcome 
by arrayed packaging of lentiviral libraries, which drastically reduces the throughput and 
scalability of screening experiments. Even though some studies have proposed alternatives to 
use Perturb-seq in lentiviral pooled libraries (Adamson et al. 2018; Feldman et al. 2018), the 
CROP-seq strategy completely abolishes the problem of barcode uncoupling, making it more 
suitable for pooled CRISPR screening (Hill et al. 2018). However, CROP-seq does not come 
without constraints. As mentioned earlier, disruption of the 3’ LTR with the U6-sgRNA 
cassette reduced the titer of the lentivirus (Datlinger et al. 2017) (see Materials and Methods), 
and, consequently, cloning more than one sgRNA in the CROP-seq vector to introduce multiple 
perturbations in a cell is not feasible, unless using high MOI transductions to introduce multiple 
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random combinatorial perturbations in a cell. Recently, an alternative strategy was proposed to 
capture directly the non-polyadenylated sgRNA sequence in 10X Genomics scRNA-seq 
libraries using a specialised barcode introduced in the beads together with oligo(d)T adaptors 
(Replogle et al. 2018). This strategy combines the best features of each method and is likely to 
be implemented widely for CRISPR screening at single-cell resolution. 
I adapted the CROP-seq vector (Datlinger et al. 2017) to include MS2 loops in the scaffold 
sequence of the sgRNA and allow recruitment of MS2-p65-HSF1 protein in SAM22 cells 
(Figure 3.27). The sgRNA expressed from this CROP-sgRNA-MS2 vector could be captured 
by oligo(d)T adaptors (Figure 3.28), simulating capture of polyadenylated transcripts in 10X 
Genomics 3’ scRNA-seq droplets, and did not impair CRISPRa of endogenous targets (Figures 
3.29 and 3.30). Moreover, specific amplification of sgRNA-containing fragments in scRNA-
seq libraries (Hill et al. 2018) showed that approximately 96% of the cell barcodes recovered 
could be assigned to a unique sgRNA (Figure 3.31-3.34). Therefore, CROP-seq adaptation to 
CRISPRa SAM coupled to sgRNA amplification promises to be a highly efficient method to 
use and assign sgRNA expression to each individual cell in the pooled screen for regulators of 
ZGA (see chapter 4). However, it is important to consider that the 96% unique assignment rate 
might be optimistic for two reasons: 1) it was calculated based on captured cell barcodes in the 
amplicon libraries which were not compared to the total number and quality of cells captured 
in the whole-transcriptome libraries; and 2) I did individual sgRNA transductions and only 
pooled cells at the time of sequencing, therefore discarding the possibility of infecting a cell 
with multiple different sgRNAs.  
Lastly, in addition to CRISPRa SAM, I anticipate the CROP-sgRNA-MS2 vector could also 
be used in multiple other CRISPR editing strategies with scRNA-seq read-out, by fusing the 
MS2 RNA binding protein to other epigenetic modifiers (see section 1.4.1).  
 
Chapter 4 Single-cell transcriptomics CRISPR 
activation screen for regulators of ZGA 
4.1 Background and summary 
To identify regulators of ZGA, one could perform a flow-cytometry-based screen using ZGA 
reporters, such as MERVL or Zscan4 (Macfarlan et al. 2012; Zalzman et al. 2010; Eckersley-
Maslin et al. 2016), as previously done in recent studies (Rodriguez-Terrones et al. 2018; 
Eckersley-Maslin et al. 2019; X. Fu et al. 2019; Y.-L. Yan et al. 2019). However, 
transcriptomic analysis have shown that ZGA is a complex transcriptional process and, 
additionally, the MERVL/Zscan4-regulated network only comprises a small fraction of all the 
genes that are transcribed during ZGA (Xue et al. 2013; Deng et al. 2014; S.-J. Park et al. 2015; 
Eckersley-Maslin et al. 2016). Therefore, relying on a few markers for screening might hamper 
the identification of crucial ZGA regulators. Pooled CRISPRa screening at single-cell 
transcriptomic resolution represents an ideal system for high-throughput identification of 
regulators of complex transcriptional activation process, such as ZGA, by providing 
transcriptome-wide insights into the changes triggered by potential hits. However, while 
powerful in its read-out, scRNA-seq methods are limited by the sequencing costs per cell and, 
therefore, a targeted approach is required in the selection of the screen candidates. 
ZGA occurs as part of the MZT, a developmental transition in which there is not only a 
transcriptional handover from the mother to the embryo, but also extensive remodeling of the 
epigenetic and chromatin landscapes (reviewed in Eckersley-Maslin, Alda-Catalinas & Reik 
2018; Jansz & Torres-Padilla 2019; Ladstatter & Tachibana 2019) (see section 1.1). With these 
premises, I hypothesised that maternal epigenetic and transcriptional factors play a crucial role 
in ZGA regulation.  
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In this chapter, I first defined a list of screen candidates consisting of maternal proteins with 
epigenetic and transcriptional roles. A pooled sgRNA lentiviral library targeting the promoters 
of these candidates was designed and constructed and, after titration, transduced into SAM22 
mESCs. scRNA-seq of more than 300,000 cells, together with amplicon sgRNA libraries, 
allowed analysis of the sgRNA expressed in each cell and, consequently, analysis of target 
gene activation. This large dataset provided an opportunity to systematically identify features 
that contribute to CRISPRa efficiency. I evaluated both sgRNA and target gene features to 
understand, on the one hand, what makes an efficient sgRNA and, on the other hand, whether 
some genes have transcriptional or epigenetic patterns that make them more prone to 
upregulation by CRISPRa. I also investigated CRISPRa efficiency at the single-cell level since 
both the results from this screen and previous results presented in chapter 3 revealed that even 
with all the CRISPRa machinery active and functional sgRNAs, some cells are resistant to 
activate the target gene. 
4.2 Results 
4.2.1 Selection of candidates and screen design 
Given the extensive epigenetic and transcriptional changes that occur during the MZT 
(reviewed in Eckersley-Maslin, Alda-Catalinas & Reik 2018; Jansz & Torres-Padilla 2019; 
Ladstatter & Tachibana 2019), I decided to screen for maternal factors with epigenetic and 
transcriptional regulation roles. For that, I looked into three proteomic studies of mouse oocytes 
and zygotes (Pfeiffer et al. 2011; Pfeiffer et al. 2015; B. Wang et al. 2016). The Pfeiffer et al. 
2011 dataset analysed the proteome of MII mouse oocytes to a depth of 3,699 proteins using 
label-free liquid chromatography tandem-mass spectrometry (LC-MS/MS); the Pfeiffer et al. 
2015 dataset used stable isotope labelling with amino acids in cell culture (SILAC) in 
conjunction with LC-MS/MS to detect 2,010 proteins present simultaneously in MII oocytes 
of four inbred strains (129/Sv, C57Bl/6J, C3H/HeN, DBA/2J); and the B. Wang et al. 2016  
dataset detected 5,350 proteins in MII oocytes and 5,448 in zygotes using SILAC LC-MS/MS, 
for which I selected 2,897 detected both in MII oocytes and zygotes. Next, I used gene ontology 
(GO) to identify 1,683 genes with roles in transcription, chromatin and epigenetic regulation 
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in any given biological context (see Materials and Methods) and, by intersecting this GO list 
with each proteomic dataset, I obtained a list of 230 screen candidates (Figure 4.1 and 
Appendix C). These included 22 positive controls of proteins previously described to play a 
role in ZGA regulation, either in vivo – HSF1 (Christians et al. 2000), SMARCA4 (Bultman et 
al. 2006), CTCF (Wan et al. 2008), SOX2 (Pan & Schultz 2011), NFYA (F. Lu et al. 2016), 
LIN28A (K.-H. Kim et al. 2016), YAP1 (C. Yu, Ji, Dang, et al. 2016), DUX (Hendrickson et 
al. 2017; De Iaco et al. 2017; Iaco et al. 2019; Z. Chen & Yi Zhang 2019) and KDM5B (Dahl 
et al. 2016; B. Zhang et al. 2016) – or shown to upregulate a ZGA-like signature in mESCs –  
MERVL, ZSCAN4 (Macfarlan et al. 2012; Zalzman et al. 2010; Eckersley-Maslin et al. 2016; 
Eckersley-Maslin et al. 2019, W. Zhang et al. 2019, and results presented in chapter 3), 
BAHD1, EYA1, IRF1, GATA3, TOX3, TRP63, HDAC9, USP3, TET3, DPPA2 and DPPA4 
(Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et al. 2019) (Figure 1.12). 
Moreover, six factors tested in a previous study in mESCs that did not upregulate a ZGA-like 
network, namely PLAC8, LHX2, CALCOCO1, RB1, SS18L1 and NPM2 (Eckersley-Maslin 
et al. 2019), were included as negative controls together with four genes not expressed in 
oocytes or during pre-implantation development (LYG2, SPATA3, GPR6 and FAM17A).  
 
Figure 4.1– Selection of screen candidates: maternal transcription factors and epigenetic 
regulators 
The 230 screen candidates were selected from three proteomic datasets of metaphase II (MII) mouse 
oocytes and zygotes (Pfeiffer et al. 2011; Pfeiffer et al. 2015; B. Wang et al. 2016) using gene 
ontology (GO) enrichment of transcription, chromatin, epigenetic regulation. Factors detected in any 
of the three datasets with a relevant GO term were selected, together with 22 positive and 10 negative 
controls. 
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Not only at the proteome level, but also at the mRNA level, these candidates are expressed in 
oocytes, zygotes and during early stages of pre-implantation development (Figure 4.2). 
Importantly, their expression is not affected by constitutive expression of dCas9-VP64 and 
MS2-p65-HSF1 in mESCs (Figure 4.3), consistent with the largely unaltered transcriptome of 





Figure 4.2– Expression of screen candidates in oocytes, zygotes, 2-cell and 4-cell embryos 
Dot-plots showing normalised expression in log2 reads per million (RPM) of screen candidates in 
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Figure 4.3– Expression of screen candidates in SAM22 and E14 mESCs 
Scatterplot showing normalised gene expression in log2 reads per million (RPM) of SAM22 mESCs 
against E14 mESCs, highlighting screen candidates in blue and dCas9-VP64 and MS2-p65-HSF1 
transcripts in black. 
 
Despite the considerable reduction of the costs of scRNA-seq, especially with droplet-based 
automated technologies such as 10X Genomics, the sequencing cost per cell still represents an 
important limitation and, therefore, a carefully considered experimental design is needed. First, 
to account for ineffective sgRNAs, at least two sgRNAs per target gene should be included in 
the pooled library, alongside multiple non-targeting sgRNA controls (Figure 4.4). In a 
preliminary experiment (section 3.2.3), I determined that, in order to have the statistical power 
to detect a ZGA-like signature in a positive screen hit, a minimum of 367 cells had to be 
sequenced per sgRNA. Furthermore, the efficiency for assigning sgRNA expression to a cell 
is approximately 96% (Figure 3.34), that is, without accounting for multiple infection events 
that can occur with a pooled lentiviral library, 4% of the cells sequenced would have to be 
discarded. Altogether, these calculations suggested that at least ~181,600 cells would need to 
be sequenced to cover the 230 perturbations, each with 2 sgRNAs, with enough statistical 
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10,000 single cells. Consequently, after delivery and selection of the pooled sgRNA library, 
cells would need to be sequenced across at least 19 10X Gennomics lanes, that is, two full chips 
and three extra lanes from a third chip. To increase statistical power, and considering that not 
all ZGA regulators might act via the MERVL/Zscan4-regulated transcription network used to 
perform power calculations, I decided to sequence cells across three full 10X Genomics chips 
(Figure 4.4).  
 
 
Figure 4.4– Work-flow to determine the number of cells to be sequenced 
The 230 screen candidates will be targeted with two sgRNAs each. Additionally, 15 non-targeting 
sgRNA controls will be included, constituting a pooled lentiviral library of 475 sgRNAs. To cover 
each sgRNA with 367 cells, based on previous power calculations, 174,325 cells would be needed. 
Additionally, the efficiency of sgRNA detection in a cell is approximately 96%, which increases the 
number of cells to be sequenced to 181,589. Up to 10,000 cells can be captured per 10X Genomics 
chip lane, that is, to sequence 181,589 cells, 19 lanes would be needed (more than two chips). To 
increase statistical power, a final decision was made to sequence cells across 3 full chips.   
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4.2.2 Design, construction and transduction of a custom sgRNA lentiviral 
library 
Using the genome-wide CRISPRa library designed by Joung and colleagues (Joung et al. 
2017), I designed a custom oligo library containing two sgRNAs per candidate gene with 
flanking sequences for cloning into the CROP-sgRNA-MS2 construct, which was then 
assembled by VectorBuilder (see Materials and Methods). I selected the top two sgRNAs for 
each target gene ranked based on on-target and off-target scores (Joung et al. 2017). These 
sgRNAs were targeted to the 180 bp window upstream of the TSS of each candidate gene. 
Importantly, for genes with multiple isoforms, I selected sgRNAs that would target the oocyte-
specific isoform, based on expression data from Veselovska et al. 2015. Fifteen non-targeting 
sgRNA controls were also included, as design in Joung et al. 2017, constituting a library of 475 
sgRNAs. After cloning into the CROP-sgRNA-MS2 vector, next-generation sequencing 
confirmed representation of all sgRNAs in the cloned oligo library (Figure 4.5, Appendix C). 
 
Figure 4.5– Histogram showing the distribution of sgRNA representation in the cloned oligo 
library  
Histogram of sgRNAs showing normalised log10 average of read 1 and read 2 from next-generation 
sequencing analysis of the 475 oligo sgRNA library cloned into the CROP-sgRNA-MS2 lentiviral 
construct. The blue line represents a mean of 3.74 log10 average of read 1 and read 2; the standard 
deviation from the mean is 0.39; representation of 90% of sgRNAs in the library is within 19.9 folds. 
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After lentiviral packaging, transduction of this pooled sgRNA library at low MOI (number of 
lentiviral particles infecting each cell) was crucial to ensure the introduction of a unique 
perturbation in each cell and avoid the confounding effects of multiple perturbations or 
activation of multiple genes. The number of integration events achieved by lentiviral 
transduction follows a Poisson distribution (Fehse et al. 2004), which suggests that transduction 
at a MOI of 0.1 reduces the probability for every cell to acquire two or more infection events 
to 0.47% (Figure 4.6). Therefore, I transduced different volumes of the lentiviral sgRNA library 
into 120,000 SAM22 mESCs and analysed mCherry expression by flow cytometry analysis 
(Figure 4.7). As mCherry was included in the CROP-sgRNA-MS2 vector (Figure 3.27), this 
experiment allowed titration of the library and calculation of a simple equation by linear 





Figure 4.6– Pie chart showing probability of number of infection events at a MOI of 0.1 
Pie chart showing the probability of a cell being transduced with 0, 1, 2 or more lentiviruses when 
the transduction is performed at a MOI of 0.1, as calculated by Poisson distribution.  
 
 
0 infection events: 90.48%
1 infection event: 9.05%
2 or more infection events: 0.47%
4.2 Results 161 
 
 
Figure 4.7– mCherry histograms for library titration analysed by flow cytometry 
Histograms showing expression of mCherry in SAM22 mESCs transduced with different volumes of 
the 475 sgRNA lentiviral library, analysed by flow cytometry two days after transduction; 
percentages of cells transduced (expressing mCherry) are shown.  
 
 
Figure 4.8– Calculation of lentiviral MOI equation 
Scatterplot showing the percentage of transduced SAM22 mESCs (mCherry+) with different volumes 
(V) of the 475 sgRNA lentiviral library. From the data, a linear regression equation was calculated 
to allow estimation of the multiplicity-of-infection (MOI) as percentage of transduced cells, as a 
function of lentiviral volume in µL. 
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With this formula, I could estimate that approximately 3.4 µL were required to transduce 
120,000 SAM22 mESCs at a MOI of 0.1. In other words, transduction with 3.4 µl of lentiviral 
library into 120,000 cells would lead to 10% of transduced cells, most of them likely with a 
unique lentivirus. I aimed to have a coverage of at least 1,000 cells for each of the 475 sgRNAs 
in the library at the time of transduction to minimise potential proliferation biases and guarantee 
sufficient representation of each perturbation at the time of scRNA-seq. Accounting for that 
and for a MOI of 0.1 (10% of transduced cells), I transduced 4.75 million SAM22 mESCs with 
135 µl of lentiviral library, in triplicate. 
 For	120,000	cells:	𝑀𝑂𝐼	(%) = 2.75	𝑥	𝑉 + 0.6638 ; 	




𝑠𝑔𝑅𝑁𝐴 = 475,000	𝑡𝑟𝑎𝑛𝑠𝑑𝑢𝑐𝑒𝑑	𝑐𝑒𝑙𝑙𝑠	 









Flow cytometry analysis two days after transduction, before starting puromycin selection, 
revealed that less than 10% of the cells were transduced (Figure 4.9), which ensured that after 
antibiotic selection, most remaining cells would have a unique single perturbation.  
 
Figure 4.9– mCherry histograms of three screen replicates analysed by flow cytometry 
Histograms showing expression of mCherry in three replicates of SAM22 mESCs transduced with 
the 475 sgRNA lentiviral library at low MOI, analysed by flow cytometry two days after transduction; 
percentages of cells transduced (expressing mCherry) are shown.  
4.2 Results 163 
 
After selecting and expanding the CRISPRa-perturbed cells for 10 days (Figure 4.10) (see 
Materials and Methods), 160,000 cells from each replicate were loaded across 8 lanes of a 10X 
Genomics chip, aiming to recover 80,000 single-cell transcriptomes for each replicate. While 
having previously calculated that a minimum of 367 cells per sgRNA were required to have 
enough statistical power, I decided to perform the lentiviral transduction three times to account 
for technical variability and sequence less cells per sgRNA in each individual replicate, 
reasoning that, if there were no major batch effects between replicates, they could be pooled to 
reach statistical power.   
After running the cells through the 10X Genomics chromium controller, 10 ng of barcoded 
cDNA were used to perform sgRNA amplicon libraries, as described in chapter 3, and 700-




Figure 4.10– Schematic overview of the CRISPRa scRNA-seq screen 
Schematic overview of the screen showing transduction of a lentiviral library of 475 sgRNAs at ~0.1 
MOI into SAM22 mESCs, aiming for a representation of a 1000 cells per sgRNA, considering only 
~10% of the cells would be transduced; the cells were selected with puromycin, encoded in the 
CROP-sgRNA-MS2 vector, and expanded for 10 days in culture before being sequenced using 10X 
Genomics 3’ single-cell RNA-sequencing technology; full transcriptome libraries as well as barcoded 
sgRNA amplicon libraries were generated. 
 
Lentiviral library of 475 
sgRNAs targeting
candidate gene promoters:
2 sgRNAs / candidate 
+ 15 non-targeting sgRNAs
4.75 million
SAM22 mESCs
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4.2.3 Quality control of single-cell RNA-sequencing and sgRNA assignment  
Each 10X whole transcriptome scRNA-seq library corresponding to a 10X Genomics chip lane 
was sequenced on an Illumina HiSeq4000 lane and the amplicon sgRNA libraries were 
multiplexed and run across two HiSeq2500 lanes (see Materials and Methods). A total of 
341,103 cells were captured (Figure 4.11), which represents a capture efficiency of 71%.  
 
Figure 4.11– Number of cells captured in each 10X Genomics scRNA-seq library 
Number of cells captured in each 10X Genomics scRNA-seq library out of the 20,000 loaded SAM22 
mESCs transduced with the 475 sgRNA lentiviral library. Each transduction replicate (1, 2 or 3) was 
run across 8 lanes (1 to 8). 
 
For each of the transduction replicates, cells with less than 4,000 or more than 20,000 unique 
molecular identifiers (UMIs), cells with less than 1,600 or more than 5,000 detected genes and 
cells with more than 5% reads coming from mitochondrial genes were filtered-out to discard 
low-quality input and cell doublets (Figure 4.12) (see Materials and Methods). A total of 
317,847 cells across the three replicates (93,2%) passed this quality control. Next, sgRNA 
expression was assigned to each single cell using the barcoded sgRNA amplicon libraries (see 
Materials and Methods). Out of the 317,847 cells that passed quality control, 249,676 cell 
barcodes (78.6%) were captured in the amplicon libraries. Out of these, a total of 203,894 cells 
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across the three replicates (81.66%) were assigned to a unique sgRNA, while the remaining 
cells showed expression of two (3.73 %) or more sgRNAs (14.15%) or could not be confidently 
assigned to a sgRNA in the pooled library (0.46%) (Figure 4.13) (see Materials and Methods). 
These percentages and their significance are discussed in detail in section 4.3 of this chapter. 
For downstream analysis, only cells with expression of a single sgRNA were taken forward to 
avoid potential confounding effects of multiple sgRNAs.  
 
Figure 4.12– Quality control and filtering of 10X Genomics scRNA-seq libraries 
Histograms showing number of unique molecular identifiers (UMIs) (top panel), number of genes 
detected (middle panel) and percentage of reads from mitochondrial genes (bottom panel) in each of 
the transduction replicates (1-3).  As indicated with red vertical lines, cells with more than 4,000 and 
less than 20,000 UMIs (top panel), more than 1,600 and less than 5,000 genes (middle panel) and 
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Figure 4.13– Number of cells assigned to sgRNA expression  
Number of cells assigned to a single unique sgRNA (blue), two sgRNAs (dark grey), more than two 
sgRNAs (light grey) or none (pink) in each of the three transduction replicates (1-3). The number of 




Given that not all the sgRNAs were equally represented in the sgRNA plasmid library (Figure 
4.5), I next analysed the number of cells transduced and captured with each sgRNA (Appendix 
C). The distribution of number of cells per sgRNA was almost identical between replicates 
(Figure 4.14) and, after merging them, the dataset consisted of 437 cells per sgRNA on average 
(Figure 4.15), which was above the power estimate of a minimum of 367 cells per sgRNA to 
detect a ZGA signature. All sgRNAs cloned into the lentiviral library were represented in the 
10X Genomics scRNA-seq dataset (Appendix C). The number of cells captured expressing 
each sgRNA ranged from 9 to 3,300 (Appendix C) and correlated with sgRNA representation 
in the plasmid library before transduction, indicating that activation of the target genes did not 
have any strong effects on cell proliferation or viability (Figure 4.16). 
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Figure 4.14– Histograms of sgRNA count in relation to number of cells per sgRNA, in each 
replicate 
Histograms of the number of cells expressing a given unique sgRNA from the 475 sgRNA library in 
each transduction replicate (1-3); the number of cells per sgRNA is depicted in logarithmic scale and 
the vertical blue line represents the average of cells per sgRNA (150 cells in replicate 1, 151 cells in 
replicate 2, and 131 cells in replicate 3). 
 
 
Figure 4.15– Histogram of sgRNA count in relation to number of cells per sgRNA for the 
combined dataset 
Histogram of the number of cells across the three transduction replicates expressing a given unique 
sgRNA from the 475 sgRNA library; the number of cells per sgRNA is depicted in logarithmic scale 
and the vertical blue line represents the average of 437 cells per sgRNA. 
 
 





Figure 4.16 – Scatterplot showing number of cells vs sgRNA representation in the oligo library 
Scatterplot between the number of cells expressing a given sgRNA in the scRNA-seq CRISPRa 
screen data (y axis) and the normalised representation of the sgRNA in the cloned oligo library before 
transduction (log10 average of read 1 and read 2- x axis). The sgRNA representation in the oligo 




Both PCA and UMAP (Uniform Manifold Approximation and Projection) are algorithms for 
high-dimensionality reduction (Pearson 2010; McInnes et al. 2018). Analysis the whole dataset 
of 203,894 cells expressing a unique sgRNA using both of these methods, on highly variable 
genes (see Materials and Methods), showed high transcriptional similarity between replicates 
(Figures 4.17), validating the robustness of the screen. Therefore, cells across the three 
transduction replicates were merged for downstream analysis to reach the statistical power of 
at least 367 cells per sgRNA, on average.  

















Average read 1 and read 2 sgRNA library







Figure 4.17– Reproducibility of transduction replicates, analysed by PCA and UMAP  
Principal component analysis (PCA) (top panel) and UMAP (Uniform Manifold Approximation and 
Projection) (bottom panel) was performed on the whole dataset of 203,894 cells expressing a unique 
sgRNA. For PCA, the first two principal components (PC1 and PC2) are shown (top panel). PC1 (x 
axis) explains 2.6% of total variance in the whole dataset whereas PC2 (y axis) explains 2.3% of 
variance. For UMAP, UMAP factor 1 (UMAP1, x axis) and UMAP factor 2 (UMAP2, y axis) are 
shown (bottom panel). The cells from each transduction replicate (1-3) contributing to the analysis 
are shown in each column and highlighted in blue.  
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4.2.4 Target gene activation and CRISPR activation performance 
Before I could identify candidate genes whose activation triggered a ZGA-like signature, I first 
needed to systematically assess the functionality of sgRNAs. In order to do that, the expression 
of each target gene was analysed in the cells transduced with the corresponding targeting 
sgRNA in comparison to the basal gene expression in the non-targeting sgRNA control cells 
(see Materials and Methods). By doing this, activated (cells with higher target gene expression 
than the basal level in non-targeting sgRNA control cells, FDR<10%, see Materials and 
Methods) and not-activated (cells with equal or lower target gene expression than the basal 
level in non-targeting sgRNA control cells, FDR>10%, see Materials and Methods) cells were 
called for each targeting sgRNA. This method allowed the identification of target genes for 
which both sgRNAs triggered activation, target genes for which only one of the targeting 
sgRNAs activated gene expression, and target genes for which none of the sgRNAs upregulated 
gene expression compared to the non-targeting sgRNA control cells (Figure 4.18). Importantly, 
the number of activated cells for each sgRNA did not correlate with the total number of cells 
expressing that sgRNA (Figure 4.19 and Appendix C), indicating that the method established 
to call activated cells is independent on the total number of cells and that CRISPRa efficiencies 
at the single-cell level are variable from one sgRNA to another. 
Using this method, I considered that a sgRNA had worked effectively when at least 10 
transduced cells showed target gene activation. I set this thereshold on the basis that technical 
drop-outs are common in scRNA-seq data (Qiu et al. 2018) and, therefore, cells classified as 
not-activated could be the result of biological lack of target gene activation or technical lack of 
target gene activation detection. Moreover, 10 would be the minimum number of single-cells 
to be analysed per sgRNA for confident downstream analysis. Using this criterion, a total of 
108 sgRNAs were found to be functional (Appendix C). This corresponded to effective target 
gene activation for 82 out of 230 candidates, 26 of which were activated with both targeting 
sgRNAs and 56 with only one sgRNA (Figure 4.20 and Appendix C). Given the surprising 
variability in sgRNA efficiency not only between sgRNAs (Figure 4.19, 4.20) but also between 
single cells for a given sgRNA (Figure 4.18), I decided to maximise the power of my 
comprehensive single-cell transcriptomic dataset to investigate in detail the features that drive 
CRISPRa efficiency.  








Figure 4.18– Representatives examples of target gene activation 
Dot-plots (upper panels) and density plots (bottom panels) of representative examples of effective 
target gene activation with the two targeting sgRNAs (Smarca5 - left panel), one of the targeting 
sgRNAs (Ezh2 - middle panel) or ineffective target gene activation with either of the two targeting 
sgRNAs (Ubtf - right panel). SAM22 mESCs expressing the respective targeting sgRNAs are 
shown in red and orange and SAM22 mESCs expressing either of the 15 non-targeting sgRNA 
controls are shown in blue. In the dot-plots, each dot represents a cell plotted as a function of fold 
change expression to the average expression in the non-targeting sgRNA control cells. In the 
density plots, normalised gene expression is calculated as loge(number of UMIs for target gene / 
sum (number of total UMIs in a cell) *10,000 + 1) and plotted as a function of density. Vertical 
dashed lines represent an FDR 10% cut-off for activated and not-activated cells within each 
sgRNA, with cells above the cut-off being activated for the corresponding target gene and cells 
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Figure 4.19– Target gene activation is independent on total number of cells 
Scatterplot between number of activated cells for each sgRNA (y axis) against total number of cells 
expressing that sgRNA (x axis), showing there is no linear correlation between the two (R2 = 0.0195). 
 
 
Figure 4.20– Pie chart of number of candidate genes activated  
Pie chart showing number of candidate genes not activated by either of the two targeting sgRNAs 
(black), number of candidate genes effectively activated with one of the targeting sgRNAs (light 
green), and number of candidate genes effectively activated with the two targeting sgRNAs (dark 
green). A sgRNA was considered effective when at least 10 transduced cells showed target gene 
activation. 
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Even though the screen was performed on the clonal SAM22 mESC line, I first asked whether 
some cells might had lost expression of the stably integrated CRISPRa machinery (dCas9-
VP64 and MS2-p65-HSF1) and, if that was the case, whether that explained the differences 
observed in CRISPRa efficiency. For that, scRNA-seq reads that did not map to the mouse 
genome assembly were mapped to the integration sequence of dCas9-VP64 and/or MS2-p65-
HSF1 plasmids (see Materials and Methods). The two plasmids are identical between 
themselves in the region immediately upstream of the polyadenylation signal (Figure 3.2), 
making it impossible to distinguish between the two in 3’-primed scRNA-seq libraries. 
Furthermore, given the sequence similarity of these two plasmids to the CROP-sgRNA-MS2 
plasmid in this same region upstream of the polyadenylation signal, and the limited sequencing 
read length at the 3’ end of transcripts in 10X Genomics scRNA-seq libraries (see Materials 
and Methods), very few reads mapped confidently to dCas9-VP64 and/or MS2-p65-HSF1 
transcripts (Figure 4.21). Therefore, with 3’-primed 10X Genomics scRNA-seq libraries, it is 
not possible to assess expression of CRISPRa machinery. 
 
Figure 4.21– dCas9-VP64 and/or MS2 p65-HSF1 expression in not-activated and activated cells   
Violin plots showing number of dCas9-VP64/MS2-p65-HSF1 reads per cell in not-activated and 
activated cells for any given sgRNA. Differences between the two groups assessed by Mann-Whitney 
test were not statistically significant 
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Before sequencing, the cells transduced with the pooled sgRNA library were selected with 
puromycin for expression of the sgRNA (Figure 4.10). However, it was possible to think that 
not-activated cells had lower sgRNA expression due to the random integration nature of 
lentiviruses, reasoning that not-activated cells could have integrated the sgRNA construct in a 
genomic site that allowed expression to sufficient levels to survive puromycin selection but not 
to trigger efficient target gene activation. Using the amplicon sgRNA libraries, I could estimate 
the number of sgRNA reads per cell. Surprisingly, I found no differences in sgRNA expression 
between activated and not-activated cells (Figure 4.22), discarding this as a cause for 




Figure 4.22– sgRNA expression in not-activated and activated cells  
Dot-plots and violin plots showing number of sgRNA reads in not-activated and activated individual 
cells for any given sgRNA. sgRNA reads were quantified from the sgRNA amplicon libraries. 
Differences between the two groups assessed by Mann-Whitney test were not statistically significant. 
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Next, I hypothesised that features of the sgRNAs themselves are responsible for CRISPRa 
efficiency, since for 56 out of the 82 effectively activated candidates, only one of the sgRNAs 
was effective (Figure 4.20). The targeting position of the sgRNA has been shown to be crucial 
both for CRISPRa and CRISPRi and related to nucleosome occupancy (Konermann et al. 2015; 
Braun et al. 2016; Horlbeck et al. 2016; Horlbeck, Witkowsky, et al. 2016; Radzisheuskaya et 
al. 2016). All sgRNAs in my custom library were targeted to the 180 bp region upstream of the 
TSS of the candidate gene, as this was previously shown to be optimal for CRISPRa 
(Konermann et al. 2015). Interestingly, I observed that, within this 180 bp window, the 
targeting position of the sgRNA relative to the TSS was significantly different between 
effective and ineffective sgRNAs, with effective sgRNAs mapping further away from the TSS 
than the ineffective ones (Figure 4.23). This difference was more pronounced between effective 
and ineffective sgRNAs within activated candidates in the dataset (Figure 4.23). These results 
suggest that the targeting position of the sgRNA was crucial for optimal efficiency, whereas 
for candidate genes that were not activated with either of the two targeting sgRNAs, other 
factors might contribute to make those genes less susceptible to activation.  
sgRNA base content is also key for CRISPR efficiency and specificity (T. Wang et al. 2014; 
Radzisheuskaya et al. 2016; Chari et al. 2015; Doench et al. 2016; H. Xu et al. 2015; X. Xu et 
al. 2017; Graf et al. 2019). While I found no differences in overall GC content between 
effective and ineffective sgRNAs (Figure 4.24), base-by-base analysis revealed that base 
composition at positions 8, 15 and 17 (with position 20 being just upstream of PAM) was 
different for effective and ineffective sgRNAs (Figure 4.25). Positions 8 and 15 were enriched 
in “C” and position 17 enriched in “G” in effective sgRNAs, whereas ineffective sgRNAs 
within effectively activated targets were enriched in “G” at position 15 (Figures 4.25, 4.26). 
Statistical quantification of the proportions of each base at each position in each group, in 
comparison to the expected proportions, showed that the presence of a “G” at position 15 was 
predicted for ineffective sgRNAs, and presence of a “C” at position 8 was also close to be 
statistically significant (p-value = 0.07) for effective sgRNAs (Figure 4.26). Similar to the 
effect observed for the sgRNA targeting distance to the TSS (Figure 4.23), these differences 
were overall more pronounced between effective and ineffective sgRNAs within activated 
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candidates in the dataset, suggesting again that other factors might play a role in the 





Figure 4.23– sgRNA targeting position for effective and ineffective sgRNAs 
Box-whisker plots showing mapping distance in base-pairs (bp) from the 3’ end of the sgRNA (base 
proximal to PAM) to the TSS, for effective sgRNAs (green) and ineffective sgRNAs (grey and 
black); ineffective sgRNAs are sub-divided into two categories: those targeting activated candidate 
genes in the dataset by the alternative sgRNA (grey) and those targeting not-activated candidate genes 
in the dataset by either of the two sgRNAs (black). A sgRNA was considered effective when at least 
10 transduced cells showed target gene activation. Statistically significant differences between 

































Figure 4.24– Percentage of GC content in effective and ineffective sgRNAs 
Box-whisker plots showing percentage of GC content in effective sgRNAs (green) and ineffective 
sgRNAs (grey and black); ineffective sgRNAs are sub-divided into two categories: those targeting 
activated candidate genes in the dataset by the alternative sgRNA (grey) and those targeting not-
activated candidate genes in the dataset by either of the two sgRNAs (black). A sgRNA was 
considered effective when at least 10 transduced cells showed target gene activation. Differences 
























Figure 4.25– Base content at each position of effective and ineffective sgRNAs 
Logo representation of sgRNA base content at each position of effective sgRNAs (top panel - green) 
and ineffective sgRNAs (middle and bottom panels - grey and black); ineffective sgRNAs are sub-
divided into two categories: those targeting activated candidate genes in the dataset by the alternative 
sgRNA (middle panel - grey) and those targeting not-activated candidate genes in the dataset by 
either of the two sgRNAs (bottom panel - black). Position 1 is the furthest away from the PAM region 
and base 20 is just upstream of it. A sgRNA was considered effective when at least 10 transduced 
cells showed target gene activation.  
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Figure 4.26– Quantification of base content at each position of effective and ineffective sgRNAs 
Heatmaps showing percentage of each base in sgRNA positions 8 (top panel), 15 (middle panel) and 
17 (bottom panel) for effective sgRNAs (left columns) and ineffective sgRNAs (middle and right 
columns), as well as the percentage of each base in the total 460 targeting sgRNAs in the library 
(grey). Ineffective sgRNAs are sub-divided into two categories: those targeting activated candidate 
genes in the dataset by the alternative sgRNA (middle columns) and those targeting not-activated 
candidate genes in the dataset by either of the two sgRNAs (right columns). The p-value of chi-square 
tests for the proportions of each base in each sgRNA category and each position in comparison to the 
expected proportion is shown. A sgRNA was considered effective when at least 10 transduced cells 
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Therefore, I next grouped the targeted genes into “activated” (with one or both sgRNAs) and 
“not-activated” genes and investigated the differences, if any, in their basal expression as well 
as multiple epigenetic features. The CRISPRa SAM system has been shown to work better for 
lowly expressed target genes, with fold changes achieved being anti-correlated with basal gene 
expression (Konermann et al. 2015; Chavez et al. 2016). However, I found no differences in 
basal gene expression between activated and not-activated genes in my screen when I looked 
at their normalised expression in untransduced SAM22 mESCs bulk RNA-sequencing libraries 
(Figure 4.27) or in E14 mESCs bulk RNA-sequencing libraries from multiple datasets and 
studies (Barisic et al. 2019, von Meyenn et al. 2016, this dissertation) (data not shown).  
 
Figure 4.27– Basal expression of activated and not-activated genes in SAM22 mESCs by bulk 
RNA-sequencing 
Box-whisker plots showing basal normalised expression in log2 reads per million (RPM) in SAM22 
mESCs of effectively activated (green) and not-activated (black) gene candidates in the screen, 
analysed by bulk RNA-sequencing. A gene was considered activated when at least one of the 
targeting sgRNAs lead to efficient target gene activation. A sgRNA was considered effective when 
at least 10 transduced cells showed target gene activation. Differences between the two groups 
assessed by Mann-Whitney test were not statistically significant. 
 
Since gene expression can be heterogeneous in mESCs (reviewed in Tanaka 2009), I also 
analysed basal expression levels of activated and not-activated genes in cells transduced with 
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untransduced E14 mESCs analysed by either 10X Genomics or Smart-Seq2 scRNA-seq. E14 
10X Genomics scRNA-seq libraries were described in chapter 3 and E14 Smart-Seq2 scRNA-
seq libraries were published in Rulands et al. 2018 (see Materials and Methods). Unexpectedly, 
in all three cases, I observed that the basal level of gene expression was higher for effectively 
activated gene targets (Figure 4.28). 
 
Figure 4.28– Basal expression of activated and not-activated genes in scRNA-seq libraries 
Box-whisker plots showing basal normalised expression in log2 reads per million (RPM) of 
effectively activated (green) and not-activated (black) gene candidates in the screen, in SAM22 
mESCs transduced with non-targeting sgRNAs and analysed by 10X Genomics scRNA-seq and in 
E14 mESCs analysed by either 10X Genomics scRNA-seq or by Smart-Seq2 scRNA-seq (E14 Smart-
Seq2 data analysed from Rulands et al. 2018). A gene was considered activated when at least one of 
the targeting sgRNAs lead to efficient target gene activation. A sgRNA was considered effective 
when at least 10 transduced cells showed target gene activation. Differences between activated and 
not-activated genes for each of the three cell types and/or platforms of sequencing were assessed by 
Mann-Whitney test: * p-value <0.05, p-value = 0.07 for E14 mESCs analysed by Smart-Seq2.  
 
Observing differences in basal gene expression between these two groups by scRNA-seq but 
not by bulk RNA-sequencing suggested heterogeneity at the single-cell level in the expression 
of these genes. However, I observed no differences in the variability of basal expression 

































182 Single-cell transcriptomics CRISPR activation screen for regulators of ZGA 
 
Therefore, it is difficult to conclude whether the higher basal gene expression observed for 
activated genes in scRNA-seq libraries makes these genes more susceptible to activation by 
CRISPRa SAM in mESCs or whether the differences observed are a technical artifact of 
scRNA-seq by which these genes are generally detected at higher levels.  
 
 
Figure 4.29– Basal expression variability of activated and not-activated genes by scRNA-seq  
Box-whisker plots showing basal variability in expression across single-cells (see Materials and 
Methods) of effectively activated (green) and not-activated (black) gene candidates in the screen, in 
E14 mESCs analysed by Smart-Seq2 scRNA-seq (data analysed from Rulands et al. 2018). A gene 
was considered activated when at least one of the targeting sgRNAs lead to efficient target gene 
activation. A sgRNA was considered effective when at least 10 transduced cells showed target gene 
activation. Differences between the two groups assessed by Mann-Whitney test were not statistically 
significant. 
 
To distinguish between these two possibilities, I next used published sequencing datasets of 
mESCs to analysed a wide range of basal epigenetic features of these genes that might influence 
their expression levels. First, I analysed ATAC-seq (King et al. 2018; Dongwei Li et al. 2017) 
and DNase-seq (ENCODE) datasets and determined that the accessibility of the chromatin at 
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The histone post-translational modifications H3K4me3 and H3K27ac are generally associated 
with transcriptional activity and open chromatin, respectively (reviewed in Kouzarides 2007) 
(Figure 1.6). However, and consistent with the results observed by ATAC-seq and DNase-seq, 
no differences were detected on average in these two marks at the promoters of activated and 
not-activated genes by ChIP-seq (Figure 4.31) (data analysed from Hernandez et al. 2018). 
Conversely, H3K27me3 and H3K9me3 are both marks associated with inactive chromatin and 
repressive gene expression (reviewed in Kouzarides 2007) (Figure 1.6). Overall, the candidate 
genes included in the screen are depleted of H3K27me3 and H3K9me3 at their promoters in 
mESCs (Figure 4.32), consistent with their expression levels (Figure 4.3) and regardless of 
their activation state in the screen (Figure 4.32) (H3K27me3 ChIP-seq data analysed from 
Hernandez et al. 2018 and H3K9me3 ChIP-seq data analysed from Bilodeau et al. 2009).  
 
Figure 4.30– Basal chromatin accessibility in the promoters of activated and not-activated 
genes  
Box-whisker plots showing basal chromatin accessibility of gene promoters of effectively activated 
(green) and not-activated (black) gene candidates in the screen, measured as log2 reads per million 
(RPM) in the region 1 kilobase upstream of the gene TSS in mESC ATAC-seq (King et al. 2018, 
Dongwei Li et al. 2017) and DNase-seq (ENCODE) libraries. A gene was considered activated when 
at least one of the targeting sgRNAs lead to efficient target gene activation. A sgRNA was considered 
effective when at least 10 transduced cells showed target gene activation. Differences between 

































Figure 4.31– Basal H3K4me3 and H3K27ac in the promoters of activated and not-activated 
genes  
Box-whisker plots showing basal H3K4me3 and H3K27me3 at gene promoters of effectively 
activated (green) and not-activated (black) gene candidates in the screen, measured as log2 reads per 
million (RPM) in the region 1 kilobase upstream of the gene TSS in H3K4me3 and H3K27ac mESC 
ChIP-seq libraries (data analysed from Hernandez et al. 2018). A gene was considered activated when 
at least one of the targeting sgRNAs lead to efficient target gene activation. A sgRNA was considered 
effective when at least 10 transduced cells showed target gene activation. Differences between 
activated and not-activated genes for each histone mark were assessed by Mann-Whitney test and 
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Figure 4.32– Basal H3K27me3 and H3K9me3 in the promoters of activated and not-activated 
genes  
Box-whisker plots showing basal H3K27me3 and H3K9me3 at gene promoters of effectively 
activated (green) and not-activated (black) gene candidates in the screen, measured as log2 reads per 
million (RPM) in the region 1 kilobase upstream of the gene TSS in H3K27me3 mESC ChIP-seq 
libraries (analysed from Hernandez et al. 2018) and H3K9me3 mESC ChIP-seq libraries (analysed 
from Bilodeau et al. 2009). A dashed line at y = 0 indicates that the promoters analysed are largely 
depleted of H3K27me3 and H3K9me3 marks in mESCs. A gene was considered activated when at 
least one of the targeting sgRNAs lead to efficient target gene activation. A sgRNA was considered 
effective when at least 10 transduced cells showed target gene activation. Differences between 
activated and not-activated genes for each histone mark were assessed by Mann-Whitney test and 
were not statistically significant. 
 
DNA methylation at gene promoters has long been associated to transcriptional repression 
(Razin & Riggs 1980) via different mechanisms such as recruitment of histone post-
translational modifications or by preventing the binding of transcription factors (reviewed in 
Klose & Bird 2006) (Figure 1.6). Therefore, I analysed the DNA methylation state of the gene 
promoters of activated and not-activated genes in whole-genome bisulfite sequencing libraries 
(Ficz et al. 2013, Habibi et al. 2013, Milagre et al. 2017, Berrens et al. 2017) and found overall 
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Lastly, H3K36me3, which is often found in gene bodies of actively transcribed genes (reviewed 
in Kouzarides 2007) (Figure 1.6), was overall present at basal levels in all screen candidates 
and its average occurrence was not different between the groups of activated and not activated 
genes (Figure 4.34) (data analysed from Neri et al. 2017). Altogether, these observations point 
to an overall similar basal epigenetic and transcriptional state between the group of activated 




Figure 4.33– Percentage of basal DNA methylation in the promoters of activated and not-
activated genes  
Box-whisker plots showing percentage of basal CpG methylation at gene promoters of effectively 
activated (green) and not-activated (black) gene candidates in the screen, analysed by whole-genome 
bisulfite sequencing (Ficz et al. 2013, Habibi et al. 2013, Milagre et al. 2017, Berrens et al. 2017). 
Whole-genome bisulfite libraries from wild-type mESCs from the four studies were merged to 
increase sequencing coverage. Gene promoters are defined as the region 1 kilobase upstream of the 
gene TSS. Percent DNA methylation was calculated as the percent of methylated CpGs over total 
CpGs in the region of interest. A gene promoter was considered for analysis if it had at least 10 CpGs 
covered by at least 10 reads. A gene was considered activated when at least one of the targeting 
sgRNAs lead to efficient target gene activation. A sgRNA was considered effective when at least 10 
transduced cells showed target gene activation. Differences between activated and not-activated 
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Figure 4.34– Basal H3K36me3 in the gene bodies of activated and not-activated genes  
Box-whisker plots showing basal H3K36me3 in gene bodies of effectively activated (green) and not-
activated (black) gene candidates in the screen, measured as log2 reads per kilobase per million 
(RPKM) over gene bodies in H3K36me3 mESC ChIP-seq libraries (data analysed from Neri et al. 
2017). A gene was considered activated when at least one of the targeting sgRNAs lead to efficient 
target gene activation. A sgRNA was considered effective when at least 10 transduced cells showed 
target gene activation. Differences between activated and not-activated genes were assessed by 
Mann-Whitney test and were not statistically significant. 
 
 
Moreover, I also performed transcription factor motif analysis on the promoters of activated 
genes on the one hand and the promoters of not-activated genes on the other hand (see Materials 
and Methods). However, I did not find motifs differentially enriched between the groups (data 
not shown), suggeting that there are no transcription factors that specifically mediate CRISPRa 
SAM to contribute to its efficiency in the target genes tested. 
To sum up, the sgRNA targeting position within the 180 bp window upstream of the gene TSS 
determined transcriptional upregulation mediated by CRISPRa SAM in my screen (Figure 
4.23). However, within the genes that were not effectively activated by either sgRNA, there 
might be multiple factors, including the targeting position of the sgRNAs, but also others such 
as basal gene expression or epigenetic state, that individually cannot explain why this group of 
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As also noted earlier, not all cells transduced with a given effective sgRNA showed target gene 
activation (Figures 4.18, 4.19) and this was not due to differences in sgRNA expression (Figure 
4.22). Therefore, I next sought to investigate the differences, if any, in the epigenetic state of 
activated and not-activated cells, reasoning that the epigenetic heterogeneity present in mESC 
cultures (Rulands et al. 2018; Luo et al. 2018; Clark et al. 2018) might influence the ability of 
a cell to activate the target gene by CRISPRa, i.e., a cell with a closed chromatin state in the 
promoter of the target gene might be less susceptible to activation than a cell with a wider open 
chromatin in the target gene promoter. To address this question, I used scNMT-seq (single-cell 
NOMe, methylation and transcription-sequencing) (Clark et al. 2018), a technique that allows 
profiling chromatin accessibility, DNA methylation and transcription from the same single cell. 
Using this method, I could assess target gene activation by CRISPRa SAM at the transcriptional 
level and correlate it to the chromatin accessibility and DNA methylation state of the target 
gene promoter in each individual cell. Due to the cost and throughput limitations of this 
technique, it was not possible to profile all the cells in the screen targeted with the 475 sgRNA 
library. For this reason, I selected one effective sgRNA, Dppa3 sgRNA 1 (or sgRNA 379, 
Appendix C), previously shown to activate Dppa3 expression both at the mRNA (Figure 3.29) 
and protein levels (Figure 3.30), but at different efficiencies in individual cells (Figure 4.35).  
After transducing SAM22 mESCs with the Dppa3 sgRNA or with a non-targeting sgRNA 
control, I sorted 44 single cells from each condition into a GpC methyltransferase-containing 
mix, which was used to label open chromatin. Subsequently, the RNA and DNA were 
physically separated using oligo(d)T-conjugated beads. Then, the RNA was processed to obtain 
the transcriptome information, and the DNA was bisulfite-treated and DNA libraries processed 
to obtain chromatin accessibility (GC methylation) and CpG DNA methylation information 
(Clark et al. 2018) (see Materials and Methods).  
After quality control of the scRNA-seq libraries, 38 cells transduced with Dppa3 sgRNA and 
21 cells transduced with non-targeting sgRNA control were kept for analysis (see Materials 
and Methods). I first corroborated efficient target gene activation showing that Dppa3 was the 
highest upregulated gene in targeted cells compared to non-targeting sgRNA control cells 
(Figure 4.36). Next, I analysed the level of Dppa3 expression at the single-cell level to 
determine whether the expression pattern recapitulated what I observed in the 10X Genomics 
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scRNA-seq libraries, with targeted cells ranging from low to high activation (Figure 4.35). 
However, the expression of Dppa3 was less dynamic between single-cells after Dppa3 
targeting in this experiment, with 37 out of 38 Dppa3-targeted cells showing levels of Dppa3 
expression higher than the non-targeting sgRNA control (Figure 4.37). This was probably due 




Figure 4.35– Dppa3 expression by CRISPRa in the screen 10X Genomics scRNA-seq data 
Box-whisker and dot-plot showing normalised Dppa3 expression (loge(number of Dppa3 UMIs / 
sum (number of total UMI in a cell) *10,000 + 1)) in SAM22 mESCs transduced with Dppa3 sgRNA 
379 or with either of the 15 non-targeting sgRNA controls (see Appendix C), analysed by 10X 
Genomics 3’ scRNA-seq in the CRISPRa screen dataset. Each dot represents a single cell. Red dots 
represent cells with activated Dppa3 expression. A cell was considered activated when Dppa3 
expression levels were above a 10% FDR cut-off compared to non-targeting sgRNA controls. 
 
 







Figure 4.36– Pseudo-bulked transcriptome upon Dppa3 CRISPRa, analysed by scNMT-seq 
Scatterplot showing normalised gene expression in log2 reads per million (RPM) of pseudo-bulked 
SAM22 mESCs transduced with Dppa3 sgRNA 379 (y axis) or with non-targeting sgRNA control 
462 (x axis) (see Appendix C), analysed by scNMT-seq, highlighting Dppa3 transcript. 
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Figure 4.37– Dppa3 expression by CRISPRa, analysed by scNMT-seq 
Box-whisker and dot-plot showing normalised Dppa3 expression in log2 reads per million (RPM) in 
SAM22 mESCs transduced with Dppa3 sgRNA 379 or with non-targeting sgRNA control 462 (grey) 
(see Appendix C), analysed by scNMT-seq. Each dot represents a single cell. Red dots represent cells 
with higher Dppa3 expression than cells transduced with non-targeting sgRNA controls. Differences 
between the two groups were statistically significant (Mann-Whitney test: p-value < 4.89 x 10-13). 
 
Next, I analysed global chromatin accessibility after Dppa3 CRISPRa. 27 cells transduced with 
Dppa3 sgRNA and 31 cells transduced with non-targeting sgRNA passed quality control for 
accessibility (see Materials and Methods). At a global level, Dppa3 activation induced a slight 
increase in chromatin accessibility (Figure 4.38). However, I was interested to see whether 
cells with higher target gene activation also had an increased chromatin accessibility in the 
promoter of the target gene. For that, I analysed the correlation between Dppa3 expression and 
Dppa3 promoter accessibility. Unfortunately, only 11 cells transduced with Dppa3 sgRNA and 
10 cells transduced with non-targeting sgRNA passed quality control for both accessibility at 
the Dppa3 promoter and scRNA-seq (see Materials and Methods), reducing significantly the 
number of cells that could be used for this analysis. Nevertheless, using these few cells, there 
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was a clear difference in Dppa3 promoter accessibility between non-targeting sgRNA control 
cells and Dppa3-targeted cells (Figure 4.39). This could reflect the observed global changes in 
accessibility upon Dppa3 CRISPRa (Figure 4.38) or, alternatively, a specific opening of the 
promoter as a result of the recruitment of CRISPRa SAM machinery which, consequently, 
allows transcriptional activation of the target gene. However, there was no linear relationship 
between Dppa3 transcriptional activation by CRISPRa and target promoter accessibility within 
the Dppa3-targeted cells (Figure 4.39). Given the limited range of Dppa3 expression in cells 
transduced with Dppa3 sgRNA (Figure 4.37 and 4.39), it was not possible to conclude with 
this experiment whether the CRISPRa efficiency achieved at the single-cell level within cells 
expressing the targeting sgRNA correlates with target promoter accessibility. 
Next, I assessed the global changes in DNA methylation in the 27 cells transduced with Dppa3 
sgRNA and 32 cells transduced with non-targeting sgRNA that passed quality control (see 
Materials and Methods). Dppa3 CRISPRa induced a marked decrease in global DNA 
methylation (Figure 4.40). This is consistent with the observed increase in global chromatin 
accessibility (Figure 4.38) and with literature showing that DPPA3 prevents de novo DNA 
methylation and regulates the machinery for maintenance methylation (Y. Li et al. 2018; 
Mulholland et al. 2018). 
Similar to the analysis done for chromatin accessibility, I next aimed to find a correlation 
between DNA methylation in the Dppa3 promoter and Dppa3 expression after CRISPRa. 
However, due to the sparsity of the data, few cells passed quality controls for both expression 
and DNA methylation data (see Materials and Methods), and the trend observed rather reflected 
the global DNA methylation changes induced after Dppa3 CRISPRa than a correlation between 
target gene overexpression and promoter methylation (Figure 4.41). 
Altogether, this scNMT-seq experiment did not provide the answers sought due to the sparsity 
of the data that makes the method unsuitable to assess chromatin accessibility and DNA 
methylation changes in small genomic regions such as a single specific gene promoter.  
 
 





Figure 4.38– Global chromatin accessibility after Dppa3 CRISPRa, analysed by scNMT-seq  
Violin plots showing percentage of global chromatin accessibility in SAM22 mESCs transduced with 
Dppa3 sgRNA 379 (light red) or with non-targeting sgRNA control 462 (grey) (see Appendix C), 
analysed by scNMT-seq. Percentage accessibility was calculated as the percentage of methylated 
GpCs over total GpCs in 10 kilobases windows, with a minimum of 10 observations, and the mean 
accessibility per window across all cells is shown. Differences between the two groups were 











Figure 4.39– Correlation between Dppa3 transcriptional activation by CRISPRa and Dppa3 
promoter accessibility  
Scatterplot between normalised expression of Dppa3 in log2 reads per million (RPM) (x axis) and 
percentage chromatin accessibility in the Dppa3 promoter (y axis) in SAM22 mESCs transduced 
with Dppa3 sgRNA 379 (light red) or with non-targeting sgRNA control 462 (grey) (see Appendix 
C), analysed by scNMT-seq. Each dot represents a single cell. Percentage chromatin accessibility in 
the Dppa3 promoter was calculated as the percentage of methylated GpCs over total GpCs in cells 
with a minimum of 10 observations in the region 1.5 kilobases upstream and 0.5 kilobases 
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Figure 4.40– Global DNA methylation after Dppa3 CRISPRa, analysed by scNMT-seq  
Violin plots showing percentage of global CpG methylation in SAM22 mESCs transduced with 
Dppa3 sgRNA 379 (light red) or with non-targeting sgRNA control 462 (grey) (see Appendix C), 
analysed by scNMT-seq. Percentage DNA methylation was calculated as the percent of methylated 
CpGs over total CpGs in 10 kilobases windows with a minimum of 10 observations, and the mean 
methylation per window across all cells is shown. Differences between the two groups were 
statistically significant (Mann-Whitney test: p-value < 2.2 x 10-16). 
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Figure 4.41– Correlation between Dppa3 transcriptional activation by CRISPRa and Dppa3 
promoter DNA methylation 
Scatterplot between normalised expression of Dppa3 in log2 reads per million (RPM) (x axis) and 
percentage DNA methylation at the Dppa3 promoter (y axis) in SAM22 mESCs transduced with 
Dppa3 sgRNA 379 (light red) or with non-targeting sgRNA control 462 (grey) (see Appendix C), 
analysed by scNMT-seq. Each dot represents a single cell. Percentage DNA methylation in the Dppa3 
promoter was calculated as the percent of methylated CpGs over total CpGs in the region 1.5 
kilobases upstream and 0.5 kilobases downstream of the Dppa3 TSS, without a threshold for 
minimum number of observations.  
 
4.3 Conclusions and discussion 
In this chapter, I describe the steps I took to select relevant candidate genes to screen for 
regulators of ZGA, by identifying epigenetic and transcriptional factors whose proteins are 
present in MII oocytes (Figures 4.1 and 4.2). Subsequently, a lentiviral library containing 
sgRNAs to target the promoters of these screen candidates was generated and transduced at 
low MOI into SAM22 mESCs (Figures 4.5-4.9). After scRNA-seq of the pool of transduced 
cells and generation of amplicon sgRNA libraries (Figure 4.10), I assigned sgRNA expression 
to each individual cell (Figure 4.13) and assessed the effectiveness of target gene activation by 
the CRISPRa SAM system (Figures 4.18-4.41). Consistent with the immunofluorescence and 



























0 5 10 15
75
4.3 Conclusions and discussion 197 
 
CRISPRa efficiency of target gene activation at the single-cell level (Figure 4.18); however, I 
found this could not be explained by expression of the sgRNA (Figure 4.22). Furthermore, I 
categorised the 460 transduced targeting sgRNAs as effective and ineffective as well as the 230 
target genes as activated and not-activated (Figure 4.20). While I could partially underpin the 
cause of sgRNA effectiveness to the targeting position within the gene promoter (Figure 4.23), 
I could not find a single factor that, on its own, explained why some target genes could not be 
activated (Figures 4.26-4.34). In this section, I discuss the relevance of these results in relation 
to published literature, speculate about different possibilities to interpret these results and 
propose further experiments and/or analysis that could help towards the understanding of the 
molecular mechanisms governing CRISPRa.  
In the first description of CROP-seq as a screening tool using pooled CRISPR KO libraries 
(Datlinger et al. 2017), the authors applied computational downsampling analysis to show that 
only 12-13 cells per sgRNA can suffice to detect the expected transcriptional signatures upon 
deletion of T-cell receptor signalling regulators. In chapter 3 of this dissertation, I performed a 
priori power calculations to estimate that at least 367 cells were required per sgRNA to 
confidently detect a ZGA-like transcriptional response, with the assumption that a positive hit 
would have similar effects to MERVL and Zscan4 CRISPRa (Figure 3.24). While these design 
choices are highly dependent on the biological context under investigation, it is crucial to 
determine these parameters using prior knowledge or preliminary data. For instance, these 
preliminary tests allowed me to calculate the total number of cells to be sequenced to cover the 
230 perturbations with enough statistical power (Figure 4.4). In fact, after merging single-cells 
across the three transduction replicates, which are highly reproducible (Figure 4.17), the dataset 
obtained for analysis consisted, on average, of 437 cells per sgRNA (Figure 4.15), surpassing 
the number of 367 cells per sgRNA estimated in chapter 3 to reach statistical power. However, 
the number of cells captured expressing each sgRNA ranged from 9 to 3,300, following the 
distribution of sgRNA representation in the plasmid library before transduction (Figure 4.16, 
Appendix C) and, therefore, for some sgRNAs, less than 367 cells were captured even after 
merging replicates (Figure 4.15, Appendix C). This raises the question of whether, for these 
sgRNAs, there was going to be enough statistical power to detect a ZGA signature in case they 
triggered one. Consequently, when identifying potential hits (see chapter 5), one needs to pay 
198 Single-cell transcriptomics CRISPR activation screen for regulators of ZGA 
 
particular attention on cell numbers and be aware that false negatives might arise as a 
consequence of lack of statistical power. Nevertheless, it is important to remember that the 367 
cells per sgRNA were calculated on the basis of MERVL and Zscan4 CRISPRa triggering a 
ZGA-like signature in ~10% of cells. However, and as I already discussed in chapter 3, it is 
possible to speculate that a ZGA regulator independent on the MERVL/Zscan4-regulated 
transcriptional pathway could be stronger in the induction of a ZGA-like signature in mESCs 
and, therefore, the triggered transcriptional signature would be detected with less than 367 
cells.  
On the technical aspect, 78.6% of the cells that passed quality control were also detected in the 
amplicon libraries (see Materials and Methods). Importantly, the 96% capture efficiency rate 
reported in the pilot test presented in chapter 3 (Figure 3.34) was calculated on the basis of 
amplified 10X Genomics cell barcodes in the amplicon libraires that could be associated to a 
sgRNA, without considering captured cell barcodes in the whole-transcriptome data. 
Consequently, the assignment rate after merging the amplicon data with whole-transcriptome 
libraries and quality controls is lower in the screen presented in this chapter. For the remaining 
21.4% of cells whose cell barcode was not captured in the amplicon sgRNA libraries, it could 
be due to one or several of the following reasons: 1) the sgRNA was expressed but it was not 
captured (drop-out) with in the oligo(d)T-coated beads; 2) the sgRNA was expressed and 
captured with the oligo(d)T-coated beads but was not sufficiently amplified in the amplicon 
sgRNA libraries; or 3) more unlikely, the cells did not express a sgRNA despite surviving 
puromycin selection.   
From the cells that passed quality control and were detected in the amplicon libraries, 99.54% 
could be assigned to one or multiple sgRNAs (Figure 4.13). In a small percentage of cell 
barcodes captured in the amplicon libraries (0.46%), a sgRNA sequence from those included 
in the pooled lentiviral library could not be confidently assigned (Figure 4.13). This is due PCR 
and sequencing errors in the sgRNA amplicon libraries (see Materials and Methods). More 
than 80% of cells were assigned to expression of a unique sgRNA (Figure 4.13). This 
percentage is lower than what was achieved in the pilot test (Figure 3.34). However, this is not 
surprising as, in the pilot test, sgRNAs were individually transduced and cells from different 
transductions only pooled together at the time of sequencing. This means that if a cell was 
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assigned to multiple sgRNAs, it was due to either the formation of cell doublets at the time of 
droplet generation in the 10X Genomics chromium controller or due to the formation of 
transcript chimeras during amplicon sgRNA library preparation, but not due to multiple 
infection events. On the contrary, detection of multiple sgRNAs in a cell after transduction of 
a pooled sgRNA library could be the result of cell doublets, transcript chimera formation or 
multiple infection events. Considering that the probability of multiple infection events at a MOI 
of 0.1 is minimal (Figure 4.6), it is likely that most of the cells assigned to two or more sgRNAs 
are due to noise introduced by chimeric transcripts in the amplicon libraries or due to doublets 
or “multiplets” formed during scRNA-seq droplet formation. Importantly, the doublet rate in 
10X Genomics scRNA-seq libraries increases with the number of cells loaded 
(https://support.10xgenomics.com/single-cell-gene-expression), which was considerably 
higher in the screen than in the pilot test. Several computational and experimental methods 
have been developed in recent years to discriminate doublets in scRNA-seq libraries (Stoeckius 
et al. 2018; Kang et al. 2018; Gehring et al. 2018; C. Guo et al. 2018; Rosenberg et al. 2018; 
McGinnis et al. 2019). The results presented in this chapter indicate that the introduction of 
unique genomic barcodes can be used as a robust tool for doublet detection, which is consistent 
with a previous study (C. Guo et al. 2019).  
To assess target gene activation, a method was developed to detect statistically-confident 
activated cells for the target gene compared to non-targeting sgRNA control cells (Figure 4.18, 
Appendix C, see Materials and Methods). Since this classification of activated and not-
activated cells might be influenced by technical scRNA-seq drop-outs, I established a 
somewhat relaxed cut-off of 10 activated cells to call a sgRNA effective and classify the 
candidate genes as activated or not-activated in the dataset (Figure 4.20). The sgRNAs included 
in the lentiviral library were previously designed to increase on-target activity and decrease 
off-target effects (Konermann et al. 2015; Joung et al. 2017), however, I found a wide range of 
CRISPRa efficiencies after applying this cut-off (Figure 4.20). The most striking observation 
was that, within activated genes and a window of 180 bp upstream of the gene TSS, ineffective 
sgRNAs mapped closer to the TSS than effective sgRNAs (Figure 4.23). Most effective 
sgRNAs mapped to a window of 50-140 bp upstream of the TSS (Figure 4.23), further 
narrowing down the window for optimised efficiency in CRISPRa applications in comparison 
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to the optimal 0-200 bp window that others have previously described (Konermann et al. 2015; 
Horlbeck et al. 2016). These results are however in agreement with a recently optimised 
CRISPRa library containing sgRNAs targeting the region 75-150bp upstream of the gene TSS 
(Sanson et al. 2018). Validation experiments, as well as larger CRISPRa sgRNA libraries that 
can be assessed using a transcriptomic read-out, are needed to further confirm this targeting 
preference. Moreover, previous studies have shown that annotation of TSSs with the FANTOM 
database (Forrest et al. 2014), which identifies TSSs using Cap Analysis of Gene Expression 
(CAGE), is more accurate for sgRNA design in both CRISPRi and CRISPRa application than 
RefSeq or Ensembl annotations (Radzisheuskaya et al. 2016; Horlbeck et al. 2016; Sanson et 
al. 2018). Given that the Joung et al. 2017 library that I used to generate my custom sgRNA 
library used TSS RefSeq annotation, it would be important to analyse the sgRNA distance to 
the TSS using a mESC-specific FANTOM database to see if the differences observed for 
efficient and ineffective sgRNAs hold true. 
Even though sgRNA GC content has been shown to be critical for CRISPR applications (T. 
Wang et al. 2014; Radzisheuskaya et al. 2016; Chari et al. 2015; Doench et al. 2016; H. Xu et 
al. 2015; X. Xu et al. 2017; Graf et al. 2019), it was expected to find no differences between 
effective and ineffective sgRNAs in the dataset (Figure 4.24), since they were all pre-selected 
to have an optimal GC content (Konermann et al. 2015; Joung et al. 2017). However, I observed 
some subtle differences in base composition in positions 8, 15 and 17 (Figures 4.25 and 4.26). 
These differences are in agreement with previous studies showing that sgRNA PAM-proximal 
bases influence on-target (Konermann et al. 2015; Joung et al. 2017) and off-target activity 
(Hsu et al. 2013; B. X. H. Fu et al. 2014; T. Wang et al. 2014; Chari et al. 2015; Graf et al. 
2019), with one study specifically showing that position 17 determines the precision of DNA 
editing in CRISPR KO applications (Chakrabarti et al. 2019). It is therefore possible to 
speculate that the bases in positions 8, 15 and 17 are important for on-target dCas9-sgRNA 
binding in CRISPRa applications. However, similar to the observation made for the sgRNA 
targeting position upstream of the gene TSS, these observations are limited by the relatively 
small sgRNA library size used in this study and, therefore, need to be corroborated with larger 
libraries and independent validations. Importantly, given also the variety of CRISPRa methods 
(Chavez et al. 2016) (Figure 1.16), it will be crucial to test whether these rules are universal for 
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CRISPRa or method-dependent and whether they also apply to other CRISPR-editing 
applications (Figure 1.15). Furthermore, multiple algorithms have been developed in recent 
years taking into account sgRNA base content, targeting position and other factors to aim to 
predict CRISPR efficiency in different applications (H. Xu et al. 2015; Horlbeck et al. 2016; 
Doench et al. 2016; Radzisheuskaya et al. 2016; Haeussler et al. 2016; Labuhn et al. 2017), 
although very few applicable to CRISPRa (H. Xu et al. 2015; Horlbeck et al. 2016) and none 
of them based on scRNA-seq read-outs. Nonetheless, it would be interesting to see whether 
these algorithms can predict the observed efficiency in my CRISPRa dataset.  
Having underpinned the cause of sgRNA effectiveness to the targeting position and, possibly, 
to base content in certain nucleotides, I next asked whether there were also features of the 
targeted genes themselves that made them more or less susceptible to CRISPRa. The first 
evidence that indicated differences in gene susceptibility to CRISPRa was that, whereas the 
differences in the sgRNA targeting position, and partially base content, were clear between 
effective and ineffective sgRNAs for genes that were activated with at least one sgRNA, those 
differences were not as clear for sgRNAs targeting genes that were not activated by either 
sgRNA (Figures 4.23-4.26). The basal level of gene expression was similar between activated 
and not-activated genes when analysing bulk RNA-sequencing data from untransduced mESCs 
(Figure 4.27), but consistently higher in activated genes when analysing scRNA-seq data from 
different library preparation methods (Figure 4.28). Whereas this contradicts previous 
observations that low levels of basal gene expression favour CRISPRa (Gilbert et al. 2014; 
Konermann et al. 2015), it is important to notice that most of the tested candidate genes are 
expressed at relatively high basal levels in mESCs (Figure 4.3). This is consistent with the high 
basal levels for ATAC-seq, DNase-seq, H3K4me3 and H3K27ac signals and low basal levels 
for H3K27me3, H3K9me3 and DNA methylation signals at these gene’s promoters, as well as 
high basal levels of H3K36me3 in gene bodies, regardless of the activation state of the gene 
achieved by CRISPRa (Figures 4.30-4.34). These observations, together with the lack of 
differences in expression variability at the single-cell level (Figure 4.29), suggest that the 
higher basal expression detected for activated genes is probably a technical artifact of scRNA-
seq libraries that makes those genes more easily detectable, consistent with drop-outs being 
more common for lower expressed genes (Qiu et al. 2018). If this was true, it raises the 
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possibility that genes that I classified as “not-activated” were actually activated but the level of 
activation was not detectable or did not pass the threshold of 10 activated cells. 
Several epigenetic features have been shown to influence CRISPR efficiency, although there 
has not been any study so far addressing epigenetic influence in CRISPRa applications. An 
open chromatin state and low nucleosome occupancy generally favours both Cas9 and dCas9 
binding (Kuscu et al. 2014; Xuebing Wu et al. 2014; Chari et al. 2015; Singh et al. 2015; Knight 
et al. 2015; Horlbeck, Witkowsky, et al. 2016; Isaac et al. 2016; Radzisheuskaya et al. 2016; 
Jensen et al. 2017; Uusi-Mäkelä et al. 2018; Yarrington et al. 2018). H3K27ac, H3K9ac, 
H3K4me2 and H3K79me2 have also been shown to favour CRISPR editing (Radzisheuskaya 
et al. 2016; Chari et al. 2015) and DNA CpG methylation was paradoxically reported to affect 
CRISPR mutagenesis in some studies but not in others (Xuebing Wu et al. 2014; Hsu et al. 
2013; Perez-Pinera et al. 2013). In the categories that I established to study CRISPRa efficiency 
in my dataset, I could not find any epigenetic feature that individually explains the differences 
observed between activated and not-activated genes (Figures 4.30-4.34). This does not 
necessarily contradict previous studies, as none of them specifically analysed CRISPRa sgRNA 
libraries and also, it might be context- and/or tissue/cell type-dependent. It is possible that a 
combination of several of these features, but none of them individually, can predict CRISPRa 
efficiency. Therefore, in the future, it will become important to systematically analyse larger 
CRISPRa libraries in relation to the basal epigenetic state of the targeted genes in different cell 
types, and generate algorithms that can predict which feature or combination of features 
determine CRISPRa efficiency. 
As mentioned earlier, an important consideration when interpreting these results is that I am 
setting a threshold for each sgRNA to consider it effective (10 activated cells) and therefore 
categorise the target gene as activated. Nevertheless, one could speculate that effective 
activation of less than 10 cells is also sufficient to trigger a transcriptional response downstream 
of the upregulation of the targeted gene. Consequently, it is possible that sgRNAs that were 
categorise as ineffective were actually effective to trigger an activation of the endogenous 
target sufficient to detect a downstream transcriptional response. If this was the case, the signal-
to-noise ratio in the epigenetic features analysed for the groups of activated and not-activated 
genes might be too low to detect statistically significant differences. Another possibility is that 
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the dynamics of target gene activation is gene dependent, as shown in Yanxia Liu et al. 2018, 
and, therefore, one could imagine that, before the cells were analysed by scRNA-seq 10 days 
after transduction of the lentiviral library, some target genes had a peak of activation during 
that time course that led to downstream transcriptional effects, but target gene activation was 
not retained until day 10, therefore uncoupling target gene activation and downstream response. 
Consequently, when calling screen hits (see chapter 5), it will be important to consider that a 
sgRNA could have induced a ZGA-like response in mESCs even if activation of the target gene 
is not strikingly observed. 
At the single-cell level, I already discovered in chapter 3 that there was variability in target 
gene activation (as analysed for MERVL and Zscan4) between single-cells transduced with the 
same effective sgRNA (Figures 3.7, 3.21, 3.22 and 3.31). From those immunofluorescences 
and scRNA-seq experiments, I could not tell whether the cells were expressing the sgRNA to 
conclude whether there was real heterogeneity. In this chapter, I could confirm these 
observations for multiple sgRNAs and target genes (Figures 4.18, 4.19 and Appendix C). Since 
Cas9/dCas9 and sgRNA expression levels have been shown to be critical for effective CRISPR 
in multiple studies (Hsu et al. 2013; Doench et al. 2014.; Labuhn et al. 2017; Yuen et al. 2017), 
I used the information derived from the sgRNA amplicon libraries to confirm that sgRNAs 
were not differentially expressed in activated and not-activated cells (Figure 4.22). 
Unfortunately, due to technical reasons, I could not assess whether this was also the case for 
dCas9/VP64 and/or MS2-p65-HSF1 expression (Figure 4.21), although it is unlikely that these 
two fusion proteins were expressed differentially between cells given the clonal nature of the 
SAM22 cell line (Figure 3.3). As I discussed in chapter 3, the other alternative that could 
explain variability between single-cells in target gene activation by CRISPRa would be the 
presence of epigenetic heterogeneity at the target gene promoter. mESCs present 
transcriptional and epigenetic heterogeneity (Rulands et al. 2018; Luo et al. 2018; Clark et al. 
2018; reviewed in Tanaka 2009) and, therefore, it was possible to think that this heterogeneity 
determined the ability of single-cells to activate the target gene even when all the CRISPRa 
machinery was expressed. To test this hypothesis, I used scNMT-seq on Dppa3 CRISPR-
activated cells, aiming to find a correlation between Dppa3 promoter accessibility and/or DNA 
methylation and the Dppa3 level of expression triggered in each cell by CRISPRa. However, 
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due to the sparsity of the data, very few cells had enough reads at the Dppa3 promoter in the 
single-cell bisulfite libraries to be able to do confident analysis, making this experiment less 
than ideal to address this question. Furthermore, even if a correlation between target gene 
activation and chromatin accessibility and/or DNA methylation at the target gene promoter had 
been observed, it would have been difficult to assess the causality of the events, i.e, does a 
certain epigenetic state at the target gene promoter determine effective target gene activation 
by CRISPRa, or is the epigenetic state of the promoter observed after CRISPRa a consequence 
of the targeting? scNMT-seq could not have answered this question since it requires lysis of 
the cells for analysis (Clark et al. 2018). A live cell imaging system where the expression of 
the target gene as well as the promoter epigenetic state can be reported before and after 
induction of CRISPRa is the only way to address such questions and, to the best of my 
knowledge, there is currently no technology to perform an experiment of this kind. 
Alternatively, and similarly to what was proposed above, it is possible to think about a cycling 
effect in target gene activation, where some cells silence the gene after having induced it with 
CRISPRa. This dynamic expression could also be dependent on cell cycle and, to test this 
hypothesis, future analysis should assess the cell cycle state of activated versus not-activated 
cells. 
To conclude, in this chapter, I generated a dataset of single-cells with individual CRISPRa 
perturbations and found that CRISPRa efficiency was sgRNA- and gene-dependent. While I 
analysed multiple features to try to explain these differences in efficiency, I only found a 
significant effect in the targeting position of the sgRNA. Larger studies using more sgRNAs as 
well as different biological contexts are needed to systematically identify the targeting rules of 
CRISPRa. For the next chapter of this dissertation, where I identify screen hits for ZGA 
regulators, there are two important considerations that derive from the conclusions presented 
here: 1) detection of target gene activation might be uncoupled to downstream transcriptional 
responses and, therefore, it is possible to identify screen hits where no target gene activation is 
observed, and 2) due to this wide range in efficiency, it is possible to obtain only one sgRNA 
as a hit out of the two included for the target gene, lowering the confidence in the identification 
of hits. For both of these reasons, it becomes crucial to validate screen hits individually and 
with alternative approaches. 
 
Chapter 5 Identification and molecular 
characterisation of regulators of ZGA 
5.1 Background and summary 
In the previous two chapters, I set up a CRISPRa method in mESCs with scRNA-seq read-out 
(chapter 3), which I subsequently applied to screen 230 maternal epigenetic and transcriptional 
factors (chapter 4). In this final chapter of results, I collaborated with Danila Bredikhin and 
Oliver Stegle (from EMBL, Heidelberg, see Table of Acknowledgement of Assistance) to 
implement a computational method to identify screen candidates that activated a ZGA-like 
transcriptional signature in the CRISPRa scRNA-seq dataset that I generated. This method used 
an integrative dimensionality reduction approach of the expression of coding genes as well as 
repetitive elements in each single cell based on multi-omics factor analysis models (MOFA) 
(Argelaguet et al. 2018). MOFA was used to infer a set of “factors” that captured expression 
variability within the dataset, one of these factors being a ZGA-like factor which was 
subsequently used to identify 44 screen hits.  
Amongst the identified hits for ZGA regulation were the DNA binding protein Dppa2, the 
chromatin remodeller Smarca5 and the POZ-, AT hook-, and zinc finger protein-1 (Patz1). I 
independently validated these three hits, together with the negative control Calcium-Regulated 
Heat Stable Protein-1 (Carhsp1), by individual CRISPRa experiments as well as cDNA-eGFP 
overexpression, both followed by bulk RNA-sequencing. These validation experiments further 
confirmed that, upon transcriptional upregulation of these factors by either overexpression 
method, mESCs adopted an early embryonic-like state that resembled the transcriptional 
profile of mid-to-late two-cell embryos. 
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Finally, through a series of KO and overexpression experiments, I disentangled part of the ZGA 
regulation network by showing that Smarca5 regulates the expression of ZGA genes via 
Dppa2. In turn, Dppa2 mediates its effects via the previously described transcription factor 
Dux (Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et al. 2019).  
5.2 Results 
5.2.1 CRISPRa of selected candidates induced a ZGA-like transcriptional 
response in mESCs 
Having generated a high-quality scRNA-seq dataset of perturbed cells by CRISPRa of maternal 
epigenetic and transcriptional factors, I first addressed whether this targeting strategy had 
worked for inducing a ZGA-like signature in SAM22 mESCs. To this end, I used the PCA 
performed in chapter 4 on highly-variable genes amongst the 203,894 single-cells expressing 
a unique sgRNA (Figure 4.17) to understand the major sources of variation in the dataset. Gene 
ontology analysis of the top 50 gene loadings for the first component (PC1), using all highly 
variable genes in the dataset as a background (see Materials and Methods), suggested that this 
component captured intrinsic variance in cell shape and cell contacts (Appendices E and F), 
likely reflective of different pluripotent and differentiation states of the cells upon CRISPRa of 
different screen candidates. Enriched gene ontology terms for the top gene loadings for PC1, 
although with relatively high corrected p-values (or FDR), included “actomyosin structure 
organization” (FDR = 0.0022), “actin filament-based process” (FDR = 0.34), “sarcomere 
organization” (FDR = 0.29) or “cell adhesion” (FDR = 0.22), with markers such as the calponin 
variants Cnn1 or Cnn2, which are involved in actin-myosin regulation (Boraas et al. 2018), the 
keratin proteins Krt8 or Krt19, which are key fibrous structural proteins involved in mESC 
differentiation (Maurer et al. 20108), or actin gamma cytoplasmic-1 (Actg1), also involved in 
cytoskeletal reorganization during cell adhesion and differentiation (reviewed in Ambriz et al. 
2018) (Appendices E and F). In contrast, gene ontology analysis of the top 50 gene loadings 
for the second component (PC2) did not reveal any enriched functional processes other than 
telomeric regulation (FDR = 0.28) with Zscan4 genes as markers (Appendices E and F).  
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Since ZGA genes are largely uncharacterised and, consequently, they are not generally 
associated with gene ontology functions (Eckersley-Maslin et al. 2016), I decided to analyse 
whether the top gene loadings for PC2 were enriched in genes expressed during the major wave 
of ZGA. To this end, I constructed a list of ZGA genes by merging different relevant published 
datasets, including the MERVL/Zscan4-driven network described in Eckersley-Maslin et al. 
2016, Dux-regulated genes as described in Hendrickson et al. 2017, and other transcripts 
expressed in two-cell mouse embryos, as recently reported in Y Li et al. 2018 (Appendix I). 
Excitingly, comparison of the top gene loadings for PC1 and PC2 to this ZGA gene list revealed 
that PC2, but not PC1, captured expression variation of a ZGA-like transcriptional signature 
(Figure 5.1, Appendix E, Appendix I).  
To further verify this, I next looked at the expression of ZGA markers, such as Zscan4c, 
Zscan4d, Gm8300 or Tmem92, in cells plotted along PC1 and PC2 axis and confirmed that the 
cells contributing to PC2 variance had higher expression of these markers (Figure 5.2). 
Furthermore, while the top 50 gene loadings for PC1 are highly expressed at the blastocyst 
stage, reflecting the transcriptome of serum-grown mESCs, the top 50 gene loadings for PC2 
showed a peak of expression in mid-to-late two-cell embryos, when the major wave of ZGA 
occurs (Figure 5.3), confirming that PC2 captured a ZGA-like signature in the dataset.  
Importantly, despite the variance captured in PC1, which might be indicative of cell 
differentiation (Appendices E and F), the pluripotecy marker Pou5f1 (also known as Oct4) 
showed high and uniform expression across the majority of cells in the dataset (Figure 5.4). 
Consistently, it was not detected as a highly variable gene (Appendix E). This is also in 
agreement with the high corrected p-values of enriched gene ontology terms for the top gene 
loadings for PC1 (Appendix F) and with previous reports showing that 2C-like cells lack OCT4 
protein but the mRNA is not downregulated (Macfarlan et al. 2012; Ishiuchi et al. 2015; 









Figure 5.1– Highly variable genes ranked by their loadings in PC1 and PC2  
965 highly variable genes ranked by their loading value in principal component 1 (PC1) (left) and 
principal component 2 (PC2) (right), highlighting in red genes previously known to be expressed 
during the major wave of ZGA or ZGA-like transcriptional responses, as described in Appendix I 
(Eckersley-Maslin et al. 2016; Hendrickson et al. 2017; Y. Li et al. 2018). The loading value for each 










Figure 5.2– Expression of ZGA markers along PC1 and PC2 
Visualisation of cells along principal component 1 (PC1, x axis) and principal component 2 (PC2, y 
axis) coloured by the logarithmic normalised expression of the ZGA markers Zscan4c (top left), 
Zscan4d (top right), Gm8300 (bottom left) and Tmem92 (bottom right). Marginal distributions of 
PC1 and PC2 values are displayed as rug plots along the respective axis. PC1 explains 2.6% of total 
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Figure 5.3– Expression of top loadings for PC1 and PC2 during pre-implantation development 
Box-whisker plots showing normalised expression in log2 reads per million (RPM) of the top 50 gene 
loadings for PC1 (grey - left) and the top 50 gene loadings of PC2 (light blue - right) during mouse 
pre-implantation development (data analysed from Deng et al. 2014). The loading value for each 
gene in each PCA component is available in Appendix E.  
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Figure 5.4– Expression of Pou5f1 along PC1 and PC2 
Visualisation of cells along principal component 1 (PC1, x axis) and principal component 2 (PC2, y 
axis) coloured by the normalised expression of the pluripotency gene Pou5f1 (Oct4). Marginal 
distributions of PC1 and PC2 values are displayed as rug plots along the respective axis. PC1 explains 
2.6% of total variance in the whole dataset whereas PC2 explains 2.3% of variance. 
 
 
Next, I set to characterise the observed ZGA-like transcriptional signature in more detail. As 
introduced in chapter 1 (section 1.1.3.3), transposable or repeat elements are key drivers of 
gene expression during early embryonic development (reviewed in Rodriguez-Terrones & 
Torres-Padilla 2018). To account for their expression in the screen dataset and identify factors 
that induced a ZGA-like response both in the protein-coding and non-coding transcriptome, we 
trained a multi-omics factor analysis (MOFA) model (Argelaguet et al. 2018). This approach 
allowed treating the coding transcriptome and repeat elements as distinct “views” and identify 
“MOFA factors” that explain the transcriptional variability within the dataset (Figure 5.5, see 
Materials and Methods). Moreover, sgRNA-cell assignment information was inputted to the 
model (Figure 5.5, see Materials and Methods). We included eight relevant repeat families in 
the analysis whose expression could be detected in the dataset: LINE-1, ERVK, SINE B2, 
ERV1, MERVL, SINE B4, SINE Alu B1 and major satellites, compared to other repeat 
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Figure 5.5– Schematic of a MOFA model to identify screen hits 
Schematic of the joint analysis of protein-coding gene and repeat elements expression in the 
CRISPRa scRNA-seq dataset using multi-omics factor analysis (MOFA). Matrices of dimension 
features (genes or repeat elements) in cells grouped by sgRNA expression were treated as distinct 
views in the model and decomposed into the product of weights (or loadings) and factors. Factor 3 
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Figure 5.6– Expression of repeat families in the CRISPRa scRNA-seq dataset 
Top panel: Average number of unique molecular identifiers (UMIs) per cell in the dataset for each 
of the ten repeat families analysed.  
Bottom panel: Total number of cells in the dataset for which each repeat family is detected (UMI>0), 
out of a total of 203,894 cells analysed. 
 
Excitingly, amongst the MOFA factors identified (Appendix G), the expression variance 
captured uniquely by factor 3 corresponded to a ZGA-like signature (Figure 5.5). This factor 
was identified as the ZGA-like factor for three reasons: 1) similar to PC2, the variable protein-
coding genes that ranked top by their loadings in this factor, and not the top loadings for other 
factors, were enriched in ZGA or ZGA-like genes previously defined in published literature 
(Eckersley-Maslin et al. 2016; Hendrickson et al. 2017; Y. Li et al. 2018) (Appendix I) (Figure 
5.7); 2) consistently, the top loading genes for this factor, and not for others, are highly 
expressed in mid-to-late two-cell embryos, at the time of the major wave of ZGA (Figure 5.8); 
and 3) the ZGA-associated MERVL (Macfarlan et al. 2012) and major satellite repeats 
(Casanova et al. 2013) were most prominently associated to factor 3 amongst the repeat classes 
analysed (Figure 5.9). 
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Figure 5.7– Highly variable genes ranked by their loadings in MOFA factors 1-5  
965 highly variable protein-coding genes ranked by their loading value in MOFA factors 1-5, 
highlighting in red genes previously known to be expressed during the major wave of ZGA or ZGA-
like transcriptional responses, as described in Appendix I (Eckersley-Maslin et al. 2016; Hendrickson 
et al. 2017; Y. Li et al. 2018). The enrichment of ZGA genes in factor 3 identifies it as the ZGA-like 
factor. The loading value for each gene in each MOFA factor is available in Appendix G.   





Figure 5.8– Expression of top gene loadings for MOFA factors 1-5 during pre-implantation 
development 
Box-whisker plots showing normalised expression in log2 reads per million (RPM) of the top 50 protein-
coding gene loadings for MOFA factors 1-5 during mouse pre-implantation development (data analysed 
from Deng et al. 2014). The high expression in mid-to-late two-cell embryos of the top loadings for 
MOFA factor 3 identifies it as the ZGA-like factor. The loading value for each gene in each MOFA 
factor is available in Appendix G. 
 
 






Figure 5.9– Repeat element families ranked by their loadings in MOFA factors 1-5 
Repeat element families ranked by their loadings in MOFA factors 1-5. The high variance explained 
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Interestingly, unlike the top gene loadings for PC1 that showed a peak of expression in 
blastocyst stages (Figure 5.3), the top gene loadings for MOFA factors 1, 2, 4 and 5 showed 
high and uniform expression during all stages of pre-implantation development (Figure 5.8). 
This suggested that these factors captured biological or technical variability associated with 
mESC cultures rather than with specific transcriptional programmes in pre-implantation 
development. In fact, gene ontology analysis showed that factor 1 captured variability 
associated with protein metabolism and cell cycle; factor 2 is associated with epigenetic 
regulation, consistent with the epigenetic heterogeneity found in mESC cultures (Rulands et 
al. 2018; Luo et al. 2018; Clark et al. 2018; reviewed in Tanaka 2009); gene ontology analysis 
of factor 4 did not reveal any significant enrichment; and factor 5 seems associated with 
apoptotic and DNA damage responses, although the statistical significance of the enriched gene 
ontology terms was not very high, consistent with the removal of low-quality input during 
quality control of the dataset (Figure 4.12) (Appendices G and H, see Materials and Methods). 
Gene ontology analysis of the top loadings for factor 3 or ZGA-like factor did not reveal any 
enriched functional processes other than telomeric regulation with Zscan4 genes as markers 
(Appendices G and H), same as what was observed for PC2 and consistent with the 
uncharacterised function of ZGA genes.  
Altogether, this unsupervised analysis of the dataset indicated that CRISPR-activating maternal 
epigenetic and transcriptional factors in mESCs induced expression variation that mimics a 
ZGA-like transcriptional response, suggesting that a substantial fraction of the targeted 
candidates induced ZGA-like gene expression. 
5.2.2 Identification of activators of a ZGA-like transcriptional signature 
To reveal these screen hits whose CRISPRa induced ZGA-like expression, we grouped cells in 
the dataset by the expression of the targeting sgRNA and ranked each group based on its 
contribution to the overall transcriptional variance explained by the MOFA ZGA-like factor 
(Appendix C, see Materials and Methods). Since no major conclusions were obtained from the 
CRISPRa efficiency analysis performed in chapter 4 and, as discussed earlier, it is possible to 
speculate that target gene activation is uncoupled from downstream transcriptional responses, 
I decided to include all targeting sgRNAs in this ranking analysis, regardless of the target gene 
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activation state. This approach identified 46 sgRNAs targeting 44 unique candidate genes for 
which the MOFA factor explained a larger fraction of variance than for the 15 non-targeting 
sgRNA controls (Figure 5.10, Appendix C). At the top of the ranking were Dppa2 and 
Smarca5, with both targeting sgRNAs as hits, and the transcription factor Patz1 (Figure 5.10, 
Appendix C).  
 
Figure 5.10– Ranking of sgRNAs by their contribution to ZGA-like signature variance 
Ranking of the 460 targeting sgRNAs by the fraction of expression variance (average of protein-
coding genes and repeat elements) explained by MOFA factor 3 or ZGA-like factor. The fraction of 
expression variance explained by MOFA factor 3 for the 15 non-targeting sgRNA controls is depicted 
in the background as mean (dashed line) and plus and minus one standard deviation (shaded area). 
The names of the 44 target genes whose sgRNAs were identified as hits because they exceed the 
variance explained by non-targeting sgRNA controls are labelled, with Dppa2 (orange), Smarca5 
(purple) and Patz1 (green) sgRNA hits highlighted. The fraction of variance and rank position for 
each sgRNA is available in Appendix C.  
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Importantly, SAM22 mESCs expressing these 46 sgRNAs not only showed an increased ZGA-
like variance but also specifically induced the expression of ZGA genes associated with MOFA 
factor 3, while genes contributing to the variance of other MOFA factors remained largely 
unaltered between cells expressing the 46 sgRNA hits and cells expressing other targeting 
sgRNAs (Figure 5.11).  
 
 
Figure 5.11– Expression of top gene loadings for MOFA factors 1-5 in cells expressing sgRNA 
screen hits 
Box-whisker plots showing log10 fold change expression of the top 50 protein-coding gene loadings 
for MOFA factors 1-5 in SAM22 mESCs expressing the 46 sgRNA hits and SAM22 mESCs 
expressing other targeting sgRNAs, compared to SAM22 mESCs expressing non-targeting sgRNA 
controls. Expression was quantified in normalised counts. Statistically significant differences 
between the two groups were assessed by Mann-Whitney test: ****: p-value < 0.0001, **: p-value 
<0.01, ns: non- significant. The loading value for each gene in each MOFA factor is available in 
Appendix G. The list of the 46 sgRNAs identified as hits is available in Appendix C. 
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Similarly, MERVL and major satellite repeats were significantly upregulated in SAM22 
mESCs expressing the 46 sgRNA hits (Figure 5.12), consistent with these repeat families 
ranking top in the MOFA ZGA-like factor (Figure 5.9). Interestingly, ERV1, SINE B2 and 
LINE-1 families, which followed MERVL and major satellites in the MOFA ZGA-like factor 
ranking (Figure 5.9), were also induced, although to a lesser extent, by the screen hits (Figure 
5.12). Consistently, these transposon families have also been previously implicated in ZGA 
(W. Zhang et al. 2019; Vasseur et al. 1985; Percharde et al. 2018). 
 
Figure 5.12– Expression of repeat elements in cells expressing sgRNA screen hits 
Box-whisker plots showing log10 fold change expression of different repeat families in SAM22 
mESCs expressing the 46 sgRNA hits and SAM22 mESCs expressing other targeting sgRNAs, 
compared to SAM22 mESCs expressing non-targeting sgRNA controls. Expression was quantified 
in normalised counts. Statistically significant differences between the two groups were assessed by 
Mann-Whitney test: ****: p-value < 0.0001, ***: p-value <0.001, *: p-value <0.05, ns: non-
significant. The list of the 46 sgRNAs identified as hits is available in Appendix C. 
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Next, I sought to understand the transcriptional changes triggered by each of these 46 sgRNAs. 
First, I analysed target gene activation. In chapter 4, I considered that a minimum of 10 cells 
out of all the cells that expressed a given sgRNA had to show target gene activation 
(FDR<10%, see Materials and Methods) to classify the sgRNA as effective. Strikingly, out of 
the 46 sgRNA hits, only 15 of them (32.6%) induced target gene activation in more than 10 
cells (Figure 5.13).  
 
Figure 5.13– Number of activated cells expressing sgRNA screen hits 
Number of activated cells (FDR<10%, as described in chapter 4 and Materials and Methods) ordered 
by MOFA sgRNA hit rank. Each dot represents the number of activated cells in each of the 46 sgRNA 
hits. The sgRNA hit rank is available in Appendix C. 
 
This observation raised two alternative hypotheses: 1) the threshold of more than 10 activated 
cells considered in chapter 4 might not be reflective of sgRNA effectiveness, or 2) 67.4% of 
the sgRNA hits did not induce target gene activation. To distinguish between these two 
possibilities, I analysed target gene expression as the average in all the cells expressing a given 
sgRNA (Appendix C, see Materials and Methods) and found that target gene activation could 
be detected in 26 out of these 46 sgRNA hits (56.5%) when considering a mean log fold change 
to non-targeting sgRNA controls > 0 (Figure 5.14) (Appendix C). Therefore, these results 
indicate that target gene activation in the population of cells expressing a given sgRNA can be 
induced even with less than 10 cells showing stringent target gene activation. As discussed in 
chapter 4, lack of detection of target gene activation for the remaining 20 sgRNA hits (43.5%) 
could be due to technical reasons such as drop-outs commonly associated to scRNA-seq data 
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or due to biological uncoupling between target gene upregulation and downstream 
transcriptional responses. Alternatively, it is also possible that lack of target gene activation in 
sgRNA hits is associated with false positives introduced during hit calling. In these regards, 
except for Dppa2 and Smarca5, only one out of the two targeting sgRNAs included for the 
remaining 42 hits were ranked for inducing a ZGA-like signature (Figure 5.10). Strikingly, 
while for the top-ranking hits the sgRNA that induced ZGA-like expression (sgRNA hit) 
corresponded to the one triggering higher target gene activation out of the two, this was not 
always the case for lower-ranking hits (Figure 5.14). Since no major off-target effects were 
detected for these sgRNAs (Appendix C), this likely reflects noise in the hit calling performed 
based on MOFA ZGA-like variance and highlights the importance to perform screen 
validations with alternative methods and systems.  
 
Figure 5.14– Target gene expression in cells expressing sgRNA screen hits 
Target gene expression for the 46 sgRNA hits, measured by mean log10 fold change expression 
between SAM22 mESCs expressing the relevant targeting sgRNA and SAM22 mESCs expressing 
non-targeting sgRNA controls. Both sgRNAs targeting the gene of interest are shown (outer and inner 
circle) and sgRNAs that were identified as a hit for inducing a ZGA-like signature (as ranked by the 
contribution to MOFA factor 3) are highlighted with a black dot. Log fold change target gene 
expression values for every sgRNA and the complete sgRNA hit rank are available is Appendix C. 
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To validate the sgRNA hit calling by MOFA, I performed more conventional differential gene 
expression analysis. However, in most cases, only a small subset of genes was significantly 
differentially expressed (EdgeR, FDR<10%) in SAM22 mESCs expressing sgRNA hits 
compared to cells expressing non-targeting sgRNA controls (between 0 and 224 genes for 
different sgRNA hits, median 4.5) (Appendix C and see Materials and Methods), consistent 
with the sparsity observed in 10X Genomics scRNA-seq data. To overcome this limitation, I 
considered the top 400 upregulated genes for each sgRNA, ranked them by statistical 
significance and then analysed the cumulative frequency of known ZGA genes, as described 
in published literature (Eckersley-Maslin et al. 2016; Hendrickson et al. 2017; Y. Li et al. 2018) 
(Appendix I), in this rank. This analysis revealed that 32 out of the 46 sgRNA hits (69.6%) 
induced a transcriptome downstream of them that was prominently enriched for known ZGA 
transcripts, compared to the background level of enrichment calculated by differential gene 
expression between cells expressing non-targeting sgRNA controls (Figure 5.15) (Appendix 
C). Importantly, the remaining 14 sgRNA hits called by MOFA that overlapped with non-
targeting sgRNA controls in this differential gene expression rank (Figure 5.15) were not 
associated with lower effects on target gene activation (Figure 5.16) or with a lower position 
in the MOFA rank (Figure 5.10, Appendix C). Therefore, I can speculate about three reasons 
that could explain why these 14 sgRNA hits were not detected as statistically significant in the 
differential gene expression ZGA rank: 1) they are strong inducers of ZGA-associated repeat 
elements but not as much of ZGA genes and, consequently, they were captured by MOFA but 
not by this rank which only considers protein-coding genes; 2) lack of power to detect the 
effects on individual genes in a pre-defined list of ZGA genes (as defined in Appendix I) might 
have hampered the identification of relevant hits using differential gene expression analysis, 
while they could be identified by MOFA because it considers a gene signature rather than 
individual genes; or 3) the hit calling performed based on MOFA introduced false positive hits. 
Either way, these results validate the MOFA analysis for the majority of screen hits. 
In summary, using MOFA to integrate the expression of protein-coding genes and repeat 
elements in the CRISPRa scRNA-seq dataset, we identified 44 factors whose activation 
induced a ZGA-like transcriptional response. These included four positive controls known to 
regulate ZGA, namely Dppa2 (Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et 
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al. 2019), Yap1 (C. Yu, Ji, Dang, et al. 2016), Ctcf (Wan et al. 2008) and Gata3 (Eckersley-
Maslin et al. 2019). Interestingly, two of the candidates included as negative controls for not 
being expressed in oocytes or during pre-implantation development, Spata3 and Gpr6, were 
obtained as top-ranking hits (Figures 5.10 and 5.15), indicating they might have a function in 
inducing 2C-like mESCs but could not regulate ZGA in vivo. These observations emphasise 
the need to validate these hits in the embryo.  
 
Figure 5.15– Differential gene expression ZGA rank for sgRNA screen hits 
Cumulative rank of the number of previously described ZGA genes (as described in Appendix I - 
Eckersley-Maslin et al. 2016; Hendrickson et al. 2017; Y. Li et al. 2018) upregulated in SAM22 
mESCs expressing each sgRNA hit compared to non-targeting sgRNA controls, considering the top 
400 genes ranked by statistical significance of differential gene expression test (generalised linear 
model likelihood ratio test as implemented in EdgeR, FDR<100%). The background distribution 
based on differential gene expression between SAM22 mESCs expressing non-targeting sgRNA 
controls is shown in grey, displaying plus and minus one standard deviation around the mean of ZGA 
genes recovered by non-targeting sgRNAs. The names of the target genes for sgRNAs hits are 
depicted from top to bottom and left to right according to the rank order based on number of ZGA 
genes recovered, with those for which the differential gene expression rank overlaps with the non-
targeting sgRNA control background shown in grey in the third column. The top-ranking sgRNA hits 
for Dppa2 (orange), Smarca5 (purple) and Patz1 (green) are highlighted. The number of upregulated 
ZGA genes recovered for each sgRNA is available in Appendix C.  








Figure 5.16– Target gene expression in cells expressing sgRNA screen hits, classified according 
to the differential gene expression ZGA rank 
Target gene expression for the 46 sgRNA hits, measured by mean log10 fold change expression 
between SAM22 mESCs expressing the relevant targeting sgRNA and SAM22 mESCs expressing 
non-targeting sgRNA controls, grouped according to their performance in the differential gene 
expression rank ZGA rank (DGE rank). Differences between the two groups assessed by Mann-
Whitney test were not statistically significant. The classification of the 46 sgRNA hits according to 
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5.2.3 Validation of Dppa2, Smarca5 and Patz1 as regulators of ZGA in 
mESCs 
Next, I selected three top-ranking screen hits to validate in vitro in mESCs. As discussed earlier, 
false positive and negative hits can arise from pooled screens and, therefore, individual 
validations of hits using CRISPRa and alternative methods are necessary before considering 
their molecular mechanism of action. I validated the DNA binding protein Dppa2, the ATPase 
subunit of the ISWI chromatin remodeling complex Smarca5 and the transcription factor Patz1 
(Figure 5.17). Both Dppa2 and Smarca5 were strong hits because both of their targeting 
sgRNAs induced a ZGA-like response in the screen (Figures 5.10 and 5.15). Moreover, while 
this study was undergoing, Dppa2 was confirmed in the Reik laboratory and by other groups 
as a key regulator of ZGA-like transcriptional programmes using cDNA overexpression and 
KO approaches in mESCs (Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et al. 
2019). Although not comprehensively studied for its role in ZGA, Smarca5 has been previously 
implicated in early embryogenesis with hints to a role in transcriptional regulation (Stopka & 
Skoultchi 2011; Torres-Padilla & Zernicka-Goetz 2006). Therefore, the identification of 
Dppa2 and Smarca5 in the screen supports my pooled CRISPRa approach coupled to scRNA-
seq as a reliable method to identify relevant regulators. Excitingly, the top-ranking hit 
transcription factor Patz1 (Figures 5.10 and 5.15), although previously linked to mESC 
pluripotency (Ow et al. 2014), had never been studied in the context of ZGA. In this validation 
panel, I also included the negative control candidate Carhsp1 (Figure 5.17), since both of its 
targeting sgRNAs induced effective target gene activation without triggering ZGA-like 
transcription (Appendix C). Other candidate genes were also validated as described in 
Appendix J. 
I used two alternative methods of gene overexpression to validate these screen candidates 
(Figure 5.17). Firstly, CRISPRa by transducing one of the sgRNAs used in the screen 
(Appendix C) cloned into the CROP-sgRNA-MS2 construct into SAM22 mESCs, followed by 
antibiotic selection and cell expansion for 10 days; and secondly, ectopic cDNA overexpression 
by transiently transfecting a cDNA-eGFP fusion construct into E14 mESCs for 48 hours, 
followed by FACS sorting of GFP+ cells. In both cases, the transcriptome was analysed by bulk 
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Figure 5.17– Approaches for hit validation: CRISPRa and cDNA overexpression 
Schematic representation of two sets of validation approaches to confirm the screen hits Dppa2 
(orange), Smarca5 (purple) and Patz1 (green), using Carhsp1 (pink) as a negative control candidate. 
The first approach consists of lentiviral transductions (purple viral particles) with individual effective 
sgRNAs targeting gene promoters and cloned into the CROP-sgRNA-MS2 construct into SAM22 
mESCs, followed by antibiotic selection, cell expansion for 10 days and analysis by bulk RNA-
sequencing (top panel). The second approach consist of ectopically overexpressing the gene of 
interest by cloning its cDNA into an eGFP fusion construct and transiently transfecting it into E14 
mESCs, followed by fluorescence-activated cell sorting (FACS) of GFP+ cells 48 hours later and 
analysis by bulk RNA-sequencing (bottom panel). Control samples were lentiviral transductions of 
two non-targeting sgRNAs into SAM22 mESCs for CRISPRa (top panel) and GFP+-only transfection 
in E14 mESCs for cDNA overexpression (bottom panel). Both sets of experiments were done in 
triplicate. The sgRNAs used for CRISPRa in these bulk RNA-sequencing experiments are described 
in Appendix C. 
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The sgRNAs selected for validation experiments had shown to be effective in triggering target 
gene activation in the scRNA-seq CRISPRa screen (Figure 5.18). Consistently, both individual 
CRISPRa and cDNA transient transfection led to target gene upregulation, as analysed by bulk 
RNA-sequencing (Figure 5.19).  
 
 
Figure 5.18– Target gene expression of Dppa2, Smarca5, Patz1 and Carhsp1 in the CRISPRa 
screen dataset analysed by scRNA-seq 
Dot-plot (top panels) and density representation (bottom panels) of expression levels induced by 
CRISPRa of Dppa2 (top left, orange), Smarca5 (top right, purple), Patz1 (bottom left, green) and 
Carhsp1 (bottom right, pink) in SAM22 mESCs expressing their respective targeting sgRNAs (red 
and orange, see Appendix C for sgRNA identifiers) and in SAM22 mESCs expressing either of the 
15 non-targeting sgRNA controls (blue). In the dot-plots, each dot represents a cell plotted as a 
function of fold change expression to the average expression in the non-targeting sgRNA control 
cells. In the density plots, normalised gene expression is calculated as loge(number of UMIs for target 
gene / sum (number of total UMIs in a cell) *10,000 + 1) and plotted as a function of density. The 
sgRNA for each target gene used for validation bulk RNA-sequencing experiments is highlighted in 
bold. 
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Figure 5.19– Target gene expression of Dppa2, Smarca5, Patz1 and Carhsp1 after CRISPRa and 
cDNA overexpression, analysed by bulk RNA-sequencing 
Fold change upregulation of Dppa2 (orange), Smarca5 (purple), Patz1 (green) and Carhsp1 (pink) 
by CRISPRa (black) and cDNA overexpression (grey) compared to respective controls (two non-
targeting sgRNAs for CRISPRa and GFP+-only for cDNA overexpression), measured by bulk RNA-
sequencing. Data is shown as mean plus standard deviation of three biological replicates. Differences 
to controls are statistically significant (homoscedastic two-tailed t-test, ****: p-value < 0.0001). A 
dashed line at x = 1 is used to indicate the minimum value to observe fold change upregulation to 
controls. The sgRNAs used for CRISPRa in these bulk RNA-sequencing experiments are described 
in Appendix C. 
 
Next, I assessed the similarities between the transcriptional changes captured by scRNA-seq 
and bulk RNA-sequencing upon CRISPRa of these targets and, overall, I found that despite the 
increased power in calling differential gene expression using bulk RNA-sequencing, they were 
highly correlated (Figure 5.20). Then, similar to the comparison analysis between CRISPRa 
and cDNA overexpression presented in chapter 3 (section 3.2.2), I calculated correlation 
coefficients between transcriptome-wide bulk gene expression profiles of Dppa2, Smarca5, 
Patz1 and Carhsp1 CRISPRa and cDNA overexpression (Figure 5.21). Interestingly, I 
observed markedly correlated transcriptional responses between CRISPRa and cDNA 
overexpression of the same target, but also strikingly similar profiles induced by Dppa2, 
Smarca5 and Patz1 by either overexpression method (Figure 5.21). Furthermore, the 
transcriptome induced by these three screen hits was remarkably distinct from the 
transcriptome triggered by the negative control Carhsp1 (Figure 5.21), consistent with the 
small effects that Carhsp1 CRISPRa had on mESCs (Figure 5.20). Together, these validation 
experiments confirmed that CRISPRa coupled with scRNA-seq readout is a robust method to 
assess the transcriptional responses triggered by gene overexpression. 
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Figure 5.20– Correlation between the transcriptional changes captured by scRNA-seq and bulk 
RNA-sequencing after CRISPRa of Dppa2, Smarca5, Patz1 and Carhsp1 
Scatterplot between fold change values of differentially expressed genes estimated based on bulk 
CRISPRa RNA-sequencing data (EdgeR, FDR<10%) (x axis) and fold change estimates for the 
corresponding genes in cells expressing the same sgRNA based on the CRISPRa scRNA-seq data (y 
axis) for the target genes Dppa2 (orange, top left), Smarca5 (purple, top right), Patz1 (green, bottom 
left) and Carhsp1 (pink, bottom right). Genes that were also differentially expressed in scRNA-seq 
data (EdgeR, FDR<10%) are labelled in dark grey whereas those genes differentially expressed by 
bulk RNA-sequencing but not in scRNA-seq are labelled in light grey (not significant). In each panel, 
the top 20 genes with the highest average log fold change in scRNA-seq and bulk RNA-sequencing 
are labelled and a regression line was fitted to highlight the correlation trend between both read-outs. 
Dashed lines mark a y = x line. The sgRNAs used for CRISPRa in bulk RNA-sequencing experiments 
are described in Appendix C. 
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Figure 5.21– Correlation heatmap between CRISPRa and cDNA overexpression of Dppa2, 
Smarca5, Patz1 and Carhsp1, as analysed by bulk RNA-sequencing 
Heatmap of Pearson correlation coefficients (displayed in numbers in each square) between bulk 
RNA-sequencing gene expression profiles of Dppa2 (orange), Smarca5 (purple), Patz1 (green) and 
Carhsp1 (pink) CRISPRa and cDNA overexpression. The scale from green to red represents low to 
high correlation. The sgRNAs used for CRISPRa in these bulk RNA-sequencing experiments are 
described in Appendix C. 
 
The strikingly similar transcriptional responses observed upon upregulation of Dppa2, 
Smarca5 and Patz1 (Figure 5.21) suggested they might regulate similar transcriptional 
networks. To validate whether these networks corresponded to a ZGA-like response, I analysed 
the expression levels of the genes capture by the MOFA ZGA-like factor in these bulk RNA-
sequencing validation experiments and observed that both CRISPRa and cDNA overexpression 
of Dppa2, Smarca5 and Patz1, but not Carhsp1, induced a ZGA-like response (Figure 5.22). 
Importantly, despite the high correlation between the transcriptome-wide changes triggered by 
CRISPRa and cDNA overexpression of these hits (Figure 5.21), the ZGA-like transcriptome 
induced presented differences both between target genes and between overexpression methods 
(Figure 5.22). Therefore, these results suggest that Dppa2, Smarca5 and Patz1 might regulate 
different networks within the ZGA programme and, additionally, the differences in 
experimental design (Figure 5.17) and target gene dosage (Figure 5.19) could explain the 
slightly different gene expression profiles triggered by either method (Figure 5.21). 
Dppa2 Smarca5 Patz1 Carhsp1 Dppa2 Smarca5 Patz1 Carhsp1
Dppa2 1 0.99615335 0.99515086 0.4625367 0.99281627 0.9863467 0.98981076 0.44171056
Smarca5 0.99615335 1 0.99493474 0.4625575 0.9943796 0.9895659 0.991365 0.4406198
Patz1 0.99515086 0.99493474 1 0.4630882 0.99211645 0.9860616 0.9913162 0.44227436
Carhsp1 0.4625367 0.4625575 0.4630882 1 0.46148068 0.44955397 0.4541936 0.947074
Dppa2 0.99281627 0.9943796 0.99211645 0.46148068 1 0.9930483 0.9941342 0.4434421
Smarca5 0.9863467 0.9895659 0.9860616 0.44955397 0.9930483 1 0.9922844 0.43217552
Patz1 0.98981076 0.991365 0.9913162 0.4541936 0.9941342 0.9922844 1 0.43673247
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Figure 5.22– Heatmaps of ZGA-like gene expression after CRISPRa and cDNA overexpression 
of Dppa2, Smarca5, Patz1 and Carhsp1, analysed by bulk RNA-sequencing 
Heatmaps showing transcript normalised expression, scaled per transcript, of the top 100 loading 
genes for MOFA factor 3 (ZGA-like factor), in bulk RNA-sequencing libraries of Dppa2, Smarca5, 
Patz1 and Carhsp1 CRISPRa (top panel) and cDNA overexpression (bottom panel). Controls are two 
different non-targeting sgRNAs (NT1 and NT2) for CRISPRa and GFP only overexpression for 
cDNA. The sgRNAs used for CRISPRa in these bulk RNA-sequencing experiments are described in 
Appendix C. 
Dppa2 Smarca5 Patz1 NT 1 NT 2
CRISPRa
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Furthermore, MERVL and ERV1 elements, which captured significant variability amongst the 
repeat families in the scRNA-seq dataset as analysed by MOFA (Figure 5.9), were significantly 
upregulated by Dppa2, Smarca5 and Patz1, but not by Carhsp1, regardless of the 
overexpression method (Figure 5.23). Major satellites, despite ranking second top of the repeat 
families in the variability explained by the MOFA ZGA-like factor (Figure 5.9) and being 
overall upregulated by SAM22 mESCs expressing the 46 sgRNA hits compared to cells 
expressing other sgRNAs (Figure 5.12), were not specifically upregulated by Dppa2, Smarca5, 
Patz1 or Carhsp1. SINE B2 elements, also expressed during the major wave of ZGA (Vasseur 
et al. 1985) were slightly induced by Dppa2, Smarca5 and Patz1, although not consistently 
between CRISPRa and cDNA overexpression methods. LINE-1 expression, also linked to 
ZGA (Percharde et al. 2018) was consistently upregulated by Dppa2 and Patz1, but not by 
Smarca5 (Figure 5.23). The rest of the repeat families analysed (ERVK, SINE Alu B1 and 
SINE B4) were overall not induced upon overexpression of these factors (Figure 5.23), 
consistent with the low contribution of these families to the MOFA ZGA-like factor variance 
(Figure 5.9) and the lack of upregulation by the 46 sgRNA screen hits (Figure 5.12). 
Lastly, to account for the differences between CRISPRa and cDNA overexpression (Figure 
5.22), I defined highly-confident differentially expressed genes downstream of Dppa2, 
Smarca5 and Patz1 as those differentially expressed both after CRISPRa and cDNA 
overexpression (intersect of EdgeR FDR <5% to respective controls). Notably, highly-
confident upregulated genes by Dppa2, Smarca5 and Patz1 showed a peak of expression in 
mid-to-late two-cell embryos, compared to a random set of expressed genes in the bulk RNA-
sequencing dataset (Figure 5.24), suggesting these maternal factors regulate genes expressed 
during the major wave of ZGA. In conclusion, these validation approaches provided robust 
evidence that Dppa2, Smarca5 and Patz1 activate a ZGA-like programme in mESCs and are, 
therefore, strong candidates for ZGA regulation in vivo. 
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Figure 5.23– Expression of repeat elements upon CRISPRa and cDNA overexpression of 
Dppa2, Smarca5, Patz1 and Carhsp1, analysed by bulk RNA-sequencing 
Box-whisker plots of three biological replicates showing expression of different repeat families in 
percentage of total reads, measured by bulk RNA-sequencing after CRISPRa and cDNA 
overexpression of Dppa2 (orange), Smarca5 (purple), Patz1 (green) and Carhsp1 (pink) and in 
controls (average of two non-targeting sgRNAs for CRISPRa and GFP+-only for cDNA 
overexpression, grey). Statistically significant differences to controls are reported as ****: p-value < 
0.0001, ***: p-value <0.001, **: p-value <0.01, *: p-value <0.5, absence of stars: non-significant 
homoscedastic two-tailed t-test. The sgRNAs used for CRISPRa in these bulk RNA-sequencing 
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Figure 5.24– Expression of upregulated genes by Dppa2, Smarca5 and Patz1 in pre-
implantation development 
Box-whisker plots showing normalised expression in log2 reads per million (RPM) of differentially 
upregulated genes by both CRISPRa and cDNA overexpression of Dppa2 (orange), Smarca5 
(purple), Patz1 (green), and Carhsp1 (pink), as well as of a random set of expressed genes (grey) in 
the bulk RNA-sequencing dataset, during mouse pre-implantation development (data analysed from 
Deng et al. 2014). Differential gene expression was calculated by EdgeR (FDR <5%). The number 
of analysed genes in each case is depicted in brackets and corresponds to the intersect of differentially 
upregulated genes by both CRISPRa and cDNA overexpression of each target. The sgRNAs used for 
CRISPRa in these bulk RNA-sequencing experiments are described in Appendix C. 
 
5.2.4 Interplay between Smarca5 and Dppa2 during ZGA regulation 
I next focused on the mechanistic regulation of the validated screen hits Dppa2 and Smarca5. 
I chose to follow up the molecular mechanism of these two hits based on a previously proposed 
hypothesis that DPPA2 protein might require an open chromatin landscape to regulate mESC 
entry to the 2C-like state (Eckersley-Maslin et al. 2019). This hypothesis is derived from the 
observation that DPPA2 is expressed across all mESCs but it only induces ZGA-like 
transcription in a subset of them, possibly those with chromatin permissive conditions 
(Eckersley-Maslin et al. 2019). With this in mind, I hypothesised that SMARCA5, as a strong 
regulator of ZGA (Figures 5.10, 5.15, 5.22-5.24), might help providing such chromatin 
conditions to regulate DPPA2’s function during ZGA. 
Since SMARCA5 is the ATPase subunit of a larger protein complex, the ISWI chromatin 
remodeling complex (reviewed in Hota & Bruneau 2016), I first analysed recently published 
Upregulated genes - 
Dppa2 (21)
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RNA-sequencing data (Barisic et al. 2019) to investigate whether SMARCA5 exerts its ZGA 
regulatory function through its catalytic activity or through interactions with accessory subunits 
of the ISWI complex. In this published dataset, the authors generated bulk RNA-sequencing 
libraries of Smarca5 KO mESCs and subsequent complementation of this cell line with either 
wild-type (WT) SMARCA5 or a catalytic mutant (Barisic et al. 2019). Remarkedly, I found 
391 ZGA genes (as described in Appendix I) differentially downregulated in Smarca5 KO 
mESCs compared to WT mESCs (Figure 5.25). The expression levels of most of these genes 
were partially or completely restored with the WT but not with the catalytically-dead version 
of SMARCA5 (Figure 5.25), indicating that the regulation of ZGA by SMARCA5 is dependent 
on its ATPase activity. 
 
Figure 5.25– Expression of ZGA genes in Smarca5 KO mESCs rescued with wild-type or 
catalytically-dead mutant SMARCA5 
Heatmap showing normalised transcript expression, scaled per transcript, of downregulated ZGA 
genes in Smarca5 knock-out (KO) mESCs compared to wild-type (WT) (EdgeR, FDR<5%, 
overlapping with the gene list from Appendix I), in WT mESCs, Smarca5 KO mESCs and Smarca5 
KO mESCs expressing a SMARCA5 WT protein or a SMARCA5 catalytic-dead mutant protein 



















































5.2 Results 237 
 
At the transcript level, both Dppa2 and Smarca5 are expressed in oocytes and throughout pre-
implantation development (Figure 5.26). Smarca5 is slightly more highly expressed in the 
oocyte than Dppa2, however, after fertilisation, Dppa2 rapidly increases in its expression, 
specially after the major wave of ZGA at the two-cell stage (Figure 5.26), consistent with 
Dppa2 being not only a maternal protein but also a transcript expressed from the zygotic 
genome during ZGA (Eckersley-Maslin et al. 2019; Iaco et al. 2019; Appendix I). Smarca5 
expression also increases at the time of major ZGA, which could indicate transcription from 




Figure 5.26– Expression of Dppa2 and Smarca5 during pre-implantation development 
Normalised expression in log2 reads per kilobase per million (RPKM) of Dppa2 (orange triangles) 
and Smarca5 (purple squares) in mouse oocytes and pre-implantation development (data analysed 
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At the protein level, immunofluorescence analysis performed by Oana Kubinyecz and Fátima 
Santos in the Reik laboratory show that DPPA2 localised in the cytoplasm of zygotes, while 
SMARCA5 was present in both pronuclei (Figure 5.27). Strikingly, in two-cell embryos, at the 
time of the major wave of ZGA, DPPA2 was found in the nuclei co-localising with SMARCA5 
(Figures 5.27 and 5.28). Given the uncoupling between transcription and translation in early 
embryos (Nothias et al. 1996; Gao et al. 2019), these results suggest translocation of the 
maternal DPPA2 protein from the cytoplasm to the nuclei in the transition from zygote to two-
cell stage, rather than new DPPA2 protein being produced from the zygotic genome. 
Importantly, a previous study has shown that DPPA2 and SMARCA5 physically interact in 
mESCs (Hernandez et al. 2018). Together, their co-localisation in two-cell embryos (Figures 
5.27 and 5.28), physical interaction in mESCs (Hernandez et al. 2018) and similar 
transcriptional effects (Figures 5.21-5.24) suggest that DPPA2 and SMARCA5 act together to 




Figure 5.27– Expression and localisation of DPPA2 and SMARCA5 proteins in zygotes and 
two-cell embryos 
Representative single optical slices of mouse zygotes (top row) and two-cell stage embryos (bottom 
row) immunostained for DPPA2 (green) and SMARCA5 (red). DNA was stained with DAPI to mark 
the pronuclei (zygote) and nuclei (two-cell embryos). Scale bars represent 20 µm. 
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Figure 5.28– Co-localisation of DPPA2 and SMARCA5 in zygotes and two-cell embryos 
Box-plots showing Pearson correlation coefficients calculated for co-localisation of DPPA2 and 
SMARCA5 in the pronuclei of 10 mouse zygotes and in the nuclei of 10 two-cell stage mouse 
embryos, analysed by immunofluorescence. Co-localisation values in the two pronuclei of zygotes 
and nuclei of each blastomere in two-cell embryos were measured separately and values were 
comparable. DPPA2 and SMARCA5 co-localise in two-cell embryos but not in zygotes (****: p-
value < 0.0001; Mann-Whitney test). 
 
Next, I investigated the mechanistic interdependencies, if any, between Dppa2 and Smarca5 
through a series of KO and cDNA overexpression experiments analysed by qPCR. First, to test 
whether SMARCA5 protein is required for DPPA2’s function, I overexpressed DPPA2-eGFP 
in WT and Smarca5 KO mESCs (Smarca5 KO mESCs from Barisic et al. 2019). After 48 
hours transfection and GFP+ FACS sorting, I first confirmed Dppa2 overexpression and 
Smarca5 KO at the transcript level, as well as maintenance of pluripotency measured by the 
marker Pou5f1 (also known as Oct4) (Figure 5.29). Analysis of a panel of ZGA genes 
confirmed the RNA-sequencing results from published data (Barisic et al. 2019) (Figure 5.25) 
showing downregulation, although not complete loss, of these transcripts in Smarca5 KO 
mESCs (Figure 5.30), in agreement also with the overexpression results in the screen and 
validation experiments (Figures 5.10, 5.15, 5.22-5.24). Excitingly, the expression of these ZGA 
genes was partially rescued in Smarca5 KO mESCs after DPPA2 overexpression (Figure 5.30), 
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Figure 5.29–Dppa2, Smarca5 and Pou5f1 expression in Smarca5 KO mESCs transfected with 
DPPA2-GFP, analysed by qPCR 
Analysis of Dppa2 (left panel, orange), Smarca5 (middle panel, purple) and Pou5f1 (Oct4) (right 
panel, blue) relative mRNA levels by qPCR in wild-type (WT) and Smarca5 knock-out (KO) mESCs 
after 48 hours transient transfection of GFP or DPPA2-GFP and FACS-sorting for GFP+ cells. The 
experiment was performed in triplicate and the qPCR run in two technical replicates. Data is shown 
as mean plus standard deviation. Statistically significant differences to WT GFP+ control are reported 
(homoscedastic two-tailed t-test, **: p-value <0.01, ****: p-value < 0.0001, ns: non-significant). 
 
 
Figure 5.30– ZGA markers expression in Smarca5 KO mESCs transfected with DPPA2-GFP, 
analysed by qPCR 
Analysis of relative RNA levels of a panel of ZGA markers by qPCR in wild-type (WT) and Smarca5 
knock-out (KO) mESCs after 48 hours transient transfection of GFP or DPPA2-GFP and FACS-
sorting for GFP+ cells. The experiment was performed in triplicate and the qPCR run in two technical 
replicates. Data is shown as mean plus standard deviation. Statistically significant differences to WT 
GFP+ control are reported (homoscedastic two-tailed t-test, *: p-value <0.5, **: p-value <0.01, ***: 
p-value <0.001, absence of starts: non-significant). 
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To confirm these observations, I overexpressed SMARCA5-eGFP in WT and Dppa2 KO 
mESCs (Dppa2 KO mESCs from Eckersley-Maslin et al. 2019). Again, the transcript levels of 
Smarca5 and Dppa2 were as expected according to overexpression and KO phenotypes, and 
the pluripotency marker Pou5f1 (also known as Oct4) remained largely unaltered (Figure 5.31). 
Importantly, although Dppa2 transcript was not completely lost in Dppa2 KO cells, its protein 
was undetectable by western-blot analysis (Appendix K, Eckersley-Maslin et al. 2019).  
 
Figure 5.31– Smarca5, Dppa2 and Pou5f1 expression in Dppa2 KO mESCs cells transfected 
with SMARCA5-GFP, analysed by qPCR 
Analysis of Smarca5 (left panel, purple), Dppa2 (middle panel, orange) and Pou5f1 (Oct4) (right 
panel, blue) relative mRNA levels by qPCR in wild-type (WT) and Dppa2 knock-out (KO) mESCs 
after 48 hours transient transfection of GFP or SMARCA5-GFP and FACS-sorting for GFP+ cells. 
The experiment was performed in triplicate and the qPCR run in two technical replicates. Data is 
shown as mean plus standard deviation. Statistically significant differences to WT GFP+ control are 
reported (homoscedastic two-tailed t-test, ****: p-value <0.0001, ns: non-significant). 
Consistent with the screen results and validation experiments (Figures 5.10, 5.15, 5.22-5.24), 
in WT mESCs, SMARCA5 overexpression strongly upregulated ZGA genes, including Dux, 
the Zscan4 cluster and MERVL, the former measured not only by qPCR but also by flow 
cytometry analysis of a fluorescent reporter incorporated in these cell lines (Figures 5.32 and 
5.33). Dppa2 KO mESCs presented nearly absent levels of ZGA transcripts (Figures 5.32 and 
5.33), in agreement with the overexpression phenotype (Figures 5.10, 5.15, 5.22-5.24) and 
previous reports (Eckersley-Maslin et al. 2019). In these Dppa2 KO mESCs, ZGA-like gene 
expression could not be rescued by SMARCA5 overexpression (Figures 5.32 and 5.33). These 
results show that DPPA2 is required for SMARCA5-mediated regulation of ZGA-like 
expression in mESCs, confirming SMARCA5 acts upstream of DPPA2. 
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Figure 5.32– ZGA markers expression in Dppa2 KO mESCs transfected with SMARCA5-GFP, 
analysed by qPCR 
Analysis of relative RNA levels of a panel of ZGA markers by qPCR in wild-type (WT) and Dppa2 
knock-out (KO) mESCs after 48 hours transient transfection of GFP or SMARCA5-GFP and FACS-
sorting for GFP+ cells. The experiment was performed in triplicate and the qPCR run in two technical 
replicates. Data is shown as mean plus standard deviation. Statistically significant differences to WT 
GFP+ control are reported (homoscedastic two-tailed t-test, *: p-value <0.5, **: p-value <0.01, ***: 
p-value <0.001, ****: p-value <0.0001, absence of starts: non-significant). 
 
 
Figure 5.33– MERVL reporter expression in Dppa2 KO mESCs transfected with 
SMARCA5-GFP, analysed by flow cytometry 
Percentage of GFP+ cells expressing a MERVL::tdTomato reporter in WT and Dppa2 knock-out 
(KO) mESCs after 48 hours transient transfection of GFP or SMARCA5-GFP, analysed by flow 
cytometry. Data is shown as mean plus standard deviation of three biological replicates. 
Statistically significant differences to WT GFP+ control are reported (homoscedastic two-tailed t-
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Notably, in WT cells, SMARCA5 overexpression resulted in Dppa2 upregulation (Figure 5.31, 
middle panel) but DPPA2 overexpression did not induce Smarca5 expression (Figure 5.29, 
middle panel). Consistently, Dppa2 was downregulated in Smarca5 KO mESCs (Figure 5.29, 
left panel) but not vice versa (Figure 5.31, left panel). These results could indicate either direct 
regulation of Dppa2 expression by SMARCA5 or, alternatively, could be explained by a 
transcriptional feedback loop, since Dppa2 is also upregulated as part of the 2C-like network 
and during the major wave of ZGA (Figure 5.26, Appendix I). Analysis of SMARCA5 ChIP-
seq data in mESCs could reveal whether it binds directly to the Dppa2 promoter. However, the 
SMARCA5 ChIP-seq libraries in mESCs that are publicly available (Local et al. 2018) showed 
poor genome-wide enrichment over controls (data not shown), consistent with the technical 
difficulties to ChIP large chromatin remodeling complexes (Iurlaro, M., personal 
communication). 
Finally, given the role of Dux in 2C-like and ZGA regulation (Hendrickson et al. 2017; De Iaco 
et al. 2017; Iaco et al. 2019; Z. Chen & Yi Zhang 2019; Vuoristo et al. 2019) (Figure 1.9) and 
my previous results showing that both DPPA2 and SMARCA5 strongly induce its expression 
in mESCs (Figures 5.30 and 5.32), I investigated the link between Dppa2 and Dux using Dux 
KO mESCs (obtained from De Iaco et al. 2017). Since the Dux KO mESC line contained an 
endogenous eGFP reporter, I could not overexpress GFP-fusion proteins. Instead, I transfected 
an empty vector control or a vector expressing Dppa2 cDNA for 48 hours and, subsequently, 
analysed the transcriptome on the whole population by qPCR. Dppa2 expression levels were 
not affected in Dux KO mESCs, suggesting Dux does not regulate Dppa2 expression (Figure 
5.34). As expected, Dux expression was undetectable in Dux KO mESCs and slightly induced 
upon DPPA2 overexpression in WT cells (Figure 5.34). However, unlike previous experiments 
(Figure 5.30), the upregulation of Dux by DPPA2 was not statistically significant (Figure 5.34), 
which could be due to the analysis being done on the whole population of cells rather than on 
transfected cells selected by FACS sorting. Similar to previous experiments, the pluripotency 
marker Pou5f1 (also known as Oct4) was unaltered in Dux KO mESCs transfected with either 
an empty vector or DPPA2 (Figure 5.34). As shown in previous studies (Eckersley-Maslin et 
al. 2019) and in this dissertation (Figures 5.10, 5.15, 5.22-5.24, 5.30), ZGA-like expression 
was induced downstream of DPPA2 (Figure 5.35). Consistent with the reported role of Dux in 
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ZGA regulation (Hendrickson et al. 2017; De Iaco et al. 2017), Dux KO mESCs almost 
completely abrogated the expression of ZGA genes, and, interestingly, these genes remained 
expressed at very low levels after these cells were transfected with DPPA2 (Figure 5.35), 
suggesting DPPA2 acts upstream of DUX. Validating this observation, parallel work to this 
dissertation showed that the expression levels of ZGA genes in Dppa2/Dppa4 KO mESCs can 





Figure 5.34– Dppa2, Dux and Pou5f1 expression in Dux KO mESCs cells transfected with 
DPPA2, analysed by qPCR 
Analysis of Dppa2 (left panel, orange), Dux (middle panel, brown) and Pou5f1 (Oct4) (right panel, 
blue) relative mRNA levels by qPCR in wild-type (WT) and Dux knock-out (KO) mESCs after 48 
hours transient transfection with an empty vector (EV) control or a vector expressing Dppa2 cDNA. 
The experiment was performed in three biological replicates and the qPCR run in two technical 
replicates. Data is shown as mean plus standard deviation. Statistically significant differences to WT 
EV control are reported (homoscedastic two-tailed t-test, ****: p-value <0.0001, ***: p-value 
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Figure 5.35– ZGA markers expression in Dux KO mESCs transfected with DPPA2, analysed 
by qPCR 
Analysis of relative RNA levels of a panel of ZGA markers by qPCR in wild-type (WT) and Dux 
knock-out (KO) mESCs after 48 hours transient transfection with an empty vector (EV) control or a 
vector expressing Dppa2 cDNA. The experiment was performed in three biological replicates and 
the qPCR run in two technical replicates. Data is shown as mean plus standard deviation. Statistically 
significant differences to WT EV control are reported (homoscedastic two-tailed t-test, *: p-value 




Putting together these results, I propose the following model which might explain the interplay 
between DPPA2, SMARCA5 and DUX during ZGA regulation in mouse embryos (Figure 
5.36): at the one-cell or zygote stage, before the major wave of ZGA, SMARCA5 is already 
present in the pronuclei (Figure 5.27), maintaining a poised open chromatin state of the 
promoters of ZGA genes and possibly contributing to the low levels of transcription observed 
during the minor wave of ZGA, including expression of Dux transcripts; upon translocation of 
DPPA2 to the nuclei in the two-cell embryo (Figure 5.27), SMARCA5 facilitates DPPA2 
binding to ZGA promoters and, together with DUX, they induce higher levels of transcription 
during the major wave of ZGA. This model is based on mechanistic studies in mESCs and the 
expression patterns of these three proteins in the early embryo and, therefore, it remains to be 
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Figure 5.36– Model of ZGA regulation by DPPA2, SMARCA5 and DUX 
At the one-cell embryo or zygote (top, red), the maternally-inherited DPPA2 (orange) is localised in 
the cytoplasm (light red area), while in the pronuclei, the chromatin of ZGA gene promoters is bound 
by the maternal SMARCA5 protein (purple) and transcription occurs and low levels, including 
expression of Dux. The major wave of ZGA is triggered in the two-cell embryo (bottom, green) when 
DUX is translated (brown) and DPPA2 translocates to the nucleus (dark green) to bind SMARCA5 
at ZGA gene promoters. Based on mESC data, DPPA2 and SMARCA5 physically interact 
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5.3 Conclusions and discussion 
In this chapter, I analysed the CRISPRa scRNA-seq dataset, generated in chapter 4, where I 
perturbed 203,894 mESCs to induce the activation of 230 maternally-expressed epigenetic and 
transcriptional factors, with the aim to identify candidate genes that regulate ZGA-like gene 
expression in vitro (Figure 4.10) and are, therefore, strong candidates for ZGA regulation in 
mouse embryos. After identifying a prominent ZGA-like signature in the dataset (Figures 5.1-
5.3), I collaborated with Oliver Stegle’s laboratory to performed integrative dimensionality 
reduction analysis of the expression of both protein-coding genes and repeat elements (Figures 
5.5, 5.7-5.9) to revealed 44 candidate genes that induced a transcriptional response in mESCs 
reminiscent of the major wave of ZGA (Figure 5.10-5.12). Amongst these factors were Dppa2, 
Smarca5 and Patz1, which I independently validated using complementary experimental 
approaches (Figures 5.17, 5.19-5.24), also validating my screen design. Finally, I disentangled 
the interdependencies between Dppa2, Smarca5 and the zygotic transcription factor Dux 
(Figures 5.29-5.33) and put forward a model that might explain how these three factors regulate 
ZGA in the early mouse embryo (Figure 5.36). 
Importantly, while overexpression screens using traditional open reading frame (ORF) libraries 
have already been coupled with scRNA-seq readout (Parekh et al. 2018), in this dissertation, I 
present the first screen coupling pooled CRISPRa with single-cell sequencing. As discussed in 
previous chapters, CRISPRa has key advantages over traditional cDNA overexpression, 
including target gene upregulation at physiologically-relevant levels (Chavez et al. 2015; 
Sanson et al. 2018; J. Yang et al. 2019) and the possibility to activate any gene and other 
genomic features such as repeat elements (Figures 3.5, 3.10, 3.11, 3.17 and 3.21). Consistently, 
in the validation experiments I performed for Dppa2, Smarca5, Patz1 and Carhsp1, using both 
individual CRISPRa and cDNA overexpression, I observed differences in the extent of target 
gene upregulation induced by either method (Figure 5.19). However, despite these differences 
in gene dosage and experimental design (Figure 5.17), the transcriptional changes triggered by 
the screen hits Dppa2, Smarca5 and Patz1 were considerably similar between methods in the 
induction of ZGA gene expression (Figures 5.21-5.23), confirming not only that CRISPRa is a 
robust method to interrogate regulators of ZGA-like transcription but also that these top-
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ranking screen hits are potent inductors of ZGA-like transcriptional programmes in mESCs 
(Figure 5.24). Therefore, Dppa2, Smarca5 and Patz1 are strong candidates to pursue in in vivo 
experiments. 
Screening using single-cell transcriptomics has substantial advantages in terms of scalability 
and the possibility to disentangle cell-to cell heterogeneity. However, it comes at a cost in terms 
of sensitivity for detecting transcriptional changes in individual cells (reviewed in Kelsey et al. 
2017). To mitigate this reduced sensitivity compared to bulk RNA-sequencing approaches, I 
considered a ZGA-like transcriptional signature rather than quantification of individual genes 
for identifying screen hits. This was possible because unsupervised analysis, such as PCA, 
detected prominent expression of ZGA-like transcripts in the dataset (Figures 5.1-5.3). 
Consequently, to identify relevant screen hits, in collaboration with Danila Bredikhin and 
Oliver Stegle, we built a MOFA framework to incorporate both the protein-coding and non-
coding transcriptome and define a robust and sensitive signature of ZGA-like transcriptional 
responses following CRISPRa (Figure 5.5). In this sense, the approach of using a gene 
signature identified in an unbiased manner rather than conventional differential gene 
expression analysis might be superior to identify relevant screen hits (Figures 5.10-5.12, 5.15). 
Firstly, MOFA also considers the expression of repeat elements that are essential during ZGA 
in vivo (see section 1.1.3.3). Secondly, differential gene expression analysis to identify ZGA 
regulators rely on detecting individual transcripts from a pre-defined list of genes (Figure 5.15) 
and, therefore, it can introduce biases towards highly expressed genes. In fact, for the three 
screen hits validated, I showed that most differentially expressed genes estimated based on 
bulk RNA-sequencing were not differentially expressed in scRNA-seq data and, yet, the 
transcriptional response captured by both sequencing approaches was remarkably correlated 
(Figure 5.20), showing the potency of these screen hits in inducing a ZGA-like signature and 
validating MOFA as a robust method to call screen hits. 
To also account for the reduced sensitivity of scRNA-seq, I performed a priori power 
calculations in chapter 3 that allowed me to estimate that at least 367 cells were required per 
sgRNA to confidently detect a ZGA-like transcriptional response, with the assumption that a 
positive hit would have similar effects than MERVL and Zscan4 CRISPRa (Figure 3.24). 
However, given the sgRNA distribution in the plasmid library before transduction (Figure 4.5), 
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the number of cells per sgRNA ranged from 9 to 3,300 (Figure 4.16, Appendix C). Within the 
screen hits identified (Figure 5.10), the number of cells per sgRNA ranged from 50 to 824 
(Appendix C). Therefore, it is likely that some of the screen hits with lower cell numbers 
regulate ZGA-like expression upstream of or via a different transcriptional cascade than 
MERVL and Zscan4 and, therefore, less than 367 cells are sufficient to have the power to detect 
a ZGA-like signature. Nonetheless, before embarking into the molecular characterisation of 
any of these screen hits, they should be properly validated with alternative methods, such as 
cDNA overexpression or loss-of-function studies via KO or knock-down. On the same note, it 
is possible that, within the sgRNAs with lower cell numbers that were not called as hits, there 
are false negatives that could not be identified due to lack of power. 
Even though the utilised MOFA approach could mitigate the described scRNA-seq limitations, 
detection of target gene activation might have been hampered by the reduced sensitivity in 
transcript detection in individual cells. While I showed that overall target gene activation and 
ZGA-like gene expression in the population of cells carrying a specific sgRNA could be 
detected with less than 10 stringently activated cells (Figures 5.13 and 5.14), I could not detect 
target gene activation for 20 sgRNA screen hits (Figure 5.14). While I cannot discard the 
possibility that some of those are false positives, it could also be explained by two other reasons 
already discussed in chapter 4: 1) technical drop-outs associated with scRNA-seq data, and/or 
2) uncoupling of target gene activation and downstream transcriptional responses. These 
observations further emphasise the need of independent validations for each screen hit. 
Moreover, these results suggest that the CRISPRa efficiency analysis performed in chapter 4 
after categorising effective and not effective sgRNAs based on a threshold of 10 activated cells 
in the dataset need to be revisited and, overall, more and larger CRISPRa studies coupled with 
scRNA-seq need to be done to determine robust principles governing CRISPRa efficiency. For 
instance, it would be interesting to test whether expression of more than one sgRNA targeting 
the same gene promoter in a single cell would have a synergistic effect on target gene activation 
and whether that could improve detection by scRNA-seq. In these regards, dual expression 
vectors could be used to clone two sgRNAs in the same lentiviral backbone under two different 
U6 promoters (Vidigal & Ventura 2015). However, a Perturb-seq or direct-capture Perturb-seq 
approach (Dixit et al. 2016; Adamson et al. 2016; Jaitin et al. 2016; Replogle et al. 2018) would 
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need to be used instead of CROP-seq. This is because the strategy of disrupting the 3’ LTR to 
obtain a polyadenylated transcript containing the sgRNA sequence is limited to a reduced insert 
size that does not interfere with lentiviral production (Datlinger et al. 2017). Nevertheless, the 
need to introduce a sgRNA-associated barcode in Perturb-seq-related approaches implies that 
cloning of dual sgRNA expression vectors needs to be arrayed rather than pooled, likely 
reducing the throughput of the screen. As an example, a recent studied coupled CRISPRa with 
scRNA-seq to generate genetic interaction maps in human cells using arrayed cloning of 
lentiviral Perturb-seq libraries to introduce combinatorial pair-wise combinations of sgRNAs 
in each cell (Norman et al. 2019). 
As discussed earlier, the lower-ranking screen hits were not overall associated with lower total 
cell numbers, target gene activation or lower enrichment of ZGA genes in the differential gene 
expression rank (Figures 5.13-5.16, Appendix C). However, the sgRNA obtained as a hit for 
those lower-ranking gene hits generally showed lower target gene activation than the 
counterpart sgRNA (Figure 5.14). This suggests that more stringent statistical parameters for 
calling screen hits that induce ZGA-like expression compared to non-targeting sgRNA controls 
might be needed to improve the robustness of hit identification and, therefore, the proportion 
of hits that would be validated both in vitro and in vivo. Ongoing work aims to explore all these 
aspects further, including drop-out rates and detection of target gene activation across the 
screen hit rank.  
With the current hit calling approach, out of the 230 maternal candidates screened, 44 were 
identified as inducers of a ZGA-like response in mESCs (Figures 5.10-5.12, 5.15). Importantly, 
amongst these hits, MOFA identified factors that had been previously described as ZGA 
regulators and were, therefore, included in the screen as positive controls, namely Dppa2 
(Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et al. 2019), Yap1 (C. Yu, Ji, 
Dang, et al. 2016), Ctcf (Wan et al. 2008) and Gata3 (Eckersley-Maslin et al. 2019). This not 
only validates the screen experimental approach but also the computational framework 
developed for hit calling. Furthermore, several screen hits, such as Cbx1, Smarca5, Phf1, 
Gatad2b, Smarca2, Hat1, Gata3 or Npm2, have also been shown to significantly reduce the 
2C-like subpopulation in mESCs after siRNA knock-down (Rodriguez-Terrones et al. 2018), 
consistent with their activator role of ZGA-like expression. Other hits have been implicated in, 
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but not specifically shown to regulate ZGA transcription. For example, the binding motif of 
Arnt is enriched in distal open chromatin regions of mouse embryos undergoing ZGA (F. Guo 
et al. 2017). Others, such as Smarca2, have been shown to be essential for oogenesis and early 
embryogenesis in other model organisms (Brizuela et al. 1994). Excitingly, a considerable 
number of screen hits, including Patz1, which I independently validated, have not been 
previously linked to ZGA. Together, this comparison to previous literature indicates that, 
despite the potential noise introduced during hit calling, a considerable proportion of the factors 
identified as inducers of ZGA-like expression in mESCs show great promise to be important 
regulators of mammalian ZGA. However, other positive controls included for being known 
regulators of ZGA-like expression in mESCs, such as MERVL, Zscan4 (as shown in chapter 
3) or Dux (Hendrickson et al. 2017; De Iaco et al. 2017) were not identified as positive hits. 
This could be due to two different reasons discussed above: 1) their targeting sgRNAs did not 
induce sufficient target gene activation, and/or 2) the number of cells expressing their targeting 
sgRNAs was not sufficient to detect ZGA-like expression with significant statistical power 
(Appendix C). 
Altogether, the study presented in this dissertation opens up exciting avenues for validation 
and characterisation of the 44 potential ZGA regulators both in mESCs and in vivo, testing the 
functional requirements, interdependencies and redundancies between these new regulators of 
ZGA-like expression. Of special interest are Dppa2, Smarca5 and Patz1, since I have already 
validated them independently as strong inducers of ZGA gene expression in mESCs (Figures 
5.17, 5.22-5.24). These validation experiments suggest that different ZGA regulators might 
have different mechanisms of action. For instance, while major satellites were overall 
upregulated in cells expressing the 46 sgRNA hits (Figure 5.12), none of the three validated 
hits significantly upregulated them compared to controls (Figure 5.23). Additionally, although 
the genes captured in the MOFA ZGA-like factor were overall upregulated by Dppa2, Smarca5 
and Patz1, the majority of these genes were induced to different extents by different factors 
(Figure 5.22). Illustrating these aspects of possible differential ZGA regulation by different 
screen hits, I showed that Dppa2 and Smarca5 present different expression patterns and cellular 
localisation in early mouse embryos (Figures 5.26 and 5.27). In agreement with the screen 
results and validation experiments, SMARCA5 localises to sites of active transcription in 
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zygotes and its zygotic RNAi-mediated knock-down leads to downregulation of some ZGA 
genes (Torres-Padilla & Zernicka-Goetz 2006). Moreover, Smarca5 homozygous KO embryos 
derived from heterozygous crosses arrest during pre-implantation development (Stopka & 
Skoultchi 2011). Although these studies, together with the results presented here, strongly 
suggest a role for Smarca5 during ZGA regulation in vivo, depletion of the maternal protein 
followed by observation of early development and analysis of transcription at the two-cell stage 
should reveal whether maternal SMARCA5 is truly an essential ZGA regulator. Similar studies 
are also yet to be done for Dppa2, whose ZGA regulatory role has been extensively shown in 
mESCs (Eckersley-Maslin et al. 2019; De Iaco et al. 2019; Y.-L. Yan et al. 2019) but very 
little, although promising, evidence supports its role in early embryos. For example, DPPA2-
overexpressing mESCs contribute to extraembryonic tissues in chimeric embryos, highlighting 
the increased developmental potential of these cells (Y.-L. Yan et al. 2019), and injection of a 
dominant-negative form of DPPA2 into zygotes leads to developmental arrest at the two-cell 
stage (Hu et al. 2010). 
Nevertheless, the accumulation of large pools of proteins during oocyte growth (reviewed in 
Vastenhouw et al. 2019) makes loss-of-function studies during early development challenging. 
Different strategies can be used to deplete maternal stores of proteins in early embryos: 1) 
generation of maternal KO transgenic mouse lines using a Cre-loxP system (H. Gu et al. 1993) 
with a Cre recombinase expressed in oocytes before they enter the growth phase, such as Zp3-
Cre (Lewandoski et al. 1997), so that derived embryos are maternal KOs for the protein of 
interest; 2) siRNA-mediated knock-down ex vivo in isolated follicles from young females 
followed by in vitro oocyte growth, maturation and IVF (Eppig & Schroeder 1989; Pfender et 
al. 2015); and 3) elimination of proteins ex vivo using antibody-mediated proteasomal 
degradation, a method called Trim-away (Clift et al. 2017), in mature oocytes followed by IVF 
or directly in zygotes. As it will be discussed later in chapter 6, each of these methods have its 
advantages and disadvantages and need to be carefully consider based on the protein to be 
studied.  
Preliminary data allowed me to propose a model for Dppa2 and Smarca5 mechanistic 
regulation of ZGA in early embryos (Figure 5.36). Using cDNA overexpression approaches in 
Dppa2 KO and Smarca5 KO mESCs, I showed that DPPA2 can induce ZGA-like expression 
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in the absence of SMARCA5, but the later requires DPPA2 to exerts its ZGA regulatory role 
(Figures 5.30 and 5.32). Previous observations based on DHS maps of early embryos indicate 
that transcriptionally inactive genes can have accessible promoters before they become active 
at later developmental stages (F. Lu et al. 2016). The presence of SMARCA5 in the pronuclei 
of zygotes (Figure 5.27) at its role as a chromatin remodeler (Barisic et al. 2019) suggest that 
SMARCA5 might be maintaining a poised open chromatin state of the genes that are to be 
expressed later on in the major wave of ZGA. While there could be redundancy in this function 
between different chromatin remodellers such as Smarca2 or Arid1a, both identified as screen 
hits, the other ATPase subunit of the ISWI complex, Smarca1 (also known as SNF2L), could 
not play a role during ZGA regulation since it is not expressed in oocytes or early mouse 
embryos (Pfeiffer et al. 2011; Pfeiffer et al. 2015; B. Wang et al. 2016). This potential 
redundancy is supported by the observation that Smarca5 KO mESCs downregulated, but did 
not completely abolish, expression of ZGA genes (Figure 5.30). Nevertheless, the hypothesis 
that SMARCA5 regulates the chromatin state of ZGA genes in early embryos needs to be 
proven with ATAC-seq or DNase-seq approaches upon depletion of the maternal protein. 
Additionally, low-input SMARCA5 ChIP-seq or single-cell CUT&Tag (Kaya-Okur et al. 
2019) in early embryos should reveal whether SMARCA5 binds genes in zygotes that become 
expressed later on at the two-cell stage; however, as discussed earlier, this might be challenging 
due to the difficulties to ChIP large chromatin complexes. Moreover, SMARCA5 has been 
shown to regulate TAD formation in mESCs (Barisic et al. 2019); single-cell Hi-C analysis on 
embryos depleted of the maternal protein would unravel whether this mechanism also applies 
to the MZT.  
Importantly, low levels of transcription are detected during the minor wave of ZGA in the 
paternal pronuclei of one-cell embryos (Ram & Schultz 1993; Bouniol et al. 1995; Majumder 
& DePamphilis 1995; Nothias et al. 1996; Aoki et al. 1997; F. Zeng et al. 2004; Xue et al. 
2013; Deng et al. 2014; Abe et al. 2015; S.-J. Park et al. 2015). Whether SMARCA5 contributes 
to the minor wave of ZGA and, if it does, what are the factors that protect the maternal 
pronuclei, where SMARCA5 is also expressed (Figure 5.27), from being transcribed are 
questions that remained to be answered. Strikingly, SMARCA5 upregulates Dux in mESCs 
(Figure 5.32), which is transcribed during the minor wave of ZGA (De Iaco et al. 2017; 
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Hendrickson et al. 2017), suggesting this chromatin remodeler might indeed have a function 
during zygotic transcription.  
In mESCs, SMARCA5 needs DPPA2 to induce ZGA-like expression (Figures 5.30 and 5.32). 
In mouse embryos, the trigger of the major wave of ZGA could be the translocation of DPPA2 
from the cytoplasm to the nucleus at the two-cell stage and expression DUX (Figures 5.27 and 
5.36). How this change in DPPA2 localisation is regulated remains an open question. In 
mESCs, a post-translational modification of DPPA2, sumoylation mediated by PIAS4, 
regulates DPPA2 heterodimerisation to DPPA4, subsequent transcription of Dux and 
downstream activation of a ZGA-like programme (Y.-L. Yan et al. 2019). It will be exciting to 
uncover whether such mechanisms apply in the early embryo and how they relate to DPPA2 
localisation, specially in relation to SMARCA5. This could be addressed with loss-of-function 
studies of Pias4, which is also expressed as a maternal protein (Pfeiffer et al. 2011; Pfeiffer et 
al. 2015; B. Wang et al. 2016), followed by immunofluorescence analysis of early embryos. 
Notably, Dppa4 has been shown to regulate ZGA together with Dppa2 in mESCs (Eckersley-
Maslin et al. 2019; De Iaco et al. 2019). Unfortunately, I could not verify Dppa4 in my screen, 
possibly due to their sgRNAs mediating insufficient target gene activation (Appendix C). 
However, these future functional studies proposed here should also consider Dppa4 expression 
and localisation in the early embryo for a comprehensive picture of ZGA regulation. 
Further evidence that supports the proposed model for DPPA2 and SMARCA5 regulation of 
ZGA (Figure 5.36) comes from analysis of LINE-1 expression after DPPA2 and SMARCA5 
overexpression. LINE-1 represses ZGA expression after the two-cell stage via chromatin 
remodeling (Jachowicz et al. 2017; Percharde et al. 2018). Consistent with a role for DPPA2 
in activating transcription during the major wave of ZGA and SMARCA5 merely facilitating 
it (Figure 5.36), LINE-1 is upregulated by DPPA2 but not by SMARCA5 (Figure 5.23), 
suggesting DPPA2 contributes to LINE-1 activation after ZGA is triggered to help repressing 
it later on. DPPA2-mediated regulation of LINE-1 has also been previously shown (Eckersley-
Maslin et al. 2019; De Iaco et al. 2019) and suggests a negative feedback loop that could explain 
why DPPA2, despite being expressed in all mESCs, only activates ZGA-like expression in a 
subset of them (Eckersley-Maslin et al. 2019; De Iaco et al. 2019). An alternative explanation 
to this observation is that DPPA2 needs SMARCA5 to set a specific chromatin state in mESCs 
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to induce ZGA-like expression. However, SMARCA5 is also constitutively expressed in 
mESCs (Figure 5.18) and, therefore, there might be additional mechanisms that regulate the 
entry to the 2C-like state in mESCs. In this sense, co-overexpression of DPPA2 and 
SMARCA5 in mESCs followed by transcriptional analysis of ZGA genes should be performed 
to validate whether SMARCA5 and DPPA2 have synergistic functions in ZGA regulation. 
Notably, immunoprecipitation experiments showed that DPPA2 and SMARCA5 physically 
interact in mESCs (Hernandez et al. 2018). In the embryo, co-localisation analysis showed that 
these two regulators co-localise in the nuclei of two-cell embryos (Figures 5.27 and 5.28). 
Although these results should be validated by super-resolution imaging, they could indicate 
that SMARCA5 helps recruit DPPA2 to ZGA gene promoters in two-cell embryos. To prove 
this and other hypothesis proposed here, similar mechanistic experiments to those performed 
in this chapter in mESCs should now be done in early embryos using maternal KOs for Dppa2, 




Chapter 6 Conclusions and outlook 
In this dissertation, I combined state-of-the-art technologies to develop a novel genetic 
screening strategy in mammalian cells. Since the discovery of CRISPR as a tool for genetic 
engineering in 2012 (Jinek et al. 2012; Gasiunas et al. 2012), this potent technology has been 
widely used for genetic screening applied to a vast range of research questions and across 
multiple model organisms (reviewed in Doench 2018). Nevertheless, it was not until 2016 that 
complex read-outs were implemented in pooled CRISPR screens by the combination with 
single-cell sequencing (Dixit et al. 2016; Adamson et al. 2016; Jaitin et al. 2016; Datlinger et 
al. 2017), allowing comprehensive interrogation of gene function and regulation at a cellular 
level in an unbiased manner. This powerful screening technology, implemented initially for 
loss-of-function perturbations, has been successfully applied in independent studies during the 
last few years (S. Xie et al. 2017; Replogle et al. 2018; Rubin et al. 2019; Gasperini et al. 2019). 
However, the proposal and development of gain-of-function perturbations mediated by 
CRISPR (CRISPRa) and assessed by single-cell sequencing had not been addressed until now. 
At the same time that the work presented in this dissertation was submitted for publication, a 
study was published describing the generation of genetic interaction maps in human cells by 
combining combinatorial CRISPRa with scRNA-seq (Norman et al. 2019). Nonetheless, the 
concept of coupling pooled CRISPRa with scRNA-seq for screening purposes is presented as 
novel in this dissertation. My novel screening method provides a powerful way to 
systematically interrogate a large number of genes for their effects on specific transcriptional 
programmes, such as ZGA, and I anticipate that it will be widely adaptable and used in the 
future to answer many other research questions in different biological contexts. 
Given the transcriptionally inactive state prior to ZGA in the embryo and the extensive 
epigenetic reprogramming occurring at the same time, the identification of maternally-
deposited epigenetic and transcriptional factors that induce ZGA transcription is crucial to 
understand this critical event in early development (reviewed in Eckersley-Maslin, Alda-
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Catalinas & Reik 2018). Due to the limitations of high-throughput screening in pre-
implantation mouse embryos, I turned to mESCs reasoning that activating ZGA regulators 
would induce ZGA-like transcription. In fact, this concept had been previously proven in a 
candidate-based screen using cDNA overexpression followed by qPCR and flow cytometry as 
read-outs (Eckersley-Maslin et al. 2019). Pooled CRISPRa combined with single-cell 
transcriptomics presented itself as an ideal technology to interrogate multiple factors for their 
role as ZGA regulators. I reasoned that the use of pooled CRISPRa would considerably increase 
the throughput of the screen and, consequently, the number of factors that could be 
interrogated, and scRNA-seq would allow comprehensive interrogation of the transcriptional 
changes triggered by the screen candidates. 
Therefore, I set out to optimise CRISPRa in mESCs using MERVL and the Zscan4 cluster as 
targets and showed that their activation in mESCs induced a ZGA-like response that could be 
captured by scRNA-seq (Figure 3.24 and 3.25). This initial pilot test allowed me to design a 
screen for 230 maternal epigenetic and transcriptional factors (Figure 4.10). I overcame the 
limitation of capturing sgRNAs in scRNA-seq libraries by adapting the CROP-seq strategy 
(Datlinger et al. 2017) to CRISPRa SAM (Figure 3.27), one of the most potent CRISPRa 
technologies developed to date (Konermann et al. 2015; Chavez et al. 2016). After transducing 
a lentiviral library containing two sgRNAs per candidate gene into mESCs expressing 
CRISPRa SAM machinery (SAM22 mESCs) and generating a scRNA-seq dataset, I first aimed 
to assess the principles governing CRISPRa efficiency. The most striking observation I made 
was that, within the 180 bp targeting window upstream of the gene TSS, previously defined to 
be optimal for CRISPRa SAM (Konermann et al. 2015), effective sgRNAs mapped further 
away from the gene TSS than the ineffective ones (Figure 4.23). Next, in collaboration with 
Oliver Stegle’s laboratory (EMBL, Heidelberg), we built a computational framework based on 
integrative dimensionality reduction analysis that allowed the identification of 46 sgRNAs 
targeting 44 unique candidate genes whose CRISPRa induced a ZGA-like transcriptional 
response in mESCs (Figure 5.10). After validation of three of the top-ranking hits, Dppa2, 
Smarca5 and Patz1 (Figures 5.22-5.24), I focused on the mechanistic regulation of Dppa2 and 
Smarca5 and proposed a model explaining their potential mechanism of action during ZGA 
regulation in mouse embryos (Figure 5.36). 
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By identifying novel epigenetic and transcriptional regulators of ZGA, this dissertation not 
only opens up multiple new lines of research but also constitutes a step forward towards the 
understanding of the relationship between chromatin remodeling and transcription in early 
embryos. However, detailed functional studies should be done in the future to understand the 
mechanistic regulation of these factors, both in relation to each other but also in terms of the 
specific transcriptional networks that they activate. In this sense, many questions remain 
unanswered: is there redundancy in the regulation of ZGA? how many factors are necessary to 
trigger ZGA? do these factors regulate the same genes and how many act via MERVL and/or 
Zscan4 activation? is epigenetic reprogramming necessary for ZGA to occur or is ZGA a 
consequence of this epigenetic remodeling? what is the function, if any, of the genes 
transcribed during ZGA? Understanding the mechanism of action of these newly identified 
regulators should provide some answers to these questions. 
However, before embarking into deeper mechanistic studies, these candidates should be first 
individually validated using alternative approaches. The most straight forward in vitro 
validation approach is probably the one presented in this dissertation, consisting of individual 
CRISPRa and cDNA overexpression of the candidates followed by RNA-sequencing or, 
simply, analysis of a panel of ZGA genes by qPCR. Nonetheless, it is important to consider 
that in vitro screening has the advantage of interrogating multiple genes and generating rich-
information results, but does not necessarily guarantee that the identified hits play the same 
role in the embryo and, therefore, in vivo studies are necessary. This is the example of Dux, 
which was identified as a key regulator of ZGA-like expression in mouse and human ESCs 
(Hendrickson et al. 2017; De Iaco et al. 2017) but in vivo studies revealed that it is not essential 
for development (Iaco et al. 2019; Z. Chen & Yi Zhang 2019). Notably, rather than indicating 
that Dux does not function during ZGA, these observations could also point towards 
redundancy in ZGA regulation, where multiple factors are needed for it to occur properly but, 
in the absence of one of them, others can compensate for its function. 
As discussed in chapter 5, the accumulation of large pools of proteins during oocyte growth 
makes loss-of-function studies in early embryos challenging. These can be addressed using 
three different strategies that can be complementary to each other: 1) transgenic mouse lines of 
conditional maternal KOs generated using a Cre-loxP system with an oocyte-specific Cre 
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(Lewandoski et al. 1997); 2) siRNA-mediated knock-down ex vivo in isolated follicles followed 
by in vitro oocyte growth, maturation and IVF (Eppig & Schroeder 1989; Pfender et al. 2015); 
and 3) protein depletion ex vivo using Trim-away (Clift et al. 2017) for antibody-mediated 
proteasomal degradation in mature oocytes followed by IVF or, directly, in zygotes. All these 
approaches require detailed knowledge of when the protein is expressed during folliculogenesis 
and oogenesis to target it at the right time. Transgenic deletion of maternal proteins to study 
early development is only feasible if the protein of interest is not involved in oogenesis. 
Moreover, while this approach is time- and cost-consuming, the other two approaches require 
complex micromanipulation techniques. siRNA-mediated knock-down in follicles requires 
effective siRNAs which should be tested in cells before undertaking complex in vivo studies. 
Similarly, Trim-away requires a specific antibody, which should also be tested beforehand in 
vitro. Altogether, one needs to balance the pros and cons of each of these strategies and decide 
on the best way to study maternal proteins in early development. Currently ongoing work 
together with Oana Kubinyecz and Melanie Eckersley-Maslin in the Reik laboratory aims to 
validate and understand in vivo the role of Dppa2 and Smarca5 during early development, 
specifically during ZGA regulation. Conditional KO mouse lines for these genes have been 
generated and are currently being crossed to Zp3-Cre transgenic lines to create maternal KO 
lines. If this approach turned out to be unsuitable because either of these proteins are involved 
in oocyte development, a Trim-away approach is currently being optimised using already 
validated antibodies. These studies should reveal whether Dppa2 and/or Smarca5 are essential 
ZGA regulators, and mechanistic studies downstream of protein depletion in oocytes should 
shed light into their mechanism of action, including potential interdependencies between them 
and regulation of the transcription factor Dux. 
Alternatively, instead of testing individual screen hits, one could try to narrow down the list of 
factors to study by performing a downstream combinatorial screen. This approach was not 
feasible to interrogate the 230 factors tested in this dissertation, since many more cells would 
have had to be sequenced, making the study cost-ineffective. However, with the list of 
candidates narrowed down to 44, it is possible to design combinatorial approaches as a way to 
study functional relationships between them. For that, multiple sgRNAs targeting different 
genes can be introduced into SAM22 mESCs using a high MOI transduction of the lentiviral 
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sgRNA library. Then, transcriptional analysis by scRNA-seq would reveal which CRISPRa 
combinations render a synergistic, antagonistic or neutral effect on ZGA-like expression. 
Even though I focused on epigenetic and transcriptional regulators, it is possible that proteins 
with other functions regulate ZGA directly or indirectly. Similar screens to the one described 
in this dissertation could be performed to interrogate other functionalities of ZGA regulation. 
Additionally, the sgRNA design could be improved for these future screens using the 
observations reported here and in other studies (chapter 4, Radzisheuskaya et al. 2016; 
Horlbeck et al. 2016; Sanson et al. 2018).  
Furthermore, in the future, it will also be interesting to see how these findings translate to 
human ZGA: are the regulators identified here expressed during early human development? 
can a human ZGA-like signature be induced in human ESCs and detected by scRNA-seq to 
perform similar screens? DUX4 overexpression in human ESCs suggests that similar screens 
might be possible (De Iaco et al. 2017; Hendrickson et al. 2017), however, other potential 
factors should be tested individually before performing large-scale screens.  
Moreover, pooled CRISPRa screening could be combined with other single-cell read-outs. As 
a proof-of-concept, pooled CRISPRi has been combined with single-cell-ATAC-seq (Rubin et 
al. 2019). Although this technology is currently not high-throughput, the recent development 
of single-cell-ATAC-seq in droplet-based platforms (Satpathy et al. 2019) promises exciting 
avenues for the development of high-throughput CRISPR screening with an epigenetic read-
out. The application of such strategy to interrogate the epigenetic functions of ZGA regulators 
in vitro would be extremely interesting, given the closed link between transcription and 
epigenetic remodeling during early development. 
Lastly, this study also opens up new avenues for the development of novel computational 
approaches, as shown here with the application of MOFA. For example, ongoing work aims to 
gain detailed insights into the transcriptional networks triggered by each screen hit and the 
cross-talk between them. Additionally, the main drawback I encountered in this screen was the 
lack of detection of target gene activation for a considerable number of factors (Appendix C). 
While this could be due to lack of transcript detection explained by drop-outs associated with 
scRNA-seq data, moving forward, it will be important to set ground rules to define effective 
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and ineffective sgRNAs. More CRISPRa scRNA-seq studies, which I anticipate will become 
available in the near future, should be systematically analysed to set these rules and 
comprehensively assess genomic and sgRNA features that influence CRISPRa efficiency. 
Importantly, these efficiency rules should be tested across different CRISPRa technologies and 
mammalian cell lines. This will help towards the development of improved genome-wide and 
targeted CRISPRa libraries. The dataset presented in this study constitutes a starting point to 
systematically analyse drop-out rates in relation to CRISPRa SAM efficiency, define the 
minimum number of cells required to detect target gene activation and how that relates to basal 
gene expression levels of the targeted gene and other epigenetic features. Even though such 
analysis were done preliminarily in chapter 4 of this dissertation, the sgRNA classification 
based on the threshold of 10 activated cells should be revisited in light of drop-out analysis. 
Furthermore, machine learning algorithms could be implemented using this dataset considering 
sgRNA features, basal transcriptional and epigenetic state of the target genes, detection of 
target gene activation, drop-out rates and cell cycle state of each individual cell, amogst other 
features, to provide a better understanding of CRISPRa efficiency. 
In summary, I conclude that my CRISPRa single-cell transcriptomics screen has unraveled 
novel positive regulators of ZGA. Furthermore, I showed that this novel screening method 
provides a powerful way to systematically interrogate a large number of genes for their effects 
on specific transcriptional programmes. In the future, in vitro and in vivo experiments to test 
the functional requirements, interdependencies and redundancies between these new 
regulators, additional complementary screens for ZGA regulation, adaptation of pooled 
CRISPRa screening to other single-cell read-outs, and development of novel computational 
approaches to analyse these rich-information and complex datasets show great promise to 
continue expanding our knowledge of mammalian gene function, with special emphasis on the 
critical events that occur in early development.
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Appendix A CROP-sgRNA-MS2 plasmid sequence 
 




















































































































Appendix B pIG400 plasmid sequence 
 



















































































































Appendix C Screen candidates, sgRNA sequences, 
target gene activation and screen hits 
1st column: sgRNA ID 
2nd column: sgRNA target sequence 
3rd column: target gene 
4th column: target transcript 
5th column: off-targets 
6th column: number of counts average read 1 and read 2 plasmid library 
7th column: number of cells expressing the sgRNA in 10X Genomics pooled CRISPRa dataset 
8th column: number of cells with activation (FDR 10%, chapter 4) 
9th column: effective / not effective sgRNA (more than 10 cells activated), classification 
chapter 4 
10th column: fraction of variance explained by MOFA factor 3 
11th column: hit rank 
12th column: screen hit (yes / no) 
13th column: mean log fold change expression of target gene in 10X Genomics pooled screen 
CRISPRa dataset 
14th column: number of DE genes (FDR 10%) in 10X Genomics pooled screen CRISPRa 
dataset 
15th column: number of DE genes recovered from ZGA signature (from Appendix I) in 10X 
Genomics pooled screen CRISPRa dataset 
16th column: hit above background in differential gene expression rank 
17th column: sgRNA used in other experiments 
 












C-6 Screen candidates, sgRNA sequences, target gene activation and screen hits 
 
 
Appendix D cDNA sequences 
Sequences cloned into pIG400 without stop codon and used for cDNA overexpression in the 

















































































Sequences cloned into pIG400 without stop codon and used for cDNA overexpression in the 

































































































































































































































































Appendix E PCA loading values 
The following table contains loading values for PC1 and PC2 for 965 highly-variable genes in 
the CRISPRa scRNA-seq screen dataset. 
Gene name PC1 loading value PC2 loading value 
0610040J01Rik 0.015094567 0.052495927 
1190005I06Rik -0.002397842 -0.019747118 
1500009L16Rik 0.015628465 0.007712967 
1700007K13Rik 0.002781191 0.02246037 
1700029P11Rik -0.02058883 0.023758499 
1700052K11Rik 0.015544041 0.037400838 
1700097N02Rik -0.037985995 -0.007069206 
1810032O08Rik -0.002645922 -0.0047161 
2200002D01Rik 0.06666651 -0.010332194 
2310043M15Rik -0.00924505 -0.001522274 
2810417H13Rik 0.015659865 -0.049252756 
3830417A13Rik 0.030609732 0.002949171 
4930548H24Rik -0.006180642 0.003333947 
4933402E13Rik 0.011801084 0.007870698 
5430402O13Rik 0.01647246 0.09500527 
5430416N02Rik 0.002684761 -0.003469797 
6330410L21Rik -0.013145719 0.021873567 
9530053A07Rik 0.009405954 0.011205982 
9530059O14Rik 0.017245522 0.09756264 
A330069E16Rik -0.000406597 -0.002033843 
A930014E10Rik 0.007221519 0.06124033 
AA467197 0.00573293 0.012449559 
Aard -0.048047964 0.041346278 
Aass -0.00342597 -0.010224617 
Abracl 0.042533085 -0.007854142 
Acaa2 -0.014266563 0.012860991 
Acot1 0.017250547 0.018125627 
E-2 PCA loading values 
 
Acta1 0.029686727 -0.003736086 
Acta2 0.03376475 -0.007041237 
Actb 0.031927373 -0.028425362 
Actg1 0.06180474 -0.039226115 
Acy3 0.009351596 0.054866035 
Adamts9 0.00251939 0.002826694 
Adcy2 0.008621854 0.07617312 
Adgrl2 0.049820874 -0.01919885 
Adgrl3 0.007103615 0.037204918 
Adprh -0.047208536 -0.003131277 
Adrb2 0.011310952 0.0088274 
Aebp2 -0.018760156 0.007505677 
Aes -0.064773194 0.010382351 
AF067061 0.013069687 0.0813769 
Agl -0.019933186 0.006543614 
Agpat4 0.0435728 -0.0027023 
Agpat9 0.025616627 0.009243218 
Ahnak 0.045911707 -0.001916705 
Ahnak2 0.035194464 0.002531802 
Aire -0.040366407 -0.007281113 
Ak4 -0.012940768 0.025580687 
Akap12 0.018310642 -0.016972357 
Akr1b3 -0.016898645 -0.024077412 
Aldoa 0.010901698 -0.019452162 
Amn 0.008800886 0.006152645 
Amotl1 0.04937692 -0.00564561 
Amotl2 0.04054745 -0.000305379 
Amt -0.004748545 -0.00376131 
Anp32a -0.022215739 -0.021950474 
Anxa1 0.046789225 0.002154642 
Anxa2 0.06540843 0.0133765 
Anxa3 0.109695844 -0.00502606 
Anxa5 0.033014603 0.007718445 
Anxa8 0.006824127 0.008281822 
Ap3b2 0.013319263 0.005736365 
Apela 0.051585913 -0.032512095 
Apoa2 0.003223777 0.023951797 
Apobec2 0.014635964 0.010246145 
 E-3 
 
Apoe 0.001125963 0.014355245 
Aqp3 -0.007551776 0.032101583 
Arg2 0.025373207 0.13080893 
Arhgef26 0.021730153 0.096255705 
Arl14epl -0.03452046 0.017821318 
Arl4a -0.008026663 -0.010391519 
Arl4c 0.08486886 -0.024569554 
Arl4d -0.004283476 0.022680787 
Arl6ip1 -0.007842236 0.026358351 
Arpc1b 0.020260893 -0.00683571 
Ascl2 0.01904236 0.007459578 
Asns 0.005183192 0.028264124 
Ass1 -0.007555474 0.029019162 
Atf4 0.003308763 -0.004568338 
Atg2a -0.011278303 0.005181089 
Atp5b -0.001511414 0.027984366 
Atp6v0b 0.023989808 0.005440626 
Atp6v0d1 0.007337852 0.020088376 
Atrn 0.001722835 0.01854388 
Atrx -0.001318779 -0.007089897 
Avpi1 0.023845786 0.058848053 
AY036118 -0.001742739 0.00158306 
B020031M17Rik 0.014280799 0.09668234 
B2m 0.06365098 -0.004644726 
B930036N10Rik 0.003977635 0.002061978 
Bambi 0.016732853 0.016353419 
Baz1a 0.04786045 -0.001368109 
Bbc3 0.004886779 -0.005869682 
Bbs2 -0.0401821 0.000656059 
Bbx 0.056650326 -0.006721663 
BC028528 -0.01344899 0.001536729 
BC080695 0.019547127 0.11561123 
BC147527 0.008057542 0.05154259 
Bcat1 -0.02580247 0.009828978 
Bdnf 0.017248236 0.022126278 
Bend7 0.012524447 0.000365108 
Bex1 0.052851204 -0.011966423 
Bhlhe40 0.05307626 -0.009928111 
E-4 PCA loading values 
 
Bmp4 -0.01896895 -0.000544794 
Bnip3 -0.014154435 0.009338872 
Bst2 0.03898057 -0.027949888 
Btg1 0.021517655 0.029884223 
Btg2 0.03011527 0.036223702 
C130073F10Rik -0.000534728 0.021176014 
C1d 0.016326826 0.036491755 
C2cd4b 0.004218822 0.027001975 
C730034F03Rik 0.004175168 0.002167788 
C77370 -0.010585178 3.70E-05 
Cacybp -0.043136965 -0.014030958 
Calb2 -0.006771362 0.003902945 
Calcoco2 -0.02539668 0.06307138 
Cald1 0.089361586 0.009736018 
Calm2 0.00668301 -0.017183369 
Calml4 0.002918844 -0.000479648 
Calr 0.005403424 0.00282461 
Camk2d 0.03708878 -0.001303272 
Capg 0.03781928 -0.001552605 
Car2 0.08335073 -0.056978278 
Car3 0.030876499 -0.021049932 
Car4 0.06417472 -0.012108661 
Carhsp1 0.023348901 -0.009240522 
Catip -0.024883859 0.001965289 
Cbr3 0.015500189 -0.006089454 
Cbx3 0.000847163 -0.026430955 
Ccnb1 -0.003339117 0.008294192 
Ccnd1 -0.013487862 -0.02121775 
Ccnd2 -0.003697974 -0.018208168 
Ccnd3 -0.03714356 -0.00068462 
Ccne1 -0.016595013 -0.037401453 
Ccne2 0.014058882 0.002051401 
Ccng1 0.035949346 0.022919875 
Ccno 0.010191255 0.04088658 
Ccser1 0.018254109 0.11549505 
Cd24a 0.05137069 0.003102236 
Cd37 -0.020764517 0.002678508 
Cd63 0.052259374 0.009962568 
 E-5 
 
Cd74 -0.010120583 0.012792378 
Cd81 0.035443403 0.016374405 
Cd9 0.002746664 0.01467389 
Cdc14a 0.009268099 0.003439219 
Cdc20 0.003967631 0.000153341 
Cdc42ep3 -0.000118792 0.038772427 
Cdc5l -0.048449848 0.031973846 
Cdk6 0.032568462 -0.023529418 
Cdkn1a 0.0377119 0.013237253 
Cdkn1c 0.021562133 -0.015149301 
Cdkn2a 0.028233293 0.004382915 
Cdv3 0.025066044 -0.018136246 
Cdx2 0.034287825 -0.006079288 
Cebpb 0.037028495 -0.002781794 
Cenpf -0.00696432 0.008487805 
Cenpm -0.04482287 0.028162606 
Cep57l1 -0.005306352 0.04477432 
Chac1 0.007548773 -0.014288743 
Chchd10 -0.09330636 0.001045552 
Cidea 0.002054567 0.04526647 
Cited1 0.04203834 0.010171789 
Cited2 0.055299006 -0.003543699 
Cited4 0.017075216 0.007238478 
Ckb -0.002592469 0.025500357 
Ckmt1 0.006780433 0.011775426 
Clcn5 0.03525746 0.020798948 
Cldn3 0.022947256 -0.004431147 
Cldn4 0.040846772 -0.003986615 
Cldn6 0.08158767 -0.014180548 
Cldn7 0.073592074 -0.01758181 
Clic1 0.06604909 0.003896484 
Clic4 0.013671224 0.003047593 
Clp1 0.003886337 0.050020095 
Cltb -0.029335916 -0.002472848 
Clu 0.032374803 0.00506921 
Cmtm7 0.004018967 -0.005194415 
Cnn1 0.061098456 -0.01634129 
Cnn2 0.0597088 -0.02715121 
E-6 PCA loading values 
 
Cntfr 0.027163005 -0.02068379 
Coch 0.011784329 0.027236966 
Col4a1 0.025383873 0.015150304 
Col4a2 0.029917192 0.008939553 
Commd3 0.026812669 0.021287989 
Comt -0.016400581 0.006852488 
Cox6b2 -0.013385477 0.039687626 
Cpsf4l -0.014637545 -0.005513027 
Crabp2 0.017374938 -0.002946168 
Crct1 0.012285536 0.01212075 
Crim1 0.01852431 0.006244736 
Crip2 0.04015023 -0.022849206 
Crxos 0.001357752 0.04758899 
Cryab 0.058373623 0.006871028 
Csrp1 0.08471262 -0.0098939 
Cst3 0.035102163 0.010376593 
Cstb 0.045886215 0.009141898 
Ctgf 0.06567706 -0.000594327 
Cth -0.001842269 0.00329518 
Ctnnal1 -0.016199414 -0.007401111 
Ctr9 0.027460394 0.04338847 
Ctsa 0.007530842 0.004168803 
Ctsb 0.017083723 0.010107459 
Ctsd 0.01733233 0.007856975 
Ctsl 0.061471473 0.006524167 
Cul9 -0.005204707 0.001919602 
Cwc22 0.008396202 0.056778036 
Cxcl16 0.060715612 -0.003446068 
Cyba 0.048274573 -0.002684555 
Cyp26a1 0.013697446 -0.002336123 
Cyr61 0.086159274 -0.011615293 
D630023F18Rik -0.0047449 0.0163669 
Dab2 0.031213526 0.0045787 
Dazl 0.004006715 0.037785873 
Dcaf12l1 0.021828411 0.013338806 
Dcaf17 0.005013189 0.002799126 
Dcbld1 -0.012647767 0.04350858 
Dcxr 0.021073135 0.018912673 
 E-7 
 
Ddah1 0.03765621 -0.020219272 
Ddah2 -0.003038738 0.015661106 
Ddit3 0.023030674 0.00745412 
Ddit4 0.038177192 0.03966237 
Ddit4l 0.028028483 0.065412395 
Ddr2 -0.000113222 0.03403952 
Derl3 -0.003419998 0.010177033 
Dhx16 -0.042943772 0.000432337 
Dkkl1 0.004654707 0.005099509 
Dlg1 -0.002645243 0.007913143 
Dll1 0.003777089 0.007062126 
Dmkn 0.01862967 0.006954388 
Dnajb14 0.007831642 0.03626714 
Dnajb9 0.009901268 0.046734184 
Dnajc21 -0.044168252 -0.009726992 
Dnmt3a 0.000708433 -0.01766263 
Dnmt3b 0.034354787 -0.047587495 
Dnmt3l -0.020602236 -0.020090772 
Dok2 0.039054066 -0.017521095 
Dpp7 0.002323445 0.007300701 
Dppa2 -0.023127988 0.05652287 
Dppa3 0.007235021 0.01017705 
Dppa5a -0.08626957 0.041418824 
Dpys -0.021740822 -0.003951479 
Dqx1 -0.016957076 0.022540657 
Dsp 0.043254197 0.000568998 
Dst 0.024845371 0.048654616 
Dstn 0.039652593 -0.03151753 
Dusp1 0.049871363 0.008013587 
Dusp14 0.0334446 -0.002270326 
Dusp4 0.054571792 -0.010000737 
Dusp5 0.043761633 0.00626048 
Dusp6 0.051718485 -0.023772363 
Dusp9 0.01181286 0.018920012 
Duxf3 0.011258294 0.07037724 
Dynll1 -0.00620102 0.011316283 
E130012A19Rik -0.076676786 0.000726886 
E2f5 0.00865022 -0.004996888 
E-8 PCA loading values 
 
Ebf1 0.010503617 -0.008187851 
Echdc2 -0.000268897 0.025201052 
Echdc3 0.012568678 0.05705047 
Edn1 0.011678997 0.004059735 
Edn2 -0.003892543 -0.003289369 
Eef1a1 0.021844989 0.05794018 
Eef2 0.029955793 0.017947892 
Efhc2 0.00206725 0.002763808 
Efna3 0.010761168 0.007722148 
Efnb1 0.030413523 -0.001442606 
Egr1 -0.000749228 -0.007151757 
Egr4 -0.000124314 -0.00164326 
Eif2s2 -0.062068503 0.0475361 
Eif4a1 0.000289934 -0.004212175 
Elf3 0.015611121 0.011153074 
Emb 0.019994577 -0.030172413 
Emilin1 -0.016405562 0.008160953 
Emp2 0.023016015 0.002261004 
Emp3 0.029896982 0.003426032 
En1 -0.000505638 -0.0062662 
Enah -0.05129853 -0.010647598 
Endov 0.000849611 -0.003806706 
Eno1 0.023922602 -0.03532054 
Enpp2 0.018391622 -0.013291356 
Epcam 0.050913747 -0.02809695 
Epha2 0.027004072 -0.021093363 
Eps8l2 0.028736366 0.008347368 
Ercc4 0.012984146 0.10032243 
Erdr1 0.030274814 -0.027269442 
Esco2 -0.037606016 0.023749426 
Esx1 0.018991467 0.007406469 
Eva1a 0.003622026 0.009416269 
F2r 0.039685924 -0.014354883 
F2rl1 0.018891457 -0.022135587 
F3 0.034614768 -0.004506289 
Fabp3 0.023035884 0.014178606 
Fabp5 0.05758098 -0.021719424 
Fam124a 0.012689043 0.05592422 
 E-9 
 
Fam134b 0.016535224 0.004645391 
Fam159b 0.006285528 0.000941234 
Fam162a -0.009869767 0.003922158 
Fam25c -0.04846094 0.021403132 
Fam60a 0.005196818 -0.056118388 
Fam83a -0.000325609 0.001906392 
Fblim1 -0.04170016 -0.022100853 
Fbp2 0.005118796 0.02218248 
Fbxo15 -0.010482747 0.07644365 
Fgf1 0.007225305 0.05742421 
Fgf15 9.95E-05 -0.005512751 
Fgf17 -0.012837992 -0.014580964 
Fgf4 -0.036527693 0.007016205 
Fgf5 0.023556119 -0.006828413 
Fgf8 0.007930755 -0.003702276 
Fgfbp1 0.07556955 -0.018307226 
Fhl1 0.026304467 -0.006946371 
Fhl2 0.048406772 -0.003450101 
Fkbp6 -0.011712599 0.018409675 
Flrt3 0.011473482 0.002489002 
Fmr1nb 0.002148234 0.034822974 
Folr1 0.021634636 -0.005113195 
Fos 0.01829026 0.006016003 
Foxo3 0.000551056 0.017125327 
Fst 0.03634429 -0.008764674 
Fth1 -0.000284873 -0.054010097 
Fthl17a 0.012782832 0.008670297 
Fthl17c 0.002489224 0.037902582 
Fuca2 0.016489467 -0.00165122 
Fundc1 0.018053822 0.051176306 
Fxyd6 -0.002643741 -0.008005482 
G0s2 -0.003433945 0.000814898 
Gabarapl2 -0.07046195 0.07336173 
Gadd45a 0.013230865 -0.020593867 
Gadd45b 0.034734026 0.011001428 
Gadd45g 0.016840952 -0.005709146 
Gap43 0.028587352 -0.018545061 
Gata2 0.021185473 0.01101415 
E-10 PCA loading values 
 
Gata3 0.020810654 0.012187039 
Gbp2 0.047714606 -0.010505687 
Gbp2b 0.0413234 -0.008629489 
Gbx2 -0.002578741 -0.030037615 
Gchfr 0.023111401 -0.00524553 
Gfod2 -0.002669147 0.000774122 
Gja1 0.03729728 -0.022795988 
Gjb3 0.000899088 0.001832224 
Gjb5 -0.016587796 0.004303272 
Glipr2 0.03878476 -0.010613338 
Glod5 -0.01198676 -0.008469946 
Glrx 0.018930193 0.056158848 
Glrx2 0.022932766 0.07689187 
Glul -0.007651395 0.002570058 
Gm10116 0.009434057 -0.02134013 
Gm11238 0.00871849 0.05774779 
Gm12794 0.011987051 0.06922997 
Gm13075 -0.026613394 0.001503398 
Gm13119 0.01652407 0.10431137 
Gm13145 -0.017275494 0.023041628 
Gm13225 -0.035756707 0.015297518 
Gm15879 -0.000230966 0.003720969 
Gm15915 -0.008747464 0.003994174 
Gm16233 0.056657385 -0.023414169 
Gm2016 0.019900931 0.13346794 
Gm2035 0.019177075 0.12121134 
Gm2046 0.017295599 0.10846861 
Gm2056 0.019292343 0.12318259 
Gm20767 0.015838897 0.09309257 
Gm21761 0.028489914 0.16648936 
Gm21818 0.020783337 0.12639622 
Gm26710 -0.001675538 -0.002017949 
Gm26737 -0.002618892 0.010177097 
Gm26782 -0.002579627 0.000771172 
Gm26870 -0.006236042 0.09962724 
Gm26917 -0.024129013 0.023420332 
Gm27167 0.010649298 0.07257229 
Gm29666 -0.009751109 0.005910335 
 E-11 
 
Gm33466 0.010937145 0.066742495 
Gm36266 -0.002551836 -0.000720445 
Gm37305 -0.005015675 0.001437683 
Gm4027 0.019480506 0.120306306 
Gm42418 -0.008831644 0.015085356 
Gm42637 0.028787496 0.003784247 
Gm428 0.008940176 0.059008334 
Gm4340 0.015008505 0.09167015 
Gm43409 -0.006639358 0.00504022 
Gm4349 0.000587295 0.032809667 
Gm5039 0.018662311 0.11976821 
Gm5662 0.026117979 0.17187935 
Gm7120 -0.001746533 0.017229041 
Gm7325 -0.056749877 -0.002618413 
Gm8300 0.02716212 0.17303982 
Gm8994 0.02206793 0.13588205 
Gm9112 -0.000240859 0.005932308 
Gmcl1 -0.004257055 0.002705255 
Gnas 0.049456082 -0.00803878 
Golga3 -0.013204619 0.021294672 
Gpd1l -0.004854105 -0.001267369 
Gprc5a 0.030196998 0.001127704 
Gprc5c 0.022903036 0.010446035 
Gpx3 0.025270222 0.006060973 
Gpx4 -0.044192065 0.04487611 
Grb10 0.029814072 -0.023128377 
Grn 0.007838422 0.02726066 
Gsn 0.051334053 0.001813137 
Gsta4 -0.034142185 -0.009995136 
Gstm1 0.008087546 -0.000892051 
Gsto1 0.034149937 -0.0021975 
Gtsf1l -0.055739395 -0.002540977 
Guca1a 0.004055876 0.055705376 
H19 0.026705291 0.005265772 
H1f0 0.01245636 0.023837402 
H2-D1 0.021119803 0.00669263 
H2-T23 -0.00580988 0.005367006 
H2afx -0.0426532 0.023524415 
E-12 PCA loading values 
 
H2afy 0.006108494 0.002557848 
H3f3b 0.03499717 0.007577031 
Hand1 0.02656063 0.004488193 
Hat1 -0.012885354 -0.000537764 
Hbegf 0.025257757 -0.002340328 
Hck -0.021693593 -0.001472522 
Hdc 0.006842143 0.03282815 
Herpud1 0.008867953 -0.000240387 
Hes1 0.0073727 0.002403795 
Hes6 0.030074546 -0.016650561 
Hexa 0.01706672 0.009382461 
Hexb -0.00768192 0.019732006 
Hist1h1a -0.006710325 0.002509512 
Hist1h1b -0.010880776 -0.018049197 
Hist1h1e 0.014197714 -0.014656152 
Hist1h2aa 0.001198959 -0.001707079 
Hist1h2ae -0.004707729 -0.004079382 
Hist1h2ap -0.004071913 -0.00509812 
Hist1h2bc -0.003143966 0.035367057 
Hist1h3c 0.005970402 0.03331994 
Hist1h3d 0.001558883 0.023724755 
Hist1h4i 0.008683445 0.06782613 
Hist1h4j 0.003598591 0.023746489 
Hist2h3c1 0.00390085 0.029336303 
Hist3h2a -0.000197058 0.005012439 
Hist3h2ba 0.013614152 0.027875219 
Hmces -0.06936463 -0.020522393 
Hmga2 0.055883076 -0.00339953 
Hmgb3 0.026266526 -0.008529956 
Hmgcr 0.016960127 -0.007389274 
Hmgn3 0.047155555 0.052114233 
Hmgn5 0.03150653 0.015951917 
Hmmr -0.009572479 0.032740057 
Hmox1 0.024818212 -0.022696791 
Hnrnpa1 0.03001399 -0.02950481 
Hormad1 -0.009406035 0.011291593 
Hoxa7 0.008204411 0.000837694 
Hpcal1 0.02258307 0.000602338 
 E-13 
 
Hsd17b14 -0.10991553 -0.026478708 
Hsf2 0.005301386 -0.003861517 
Hsp90aa1 0.007263745 0.01477534 
Hsp90ab1 -0.010708533 0.04429141 
Hsp90b1 0.014367413 -0.005401909 
Hspa1a 0.011883227 0.013529325 
Hspa5 0.019750461 -0.004727841 
Hspa8 0.008355865 0.030436693 
Hspb1 -0.049969357 0.04167702 
Hspb2 0.028570263 0.004832401 
Htra1 0.012080606 0.004158956 
Icam1 -0.010909056 -0.004315316 
Id1 0.02968073 -0.001653581 
Id2 0.057427086 0.000848706 
Id3 0.01877864 0.025810366 
Ier3 0.020002209 -0.003742611 
Ier5 0.033289887 -0.001175506 
Ifi30 0.014150376 -0.000506245 
Ifitm1 -0.022298144 -0.015004985 
Ifitm2 -0.083204456 -0.007295612 
Ifitm3 0.023948621 -0.02431863 
Ifrd1 0.04163054 -0.01607971 
Igf2 0.05488462 0.002633388 
Igfbp2 0.00736198 0.034500096 
Igfbp3 0.05463665 0.034464307 
Igfbp4 0.025155067 -0.009441111 
Igsf23 -0.019173983 0.005373285 
Il23a 0.001476667 -0.001180959 
Impact 0.03791328 -0.021357508 
Ina -0.007049399 -0.037153456 
Insig1 0.007154108 -0.001100667 
Irf1 0.02699284 -0.011912086 
Irgm1 0.013979862 -0.003943445 
Itga3 0.056282826 -0.016729996 
Itgb1 0.049246784 -0.02181563 
Itm2a 0.01544533 0.012279341 
Jam2 -0.06360303 0.050534934 
Jarid2 -0.037127305 -0.013621271 
E-14 PCA loading values 
 
Jun 0.059227612 0.021227775 
Junb 0.028771855 -0.022570617 
Jund 0.04185853 -0.013093876 
Kcnk1 0.052004386 -0.020354835 
Kctd12 0.010844702 0.016986847 
Kdelr3 -0.012378245 0.003609421 
Kdm5b -0.047196697 0.03207779 
Kdm6b 0.000870149 -0.004686068 
Khdc3 -0.039540254 0.016528096 
Kif1a 0.043843795 -0.010401619 
Kif21a 0.020778624 -0.010200771 
Klf2 -0.08013138 0.016469633 
Klf4 -0.059980217 0.018691417 
Klf5 -0.009370692 -0.00288512 
Klf6 0.06657653 -0.007460462 
Klf9 -0.01590595 0.021249514 
Klhl13 0.029314125 0.020981133 
Kpna7 -0.007447249 0.004292301 
Kras 0.049295247 -0.0309612 
Krt17 -0.000173826 -0.005908305 
Krt18 0.10321411 0.000387038 
Krt19 0.07333735 -0.004182681 
Krt42 -0.029897258 0.000875479 
Krt7 0.04993038 0.002116194 
Krt8 0.10330999 0.003748034 
L1td1 -0.026675548 -0.04371335 
Lama1 -0.008177145 0.001823619 
Lamb1 0.026096877 -0.003363888 
Ldha -0.000971542 -0.047040686 
Ldhb -0.01845672 0.021210525 
Ldoc1 0.014645477 0.00014748 
Lef1 0.004280104 -0.02849528 
Lefty1 0.05940725 -0.025700396 
Lefty2 0.04773168 -0.019853717 
Lepr -0.011732918 0.017883783 
Lgals1 0.0744673 -0.016787278 
Lgals3 -0.030066986 0.021918105 
Lgals4 0.020937644 0.104770355 
 E-15 
 
Lgmn 0.011774233 0.00695827 
Lgr4 0.005211347 -0.011665749 
Limch1 0.017973818 0.08596835 
Limk2 -0.003005705 0.006138702 
Lmo4 0.03952487 -0.000920154 
Lmo7 -0.000393714 0.010008211 
Lmx1a 0.010885065 0.058181003 
Lncenc1 -0.043541767 0.004422141 
Lonp2 0.020628309 0.08903978 
Lor 0.029897433 0.001895448 
Loxl2 -0.009430684 0.0063161 
Lpar1 -0.011263983 0.022718772 
Lpar4 0.028974632 -0.011288257 
Lpar6 0.042156607 -0.001224014 
Lpl 0.01072217 0.012571201 
Lpp 0.048111763 -0.009801238 
Lrp2 0.026291138 -0.006818071 
Lrpap1 0.01796728 0.025242886 
Lrrc8a 0.025152612 -0.006021878 
Lrrn4 0.030134331 0.021347338 
Ltb 0.044556923 -0.009757914 
Ly6a 0.000215918 0.019536823 
Ly6g6e -0.014162073 0.014379009 
Ly6k -0.001906297 0.02489482 
Malat1 0.057314955 -0.03672508 
Manba -0.051747307 0.008637489 
Manf 0.010473885 -0.000702933 
Map1b 0.014175134 -0.011072679 
Mapt -0.031076511 0.007832727 
Marcks 0.036807302 -0.021691866 
Marcksl1 0.022543961 -0.031025883 
Marf1 0.000749115 -0.002467677 
Marveld1 0.01210741 0.047261484 
Mbd5 0.006405154 0.030411066 
Mbnl3 0.024516828 0.000193047 
Mdk 0.031358805 -0.016537867 
Mdm2 0.030469349 0.018095024 
Mecom 0.015892126 0.07152331 
E-16 PCA loading values 
 
Meg3 0.019786512 -0.057354063 
Mest 0.045289718 -0.026361784 
Mfge8 0.005932598 0.022693532 
Mfsd1 0.016010303 0.01473751 
Mgll 0.01750019 0.08567064 
Micu1 0.009235302 0.034322266 
Mif 0.007847809 -0.07539473 
Mis18bp1 -0.012069989 0.046463285 
Mkrn1 -0.073402606 0.011514884 
Mme 0.012132841 0.013886697 
Mobp -0.010899177 0.011042444 
Morc1 -0.061956212 0.008285911 
Morc4 0.027526155 0.0080546 
Mpzl1 0.026916765 0.038218185 
Mras -0.05014885 -0.00091585 
Mreg -0.015978057 0.06502478 
Mrpl9 0.003990512 -0.002522284 
Ms4a10 0.001597203 0.012653625 
Msc -0.035349235 0.000809904 
Msmo1 0.008451441 -0.007711607 
Msx1 0.02230118 0.004735145 
Msx2 0.01838304 0.028504135 
mt-Atp6 -0.060005236 -0.00461201 
mt-Co1 -0.04622106 0.017192287 
mt-Co2 -0.03966278 0.007804764 
mt-Co3 -0.06383781 0.007576443 
mt-Cytb -0.05752422 -0.00251884 
mt-Nd1 -0.060112312 -0.003382622 
mt-Nd2 -0.035542604 0.004146815 
mt-Nd4 -0.04583455 0.013814743 
Mt1 0.005800775 -0.019519608 
Mt2 -0.003861539 -0.009523704 
Mtf2 -0.052479256 0.045621753 
Mthfd2 0.003420014 -0.020894522 
Muc3 -0.005166563 0.001622851 
Myc 0.007466979 -0.019138174 
Mycn 0.014987506 -0.04518277 
Myef2 0.010676716 -0.018849714 
 E-17 
 
Myh13 -0.006115272 0.023224454 
Myl4 -0.005642884 0.011814928 
Myl6 0.03668839 0.001788623 
Myl9 0.045190603 -0.019326176 
Mylpf -0.08297398 0.04381212 
Myo1f -0.03700731 0.003271781 
Nab2 0.002168507 -0.004773438 
Nanog -0.040753033 0.032297507 
Napsa -0.014370701 -0.006378022 
Ncoa3 -0.02217006 -0.00133258 
Ndrg1 0.009102671 0.005070039 
Ndufa4l2 -0.005779321 0.009633251 
Neat1 0.01802083 -0.006658479 
Nefh -0.014870527 0.003422987 
Nefl 0.015276651 -0.009227906 
Nefm 0.020993007 -0.002136491 
Nelfa 0.010052733 0.07832915 
Nes 0.064570814 -0.016530758 
Neurod1 0.006598843 0.00090453 
Neurog3 -0.005914768 -0.000706828 
Nexn 0.010470851 -0.008434624 
Nfatc2ip -0.052524477 0.026617693 
Nfkbia 0.012581361 0.032037217 
Ngb 2.21E-05 -0.00129646 
Ngfrap1 0.024133451 0.007734808 
Nip7 -0.047540464 -0.013668732 
Nkx2-9 0.001946361 0.007675432 
Nkx6-2 -0.004339927 -0.001939896 
Nmrk1 7.99E-05 0.006283409 
Nnat 0.049553543 -0.01899711 
Noct 0.000807107 -0.003735249 
Nodal -0.002352786 0.011091408 
Nop56 0.001066659 0.00089646 
Notch2 0.021051958 -0.007071473 
Nptxr 0.007347569 -0.001191676 
Npy 0.001377303 0.020490708 
Nr0b1 -0.06055917 -0.002848119 
Nrk 0.023927797 0.004806237 
E-18 PCA loading values 
 
Nrp2 0.015762761 -0.007330699 
Nudt4 0.00515578 0.02170633 
Nup62cl 0.018903123 0.013518163 
Nupr1 -0.004878024 -0.004618408 
Ooep -0.044575837 0.017879413 
Os9 0.011851691 0.05213031 
Otx2 -0.003979108 -0.009220701 
P2rx4 0.007916019 0.002534957 
P2rx7 0.008146117 0.005876616 
P3h3 -0.006478303 0.007346639 
P3h4 -0.00092829 -0.024164522 
P4ha2 0.026330207 0.050529126 
Parm1 0.00611063 0.010557724 
Parp1 -0.051629543 0.009794451 
Pawr 0.036791798 -0.008251214 
Pax6 -0.013641947 -0.013556893 
Pcgf5 0.039054286 0.013535514 
Pdcd4 0.000435608 0.013173285 
Pdgfa -0.018076453 0.011351427 
Pdgfrl 0.020569652 0.08402794 
Pdia3 0.022405997 0.007023453 
Pdia6 0.015307296 -0.004670825 
Pdlim3 0.01799686 0.035846457 
Pdlim4 0.008709206 0.006746862 
Pdlim7 0.07853086 -0.014697516 
Pdpn 0.021638455 -0.000112674 
Peg10 0.05086583 -0.015998336 
Peg3 0.024057368 -0.00206 
Perp 0.08387126 -0.00742062 
Pfas -0.004540946 -0.016702062 
Pfkp -0.033138867 0.01696471 
Pfn1 0.03361296 -0.07398718 
Pga5 -0.010424935 0.008379809 
Phgdh 0.03325548 -0.016655719 
Phkg1 -0.008103333 0.004237564 
Phlda1 0.055025104 0.003274372 
Phlda2 0.026554054 -0.026392858 
Phlda3 0.04163544 0.007687937 
 E-19 
 
Phldb2 0.04849776 0.019127484 
Pim1 0.04880737 -0.003834302 
Pim2 0.05631185 -0.040253673 
Pitx2 0.051216763 -0.013198326 
Pkp2 0.003561762 -0.003274379 
Plac8 0.01615424 -0.006697566 
Platr3 -0.041993182 0.019080129 
Platr31 0.020313788 0.12293335 
Plaur 0.062150825 -0.016355803 
Plet1 0.021496253 0.00272047 
Plin2 0.067612395 0.017473547 
Plk2 0.039671298 0.023353897 
Plk3 0.013478932 0.005904021 
Plk4 -0.03257671 0.007059331 
Plod2 0.022805115 0.008123179 
Pmaip1 0.03217391 0.03838537 
Pmm1 -0.00285713 -0.012517266 
Pmp22 0.04252212 -0.002578012 
Pou3f1 0.0886468 -0.03891264 
Ppdpf -0.041057065 0.001050807 
Ppig 0.004191735 0.03534577 
Pramel7 0.003946993 0.030915057 
Prdx1 -0.0015816 -0.02855898 
Prdx6 0.040108826 -0.005933631 
Prex2 0.018188821 0.07823154 
Prph 0.024338495 -0.003125917 
Prps1 0.002218143 0.035233956 
Prr13 -0.005223257 -0.002529654 
Prrc1 -0.024680434 0.028655814 
Prss8 0.039840695 -0.007705758 
Prtg 0.06548481 -0.02052452 
Psap 0.017358545 0.025149843 
Psmb8 0.03527508 -0.010623768 
Psors1c2 0.016894786 -0.007919516 
Psrc1 0.002479071 -0.000257843 
Ptch1 -0.001731897 -0.012943762 
Ptcra -0.013300842 0.000844152 
Ptges 0.009105714 0.003957763 
E-20 PCA loading values 
 
Ptgr1 0.017969768 0.018110372 
Pth1r 0.01548752 0.000931845 
Ptp4a2 0.02229632 -0.01127208 
Ptp4a3 0.004481949 0.008163252 
Pttg1 0.031276498 0.021524634 
Pxdc1 0.046567295 -0.002733822 
Pycr2 0.04551226 -0.0328982 
Rab3il1 0.009223086 0.003722931 
Rap2b 0.036107548 -0.001991218 
Rasgrp2 -0.03861917 -0.026290286 
Rasl11a 0.005770573 0.00970229 
Rassf1 0.029769907 -0.009443105 
Rbm15 0.003283433 -0.002860165 
Rbm47 -0.000416183 0.004094035 
Rbms1 0.06797447 -0.016751237 
Rbmx 0.02304335 0.031674378 
Rbp1 0.016458854 0.007730162 
Rbpj -0.03953207 0.003767239 
Rcsd1 0.00263533 0.0234671 
Rec114 -0.008597365 0.019676246 
Reep5 0.06302246 -0.001369909 
Renbp 0.007957466 0.022281904 
Rest -0.04838758 -0.038601115 
Retn -0.006249201 0.002707783 
Rgcc 0.011056006 0.012279421 
Rhob 0.031095633 -0.002731184 
Rhox13 -0.007728287 0.020375602 
Rhox5 0.004451726 0.013406365 
Rhox6 0.024675332 0.007412664 
Rhox9 0.02135351 0.008256732 
Rif1 -0.027877264 0.011302024 
Rimklb 0.006817012 0.026108313 
Rnf128 0.059317537 -0.004290893 
Rnf168 -0.004360375 0.001609128 
Rnf7 -0.028881129 0.002017015 
RP23-4H17.3 -0.036238898 0.01924155 
Rpl10l -0.01659579 0.022288768 
Rpl22l1 -0.017381923 0.013222387 
 E-21 
 
Rpl39l -0.056015678 0.03315723 
Rpl41 -0.015711447 -0.019872895 
Rpp25 -0.050927423 0.02583105 
Rps18 -0.027430108 0.037106704 
Rps19 0.012676132 0.026450522 
Rps23 -0.019110046 0.04952674 
Rps27l 0.004749517 -0.016248133 
Rps4x -0.012563138 0.045727815 
Rrad 0.024700148 -0.005643126 
Rrm2 0.004064 -0.004658698 
Rrn3 -0.017104777 -0.007383612 
Rsph6a 0.002253769 0.0047081 
Rsrp1 0.005601133 0.012154623 
Rtkn -0.000861793 0.0146809 
S100a1 0.016439274 0.007270871 
S100a10 0.051903922 0.010155744 
S100a11 0.057441738 0.03803487 
S100a13 0.0205571 0.018000882 
S100a3 0.012969553 -0.00112757 
S100a6 0.068982095 -0.001198798 
Sall3 -0.001860465 -0.000654704 
Sall4 -0.012040203 0.009051272 
Sat1 0.014477412 0.020402886 
Sbsn 0.03346857 0.003151454 
Scamp1 0.02961219 0.09533558 
Scd2 0.007169057 -0.001180985 
Scn1b 0.02148244 0.005727404 
Sct 0.031138703 0.019131266 
Sdc4 0.034923624 0.0194648 
Sdhaf3 0.003659992 0.0420364 
Sec24a -0.003607738 0.007881408 
Sema6a 0.035791382 -0.011948902 
Sepp1 0.019565145 -0.002290045 
Sep-01 -0.076747864 0.004510315 
Sepw1 0.027275132 -0.029971553 
Serpinb9b 0.023421612 -0.000467022 
Serpine2 0.028537424 0.018052759 
Serpinh1 0.08123845 -0.008475008 
E-22 PCA loading values 
 
Sfmbt2 0.037797254 -0.006549982 
Sfn 0.08270626 -0.005199599 
Sfrp1 -0.009837274 -0.0031103 
Sgk1 -0.021003142 -0.010393793 
Shkbp1 0.008606517 -0.0016724 
Sin3b 0.02685117 0.014627228 
Six1 0.007049811 -0.003473594 
Skil 0.0375166 -0.029608008 
Slamf1 -0.01944768 0.013315115 
Slbp 0.001693504 -0.015306074 
Slc11a1 -0.025275243 0.004640296 
Slc16a3 0.037926756 -0.027918458 
Slc24a5 0.009730256 -0.018596807 
Slc25a20 -0.010425132 0.01832664 
Slc25a31 0.007528547 0.022165133 
Slc25a4 0.06122272 0.00475799 
Slc25a43 0.003131504 0.000501298 
Slc25a5 -0.036147635 0.009848697 
Slc26a2 0.011719673 0.004974777 
Slc27a2 0.017212173 0.032033417 
Slc29a1 -0.03954156 -0.009067782 
Slc2a1 0.03597169 -0.014579083 
Slc2a3 0.027532816 0.013592348 
Slc30a2 0.001976221 0.000553248 
Slc39a1 0.007990097 -0.006193065 
Slc39a8 0.03822727 -0.015664298 
Slc40a1 0.03052282 -0.000360589 
Slc7a3 -0.023246983 -0.013905251 
Smad7 0.009136478 -0.004067719 
Smagp -0.00623281 -0.03939039 
Smarca5 -0.008255747 0.017914219 
Sms -0.019401489 -0.01808401 
Smtnl1 -0.01521073 0.010908905 
Snai1 0.015372855 0.033827316 
Snhg12 0.001842588 0.001062996 
Snrpn 0.018666046 -0.028992375 
Snx20 0.002996625 0.005710765 
Socs2 0.006881579 -0.03149664 
 E-23 
 
Socs3 -0.012961913 0.011435423 
Sod2 -0.066615276 0.0067039 
Soga3 -0.018426048 -0.008850227 
Sord 0.008766575 0.04990718 
Sox11 0.037886783 -0.022879835 
Sox15 -0.016951924 0.010293589 
Sox2 -0.05155959 -0.02045335 
Sox21 -0.009492586 -0.000448331 
Sox4 0.03250007 -0.028612142 
Sp110 0.013626587 0.08309444 
Sp140 0.010037819 0.04448239 
Sp5 0.025646172 -0.014795496 
Sparc 0.034611516 0.01938762 
Spesp1 0.011669086 0.06768652 
Spic -0.004022508 0.018942254 
Spink1 -0.05046564 0.0025592 
Spp1 -0.05136179 0.005936741 
Spry2 -0.004363427 -0.011807059 
Spry4 -0.014325032 -0.011115747 
Spty2d1 -0.018075317 0.030452097 
Sqstm1 0.029067406 0.018181372 
Srgn 0.009132516 0.016262546 
Stk32c 0.004145937 0.002781108 
Stk35 0.000918235 0.030470246 
Stmn1 -0.09903711 0.014209625 
Stmn2 -0.06136074 -0.01365971 
Stox1 0.004526238 0.022984631 
Stra8 -0.014611494 0.019948548 
Stx3 0.048215445 -0.02196152 
Sycp3 0.007235867 0.006303238 
Synm 0.014311908 0.006702289 
Taf7l 0.012891867 0.012279737 
Tagln 0.114366874 -0.027904114 
Tagln2 0.05336517 0.000763425 
Tapbpl -0.009307726 0.009217081 
Tax1bp3 0.06117966 0.003295737 
Tbc1d12 0.016404925 0.047058746 
Tbc1d24 -0.006835035 0.002130718 
E-24 PCA loading values 
 
Tbx3 -0.04139424 0.04918426 
Tc2n 0.002749162 0.010167855 
Tcea3 -0.06957443 -0.017842442 
Tcf15 -0.008614832 -0.051939607 
Tchh 0.011763787 0.01613659 
Tcl1 -0.053692754 0.00692011 
Tctn1 -0.000685755 0.005643691 
Tdgf1 -0.03347254 -0.030838102 
Tdh -0.05223236 -0.007554072 
Terf2ip 0.000758775 0.002160812 
Tet1 -0.061818626 -0.015976204 
Tex101 -0.000150945 0.011464384 
Tex19.1 -0.011107044 0.040944066 
Tfap2c 0.006706105 -0.00310314 
Tfpi -0.008907857 0.003504205 
Tgfb1i1 0.03312508 0.009040573 
Thbs1 0.050707042 -0.003500769 
Thnsl2 0.006680115 0.04814405 
Ticrr -0.019791996 0.036941253 
Timp2 0.033865947 0.007101935 
Tinagl1 0.062086485 0.001663974 
Tmcc1 0.006608349 0.002687044 
Tmem191c -0.010451432 0.036227405 
Tmem245 -0.03922526 0.011106262 
Tmem37 0.018643016 -0.002044049 
Tmem40 -0.021743324 0.002066627 
Tmem59 0.03584268 0.019605484 
Tmem92 0.017165937 0.10026781 
Tmsb4x -0.013534682 -0.012368309 
Tnfaip6 0.00617615 0.004526826 
Tnfrsf12a 0.06504678 -0.007175474 
Top2a -0.01578211 -0.007125981 
Tpbg 0.038690757 0.001831204 
Tpi1 0.017254356 -0.043183923 
Tpm1 0.09352723 -0.034005668 
Tpm4 0.07803035 -0.025431545 
Tppp3 -0.002905848 0.013985018 
Trap1a -0.026771378 0.004652328 
 E-25 
 
Trh -0.018443774 -0.024344252 
Trib3 0.005858367 -0.006114454 
Trim47 0.010086296 -6.39E-05 
Trp53i11 0.006203337 -0.007045247 
Trp53inp1 0.01513976 0.025013411 
Tsc22d1 0.007784756 0.010558625 
Tsen2 0.007208667 0.045730494 
Ttc39c 5.46E-05 0.008842164 
Ttn -0.017568707 -0.00347148 
Tuba1a 0.05979431 -0.012805346 
Tuba3a -0.024786158 0.024370926 
Tubb2a 0.003215023 0.015644817 
Tubb3 -0.02879702 0.011429649 
Tubb4b -0.002364613 0.01866532 
Tubb5 0.0168755 -0.011440624 
Tubb6 0.085950784 -0.011294615 
Txnip 0.010349965 -0.007884254 
Uap1l1 0.020307692 0.013724774 
Ubald2 -0.031101799 -0.011048649 
Ube2c -0.02482298 0.013243949 
Ung -0.021063453 -0.014089251 
Upp1 -0.068550006 0.008458159 
Uqcrb -0.00653793 0.006611616 
Usp13 0.004012968 0.002593527 
Usp17la 0.018881164 0.103316836 
Usp17lc 0.013823521 0.080655046 
Usp19 -0.018596541 0.011165514 
Usp26 0.006734184 0.030654024 
Utf1 -0.035537742 -0.07570607 
Vamp8 0.045024212 0.002784512 
Vgll3 0.036183413 0.000874722 
Vim -0.015108893 0.004227261 
Wbp5 0.04105525 0.002546886 
Wfdc2 0.020020818 0.008969964 
Wls 0.032121085 0.022271737 
Wnt3 0.03449491 -0.001407496 
Wnt4 0.04272397 -0.002134218 
Wnt6 0.003753461 0.005994293 
E-26 PCA loading values 
 
Wnt7b 0.030495085 4.12E-05 
Wtap -0.010470494 -0.003760451 
Xist 0.007166265 0.008428525 
Xlr3a -0.001680175 0.004776655 
Ywhaq -0.001418787 -0.006331375 
Zbtb10 0.019264381 0.01454067 
Zc3hav1 0.003201806 0.02393366 
Zfos1 0.008287739 -0.004308424 
Zfp287 -0.000165213 -1.47E-05 
Zfp296 -0.024954263 0.036445774 
Zfp316 -0.002679332 0.004225702 
Zfp326 0.01877454 -0.013425171 
Zfp42 -0.1324745 0.005638579 
Zfp428 -0.034321375 -0.028616965 
Zfp516 0.004431526 0.068341635 
Zfp560 0.018428067 0.08156205 
Zfp57 -0.05673658 0.002906088 
Zfp706 0.014492439 -0.03569876 
Zfp809 0.009048024 0.06818436 
Zic2 -0.001189461 -0.008576863 
Zic5 0.00169389 -0.016164217 
Zscan4b 0.010227794 0.06323481 
Zscan4c 0.02656372 0.15745132 
Zscan4d 0.024336398 0.14619476 
Zscan4f 0.026695814 0.15859298 
Zyx 0.080330506 -0.025026485 
 
 
Appendix F Gene ontology analysis for PC1 and 
PC2 
Gene Ontology (GO) terms enriched for the top 50 gene loadings for PC1, using 965 highly 
variable genes as a background: 
Process:      
GO term Description P-value FDR q-value 
Enrichment 





2.97E-07 2.20E-03 11.47 (901,11,50,7) 
Cnn1 - calponin 1 
Cnn2 - calponin 2 
Csrp1 - cysteine and 
glycine-rich protein 1 
Krt8 - keratin 8 
Actg1 - actin, gamma, 
cytoplasmic 1 
Zyx - zyxin 
Krt19 - keratin 19 
GO:0030029 actin filament-based process 9.14E-05 3.38E-01 
4.38 
(901,37,50,9) 
Cnn1 - calponin 1 
Cnn2 - calponin 2 
Pdlim7 - pdz and lim 
domain 7 
Csrp1 - cysteine and 
glycine-rich protein 1 
Krt8 - keratin 8 
Actg1 - actin, gamma, 
cytoplasmic 1 
Krt19 - keratin 19 
Tpm1 - tropomyosin 1, 
alpha 
Zyx - zyxin 
GO:0045214 sarcomere organization 1.16E-04 2.87E-01 
12.01 
(901,6,50,4) 
Csrp1 - cysteine and 
glycine-rich protein 1 
Krt8 - keratin 8 
Actg1 - actin, gamma, 
cytoplasmic 1 
Krt19 - keratin 19 






1.17E-04 2.17E-01 4.81 (901,30,50,8) 
Cnn1 - calponin 1 
Cnn2 - calponin 2 
Pdlim7 - pdz and lim 
domain 7 
Csrp1 - cysteine and 
glycine-rich protein 1 
Krt8 - keratin 8 
Actg1 - actin, gamma, 
cytoplasmic 1 
Krt19 - keratin 19 
Zyx - zyxin 
GO:0007155 cell adhesion 9.01E-04 1.00E+00 3.31 (901,49,50,9) 
Anxa3 - annexin a3 
Lgals1 - lectin, 
galactose binding, 
soluble 1 




nephritis antigen-like 1 
Ctgf - connective 
tissue growth factor 
Perp - perp, tp53 
apoptosis effector 
Zyx - zyxin 
Tnfrsf12a - tumor 
necrosis factor receptor 
superfamily, member 
12a 
Prtg - protogenin 
homolog (gallus 
gallus) 
Function:      
GO term Description P-value FDR q-value 
Enrichment 
(N, B, n, b)  Genes  







Cnn1 - calponin 1 
Cnn2 - calponin 2 
Tpm4 - tropomyosin 4 
Csrp1 - cysteine and 
glycine-rich protein 1 




S100a6 - s100 calcium 
binding protein a6 
(calcyclin) 
Cald1 - caldesmon 1 
Tagln - transgelin 
Tpm1 - tropomyosin 1, 
alpha 
Anxa2 - annexin a2 
Component:      
GO term Description P-value FDR q-value 
Enrichment 





1.16E-04 9.96E-02 12.01 (901,6,50,4) 
Cldn7 - claudin 7 
Cldn6 - claudin 6 
Krt8 - keratin 8 





2.11E-04 9.03E-02 3.60 (901,50,50,10) 
Tubb6 - tubulin, beta 6 
class v 
Tpm4 - tropomyosin 4 
Krt8 - keratin 8 
Tuba1a - tubulin, alpha 
1a 
Nes - nestin 
Actg1 - actin, gamma, 
cytoplasmic 1 
Krt19 - keratin 19 
Cald1 - caldesmon 1 
Tpm1 - tropomyosin 1, 
alpha 
Krt18 - keratin 18 
GO:0005856 cytoskeleton 2.17E-04 6.20E-02 2.74 (901,92,50,14) 
Rnf128 - ring finger 
protein 128 
Tpm4 - tropomyosin 4 
Tax1bp3 - tax1 
(human t cell leukemia 
virus type i) binding 
protein 3 
Csrp1 - cysteine and 
glycine-rich protein 1 
Actg1 - actin, gamma, 
cytoplasmic 1 
Tpm1 - tropomyosin 1, 
alpha 
Krt19 - keratin 19 
Cnn1 - calponin 1 
Tubb6 - tubulin, beta 6 
class v 
Cnn2 - calponin 2 
F-4 Gene ontology analysis for PC1 and PC2 
 
Pdlim7 - pdz and lim 
domain 7 
Krt8 - keratin 8 
Tuba1a - tubulin, alpha 
1a 
Zyx - zyxin 
GO:0005884 actin filament 5.00E-04 1.07E-01 9.01 (901,8,50,4) 
Tpm4 - tropomyosin 4 
Actg1 - actin, gamma, 
cytoplasmic 1 
Tpm1 - tropomyosin 1, 
alpha 
Cald1 - caldesmon 1 
GO:0099081 supramolecular polymer 6.58E-04 1.12E-01 
3.16 
(901,57,50,10) 
Tubb6 - tubulin, beta 6 
class v 
Tpm4 - tropomyosin 4 
Krt8 - keratin 8 
Tuba1a - tubulin, alpha 
1a 
Nes - nestin 
Actg1 - actin, gamma, 
cytoplasmic 1 
Krt19 - keratin 19 
Cald1 - caldesmon 1 
Tpm1 - tropomyosin 1, 
alpha 
Krt18 - keratin 18 
GO:0099080 supramolecular complex 6.58E-04 9.37E-02 
3.16 
(901,57,50,10) 
Tubb6 - tubulin, beta 6 
class v 
Tpm4 - tropomyosin 4 
Krt8 - keratin 8 
Tuba1a - tubulin, alpha 
1a 
Nes - nestin 
Actg1 - actin, gamma, 
cytoplasmic 1 
Krt19 - keratin 19 
Cald1 - caldesmon 1 
Tpm1 - tropomyosin 1, 
alpha 
Krt18 - keratin 18 
GO:0099512 supramolecular fiber 6.58E-04 8.03E-02 
3.16 
(901,57,50,10) 
Tubb6 - tubulin, beta 6 
class v 
Tpm4 - tropomyosin 4 
Krt8 - keratin 8 
Tuba1a - tubulin, alpha 
1a 
Nes - nestin 
 F-5 
 
Actg1 - actin, gamma, 
cytoplasmic 1 
Krt19 - keratin 19 
Cald1 - caldesmon 1 
Tpm1 - tropomyosin 1, 
alpha 
Krt18 - keratin 18 
GO:0015629 actin cytoskeleton 8.15E-04 8.71E-02 
4.91 
(901,22,50,6) 
Tpm4 - tropomyosin 4 
Tax1bp3 - tax1 
(human t cell leukemia 
virus type i) binding 
protein 3 
Pdlim7 - pdz and lim 
domain 7 
Csrp1 - cysteine and 
glycine-rich protein 1 
Actg1 - actin, gamma, 
cytoplasmic 1 
Tpm1 - tropomyosin 1, 
alpha 
GO:0001726 ruffle 8.63E-04 8.20E-02 8.01 (901,9,50,4) 
Pdlim7 - pdz and lim 
domain 7 
S100a6 - s100 calcium 
binding protein a6 
(calcyclin) 
Anxa2 - annexin a2 
Tnfrsf12a - tumor 
necrosis factor receptor 
superfamily, member 
12a 
GO:0031012 extracellular matrix 9.01E-04 7.70E-02 
3.31 
(901,49,50,9) 
Anxa3 - annexin a3 
Lgals1 - lectin, 
galactose binding, 
soluble 1 
Serpinh1 - serine (or 
cysteine) peptidase 
inhibitor, clade h, 
member 1 




nephritis antigen-like 1 
Ctgf - connective 
tissue growth factor 
Ctsl - cathepsin l 
S100a6 - s100 calcium 
binding protein a6 
(calcyclin) 
F-6 Gene ontology analysis for PC1 and PC2 
 
Anxa2 - annexin a2 
 
Gene Ontology (GO) terms enriched for the top 50 gene loadings for PC2, using 965 highly 
variable genes as a background: 
Process: None     
Function: None     
Component:      
GO term Description P-value FDR q-value 
Enrichment (N, 










Zscan4c - zinc finger 
and scan domain 
containing 4c 






Zscan4d - zinc finger 
and scan domain 
containing 4d 
Zscan4f - zinc finger 




Appendix G MOFA loading values 
The following table contains loading values for MOFA factors 1-5 for 965 highly-variable 














01Rik -1.64E-05 -9.84E-05 -0.016708871 5.41E-04 -6.60E-05 
1190005I
06Rik 0.05119792 -0.055497302 0.02832786 0.006066923 0.018664086 
1500009L
16Rik -0.099843855 0.026810357 0.009992215 0.016430227 -0.08113623 
1700007K
13Rik -0.102220748 0.069969535 0.006915592 -0.019718968 -0.075686096 
1700029P
11Rik -0.014803427 0.012537436 -0.018402045 -0.036534802 -0.0131944 
1700052K
11Rik -0.001807191 3.20E-04 -0.022247211 0.005591312 -0.001746657 
1700097N
02Rik -0.033606618 -0.041147103 0.014371641 -0.081424078 -0.063518977 
1810032O
08Rik -0.00205713 -0.007570531 0.004912318 -0.00331627 -0.003940054 
2200002D
01Rik -9.41E-04 -0.014305994 0.006258242 0.086622394 -0.010764645 
2310043
M15Rik -0.002837845 -6.94E-05 6.30E-04 -0.003622672 -0.002307665 
2810417H
13Rik 0.069778357 -0.061823939 0.061534978 0.077887059 -0.011982945 
3830417A
13Rik -7.38E-05 4.93E-05 -7.24E-04 0.001439154 -5.20E-05 
4930548H
24Rik 2.18E-04 -0.001324998 -0.002660038 3.12E-04 -4.78E-04 
4933402E
13Rik -2.59E-04 1.90E-04 -0.001327832 0.001698329 -1.17E-04 
5430402O
13Rik -5.26E-05 3.65E-04 -0.048736871 7.68E-05 1.18E-04 
5430416N
02Rik -0.001927967 -0.006058275 0.002302399 0.002743464 -0.003502204 
6330410L
21Rik 0.001678352 0.003991244 -0.002655588 -0.012551923 0.007723574 
G-2 MOFA loading values 
 
9530053A
07Rik -0.02472026 0.01553811 0.001332726 0.001406728 -0.018665551 
9530059O
14Rik -5.70E-04 3.34E-04 -0.053496991 1.85E-04 -6.43E-05 
A330069
E16Rik -0.001997408 -0.018511388 -0.001286207 -0.001319213 -0.006671843 
A930014
E10Rik -5.34E-05 4.75E-05 -0.00302827 5.03E-04 -1.65E-05 
AA46719
7 -0.00361004 0.003004582 -0.003688625 0.001503609 -0.001034348 
Aard -0.023992817 0.013084707 -0.024272381 -0.167875425 -0.042255623 
Aass 0.008013066 -0.006829309 0.004559668 -5.41E-04 0.008306242 
Abracl 0.030038778 -0.032464693 -0.004119042 0.093742596 0.004510957 
Acaa2 0.006275876 0.01464349 0.004809786 -0.024980532 0.009881799 
Acot1 -0.015956037 0.020631897 -0.016271576 0.014945556 -0.009259785 
Acta1 -2.01E-05 -4.55E-05 -6.72E-04 0.001052389 -9.07E-05 
Acta2 4.12E-04 -6.73E-04 -8.33E-04 0.006928899 -1.35E-04 
Actb 0.185524642 -0.260021805 0.027348548 0.160365143 -0.234287627 
Actg1 0.163897598 0.006315632 0.022374611 0.200243551 0.130849949 
Acy3 -9.10E-04 0.001850555 -0.027132225 8.10E-05 -6.28E-04 
Adamts9 -7.18E-05 -3.68E-04 -0.001208644 0.001404879 -1.65E-04 
Adcy2 -1.83E-04 3.50E-04 -0.036407559 -2.14E-05 1.47E-05 
Adgrl2 0.001094054 -0.016443337 0.003763378 0.043593273 -0.00287388 
Adgrl3 -9.43E-05 1.79E-05 -0.001792997 5.41E-04 -7.59E-05 
Adprh -0.005663084 0.014169666 0.047056789 -0.134063551 -0.012227003 
Adrb2 -0.012864867 0.009640224 -6.88E-04 0.003452909 -0.008829507 
Aebp2 -0.01654982 -0.001489818 0.017720717 -0.044559306 -0.007083431 
Aes 0.00118272 -0.025214079 0.027818741 -0.19115023 -0.027114676 
AF06706
1 2.96E-04 -3.01E-04 -0.042983776 -6.62E-05 5.40E-05 
Agl 0.017564884 -0.062610906 -0.009114699 -0.052826497 -0.010837642 
Agpat4 -0.048705255 0.018957604 0.008871251 0.055619647 -0.035722264 
Agpat9 -1.29E-04 2.47E-04 -0.001014957 0.002548952 4.76E-06 
Ahnak -0.009616902 -0.04121678 0.008523866 0.06846859 -0.029882448 
Ahnak2 -0.032093106 0.012154493 0.003579767 0.022093877 -0.01930174 
Aire 0.01877474 -0.030851763 0.024518923 -0.07970355 -2.18E-04 
Ak4 1.07E-04 -4.82E-04 -0.01489215 -0.026441386 0.0024795 
Akap12 -0.001492418 -0.113627564 0.031985218 0.055437059 -0.004030306 
Akr1b3 0.026679975 0.008677818 0.01020011 -0.018599475 -6.57E-04 
Aldoa 0.106355747 0.099319229 0.011973151 0.060156096 0.132963707 
Amn 0.001128016 9.61E-04 -0.001400202 0.002987181 8.93E-04 
 G-3 
 
Amotl1 -0.010272671 -0.002236653 0.002878633 0.036687233 -0.00867589 
Amotl2 0.004310303 -0.018334789 -0.005197745 0.054587161 -0.003253642 
Amt 0.037337771 -0.08022677 0.004366164 -0.001216859 -0.095884861 
Anp32a 0.022172238 0.035746192 0.053190988 -0.042024858 0.045445557 
Anxa1 -0.001825195 5.41E-05 -1.59E-04 0.021298232 -0.002816759 
Anxa2 -0.004877658 0.01566929 -0.01351174 0.091388141 -7.15E-04 
Anxa3 -0.002244607 -0.005473353 -0.002374091 0.132250185 -0.008042745 
Anxa5 -0.00395981 0.003830847 -0.002670417 0.019371857 -0.00353341 
Anxa8 -6.96E-04 4.83E-04 -8.55E-04 8.20E-04 -3.59E-04 
Ap3b2 -1.91E-04 8.69E-05 -0.001247699 0.001485579 -2.37E-05 
Apela 0.011321697 -0.046333351 0.011182686 0.109734898 -0.008428776 
Apoa2 -7.21E-05 5.03E-05 -0.00203238 6.38E-04 -5.80E-05 
Apobec2 7.69E-04 3.61E-04 -0.004198215 0.005607919 6.72E-04 
Apoe -0.038010405 0.094175554 -0.0130344 -0.012431727 0.041556955 
Aqp3 -0.004637531 0.025780196 -0.006612321 -0.01915915 0.012297574 
Arg2 4.99E-05 0.00291273 -0.115706891 0.001112312 4.03E-04 
Arhgef26 3.80E-04 -0.002239583 -0.076060279 0.00394275 -9.57E-04 
Arl14epl 0.014514634 0.008548342 0.007901834 -0.061056098 0.017077692 
Arl4a -0.035872277 -0.012091445 0.008096638 -0.018563717 -0.026676897 
Arl4c 0.002471111 -0.017525015 0.005553532 0.097091046 -0.004919775 
Arl4d 0.004362126 0.00106709 -0.0115497 -0.00748112 0.003701525 
Arl6ip1 -0.035846006 -0.002192206 -0.027969643 -0.03481223 0.074135384 
Arpc1b 0.050637016 -0.003534648 0.020058528 0.053152135 0.042730297 
Ascl2 0.001031246 8.29E-04 -0.003153685 0.015068226 -1.66E-04 
Asns 0.032128593 0.120271989 -0.038636024 0.014616779 0.087172986 
Ass1 -0.06141201 0.096419087 -0.004524482 -0.035667525 -0.017303248 
Atf4 0.002802434 -0.050677254 -0.00170537 0.015387163 0.013235908 
Atg2a -0.003283844 -0.011595056 -1.17E-04 -0.016090115 -0.005514998 
Atp5b -0.001555455 0.169564514 -0.028148154 0.001730636 0.084253072 
Atp6v0b -0.058097083 0.014002742 0.00258549 0.053292396 -0.03496963 
Atp6v0d1 -0.03864474 0.04750481 -0.015944998 0.003327844 -0.01620655 
Atrn -0.002468902 -0.004014658 -0.010249849 -0.001487685 -0.003281419 
Atrx 0.011781314 -0.083626 0.028975241 -0.004295632 0.025335327 
Avpi1 -0.023189299 0.025029272 -0.127308507 0.032261125 -0.003650807 
AY03611
8 -0.002329112 -0.003237887 -0.001463861 -0.003107197 -0.002034387 
B020031
M17Rik 5.92E-04 -7.51E-04 -0.094365551 -4.45E-04 1.96E-04 
B2m -0.012814985 0.004730819 -3.17E-04 0.082992882 -0.011890513 
G-4 MOFA loading values 
 
B930036
N10Rik 7.11E-04 -0.006083581 -0.00147169 0.001976699 -9.48E-04 
Bambi -7.40E-04 -7.57E-04 -0.020336492 0.017280632 0.002828387 
Baz1a 0.011985194 -0.011778463 -0.003656163 0.08009866 0.005016219 
Bbc3 -0.086464745 0.054541518 0.022943039 0.001898662 -0.076642978 
Bbs2 -0.007855784 -0.024344185 0.015533784 -0.081017872 -0.039494291 
Bbx -0.007629905 -0.013349933 0.007197867 0.105158049 -0.006844748 
BC02852
8 -0.002266885 -0.004569495 0.001771613 -0.013842376 -0.003620539 
BC08069
5 8.47E-04 -5.15E-05 -0.090865973 -1.18E-04 -5.87E-05 
BC14752
7 -5.20E-06 -2.13E-05 -0.001510012 2.51E-04 -2.36E-05 
Bcat1 0.066568095 0.002567625 0.007304005 -0.064860599 0.071445408 
Bdnf -4.62E-05 -1.86E-04 -0.003648481 0.001951382 1.67E-05 
Bend7 -2.56E-04 6.99E-05 -8.89E-04 0.001360025 -1.91E-04 
Bex1 0.075791679 0.015181976 0.027972402 0.156026497 0.057246242 
Bhlhe40 -0.001253216 -0.001541938 5.20E-04 0.023965158 -0.002428279 
Bmp4 -0.001762911 -0.006057639 0.008490173 -0.025918458 -0.004612275 
Bnip3 0.00437431 0.042005337 -0.013319041 -0.03380037 0.022067611 
Bst2 0.00959395 -0.03967841 0.014500556 0.122353748 -0.019295127 
Btg1 -0.062471779 0.038542377 -0.025140529 0.018166291 -0.039578853 
Btg2 -0.103135899 0.065864774 -0.037684591 0.027934585 -0.090672492 
C130073F
10Rik -0.003645691 -1.92E-04 -0.008364591 -0.003736167 -0.001273319 
C1d 0.029036575 0.003053305 -0.098752382 0.029763534 0.019838323 
C2cd4b -1.93E-04 1.95E-04 -0.005990939 0.001001334 -9.93E-05 
C730034F
03Rik -4.34E-04 -5.36E-04 -0.001654719 0.001681337 -4.77E-04 
C77370 8.72E-05 -0.006644547 0.009253659 -0.015318378 0.005788168 
Cacybp 0.114943413 -0.032354908 0.025161684 -0.086614299 0.091770877 
Calb2 -2.82E-04 6.38E-04 -0.001076572 -0.002784236 -1.37E-04 
Calcoco2 0.026686876 0.073174121 -0.044628411 -0.105874532 0.097703174 
Cald1 -0.064893255 0.029559859 8.50E-04 0.160028779 -0.045335754 
Calm2 0.067187566 0.036966333 0.030826652 0.036326672 0.09192958 
Calml4 0.005869401 0.001019568 0.002941414 0.001801605 0.0073673 
Calr 0.050558014 -0.039195262 0.004973551 0.011280102 0.039704829 
Camk2d -0.001626211 -5.70E-04 -4.36E-05 0.011799522 -0.001818141 
Capg -0.012250891 0.019652057 0.00603985 0.047409007 -0.004070248 
Car2 0.041337663 -0.086881879 0.058758336 0.349020991 0.008670596 
Car3 0.004953044 -0.013737058 0.003347546 0.0342049 0.001489169 
 G-5 
 
Car4 0.010810812 -0.010699766 -0.002242319 0.064545323 0.002595662 
Carhsp1 -0.038166515 -0.002096224 0.022419103 0.051148046 -0.050820425 
Catip -0.006384537 -9.89E-04 0.005187458 -0.024629173 -0.006991911 
Cbr3 -0.002731243 1.29E-04 0.001020291 0.01587 -0.004288248 
Cbx3 0.18293127 -0.340606946 0.039480465 0.049133992 -0.314584406 
Ccnb1 0.021258525 0.061726301 -0.022735935 0.002239191 0.095880172 
Ccnd1 0.033109442 -0.051319329 0.027216622 -0.019526893 0.011123962 
Ccnd2 0.023391761 -0.018852645 0.00640529 -7.33E-04 0.018103764 
Ccnd3 0.075778782 -0.033940822 0.036064228 -0.109799317 0.023242611 
Ccne1 0.190388557 -0.078209438 0.048434863 -0.011164901 0.059286369 
Ccne2 0.01798876 -0.006017423 -0.00938027 0.016004519 0.001848098 
Ccng1 -0.166363859 0.084038422 -0.019548519 0.059449155 -0.148642289 
Ccno 0.002777503 0.002827105 -0.031949444 0.003350482 0.004287386 
Ccser1 2.38E-04 3.66E-04 -0.080676572 -3.24E-04 2.39E-04 
Cd24a -0.009494851 0.003388046 -0.017272257 0.080675032 -0.009325496 
Cd37 9.37E-04 9.49E-05 0.005142041 -0.0208592 3.53E-04 
Cd63 -0.00482081 0.057713437 0.00812137 0.134095529 0.044366772 
Cd74 0.002466542 -0.001430364 -0.006320924 -0.014402953 -0.003457686 
Cd81 -0.111158738 0.139024058 -0.009013965 0.083756046 -0.064736097 
Cd9 0.01392375 0.098358928 0.01634333 0.001808993 0.077954983 
Cdc14a -4.86E-04 -3.08E-05 -0.001601476 0.001833864 -4.30E-04 
Cdc20 0.087950049 0.076920228 -0.010947202 0.031777174 0.089531418 
Cdc42ep3 -0.015303487 0.009276706 -0.027703591 -0.0128784 -0.004486343 
Cdc5l 0.004396074 0.036710642 -0.024749575 -0.154174685 0.035419267 
Cdk6 0.014269485 -0.035806689 0.006811119 0.045769295 -0.009760534 
Cdkn1a -0.112470369 0.065875039 -0.002680124 0.052702553 -0.096877639 
Cdkn1c 2.35E-05 -0.007498157 0.003670972 0.056659389 -0.009525403 
Cdkn2a -0.008543306 0.010760173 -0.002264194 0.034806426 -0.004571139 
Cdv3 0.111625495 -0.178043138 0.002600457 0.085420415 0.012816608 
Cdx2 1.38E-05 -2.89E-04 -0.001072514 0.004627946 -4.05E-04 
Cebpb -0.005275136 0.00752378 -0.002990156 0.054124281 -0.004970284 
Cenpf -0.057609275 -0.081664483 0.001261754 -0.03394279 0.006619383 
Cenpm -0.046140418 0.038331668 -0.01097005 -0.148012602 -0.027369368 
Cep57l1 -0.005872355 -0.010028269 -0.054425886 -0.020997424 1.19E-04 
Chac1 0.006620268 -0.011173837 0.004714957 0.013742636 0.011203284 
Chchd10 -0.06277249 0.001255989 0.020071699 -0.246962329 -0.029290169 
Cidea -0.001622151 0.010059251 -0.017860186 -0.005514051 0.002995881 
Cited1 0.001857397 -0.001907073 -0.004654795 0.022570736 4.57E-04 
G-6 MOFA loading values 
 
Cited2 0.009763449 -0.021046297 -0.014136973 0.138729496 0.024654853 
Cited4 7.52E-04 0.001866525 -3.06E-04 0.008993038 0.001814248 
Ckb 0.075895139 0.104520841 -0.016974494 -0.009886863 0.150356718 
Ckmt1 -0.004301252 0.00515485 -0.00248932 0.001449239 -0.00264495 
Clcn5 -3.06E-04 -0.001041867 -0.008382587 0.016843902 1.81E-04 
Cldn3 -6.88E-04 6.12E-04 7.55E-04 0.010941076 -5.97E-04 
Cldn4 -0.008349068 0.006551779 0.006819324 0.042639667 9.55E-04 
Cldn6 0.007970531 0.004301318 4.12E-04 0.144475801 0.005934536 
Cldn7 0.002019527 -0.00559098 0.005333633 0.075816932 -4.64E-05 
Clic1 -0.062706873 0.049709351 0.01187332 0.113195122 -0.049723933 
Clic4 0.005027284 -0.020984948 -0.00682073 0.018430925 -0.008756151 
Clp1 0.020959219 0.024493481 -0.087804235 -0.005040113 0.02137188 
Cltb -0.025097673 0.001557435 0.020152524 -0.082565099 -0.038199095 
Clu 0.001864753 0.003616442 -0.003694211 0.029194464 3.31E-04 
Cmtm7 -0.006416326 -0.003417852 0.027168573 0.006193871 -0.014589284 
Cnn1 0.005812599 -0.007792661 9.67E-04 0.047561496 8.98E-04 
Cnn2 0.071298209 -0.03914387 0.020733788 0.172104957 0.061669196 
Cntfr 0.004547623 -0.01399491 0.004273464 0.029474866 -0.010397838 
Coch 0.004214286 -0.001758467 -0.025456005 0.007053788 0.002796604 
Col4a1 -0.001936047 -1.31E-04 -0.002072597 0.010337535 -0.002571526 
Col4a2 -7.84E-04 -1.86E-04 -8.41E-04 0.008160315 -0.001226698 
Commd3 -0.061359348 0.047290875 -0.008445992 0.024449325 -0.040372128 
Comt 0.029302007 -0.117933642 -0.022506839 -0.067444799 -0.039429431 
Cox6b2 -0.115313962 0.043469447 -0.040333891 -0.063817788 -0.090911446 
Cpsf4l 0.014417819 -0.007198232 0.00954525 -0.019527614 0.027546795 
Crabp2 0.011253593 -0.003325621 -0.001673242 0.022559956 0.008002649 
Crct1 0.002470118 -0.007623741 -0.013054993 0.00806115 -0.003679839 
Crim1 -2.42E-04 -1.71E-04 -0.001166685 0.001755015 -3.12E-04 
Crip2 -0.051549029 0.027201374 0.04296773 0.109229543 -0.065715848 
Crxos -4.95E-06 0.00547063 -0.019324182 -0.00583892 0.004120918 
Cryab -0.010496794 0.003444534 0.001364188 0.044319273 -0.011568574 
Csrp1 -0.003747568 -0.001617014 0.005473499 0.121617278 -0.007689416 
Cst3 0.020167744 0.028125188 -0.011324862 0.084444342 0.044340143 
Cstb -0.032388744 0.015350976 -0.004244022 0.097094986 -0.028571709 
Ctgf 0.001137565 -0.011562482 -0.013963643 0.088890145 0.004267792 
Cth 0.023872198 0.033273466 0.005603243 4.32E-04 0.032896569 
Ctnnal1 0.052782033 -0.015391754 0.028128439 -0.033552404 0.058139189 
Ctr9 -0.014259479 -0.005184157 -0.069696067 0.033986501 -0.005137919 
 G-7 
 
Ctsa -0.01442814 0.019019711 0.003007513 0.00764014 0.001429553 
Ctsb -0.010068228 0.016334212 -0.005566725 0.016693219 -0.002812492 
Ctsd -0.080968805 0.084760497 0.019164551 0.02515032 -0.039431559 
Ctsl -3.71E-04 0.034242172 -0.024620947 0.145818651 0.025270595 
Cul9 -2.54E-04 -0.001044932 -0.001044119 -0.001007928 -8.38E-04 
Cwc22 0.004889109 -0.017037284 -0.098902106 -0.001607839 0.002220599 
Cxcl16 -0.003050792 -9.02E-04 5.35E-04 0.026800654 -0.003913324 
Cyba -0.013571377 0.011991322 0.005310678 0.06817394 -0.009640359 
Cyp26a1 8.44E-05 -7.24E-05 -0.0010308 0.001387127 5.83E-05 
Cyr61 0.001946902 -0.007367544 0.001088503 0.119287155 7.01E-04 
D630023
F18Rik -0.088496611 0.047470427 0.009283538 -0.02754632 -0.06998404 
Dab2 -1.10E-04 -2.90E-04 -0.001589461 0.008254913 -4.99E-04 
Dazl -0.001749509 0.00706176 -0.025556418 -0.002609924 0.002464996 
Dcaf12l1 0.009226574 -0.009975048 -0.017155671 0.025060714 0.004435548 
Dcaf17 0.007339095 -0.016986354 -0.004880772 0.006777488 0.007277458 
Dcbld1 -0.009354884 -0.00449964 -0.040195407 -0.029576078 -0.012212218 
Dcxr -0.08874999 0.062595346 -0.003288986 0.016213483 -0.057298704 
Ddah1 0.022431776 -0.024526665 0.017414382 0.085340267 0.015701634 
Ddah2 -0.02537903 0.039523182 5.63E-04 -0.014811586 5.32E-04 
Ddit3 -0.019889465 0.011401558 -0.002285091 0.020444058 -0.008525693 
Ddit4 -0.063952156 0.059287985 -0.04970163 0.044531961 -0.047330149 
Ddit4l -0.084868929 0.058088817 -0.071576953 0.014222924 -0.068988054 
Ddr2 -9.58E-05 6.56E-05 -0.001571316 4.73E-04 -8.78E-06 
Derl3 -0.012759253 0.008609676 -0.001860873 -0.006164773 -0.005419054 
Dhx16 -0.141855551 0.1040554 0.05850894 -0.151058479 -0.124998154 
Dkkl1 -0.001673051 8.38E-04 -1.28E-04 0.002103873 -0.001990243 
Dlg1 0.002677652 -0.026914269 -0.008514434 -0.007876062 -0.00693695 
Dll1 -0.001372554 4.57E-04 -0.002911209 0.001330751 -6.97E-04 
Dmkn -4.04E-04 -2.04E-04 -0.002437195 0.006417728 -0.001916393 
Dnajb14 -7.45E-04 -0.004442401 -0.031119085 0.001437798 -2.28E-04 
Dnajb9 -0.00131515 0.00569786 -0.047458063 0.002485221 0.001164692 
Dnajc21 0.050401571 -0.08743364 0.051285653 -0.123517993 0.053203139 
Dnmt3a 0.030918753 -0.046534992 0.01293488 0.010919387 0.008873098 
Dnmt3b 0.11562517 -0.137858236 0.042192718 0.147109069 0.064100381 
Dnmt3l 0.068847418 -0.032045895 0.035379875 -0.036493584 0.050372082 
Dok2 0.009431951 -0.014051977 0.00410573 0.038686403 0.001822278 
Dpp7 -0.013425823 0.007817644 -3.95E-04 -7.95E-04 -0.008026651 
Dppa2 0.057516227 0.042229329 -0.11396688 -0.08832436 0.050366908 
G-8 MOFA loading values 
 
Dppa3 0.026095039 0.03368135 -0.013929964 0.020936753 0.081884532 
Dppa5a -0.02893406 0.09518413 -0.016501663 -0.21672944 0.050783953 
Dpys -0.024712134 0.015927109 0.017975594 -0.040595264 -0.006596137 
Dqx1 0.00585105 -0.025997624 -0.030776835 -0.046239427 -0.00981035 
Dsp -0.002367313 -0.002714334 2.78E-04 0.024994979 -0.003560883 
Dst -0.02388672 -0.03706837 -0.072432238 0.022951106 -0.007662257 
Dstn 0.013090822 -0.008579842 0.032338864 0.1266342 -0.005727614 
Dusp1 -0.004468022 0.004969258 -0.009131405 0.050361787 -0.005110158 
Dusp14 0.003024268 -0.001512781 0.001650585 0.027309719 -0.001048101 
Dusp4 0.00292833 -0.00873667 -0.001365125 0.05752108 -0.003170862 
Dusp5 0.002438329 -0.003871727 -0.009834512 0.028974363 -0.002220012 
Dusp6 0.0105146 -0.01819276 0.00832839 0.076903275 -0.00736267 
Dusp9 0.00573718 -0.010671937 -0.023372183 0.01263387 -0.016531377 
Duxf3 1.59E-04 9.56E-05 -0.021762989 3.76E-04 -7.19E-05 
Dynll1 0.064217295 -0.022591575 -0.012059276 -0.011963725 0.021296379 
E130012
A19Rik 0.051030588 -0.053908744 0.066409148 -0.275357287 -0.008035156 
E2f5 0.006537197 -0.008935749 0.002289885 0.017406748 0.002717996 
Ebf1 -0.004717407 -0.003280733 0.00109076 0.004869667 -0.005410788 
Echdc2 0.011467733 0.021421721 -0.022897931 -0.009221447 0.020690461 
Echdc3 -4.52E-05 -1.13E-05 -0.021986734 3.74E-04 -3.33E-05 
Edn1 -4.74E-04 -2.09E-04 -0.001223535 0.003380792 -1.75E-04 
Edn2 1.26E-04 -1.98E-04 -9.77E-04 5.18E-04 -1.52E-04 
Eef1a1 -0.140210412 0.175179446 -0.049251631 0.010052744 -0.059237215 
Eef2 -0.100409133 0.103721978 -0.01714944 0.0518017 -0.043488528 
Efhc2 -4.16E-05 -8.41E-07 -0.001460849 0.001045154 1.24E-04 
Efna3 -0.008828266 0.009044213 -0.001817414 0.00537098 -0.00865042 
Efnb1 -2.12E-04 -9.97E-05 -0.001100262 0.003539295 -4.15E-04 
Egr1 -4.35E-04 -0.007907884 0.003715727 -0.001388342 -0.007010252 
Egr4 3.95E-05 -8.56E-05 -7.60E-04 7.86E-04 -8.32E-05 
Eif2s2 0.038484869 0.036082226 -0.01469929 -0.166231104 0.075827411 
Eif4a1 0.106236302 0.126207131 -0.01019854 0.032788772 0.138068741 
Elf3 0.00194371 0.011899388 -0.001938691 0.011812553 0.008117363 
Emb 0.108335994 -0.059511556 0.016072802 0.079885442 0.082800503 
Emilin1 0.003916392 -0.023667678 -0.005229164 -0.026148734 -0.005798606 
Emp2 -3.24E-04 1.33E-04 -7.09E-04 0.002187796 -3.15E-04 
Emp3 -0.013887099 0.010254064 9.14E-04 0.024656331 -0.014658998 
En1 9.80E-04 -0.00444255 8.87E-04 6.58E-04 1.09E-04 
Enah 0.0113391 -0.128684911 0.034236129 -0.146979717 -0.00802233 
 G-9 
 
Endov 2.73E-04 -0.004573663 8.76E-04 0.001001325 -6.66E-04 
Eno1 0.090565349 0.111180958 0.026734429 0.100715697 0.149717013 
Enpp2 1.86E-04 -7.66E-04 -0.001211657 0.003475875 1.26E-04 
Epcam 0.034010681 -0.029188862 0.021021746 0.163349484 0.027477528 
Epha2 -0.020066724 -0.028438934 0.01496961 0.04716326 -0.032603934 
Eps8l2 -0.004114629 0.004014838 -1.42E-04 0.012905676 -0.001592546 
Ercc4 -0.002215061 0.001245847 -0.095417966 -0.003868583 6.64E-04 
Erdr1 -0.020302122 -0.057958694 0.026487699 0.092811499 -0.011242796 
Esco2 -0.03554489 -2.99E-04 -0.010796055 -0.118914886 -0.04200793 
Esx1 -1.14E-04 1.77E-04 -0.001358406 0.002146922 -9.67E-05 
Eva1a -1.80E-05 -1.82E-05 -0.00209676 8.64E-04 -8.12E-05 
F2r 0.00330905 -0.012413867 0.0038407 0.044122063 -0.003526789 
F2rl1 -0.001055874 -0.028717474 0.013969573 0.033875021 -0.012502779 
F3 1.83E-04 -0.003827281 0.001274117 0.02455504 -8.13E-04 
Fabp3 -0.032035211 0.037614413 0.004125562 0.029008374 0.005081786 
Fabp5 0.052648691 -0.001557334 0.00738152 0.179776791 0.055374388 
Fam124a -1.06E-04 4.97E-05 -0.01452543 4.40E-04 -1.14E-04 
Fam134b -3.66E-04 2.00E-04 -0.001117576 0.001459293 -2.19E-04 
Fam159b -1.62E-04 -8.52E-06 -8.85E-04 0.001029853 -2.43E-04 
Fam162a -0.070648979 0.027871336 -0.004731923 -0.03974488 -0.076636836 
Fam25c -0.035323946 -0.001665553 0.014956403 -0.130688838 -0.042410936 
Fam60a 0.072622456 -0.142330875 0.077399796 0.059099101 0.023296953 
Fam83a -7.59E-05 -5.97E-06 -6.35E-04 5.14E-04 -9.43E-05 
Fblim1 0.035877628 -0.023352163 0.045056506 -0.092889344 0.035888746 
Fbp2 -0.004877602 0.006603852 -0.002595266 -5.36E-04 -0.002755656 
Fbxo15 0.021584545 0.0611058 -0.14410016 -0.05709737 0.081108409 
Fgf1 -7.23E-05 -1.24E-04 -0.022319697 3.55E-04 -2.01E-04 
Fgf15 0.010080361 -0.005923826 -0.001176662 0.002323693 0.006070613 
Fgf17 0.02450941 -0.024001795 0.00922773 -0.011281362 0.014615533 
Fgf4 0.001309944 -0.014353055 0.015750288 -0.080578117 0.018723597 
Fgf5 4.71E-05 -1.36E-04 -8.25E-04 0.001690417 -5.84E-05 
Fgf8 -3.90E-05 -4.66E-05 -8.58E-04 0.001054681 -9.98E-05 
Fgfbp1 -0.003392568 -0.011203504 -0.001590465 0.144939248 0.00534745 
Fhl1 0.011882202 0.003289324 0.004058467 0.033192659 0.016089584 
Fhl2 -1.27E-04 -2.02E-04 -6.87E-04 0.003804322 -3.39E-04 
Fkbp6 0.001857913 0.008625245 -0.006851525 -0.016321575 0.002091344 
Flrt3 -4.24E-05 -6.76E-05 -8.02E-04 0.001042444 -1.09E-04 
Fmr1nb 0.008256103 0.014050699 -0.045457311 -0.009433069 0.015813222 
G-10 MOFA loading values 
 
Folr1 0.074007562 -0.042343129 0.023033419 0.070394972 0.055520708 
Fos -6.34E-04 1.77E-04 -0.002807588 0.00357296 -7.21E-04 
Foxo3 -0.023896826 -0.01445203 -0.007575857 -0.005973554 -0.075045165 
Fst -0.003209041 -0.004802358 3.86E-04 0.023478917 -0.003992715 
Fth1 3.59E-04 -0.095314197 0.061827872 0.009774133 -0.054453451 
Fthl17a -1.37E-04 1.24E-04 -0.001318714 0.001113629 -1.09E-04 
Fthl17c 3.96E-04 7.44E-04 -0.021149556 -0.001108353 -5.47E-04 
Fuca2 -0.002394649 0.001823138 4.76E-04 0.006601601 -3.20E-04 
Fundc1 0.005905445 9.56E-04 -0.065254363 0.013147196 0.0066247 
Fxyd6 0.01360516 0.019860069 0.033838542 -0.004019895 0.053804333 
G0s2 -2.33E-04 -4.88E-04 -3.53E-04 6.05E-05 2.23E-04 
Gabarapl2 0.004545074 0.066243233 -0.066746752 -0.316302345 0.019574501 
Gadd45a 0.010510289 -0.011148653 0.024239976 0.040168359 0.020691004 
Gadd45b 0.01522284 0.004117832 -0.009637153 0.041455061 0.017838244 
Gadd45g -0.014587589 0.008225759 0.005179508 0.024498606 0.002171757 
Gap43 0.003519096 -0.011485812 0.007926244 0.037327157 6.01E-04 
Gata2 -1.55E-04 1.07E-04 -0.001571539 0.002431539 -1.02E-04 
Gata3 9.07E-05 1.97E-05 -0.003622361 0.010258101 -3.92E-04 
Gbp2 3.83E-06 -2.50E-04 -9.86E-04 0.002791261 -1.60E-04 
Gbp2b 3.22E-06 -1.54E-04 -7.79E-04 0.001818922 -1.01E-04 
Gbx2 -0.001645666 -0.055518805 0.018906978 0.002516833 -0.038771575 
Gchfr -4.54E-04 -0.003537102 0.0024851 0.021491952 -0.00515539 
Gfod2 -0.003029036 -0.030180064 -0.004155773 -0.006291436 -0.011461168 
Gja1 0.001170923 -0.051351185 0.014844467 0.093402202 -0.035534876 
Gjb3 0.021364087 0.010811068 0.017993475 -0.001436533 0.044418746 
Gjb5 -0.006634731 0.013844334 0.012363573 -0.026846886 0.002718672 
Glipr2 0.013073605 0.008864126 0.017621548 0.074427413 0.009956854 
Glod5 0.01922249 -0.004226632 0.006299184 -0.010670233 0.019875125 
Glrx -9.13E-04 0.016369989 -0.053648073 0.011795575 0.010180022 
Glrx2 -0.017792132 -0.008548025 -0.164835589 0.019343227 -0.016696287 
Glul 0.068909576 -0.008782651 -0.026729407 -0.014334736 0.052827571 
Gm10116 -0.059970923 -0.046734451 0.018676674 0.009280555 -0.070551574 
Gm11238 -1.31E-05 -1.76E-05 -0.001798697 3.77E-04 -2.93E-05 
Gm12794 5.56E-04 -4.19E-04 -0.037266974 1.74E-04 -8.99E-05 
Gm13075 0.05620451 -0.143123775 -0.010480177 -0.091262131 -0.008900889 
Gm13119 5.65E-04 1.31E-04 -0.06828406 -6.38E-05 -7.21E-05 
Gm13145 0.0111479 -0.026127387 -0.021956411 -0.030896794 0.003825941 
Gm13225 0.036458619 -0.084718361 -0.021370165 -0.100279448 0.016418349 
 G-11 
 
Gm15879 0.002964355 -0.008266023 -0.004502007 -9.88E-04 -8.23E-04 
Gm15915 -4.62E-04 -7.37E-05 -0.001136571 -5.91E-05 -5.96E-04 
Gm16233 -0.002523228 -0.018004553 0.003031246 0.055315879 -0.005475105 
Gm2016 7.94E-04 7.28E-04 -0.123628856 -0.001200224 4.34E-04 
Gm2035 0.001544452 -8.59E-04 -0.106668169 -4.02E-04 2.37E-05 
Gm2046 0.001434175 -0.001025048 -0.093631148 -3.97E-04 9.03E-05 
Gm2056 0.001552841 -6.49E-04 -0.11314788 -4.64E-04 1.18E-04 
Gm20767 5.78E-04 -3.35E-04 -0.046638029 -9.79E-05 5.15E-05 
Gm21761 1.24E-04 -0.001280855 -0.324317811 6.80E-04 -8.75E-04 
Gm21818 0.001029098 -3.71E-04 -0.116971594 -5.00E-04 2.37E-04 
Gm26710 -3.97E-06 -1.37E-04 -9.08E-04 5.89E-04 -6.69E-05 
Gm26737 0.003795886 -0.013865136 -0.009819154 -0.005177669 -0.001232345 
Gm26782 -8.36E-05 -2.04E-04 -0.001184615 7.85E-04 -1.07E-04 
Gm26870 -0.048371807 -0.032894724 -0.201867714 -0.067008097 -0.035084416 
Gm26917 -0.008628551 -0.035926995 -0.026976277 -0.087188205 -0.026586035 
Gm27167 3.43E-05 -1.99E-05 -0.029962262 9.83E-05 -1.37E-05 
Gm29666 0.005670184 -0.018087353 -0.006227679 -0.011855667 -0.003908872 
Gm33466 6.70E-05 -9.32E-05 -0.025738014 2.71E-05 1.97E-05 
Gm36266 -3.78E-05 -1.07E-04 -7.39E-04 5.68E-04 -8.24E-05 
Gm37305 -1.14E-04 -8.90E-04 -0.001387111 4.54E-04 -5.34E-04 
Gm4027 0.001679924 -0.001192756 -0.119302968 -1.24E-04 -1.09E-04 
Gm42418 0.006309766 -0.145318134 -0.031373339 -0.042889703 0.002727473 
Gm42637 -0.011605206 0.007144914 0.001258647 0.020072541 -0.006484101 
Gm428 -8.34E-06 -2.81E-05 -0.001794996 3.40E-04 -1.27E-05 
Gm4340 9.41E-04 -8.59E-04 -0.066368178 -2.20E-04 3.02E-05 
Gm43409 0.001892272 -0.010163325 -0.003060923 -0.006964956 -0.001449 
Gm4349 -7.32E-04 4.49E-04 -0.011768032 -0.001216676 -3.70E-04 
Gm5039 0.001549883 -9.40E-04 -0.10736644 -4.41E-04 -1.05E-05 
Gm5662 0.002075387 0.005085369 -0.303546775 -0.003899683 0.00289577 
Gm7120 0.001516409 -0.006307339 -0.011168227 -0.003324849 -0.001167514 
Gm7325 -0.033693534 -0.009986791 0.028811975 -0.129036505 -0.024066847 
Gm8300 0.001180977 0.003783357 -0.315622306 -0.00329574 0.001703128 
Gm8994 0.001559202 -4.71E-04 -0.170232309 -1.22E-04 7.12E-04 
Gm9112 -1.13E-04 8.87E-05 -0.001091533 5.80E-04 -4.04E-05 
Gmcl1 0.003743149 -0.004968494 -4.31E-04 -0.007809663 5.43E-04 
Gnas -0.02644024 8.61E-05 0.00463048 0.124679806 -0.027764272 
Golga3 0.017609329 -0.065818501 -0.038399674 -0.047434418 -6.89E-04 
Gpd1l 4.23E-04 -0.002179557 0.00194458 -0.004139677 -0.00131444 
G-12 MOFA loading values 
 
Gprc5a 1.43E-04 -3.36E-04 -2.96E-04 0.013384502 -5.87E-04 
Gprc5c -6.79E-05 -5.53E-05 -0.001321806 0.001577018 -8.32E-05 
Gpx3 -0.059145077 0.037090391 0.003871765 0.026520426 -0.048114678 
Gpx4 0.049080733 0.020945682 -0.060037207 -0.142074475 0.082432351 
Grb10 0.006268288 -0.025809465 0.005724258 0.049618869 -0.002620839 
Grn -0.043633882 0.038688917 -0.012531061 -0.002380122 -0.012617982 
Gsn -0.002754535 0.001102072 2.55E-04 0.028539585 -0.003046192 
Gsta4 0.065552187 0.100475391 0.034164666 -0.071561843 0.114921804 
Gstm1 -0.004104427 0.0338219 0.008567815 0.014464409 0.023985567 
Gsto1 -0.020699352 0.021062617 0.002241935 0.060763876 -0.009394321 
Gtsf1l -0.010177353 -0.043981798 0.037634535 -0.149164182 -0.018284859 
Guca1a -0.001317352 0.005648774 -0.047328327 -0.006610773 -8.37E-04 
H19 1.37E-04 0.001514035 -0.001191355 0.017758511 0.001323573 
H1f0 -0.043444265 0.024869088 -0.030456083 0.011997489 -0.015002011 
H2-D1 -0.001436822 0.006240102 -0.00422713 0.021240581 -0.003529319 
H2-T23 0.00165844 -0.003714318 -0.003415006 -0.002326803 -7.70E-04 
H2afx -0.019625377 -0.008498125 -0.046000404 -0.14422322 0.005903131 
H2afy -0.034327621 0.033212627 0.010702678 0.010072446 0.004995494 
H3f3b -0.008073847 -0.013378068 -0.025110712 0.056244883 -0.019505153 
Hand1 -1.05E-04 6.74E-05 -8.33E-04 0.001585217 -1.29E-04 
Hat1 -0.004469954 0.117902815 0.03440926 -0.034486201 0.021256657 
Hbegf -0.003598156 -0.008759868 0.005555942 0.028965254 -0.013958616 
Hck 0.019281404 -7.77E-04 0.002449918 -0.027746485 0.020792285 
Hdc -8.79E-05 7.32E-05 -0.001518002 5.91E-04 -6.93E-05 
Herpud1 0.002894335 -0.001382962 -0.005617303 0.012313442 0.009740679 
Hes1 -0.009284146 0.003444164 0.003157892 0.00645871 -0.010558028 
Hes6 -0.011916534 0.002647025 0.006956105 0.045780951 -0.015236981 
Hexa -0.028245511 0.020392295 0.001251065 0.017808653 -0.007198755 
Hexb -0.014351274 0.027310912 -0.009594757 -0.018444238 0.005198014 
Hist1h1a 0.015481442 -0.056252233 -0.005608745 -0.016923621 -0.006775839 
Hist1h1b 0.064062664 -0.185105661 0.038754887 -0.033415342 -0.016826982 
Hist1h1e 0.00485218 -0.126583793 0.018461544 0.041800408 -0.023596863 
Hist1h2aa -1.10E-05 -1.58E-04 -0.001068486 9.29E-04 -6.80E-05 
Hist1h2ae 0.027931222 -0.054981488 0.001300678 -0.008187614 -4.64E-04 
Hist1h2ap 0.032154737 -0.02691278 0.00444087 -0.010091435 -0.009922881 
Hist1h2bc -0.009476675 0.015737616 -0.040654624 -0.01702401 -0.024702514 
Hist1h3c -1.68E-04 -0.001953258 -0.022463785 2.80E-04 3.55E-04 
Hist1h3d -1.98E-05 -1.37E-04 -0.010259774 6.34E-04 -1.61E-04 
 G-13 
 
Hist1h4i -0.001313371 -0.00316427 -0.082329336 -0.004846332 -0.007704536 
Hist1h4j -7.64E-05 -3.07E-05 -0.002316947 7.58E-04 -1.22E-04 
Hist2h3c1 -3.17E-05 3.55E-05 -0.001744998 4.00E-04 -7.42E-05 
Hist3h2a -0.004703836 0.003463334 -0.001004246 -0.001278379 -0.004475031 
Hist3h2ba -0.002059292 2.27E-04 -0.01983069 0.005520341 -0.002532476 
Hmces 0.063553348 -0.007531235 0.066383834 -0.200492651 0.034617147 
Hmga2 -0.002339191 -0.007566669 4.97E-04 0.042552794 -0.005257593 
Hmgb3 0.014942031 -0.004215895 0.002666418 0.054640007 0.011420899 
Hmgcr 0.024477735 -0.051996331 0.00558123 0.03606006 -0.042784383 
Hmgn3 -0.003110238 -3.35E-04 -0.055869518 0.044010291 -0.003875943 
Hmgn5 -0.009835818 0.007378859 -0.02464618 0.040849864 0.002985787 
Hmmr -0.046006621 0.004140579 -0.044823236 -0.046304198 -0.012948049 
Hmox1 0.061353944 -0.001346621 0.023404713 0.083690324 0.020044198 
Hnrnpa1 0.061170224 -0.033787405 0.01081182 0.094396448 0.011273987 
Hormad1 -0.009264584 0.008450698 -0.001152246 -0.010439933 -0.00440209 
Hoxa7 -2.97E-04 1.26E-04 -0.001399197 0.001289343 -3.27E-04 
Hpcal1 -0.0339477 0.026875318 0.005832616 0.019091925 -0.029492456 
Hsd17b14 0.011089337 -0.044735092 0.106051413 -0.346472531 -0.044917574 
Hsf2 0.02605336 -0.053801228 -3.12E-06 0.01317644 -0.055499634 
Hsp90aa1 0.040033775 0.103634877 -0.004815912 0.024185591 0.123992784 
Hsp90ab1 -0.062028004 0.115855422 -0.024276304 -0.034291196 0.012435059 
Hsp90b1 0.057612128 -0.020935227 0.011896731 0.04975851 0.069348113 
Hspa1a -1.75E-04 1.50E-04 -0.002073984 0.001774532 -2.43E-04 
Hspa5 0.076528532 0.003503769 0.019792154 0.070144814 0.091377908 
Hspa8 0.012739096 0.189514438 -0.045972985 0.021063916 0.075811342 
Hspb1 -0.016773864 0.100173392 -0.007846261 -0.169174187 -3.21E-04 
Hspb2 -0.003230929 0.002432434 2.70E-05 0.013752853 -0.002830931 
Htra1 0.001318056 0.004833675 0.00481156 0.008540809 0.006121752 
Icam1 0.00630797 0.00703989 0.008989258 -0.013981006 0.003087132 
Id1 0.040065972 -0.04919378 -0.033985566 0.111454095 -0.018227382 
Id2 0.022338475 -0.020096399 -0.029054825 0.148246917 0.006687978 
Id3 0.096115824 -0.026196369 -0.078360946 0.050657793 0.047180667 
Ier3 0.001120546 0.001575715 -3.56E-04 0.020101386 0.00213782 
Ier5 -7.88E-04 1.99E-04 -0.001384854 0.013608566 -0.001971712 
Ifi30 -0.006581221 0.014093334 0.004032763 0.015225148 -6.38E-04 
Ifitm1 0.031893569 0.046594319 0.048821462 -0.066936477 0.158903671 
Ifitm2 0.009444954 0.069888251 0.062751191 -0.215822579 0.068095611 
Ifitm3 -0.02227293 0.021247014 0.032649632 0.094260389 0.034847059 
G-14 MOFA loading values 
 
Ifrd1 0.042927653 -0.060322708 0.001797151 0.116655365 0.025717319 
Igf2 -0.001106734 -0.001035201 -1.01E-04 0.03730004 -0.001021383 
Igfbp2 0.048492835 0.053714694 -0.070151524 0.01119684 0.089111915 
Igfbp3 0.010198626 -0.007622744 -0.051742968 0.059461642 0.002757366 
Igfbp4 2.02E-04 -0.001168631 -1.74E-04 0.007241916 -9.25E-04 
Igsf23 -0.004495851 8.05E-04 0.005000927 -0.025721906 -0.002831072 
Il23a -1.23E-04 -1.06E-04 -0.001188404 0.001151063 -7.41E-05 
Impact 0.001442159 -0.061812266 0.015261519 0.104523722 -0.063156827 
Ina 0.066211805 -0.052238787 0.033192738 0.008516785 0.034721849 
Insig1 0.013572253 -0.025435021 -0.003064399 0.010946805 -0.027900189 
Irf1 0.001811446 -0.0034823 0.001531166 0.024622773 1.26E-04 
Irgm1 -4.88E-05 -7.36E-04 -0.001366376 0.003105408 -3.79E-04 
Itga3 0.006718506 -0.023619893 0.004051268 0.061864914 -0.004849552 
Itgb1 0.020029311 -0.061455753 0.012513786 0.10528726 -1.54E-04 
Itm2a -0.017393764 0.01706275 -0.007909486 0.012558346 -0.008229278 
Jam2 -0.035622967 0.033153645 -0.039081728 -0.208039136 0.008395053 
Jarid2 -0.00578902 -0.178335454 0.032915926 -0.10858667 -0.018078995 
Jun -0.009782796 0.001643707 -0.017005339 0.03960419 -0.008617845 
Junb -0.007204448 -0.012485814 0.022476019 0.056498236 -0.016513919 
Jund -0.042146884 -0.011434556 0.024610359 0.105489615 -0.043178208 
Kcnk1 0.012389903 -0.00948012 0.003868449 0.062472283 0.007928033 
Kctd12 -1.49E-04 2.68E-05 -0.001440394 9.90E-04 -1.31E-04 
Kdelr3 -0.011338847 0.006649334 0.005593889 -0.016479096 -0.014439081 
Kdm5b -0.047258927 -0.024140177 -0.017706916 -0.158060359 0.00834516 
Kdm6b 0.009760064 -0.032905533 0.005703568 0.002663588 -0.048290782 
Khdc3 9.67E-04 0.028619104 0.01104553 -0.08141985 0.016683645 
Kif1a -0.002951886 -0.002984681 6.90E-04 0.025369345 -0.002773074 
Kif21a 9.94E-04 -0.005826411 0.001364508 0.020831772 -0.002059122 
Klf2 0.008122799 0.035622749 0.015861479 -0.307922095 0.125566655 
Klf4 -0.057337324 0.02829506 0.028441218 -0.18353764 -0.023984693 
Klf5 -0.012202198 -0.010984705 0.010210949 -0.022813991 -9.19E-04 
Klf6 -0.021867614 -0.011608955 0.002042234 0.114326704 -0.00210744 
Klf9 -0.064598374 -7.57E-04 -0.013922344 -0.063991781 -0.01069032 
Klhl13 0.046445627 0.045251506 -0.032789733 0.076959356 0.110808284 
Kpna7 -7.43E-06 -3.63E-06 -0.00101311 6.53E-04 2.81E-05 
Kras 0.011196368 -0.073045032 0.028296469 0.145576114 -0.016694108 
Krt17 0.00268999 0.001718747 0.003474725 0.001693131 0.003114328 
Krt18 -0.002980509 0.004904913 -0.002480214 0.171910917 -0.011846927 
 G-15 
 
Krt19 -0.004916974 0.001510955 0.001600314 0.057531649 -0.006035514 
Krt42 -0.001090608 0.014615946 0.015313514 -0.055519108 0.008684051 
Krt7 -0.002919847 0.00157334 6.00E-04 0.024293101 -0.003001104 
Krt8 -0.007882698 0.003019604 -0.003074924 0.155167219 -0.014985815 
L1td1 0.0693294 -0.160030121 0.073180725 -0.043800132 0.034376989 
Lama1 -0.002816016 -0.00526691 0.002512223 -0.009222626 -0.004344234 
Lamb1 0.004354365 -0.013980449 -0.003288048 0.028755435 0.003826097 
Ldha 0.105078206 0.066167015 0.043405192 0.048218227 0.088851786 
Ldhb -0.016269053 0.120017739 0.009740181 -0.067205694 0.072225293 
Ldoc1 6.03E-04 -4.37E-04 -0.002050912 0.004655214 3.50E-04 
Lef1 0.015216636 -0.046828357 0.014431509 0.017416098 -0.004533445 
Lefty1 -0.02708893 0.01521308 0.017654762 0.184881342 -0.006265126 
Lefty2 -0.008429617 -1.77E-04 0.009629743 0.075761382 -0.004611015 
Lepr 0.012620998 -0.03822612 -0.027655292 -0.028369726 -0.006545408 
Lgals1 -0.002913792 -0.002916448 0.02394044 0.239228925 -0.010333188 
Lgals3 -0.031610612 0.018309868 3.56E-04 -0.080949001 -0.027170765 
Lgals4 -1.78E-04 0.001517704 -0.079685941 0.001179022 -4.58E-04 
Lgmn 1.75E-04 0.018291372 0.002196038 0.012280877 0.01132257 
Lgr4 0.019292961 -0.056497055 0.005496263 0.014404797 -0.052293247 
Limch1 -6.69E-04 7.82E-04 -0.053491807 9.93E-04 -1.41E-04 
Limk2 0.019883691 -0.06279314 -0.018201957 -0.015907789 -0.009326561 
Lmo4 0.010125191 -0.024084184 -0.015159741 0.054703877 -0.005344354 
Lmo7 0.002039972 5.64E-04 9.58E-04 -0.002562058 0.005918777 
Lmx1a -3.18E-05 -7.87E-06 -0.002703354 4.53E-04 -2.16E-05 
Lncenc1 0.006936803 -0.039712734 -0.002566082 -0.127924613 0.010871613 
Lonp2 -0.00442493 0.008353421 -0.106099391 0.006641104 0.001233349 
Lor 6.67E-04 -0.001097469 -0.00319076 0.008326018 -3.27E-04 
Loxl2 0.024081635 -0.064187591 -0.018651662 -0.024101438 -0.006659373 
Lpar1 0.004694242 4.36E-04 -0.006247896 -0.016719301 0.006856623 
Lpar4 -0.003399593 -0.006495016 -4.62E-04 0.026953385 -0.006142586 
Lpar6 -0.008843043 0.001143145 -0.003347976 0.033403875 -0.009517438 
Lpl 9.31E-04 -6.64E-05 -0.003994969 0.00419798 0.001162876 
Lpp -0.003183668 -0.013949157 0.003166762 0.041251556 -0.005208907 
Lrp2 0.008285361 -0.023846038 0.00170884 0.030929483 0.0017057 
Lrpap1 0.030010745 0.049135124 -0.018775201 0.038380018 0.079965519 
Lrrc8a 0.011651537 -0.034420484 -0.002320984 0.032682445 -0.041489026 
Lrrn4 6.97E-04 -9.86E-04 -0.00884764 0.007466712 1.38E-04 
Ltb 0.002955557 -0.007726991 9.17E-04 0.039099967 -0.002019016 
G-16 MOFA loading values 
 
Ly6a -0.001017355 0.013027742 -0.002060189 -0.005084721 0.016410421 
Ly6g6e -0.017432326 0.018658609 0.002819784 -0.018690375 -5.23E-04 
Ly6k -4.43E-04 5.67E-04 -0.004510612 -2.97E-04 -3.54E-04 
Malat1 -0.279448406 -0.147444223 0.093435204 0.173827295 -0.021093659 
Manba -0.013986797 -0.008680398 0.010080508 -0.107235958 -0.029387813 
Manf 0.071189473 0.014602145 0.00697793 0.037214226 0.058005961 
Map1b 0.007198015 -0.027305661 0.001214677 0.033425405 0.008240411 
Mapt -0.009655641 3.07E-04 0.00971489 -0.04595987 -0.00856217 
Marcks -0.027597535 -0.009584052 0.025857711 0.074802113 -0.027544963 
Marcksl1 0.010602222 -0.014656572 0.047711419 0.069583481 -0.011188035 
Marf1 0.012099078 -0.046681972 0.003119679 0.003475733 -0.063438731 
Marveld1 -0.002902218 0.001134494 -0.026238245 8.53E-04 -0.001710972 
Mbd5 -3.15E-04 -6.94E-04 -0.014495716 0.001331401 -4.26E-04 
Mbnl3 7.02E-04 -9.01E-04 -6.54E-04 0.01163144 -5.89E-04 
Mdk -0.017799147 -0.044851346 0.010455647 0.094610832 -0.048776816 
Mdm2 -0.13549539 0.098486435 -0.007729994 0.050519678 -0.119054953 
Mecom 5.42E-05 9.47E-05 -0.036160386 9.44E-04 1.63E-04 
Meg3 -0.034614851 -0.18395029 0.075182549 0.117896147 -0.058680528 
Mest 0.055823298 -0.066856316 0.002526378 0.144922384 0.034313628 
Mfge8 -0.029252526 0.049960181 -6.86E-04 -0.002929866 0.006035723 
Mfsd1 -0.011243933 0.006377574 -0.009365582 0.014300776 -0.001905504 
Mgll -1.04E-04 1.21E-04 -0.036858247 4.92E-04 6.77E-06 
Micu1 -0.003179157 0.00207785 -0.024829364 0.001813925 -0.00212678 
Mif 0.053609472 -0.003616128 0.062402516 0.054832779 0.052932426 
Mis18bp1 -0.03140488 -0.037529006 -0.072244253 -0.054439107 0.004125188 
Mkrn1 0.01194717 -0.064751835 -0.012517709 -0.165092594 -0.048841611 
Mme 0.007481995 -0.008561705 -0.00682748 0.011310794 0.013268678 
Mobp -0.005104031 0.007457638 -7.49E-04 -0.009792575 0.001949643 
Morc1 0.002016087 -0.001477515 0.031910235 -0.170226748 0.008687144 
Morc4 2.69E-04 -0.002536429 -0.003384715 0.016316462 -6.60E-04 
Mpzl1 0.002513566 0.013817346 -0.046569409 0.031635926 0.005665422 
Mras 0.002265169 -0.028642506 0.022862827 -0.095544693 -0.012597354 
Mreg -5.81E-04 0.009955658 -0.072187041 -0.050911294 -0.012870218 
Mrpl9 0.015929406 -0.021631762 -0.001427986 0.009960488 0.005733748 
Ms4a10 -0.019586487 0.014178559 0.001086156 -0.003023907 -0.01130517 
Msc -0.003622729 -0.010812182 0.01428403 -0.054901403 0.001893051 
Msmo1 0.010892868 0.008194122 0.010504252 0.018413688 0.01625965 
Msx1 1.48E-04 -1.90E-04 -0.002162973 0.003483059 -2.90E-04 
 G-17 
 
Msx2 -0.00248295 0.005301922 -0.011661012 0.007866211 0.001500526 
mt-Atp6 0.003177401 -0.131681907 0.005973945 -0.185512095 3.31E-04 
mt-Co1 -0.031802819 -0.140797854 -0.023787161 -0.141162489 -0.0429893 
mt-Co2 -0.046539888 -0.15960579 -0.007447199 -0.187360931 -0.028969444 
mt-Co3 -0.027583513 -0.082045197 -0.003349011 -0.180695569 -0.011024762 
mt-Cytb 0.001786661 -0.089233464 0.008360164 -0.174961394 0.016060353 
mt-Nd1 0.039169866 -0.114429133 0.021088817 -0.183941797 0.037854954 
mt-Nd2 -0.023355082 -0.133786102 0.010605147 -0.141818188 -0.029212122 
mt-Nd4 -0.03969539 -0.111213792 -0.006141267 -0.179387729 -0.027555985 
Mt1 0.033603601 -0.057090086 0.048552914 0.025042508 0.005734125 
Mt2 0.039408668 -0.041825396 0.036118244 -0.006745423 0.02027861 
Mtf2 0.006378273 -0.019924715 -0.06491704 -0.173754388 0.024113626 
Mthfd2 0.087404661 -0.046644878 0.012088697 0.037497392 0.054573534 
Muc3 -9.12E-05 -2.49E-05 -9.95E-04 5.59E-04 -8.02E-05 
Myc 0.023370936 -0.020629784 0.010825168 0.017769745 6.53E-04 
Mycn 0.067411073 -0.044042419 0.044545734 0.087931627 0.075407746 
Myef2 0.076265835 -0.168188017 0.017395789 0.053682202 -0.162611084 
Myh13 -0.001528134 0.002047328 -0.004738197 -0.00456261 4.66E-04 
Myl4 -0.003342614 1.40E-04 -0.001455449 -0.008208131 -0.004188803 
Myl6 0.024229041 0.041755942 -0.005965539 0.086618219 0.049565419 
Myl9 0.038173143 -0.015026056 0.00655825 0.082022641 0.033220232 
Mylpf 0.00762264 0.016582394 -0.005905894 -0.330180946 0.017515993 
Myo1f -0.011030875 -0.001111674 0.008116494 -0.049552705 -0.014188287 
Nab2 -9.02E-04 -0.003292973 0.003788052 2.18E-04 -0.001946544 
Nanog 0.018688981 0.056836233 -0.008471113 -0.120264021 0.079350589 
Napsa 0.002106286 0.002385003 0.003459039 -0.010069528 0.002921363 
Ncoa3 0.054139592 -0.145154274 0.016198142 -0.053348413 -0.154528453 
Ndrg1 -0.002589028 3.61E-04 -0.001381648 0.005073681 -0.001648713 
Ndufa4l2 -0.009347867 0.019387993 -0.004908015 -0.008423932 -0.0037948 
Neat1 -0.033189752 -0.025853539 0.00393266 0.023543036 -0.015895944 
Nefh 0.025385395 -0.026736913 -0.00378565 -0.027549746 0.007290907 
Nefl 0.012092518 -0.008749394 0.003422366 0.019686029 0.005906706 
Nefm 2.39E-05 -3.28E-04 -9.46E-04 0.002264941 -9.34E-05 
Nelfa 0.011562373 -0.006992268 -0.182897903 -0.005356775 1.74E-04 
Nes 0.003465965 -0.013198811 1.40E-05 0.058100284 -0.003279728 
Neurod1 -0.026571582 0.015595761 0.002418989 0.002174998 -0.017704936 
Neurog3 6.47E-05 -5.76E-05 -0.001051491 6.86E-04 2.56E-05 
Nexn 0.006854108 -0.005338865 0.001274971 0.008301595 0.006757808 
G-18 MOFA loading values 
 
Nfatc2ip 0.008654283 -0.004753409 0.005003053 -0.151341233 0.01532826 
Nfkbia -0.028951272 0.034448971 -0.029404953 0.005198754 -0.013678806 
Ngb -3.98E-05 -8.38E-05 -0.001043445 8.20E-04 -8.51E-05 
Ngfrap1 0.048187073 0.00631662 0.027065202 0.052919149 0.055472698 
Nip7 0.11387971 -0.116074804 0.019283563 -0.123949609 0.02526126 
Nkx2-9 -0.030433385 0.019275775 0.001609255 -0.004328027 -0.025809169 
Nkx6-2 -0.016433635 8.91E-04 0.003086592 -0.00703547 -0.025059342 
Nmrk1 8.94E-04 -0.009448927 -0.005038132 -0.002738313 -0.001998297 
Nnat 3.77E-04 -0.013131531 0.004217984 0.058933167 -0.008536158 
Noct 0.04423333 -0.033478622 0.005857229 0.004174658 0.007174826 
Nodal -0.03129867 0.023674086 0.001045456 -0.011709675 -0.016905471 
Nop56 0.058848103 0.018406202 -0.015415849 0.019113126 0.104539997 
Notch2 0.016302808 -0.032451641 0.001413942 0.025744394 -0.034391706 
Nptxr -1.54E-04 -8.08E-05 -0.001092939 0.001536581 -3.12E-04 
Npy -1.44E-04 1.18E-04 -0.001364755 6.60E-04 -1.42E-06 
Nr0b1 0.037417734 0.0233345 0.028155083 -0.150992843 0.030194427 
Nrk -3.09E-04 1.78E-04 -9.19E-04 0.00226351 -2.22E-04 
Nrp2 -0.001011048 -0.003917209 0.003096471 0.012987042 0.002853602 
Nudt4 0.065859193 -0.065587955 -0.044712344 0.007821078 0.023398883 
Nup62cl 0.01261397 0.022636276 -0.003475617 0.022333272 0.023147364 
Nupr1 0.009942 0.01078577 0.008430029 -0.003685962 0.023428487 
Ooep -0.007366435 0.066640139 0.018363075 -0.125079248 0.035893591 
Os9 -0.00198138 0.001010564 -0.035754337 0.001886776 -7.37E-04 
Otx2 0.001965149 -0.001240393 0.007625131 -0.002152088 0.004949408 
P2rx4 -0.002693713 -0.002268247 -1.24E-04 0.004552307 -0.003283805 
P2rx7 -0.001405822 7.47E-04 -0.001105004 0.001051643 -0.0010008 
P3h3 -0.001271302 -0.007809642 -0.003065571 -0.008690969 -0.004587411 
P3h4 0.024921767 -0.025505157 0.0132048 0.008935724 0.004087212 
P4ha2 -0.003196753 0.004073027 -0.030754916 0.010441767 -0.002352356 
Parm1 -0.001419063 0.001259753 -0.001198214 0.001442999 1.89E-04 
Parp1 0.046715437 -0.16797461 -0.020898591 -0.163572803 -0.007998232 
Pawr 0.008130684 -0.01240657 0.007230153 0.049025798 0.010729179 
Pax6 0.011980882 -0.011328142 0.005606282 -0.011516659 0.007872575 
Pcgf5 0.003634731 -4.36E-04 -0.012572193 0.047488577 0.004315397 
Pdcd4 -0.00789168 -0.025852432 -0.007503915 -0.004001627 -0.072177537 
Pdgfa -0.012398769 -0.027079324 0.021827027 -0.063898847 -0.019116512 
Pdgfrl -8.26E-04 4.69E-04 -0.053583074 0.003126072 -4.97E-04 
Pdia3 0.005369373 0.017888703 -0.004200175 0.051094224 0.024729767 
 G-19 
 
Pdia6 0.050939568 0.067718363 0.018118427 0.052659041 0.083918056 
Pdlim3 -1.76E-04 2.04E-04 -0.003512829 0.001354037 -5.54E-05 
Pdlim4 -6.78E-04 0.002376229 -0.001473164 0.003117302 8.70E-04 
Pdlim7 0.020585711 -0.02158738 -0.005269746 0.15964993 0.004435017 
Pdpn 0.014262618 -0.008320707 -0.004190804 0.029969307 0.006418388 
Peg10 0.014211969 -0.064341817 0.005822721 0.10274513 -0.014651889 
Peg3 -0.004358451 -0.018175785 -1.67E-04 0.034414603 -0.001898183 
Perp -0.0932979 0.03752984 0.011761335 0.144283385 -0.084453512 
Pfas 0.06476031 -0.154837931 0.016723907 0.004444182 -0.143923056 
Pfkp 0.018230176 0.033052037 -0.002268841 -0.07208427 0.03837191 
Pfn1 0.085239224 -0.065621214 0.072980703 0.105144885 0.042757368 
Pga5 -0.003691378 0.007133614 9.78E-04 -0.007490221 0.002818068 
Phgdh 0.083580129 0.033859879 -0.007666345 0.118330375 0.091499574 
Phkg1 -7.65E-05 -0.004851624 -5.51E-04 -0.007518374 -0.002191424 
Phlda1 -0.017716848 -0.003066676 3.28E-04 0.067060241 -0.028876969 
Phlda2 0.059807473 -0.065739438 0.015924514 0.091412167 0.027658565 
Phlda3 -0.156351078 0.112591958 0.014032296 0.083272528 -0.150804628 
Phldb2 -3.74E-04 -0.001557033 -0.007006146 0.017095287 -0.001861342 
Pim1 0.042080292 -0.017677341 -0.014440433 0.135370357 0.029781873 
Pim2 0.043183702 -0.061993812 0.008671562 0.154306176 0.011228147 
Pitx2 2.72E-04 -0.003519821 3.05E-04 0.026479618 -0.002427891 
Pkp2 -0.008570319 -6.15E-05 0.009903538 0.004402135 -0.009734447 
Plac8 0.021314505 -0.00489952 0.002697094 0.026092838 0.014144945 
Platr3 0.008229817 -0.034911261 -0.01139194 -0.123509221 -0.009300424 
Platr31 -8.92E-05 1.04E-04 -0.097282535 -3.08E-05 -1.05E-04 
Plaur 0.001702406 -0.014375227 0.005672787 0.076877213 -0.009382456 
Plet1 -7.47E-04 5.76E-04 -8.16E-04 0.00441249 -5.32E-04 
Plin2 -0.010407313 0.013807161 -0.011091295 0.068974875 -0.003919518 
Plk2 -0.094190637 0.069194166 -0.01911805 0.046742238 -0.078236084 
Plk3 -0.001409872 0.002207474 -0.006693098 0.018961133 -0.003843036 
Plk4 0.068106068 -0.204552106 -0.036934095 -0.124543503 -0.013710003 
Plod2 -0.028104822 0.009768466 -0.002757666 0.021587922 -0.02447292 
Pmaip1 -0.021713652 0.010117411 -0.037237525 0.023244276 -0.023055701 
Pmm1 -0.118941212 0.068876397 0.056549966 -0.016122822 -0.10291986 
Pmp22 3.69E-05 -5.77E-04 -6.12E-04 0.010240177 -7.75E-04 
Pou3f1 0.024924201 -0.063773519 0.003318933 0.212071578 -0.010763637 
Ppdpf 0.019645287 -0.045979657 0.021001809 -0.125119235 5.79E-04 
Ppig 0.018267494 -0.04696874 -0.084325227 -0.005687535 0.021555108 
G-20 MOFA loading values 
 
Pramel7 -3.63E-05 3.18E-05 -0.001328859 4.64E-04 -1.72E-05 
Prdx1 0.090999259 0.102578976 0.009625363 0.034291555 0.11891914 
Prdx6 0.151273324 0.022948875 -0.02512435 0.154307814 0.162160303 
Prex2 -0.003842595 -0.007761019 -0.090860088 0.004845453 2.42E-04 
Prph -0.004727077 0.003031429 0.001361769 0.016044812 -0.004206345 
Prps1 0.067951947 0.062895702 -0.099460969 0.007374221 0.092581007 
Prr13 -0.013072043 -0.008890539 0.019357494 -0.016001119 -0.020239692 
Prrc1 -0.001712161 0.011354521 -0.020761412 -0.073399484 0.00241022 
Prss8 -1.99E-05 -0.001111835 9.79E-04 0.02171137 -0.001293574 
Prtg 3.03E-04 -0.013661149 0.003712767 0.055582774 -0.005875246 
Psap -0.019291258 0.03668881 -0.020065612 0.021865415 0.011627691 
Psmb8 1.25E-04 -3.35E-04 -0.001140362 0.003950877 -1.50E-04 
Psors1c2 0.018406771 -0.010691131 0.005942412 0.022180466 0.012399972 
Psrc1 -0.143519509 0.047059449 0.025567188 -0.012807948 -0.117812792 
Ptch1 -0.002802798 -0.010159911 0.007861222 -5.78E-04 0.00451781 
Ptcra 0.00944601 -0.031962909 -0.004120559 -0.024674661 -0.010375746 
Ptges 9.38E-04 0.001267701 0.001026326 0.003495016 -1.30E-04 
Ptgr1 -0.008275283 0.021970981 -0.011398685 0.01542607 0.006400384 
Pth1r -1.01E-04 6.14E-05 -0.001259953 0.002013368 -2.07E-04 
Ptp4a2 0.031366001 -0.117954183 0.018700084 0.061608144 -0.125905783 
Ptp4a3 -0.134357685 0.067374592 0.01689763 -0.012826827 -0.109204362 
Pttg1 -0.015572055 0.058570836 -0.056964406 0.075870962 0.01250702 
Pxdc1 -2.37E-04 -4.17E-04 -0.001090518 0.00696591 -6.86E-04 
Pycr2 0.02720122 0.001512636 0.034263544 0.155656412 0.02227133 
Rab3il1 -0.001761406 0.00345759 1.40E-04 0.00342679 2.55E-04 
Rap2b -0.040493995 -0.01720948 0.004639087 0.053792529 -0.079144424 
Rasgrp2 0.142654975 -0.084145431 0.067187957 -0.098523243 0.099713945 
Rasl11a -0.007115677 0.011252226 -0.003726456 0.002491248 -0.012029338 
Rassf1 0.001880055 1.61E-04 0.00412675 0.040478173 -0.007863496 
Rbm15 0.047115154 -0.10250379 -0.006951642 0.015734234 -0.112679503 
Rbm47 0.0039574 -2.63E-04 0.00364418 -0.002009678 0.004685175 
Rbms1 -0.00479094 -0.024366971 0.012785627 0.125415702 -0.01554875 
Rbmx 0.006940348 -0.003567116 -0.029511463 0.013550127 0.003860258 
Rbp1 0.013911583 0.007480073 -0.003555841 0.021065336 0.020774402 
Rbpj 0.027543178 -0.062446148 0.031453563 -0.115434783 0.016535506 
Rcsd1 -7.53E-07 3.21E-04 -0.003685952 8.59E-04 -1.03E-04 
Rec114 -0.006852748 0.009727314 -0.002742344 -0.010935564 -0.002199012 
Reep5 -0.02216472 0.013937064 0.006580697 0.10174785 -0.020488442 
 G-21 
 
Renbp -0.022606464 0.031770284 -0.007548334 0.003808536 5.96E-04 
Rest 0.080729773 -0.086419407 0.098415799 -0.111866463 0.054600858 
Retn -4.56E-04 -0.003496705 -0.00118586 -0.00266834 -9.42E-04 
Rgcc -1.23E-04 5.40E-05 -0.001507618 0.001148847 -1.16E-04 
Rhob -0.00271999 -9.68E-04 -0.001319756 0.021485492 -0.003596422 
Rhox13 -0.009295119 0.009125446 -0.009092543 -0.01706062 -0.002421038 
Rhox5 0.035659938 0.025072045 -0.002408379 7.91E-04 0.062431653 
Rhox6 0.002277232 0.010706327 -2.42E-04 0.023093509 0.00949264 
Rhox9 -5.76E-04 0.011862441 -3.65E-04 0.017572754 0.007927308 
Rif1 0.027114801 -0.115771151 -0.009695813 -0.087037284 0.038147449 
Rimklb -4.44E-04 -0.003153116 -0.027597494 0.002098542 -5.60E-04 
Rnf128 7.92E-04 -0.002675248 1.25E-04 0.033327502 -0.001180146 
Rnf168 -0.002734639 -0.026080327 6.74E-04 -0.011487862 -0.011861993 
Rnf7 0.054592704 -0.005737408 0.053069113 -0.080247834 0.057179714 
RP23-
4H17.3 0.010321917 -0.088433332 -0.02611706 -0.126065696 -0.034539983 
Rpl10l 0.007247167 0.001468115 -0.017599384 -0.030908162 0.007469238 
Rpl22l1 -0.079527423 0.020661345 -0.00827074 -0.069740476 -0.080036214 
Rpl39l -0.014857626 -0.014501862 -0.021177798 -0.217748089 -0.047485167 
Rpl41 -0.015053818 -0.098884662 0.009787067 -0.023504506 -0.059752669 
Rpp25 0.005355047 -0.001733399 -0.008759533 -0.14941101 0.010291186 
Rps18 -0.090305688 0.090650652 -0.010222382 -0.043142608 -0.058932614 
Rps19 -0.095056839 0.027932636 -0.015859715 -0.003411023 -0.084068623 
Rps23 -0.086062758 0.042136469 -0.024822171 -0.042777868 -0.068318519 
Rps27l -0.082688969 -0.043976659 0.041606466 -0.006738416 -0.103302441 
Rps4x -0.138771111 0.16270428 -0.031896199 -0.044293326 -0.08087072 
Rrad -3.59E-05 -1.57E-04 -6.87E-04 0.002155186 -1.70E-04 
Rrm2 0.062996395 0.081271004 0.004232798 0.020020293 0.023186878 
Rrn3 0.05143561 -0.125552139 0.00751245 -0.033101445 -0.132459494 
Rsph6a -0.001442344 8.94E-04 -0.001143387 7.76E-04 -9.46E-04 
Rsrp1 -0.014701825 0.022407166 -0.023871414 0.004080624 -0.017995192 
Rtkn -0.032212705 0.020219526 0.001653975 -0.008082104 -0.02648713 
S100a1 -0.001032256 6.85E-04 -0.00141131 0.003317158 -4.08E-04 
S100a10 -0.007515776 0.010709035 -0.016677122 0.134839385 -0.024146248 
S100a11 -0.017622323 0.038308948 -0.051647414 0.104227755 0.007144318 
S100a13 -0.005313137 0.005699655 -0.004220947 0.009745405 -9.20E-04 
S100a3 -7.28E-05 -4.79E-05 -8.84E-04 9.61E-04 -8.22E-05 
S100a6 -0.01750986 0.0208029 0.009223655 0.183407504 9.56E-04 
Sall3 -0.006972567 -0.003315901 0.001829552 -0.002593282 -0.00583501 
G-22 MOFA loading values 
 
Sall4 0.080407128 -0.141551666 -0.023251011 -0.029562528 -0.075382779 
Sat1 -0.037497097 0.002519412 -0.027491711 0.012912893 -0.038209509 
Sbsn -0.003396512 0.001778803 -4.66E-04 0.014858821 -0.003388966 
Scamp1 -0.001924287 -9.19E-04 -0.093333216 0.013001173 -0.002014371 
Scd2 -0.002731334 -0.035780064 -4.53E-04 0.003550758 -0.024847525 
Scn1b -0.015183191 0.009995915 0.001367609 0.011313418 -0.012533951 
Sct -0.00854992 0.007564779 -0.005478534 0.018283712 -0.005161031 
Sdc4 -0.114808771 0.056513577 0.007923624 0.058269913 -0.150240629 
Sdhaf3 0.00154874 -0.007239073 -0.063608358 -0.005147507 -0.001445062 
Sec24a 0.001534855 -0.017190496 -0.009297395 -0.009214654 -0.008498334 
Sema6a -0.001229824 -0.001598465 -5.55E-04 0.008687094 -0.001584807 
Sepp1 -0.002588991 -6.80E-04 -0.003069043 0.01317601 -0.002579083 
Sep-01 -0.021865864 5.56E-04 0.045532499 -0.230085005 -0.038977249 
Sepw1 0.024886366 -0.090775518 0.034786669 0.093957501 -0.019362021 
Serpinb9b 3.07E-04 -1.60E-04 2.08E-04 0.009423288 1.57E-04 
Serpine2 -0.086982158 0.049722233 -0.007121067 0.025940291 -0.065875181 
Serpinh1 -0.010104198 0.002705404 0.00320555 0.094037236 -0.014602483 
Sfmbt2 0.010677992 -0.011342793 0.004524032 0.044104618 0.009673981 
Sfn 0.016263553 0.004312064 0.002058849 0.21397529 0.011694449 
Sfrp1 0.002607389 -0.004371941 0.008468852 -0.012738665 0.006108912 
Sgk1 0.030643911 -0.015206026 0.023009411 -0.040170185 0.057098495 
Shkbp1 -3.56E-04 0.001220082 0.004159807 0.01120087 -2.57E-04 
Sin3b 0.008293403 0.061675554 -0.018001246 0.063286411 0.040625854 
Six1 2.67E-04 -1.55E-04 -0.001374347 0.001895693 8.96E-05 
Skil 0.03780045 -0.116804184 0.009948711 0.110930305 -0.099984465 
Slamf1 0.013278391 -0.040830895 -0.014377289 -0.035838055 -0.003114401 
Slbp 0.134867037 0.01189766 0.005888011 0.027548431 0.049909169 
Slc11a1 -0.007900244 0.00174719 0.00439865 -0.026616907 -0.007437181 
Slc16a3 0.058979401 -0.016444153 0.013551708 0.109715033 0.040361413 
Slc24a5 0.074845948 -0.167422159 0.017423379 0.049149133 -0.186476267 
Slc25a20 -0.005765402 0.012164416 1.86E-04 -0.019133076 0.003751344 
Slc25a31 -0.001520281 0.003237038 -0.008973264 0.001638449 4.39E-05 
Slc25a4 0.055833533 0.042460413 -0.013076396 0.204685089 0.067176965 
Slc25a43 -9.17E-05 -2.17E-06 -8.56E-04 8.85E-04 -2.60E-05 
Slc25a5 0.04325747 0.120312757 0.001078678 -0.064101328 0.098645001 
Slc26a2 -0.00489575 -0.002593123 -0.002238059 0.006411679 -0.005608339 
Slc27a2 0.00456625 -0.007423132 -0.039019586 0.014501676 0.004642233 
Slc29a1 0.029150164 0.003859143 0.035823688 -0.092939949 0.0379958 
 G-23 
 
Slc2a1 0.050550192 0.007672441 0.011099045 0.117551492 0.038046367 
Slc2a3 0.022019635 -0.01348105 -0.01307663 0.068712127 0.054511664 
Slc30a2 0.003449103 0.001397747 0.004264478 6.76E-04 0.004906282 
Slc39a1 0.031378041 -0.063565396 0.003622627 0.01787054 -0.078946031 
Slc39a8 9.74E-04 -0.002882923 1.29E-04 0.01229873 4.25E-05 
Slc40a1 -5.67E-04 0.00185359 -7.23E-04 0.015604466 0.001381626 
Slc7a3 0.033306032 0.001392668 0.022267516 -0.035557843 0.045667229 
Smad7 -0.005953456 -0.010465987 0.015066023 0.015158022 -0.019193387 
Smagp 0.041124727 -0.059691403 0.046757654 0.005657426 -0.02059663 
Smarca5 3.02E-04 -0.08743006 -0.029486218 -0.039434529 -0.01474764 
Sms 0.105968568 -0.075107269 0.033188686 -0.033721125 0.1013138 
Smtnl1 -0.021970016 0.012401182 0.004190501 -0.022991177 -0.01892732 
Snai1 -1.30E-06 4.76E-04 -0.013332754 0.003742773 3.82E-05 
Snhg12 -0.001269504 -0.019441422 -0.005831517 7.93E-04 -0.007852681 
Snrpn 0.086532432 -0.096974998 0.004306377 0.090750509 0.050789609 
Snx20 -4.35E-04 2.98E-04 -8.36E-04 6.28E-04 -3.26E-04 
Socs2 0.017930513 -0.037336786 0.036709165 0.032684782 0.005442333 
Socs3 -0.008710522 0.001988631 -0.016807844 -0.034478184 -0.012466812 
Sod2 0.02827312 0.017783941 0.038565632 -0.199847135 0.042087259 
Soga3 0.005238877 -0.023550209 0.006491161 -0.019517887 -0.007463357 
Sord -0.02834973 0.023346322 -0.041313672 -0.004114073 -0.015661596 
Sox11 0.005004106 -0.03077355 0.00110728 0.053960175 -0.007388504 
Sox15 -0.013305702 0.017353438 0.007362039 -0.028173918 -0.002028375 
Sox2 -0.032292684 -0.041332289 0.089978823 -0.14662022 0.006670554 
Sox21 -0.003021545 0.002847231 0.003246959 -0.007234857 0.005735028 
Sox4 -0.012998207 -0.038595687 0.021076517 0.078066104 -0.02832406 
Sp110 1.62E-04 -2.43E-04 -0.055521075 -2.02E-04 9.27E-05 
Sp140 -1.27E-04 -1.12E-04 -0.012564749 5.50E-04 -9.54E-05 
Sp5 0.00173884 -0.006261732 8.16E-04 0.016212385 -5.79E-04 
Sparc -0.011226458 -0.004374996 -0.013551364 0.069092008 0.004118967 
Spesp1 -9.45E-06 -1.87E-05 -0.018550628 2.52E-04 5.46E-06 
Spic -0.001084913 0.001690502 -0.002864992 -7.47E-04 0.001036581 
Spink1 0.009202317 -0.026808138 0.010753896 -0.142282087 -0.00450494 
Spp1 0.063499584 0.081710704 0.042511659 -0.179542182 0.148766092 
Spry2 0.06903804 -0.166660288 0.0138726 0.001953989 -0.191079438 
Spry4 -0.002729379 -0.052853531 0.010859661 -0.02658631 -0.027693194 
Spty2d1 -0.023417455 -0.010474751 -0.022905467 -0.046632767 -0.016797284 
Sqstm1 -0.019603718 0.032103436 -0.016705487 0.042550029 -0.004273325 
G-24 MOFA loading values 
 
Srgn -5.41E-05 1.40E-05 -8.16E-04 4.34E-04 -5.99E-05 
Stk32c -2.60E-05 6.87E-06 -9.31E-04 6.82E-04 -4.88E-05 
Stk35 0.002181807 -0.001218567 -0.02126966 -0.004155521 7.39E-05 
Stmn1 -0.006790149 0.094814197 0.031683501 -0.275261612 0.045357597 
Stmn2 0.01748831 0.011893068 0.040464023 -0.171369153 -0.006780733 
Stox1 -3.05E-04 1.26E-04 -0.001621905 5.60E-04 -2.82E-04 
Stra8 0.00163326 0.007369675 -0.003663478 -0.020353357 0.004136973 
Stx3 -0.022925106 -0.001614687 0.012644452 0.09261637 -0.021189014 
Sycp3 -0.004424388 0.010675615 -0.004789932 0.008353822 0.003633398 
Synm -0.006236138 0.003304678 -0.0011922 0.00312909 -0.004560674 
Taf7l -0.003042761 0.002052299 -0.004256754 0.003927276 -0.001225465 
Tagln 0.017444811 -0.027355756 0.006003767 0.181692801 0.003073052 
Tagln2 -0.007055003 0.034045821 0.008082235 0.125109566 -0.015343894 
Tapbpl 0.006351503 -0.0215806 -0.010955962 -0.014133389 -0.003086879 
Tax1bp3 0.003950829 -0.006255817 -0.010966673 0.09347374 -0.006094856 
Tbc1d12 -0.001322681 6.92E-04 -0.022061077 0.003335758 -6.88E-04 
Tbc1d24 -0.002585957 -0.007905513 6.98E-04 -0.008820908 -0.004767308 
Tbx3 -0.04554128 0.035932658 -0.006373377 -0.135304745 -0.0142048 
Tc2n -7.50E-05 -4.14E-04 -0.002499406 0.001116112 -2.00E-04 
Tcea3 0.040390526 -0.067517276 0.057219849 -0.194945333 -0.003706459 
Tcf15 -0.016374355 -0.133389215 0.08975039 -0.002428881 -0.138806691 
Tchh -1.03E-04 -5.65E-05 -0.001647405 0.001054748 -1.08E-04 
Tcl1 0.004666572 0.017234011 0.019406218 -0.123468508 0.020166421 
Tctn1 -6.22E-04 -6.81E-04 -0.00242338 7.03E-04 -0.001254814 
Tdgf1 0.035548115 -0.060323465 0.051029405 -0.069655398 0.024517603 
Tdh -0.019114841 0.0254043 0.035266166 -0.136562069 0.009687759 
Terf2ip 0.00329597 0.001253088 9.41E-05 9.89E-04 -4.41E-04 
Tet1 -0.011376711 -0.126617407 0.057614585 -0.179859118 -0.019799202 
Tex101 -1.96E-04 3.81E-04 -0.002446315 6.95E-04 7.23E-05 
Tex19.1 0.030302796 0.053691203 -0.072890754 -0.050399334 0.044186459 
Tfap2c -0.003659124 0.021629114 0.012726465 0.009844342 0.019641186 
Tfpi 0.005837204 0.014491226 0.009665238 -0.020821894 0.014611721 
Tgfb1i1 -8.26E-04 -5.17E-04 -0.002733752 0.012193504 -0.001283558 
Thbs1 1.95E-04 -0.002092082 -5.50E-04 0.014570099 -0.001111871 
Thnsl2 -7.44E-04 0.00273594 -0.021792891 -3.16E-04 1.30E-04 
Ticrr -0.005335598 -0.002250029 -0.030422961 -0.048645393 0.008064349 
Timp2 0.001110403 -2.86E-04 -0.002828483 0.017401259 -7.60E-04 
Tinagl1 -3.47E-04 -9.28E-04 2.44E-05 0.03028404 -0.00166679 
 G-25 
 
Tmcc1 -0.002629923 -0.008119509 -0.002109172 0.004069029 -0.006689455 
Tmem191
c -0.004632722 0.007886984 -0.017643003 -0.01986261 0.005076412 
Tmem245 0.061914422 -0.142560247 -0.024572116 -0.14440798 -0.021842091 
Tmem37 -0.002575682 0.0043391 0.004484148 0.013929301 -0.001752279 
Tmem40 -0.005343301 -0.002262128 0.010548602 -0.031415019 -0.00415688 
Tmem59 -0.001840633 0.050978679 -0.02265903 0.084140141 0.028300742 
Tmem92 5.34E-04 -1.67E-05 -0.059765857 3.38E-05 9.59E-06 
Tmsb4x -0.011841952 -0.087936215 0.037345172 -0.055501702 -0.054210212 
Tnfaip6 -2.24E-04 1.17E-04 -9.50E-04 7.04E-04 -2.08E-04 
Tnfrsf12a 0.002458745 -0.009743549 -0.00206313 0.086160446 -0.006528297 
Top2a -0.035564008 -0.15278487 0.023615703 -0.050582968 0.008013693 
Tpbg -8.89E-04 -0.001327996 -0.001964892 0.02399449 -0.001321577 
Tpi1 0.104392092 0.030268297 0.056830361 0.094655648 0.09177497 
Tpm1 0.074709894 -0.074961246 0.034140516 0.305329183 0.062319308 
Tpm4 0.016981044 -0.023871927 0.01636692 0.159100565 0.004022734 
Tppp3 -2.33E-04 0.005032102 -0.00287463 -0.007627871 0.004574053 
Trap1a 0.0251173 0.043527441 0.011703086 -0.072774944 0.042923267 
Trh 0.017331466 1.11E-05 0.041924522 -0.045260002 0.032257863 
Trib3 -0.01326889 0.005559874 0.007102837 0.011460562 4.13E-04 
Trim47 -6.27E-04 6.40E-04 -9.08E-04 0.001807376 -2.92E-04 
Trp53i11 -0.018744991 0.004303259 0.006958641 0.004838434 -0.018849636 
Trp53inp1 -0.104020595 0.055888927 -0.011292357 0.003549626 -0.087639199 
Tsc22d1 -0.031893044 0.007198355 -0.002233002 0.006854731 -0.034580682 
Tsen2 0.016824822 0.001894969 -0.076650506 0.002420435 0.016838644 
Ttc39c -1.88E-04 -6.53E-05 -0.001462863 7.57E-04 -2.59E-04 
Ttn 0.00415939 -0.041762918 0.009034515 -0.029935234 0.003746578 
Tuba1a -0.004364987 0.047298235 -0.005127153 0.188470036 0.038465813 
Tuba3a 0.0025798 0.025986628 -0.008402449 -0.044935185 0.011337176 
Tubb2a 0.008988741 0.01421165 -0.006732093 8.09E-04 0.015439416 
Tubb3 0.043099844 0.055410009 0.001802599 -0.068141474 0.073497107 
Tubb4b 0.051455516 0.102900773 -0.035019982 0.00457642 0.094496539 
Tubb5 0.080750371 0.113805303 0.001125909 0.061903665 0.118368445 
Tubb6 -0.013510095 0.04087267 0.006376631 0.218677916 -0.026298526 
Txnip -0.022608507 -0.008714807 0.004532519 0.016844348 -0.021175459 
Uap1l1 -0.024313752 0.022253278 -0.004798258 0.018057994 -0.006834176 
Ubald2 -0.070053764 0.050123561 0.070642731 -0.092903931 -0.025682894 
Ube2c 0.001227941 0.01489761 -0.011420286 -0.06547955 0.077675371 
Ung 0.084521108 0.024556238 0.040033 -0.042632856 0.024663399 
G-26 MOFA loading values 
 
Upp1 0.045687251 0.109770207 0.022351227 -0.21130694 0.094598683 
Uqcrb 0.010727709 0.033637388 0.001193446 -0.02526016 0.037841921 
Usp13 -1.74E-04 -5.02E-05 -0.001423277 0.001294684 -1.65E-04 
Usp17la 5.27E-04 1.28E-04 -0.085861938 -4.57E-05 -9.95E-05 
Usp17lc 1.19E-04 -2.36E-04 -0.039888132 -3.40E-05 6.13E-06 
Usp19 0.003477113 -0.051984341 -0.015792072 -0.052333743 -0.019190364 
Usp26 2.35E-04 -3.30E-04 -0.01526298 0.001379098 1.97E-04 
Utf1 0.125506859 -0.085249583 0.137647299 -0.039441996 0.051482642 
Vamp8 -0.005035676 6.99E-04 0.003879445 0.064910437 -0.011927243 
Vgll3 -5.66E-04 -0.001046278 -2.39E-04 0.016802684 -9.84E-04 
Vim -0.006004467 0.031547737 0.001697801 -0.043028038 -0.013009008 
Wbp5 0.021773584 0.010544356 0.021040523 0.114374668 0.036512312 
Wfdc2 0.017999323 0.010202317 0.002728327 0.030126048 0.026044562 
Wls -0.002000118 5.56E-04 -0.005939198 0.009773865 -0.001372056 
Wnt3 -2.58E-04 -5.72E-05 -0.001056892 0.003331351 -3.77E-04 
Wnt4 -2.34E-04 -4.23E-04 -3.22E-04 0.006292003 -6.88E-04 
Wnt6 -0.009638128 0.004688437 0.001359393 -0.001158489 -0.01205895 
Wnt7b -2.66E-04 9.11E-05 -5.32E-04 0.007474071 -2.05E-04 
Wtap 0.064959142 -0.137986609 0.006353335 -0.018111977 -0.150579208 
Xist -0.002635861 -0.001732221 -0.001707079 0.002448734 -0.008506476 
Xlr3a -7.30E-05 9.88E-05 -0.00119254 6.24E-04 3.43E-05 
Ywhaq 0.100143144 0.031235185 -0.006362319 0.019520464 0.089766266 
Zbtb10 -0.00139341 8.02E-04 -0.004099092 0.007061992 2.66E-04 
Zc3hav1 0.008614949 -0.006964434 -0.008821888 -0.001053405 -0.011471245 
Zfos1 -0.02421742 -0.029596767 0.004043892 0.01624874 -0.033703985 
Zfp287 -2.17E-04 -3.58E-04 -0.001487744 0.00109094 -2.13E-04 
Zfp296 0.016364233 0.025446963 -0.05429264 -0.068131632 0.040030117 
Zfp316 -1.44E-04 -0.001385645 -0.001937904 -1.55E-04 -7.10E-04 
Zfp326 0.003469998 -0.017138152 0.012520657 0.035213075 1.51E-05 
Zfp42 0.021628098 -0.00124428 0.108338397 -0.501610332 0.088986416 
Zfp428 0.093837115 -0.108783132 0.049686184 -0.075297815 0.018790598 
Zfp516 -0.004558494 -0.003002231 -0.050578507 -0.00647421 -0.001952521 
Zfp560 -1.05E-04 -0.017911743 -0.137954837 0.005416308 -0.008261478 
Zfp57 0.009088107 -0.011049814 0.028582625 -0.150061246 0.022108253 
Zfp706 0.052316871 -0.079185658 0.070999492 0.05294064 -0.011841548 
Zfp809 -0.00238174 -7.82E-04 -0.048392675 -0.001829533 -0.002788604 
Zic2 0.003889626 -0.006410234 0.00477635 0.001573961 0.002224383 
Zic5 0.011087826 -0.020305948 0.009983686 0.008020038 0.008656391 
 G-27 
 
Zscan4b 1.14E-05 -4.60E-05 -0.002376454 4.10E-04 -1.69E-05 
Zscan4c 0.001862291 0.001310167 -0.248795914 -9.17E-04 -8.11E-04 
Zscan4d 0.002096548 5.82E-04 -0.214888328 -8.93E-04 -7.41E-04 
Zscan4f 8.20E-04 0.002450292 -0.274776455 -0.001061091 -0.001421238 





Appendix H Gene ontology analysis for MOFA 
factors 1-5 
Gene Ontology (GO) terms enriched for the top 50 gene loadings for MOFA factor 1, using 
965 highly variable genes as a background: 
Process      
GO term Description P-value FDR q-value 
Enrichment (N, 









Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 






GO:0006412 translation 1.83E-08 6.75E-05 
12.24 
(900,12,49,8) 
Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
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Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 











Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 
















inhibitor 1a (p21) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Ddit4 - dna-damage-
inducible transcript 4 
Perp - perp, tp53 
apoptosis effector 
Phlda3 - pleckstrin 
homology-like 










Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
 H-3 
 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 
Gpx3 - glutathione 
peroxidase 3 














inhibitor 1a (p21) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Ddit4 - dna-damage-
inducible transcript 4 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 
Perp - perp, tp53 
apoptosis effector 
Phlda3 - pleckstrin 
homology-like 










Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 
Gpx3 - glutathione 
peroxidase 3 























inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Bbc3 - bcl2 binding 
component 3 
Ddit4 - dna-damage-
inducible transcript 4 
Phlda3 - pleckstrin 
homology-like 











Klf4 - kruppel-like 
factor 4 (gut) 
Btg2 - b cell 
translocation gene 2, 
anti-proliferative 
Btg1 - b cell 




inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Plk2 - polo-like kinase 
2 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 









Klf4 - kruppel-like 
factor 4 (gut) 
Btg2 - b cell 
translocation gene 2, 
anti-proliferative 
Btg1 - b cell 




inhibitor 1a (p21) 
 H-5 
 
Hsp90ab1 - heat 
shock protein 90 alpha 
(cytosolic), class b 
member 1 
Rps27l - ribosomal 
protein s27-like 
Plk2 - polo-like kinase 
2 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 
Ccng1 - cyclin g1 
Trp53inp1 - 
transformation related 
protein 53 inducible 











Rps4x - ribosomal 
protein s4, x-linked 
Klf4 - kruppel-like 




Rpl22l1 - ribosomal 
protein l22 like 1 
Hsp90ab1 - heat 
shock protein 90 alpha 
(cytosolic), class b 
member 1 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 










rich coiled-coil 1 





Klf4 - kruppel-like 
factor 4 (gut) 
Btg2 - b cell 
translocation gene 2, 
anti-proliferative 
Btg1 - b cell 




inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Plk2 - polo-like kinase 
2 
Cenpf - centromere 
protein f 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 










Rps4x - ribosomal 
protein s4, x-linked 
Klf4 - kruppel-like 
factor 4 (gut) 
Rpl22l1 - ribosomal 
protein l22 like 1 
Hsp90ab1 - heat 
shock protein 90 alpha 
(cytosolic), class b 
member 1 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 
Eef2 - eukaryotic 
translation elongation 
factor 2 





Btg2 - b cell 








inhibitor 1a (p21) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Ddit4 - dna-damage-




Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 
Ccng1 - cyclin g1 
Phlda3 - pleckstrin 
homology-like 











Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 





















inhibitor 1a (p21) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
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Ddit4 - dna-damage-
inducible transcript 4 
Phlda3 - pleckstrin 
homology-like 












Klf4 - kruppel-like 
factor 4 (gut) 
Cdkn1a - cyclin-
dependent kinase 
inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 













Serpine2 - serine (or 
cysteine) peptidase 
inhibitor, clade e, 
member 2 
Klf4 - kruppel-like 
factor 4 (gut) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Ctsd - cathepsin d 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 















Klf4 - kruppel-like 
factor 4 (gut) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Ctsd - cathepsin d 
 H-9 
 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 









04 1.72E-01 9.18 (900,8,49,4) 
Klf4 - kruppel-like 
factor 4 (gut) 
Cdkn1a - cyclin-
dependent kinase 
inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Mdm2 - transformed 






of mitotic cell 
cycle 
4.64E-
04 1.63E-01 9.18 (900,8,49,4) 
Klf4 - kruppel-like 
factor 4 (gut) 
Cdkn1a - cyclin-
dependent kinase 
inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Mdm2 - transformed 












Klf4 - kruppel-like 
factor 4 (gut) 
Cdkn1a - cyclin-
dependent kinase 
inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 










Klf4 - kruppel-like 
factor 4 (gut) 
Cdkn1a - cyclin-
dependent kinase 
inhibitor 1a (p21) 
Hsp90ab1 - heat 
shock protein 90 alpha 
(cytosolic), class b 
member 1 
Rps27l - ribosomal 
protein s27-like 
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Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 
Ccng1 - cyclin g1 









Serpine2 - serine (or 
cysteine) peptidase 
inhibitor, clade e, 
member 2 
Klf4 - kruppel-like 
factor 4 (gut) 
Hsp90ab1 - heat 
shock protein 90 alpha 
(cytosolic), class b 
member 1 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Ctsd - cathepsin d 
Plk2 - polo-like kinase 
2 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 










Rps4x - ribosomal 
protein s4, x-linked 
Klf4 - kruppel-like 
factor 4 (gut) 
Rpl22l1 - ribosomal 
protein l22 like 1 
Hsp90ab1 - heat 
shock protein 90 alpha 
(cytosolic), class b 
member 1 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 




Rps18 - ribosomal 
protein s18 











Rps4x - ribosomal 




Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Eef1a1 - eukaryotic 
translation elongation 
factor 1 alpha 1 
Plk2 - polo-like kinase 
2 
Rps23 - ribosomal 
protein s23 
Eef2 - eukaryotic 
translation elongation 
factor 2 
Ptp4a3 - protein 
tyrosine phosphatase 
4a3 
Btg2 - b cell 
translocation gene 2, 
anti-proliferative 
Btg1 - b cell 
translocation gene 1, 
anti-proliferative 
Rps19 - ribosomal 
protein s19 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 











Klf4 - kruppel-like 
factor 4 (gut) 




domain containing 10 
Fam162a - family 
with sequence 





rich coiled-coil 1 
Btg1 - b cell 
translocation gene 1, 
anti-proliferative 
Cd81 - cd81 antigen 
Cdkn1a - cyclin-
dependent kinase 
inhibitor 1a (p21) 
Hsp90ab1 - heat 
shock protein 90 alpha 
(cytosolic), class b 
member 1 
Bbc3 - bcl2 binding 
component 3 
Ctsd - cathepsin d 
Perp - perp, tp53 
apoptosis effector 












inhibitor 1a (p21) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Ddit4 - dna-damage-
inducible transcript 4 
Perp - perp, tp53 
apoptosis effector 
Phlda3 - pleckstrin 
homology-like 
domain, family a, 
member 3 
Function      
GO term Description P-value FDR q-value 
Enrichment (N, 









Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 




Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 
GO:0019843 rRNA binding 7.80E-06 5.38E-03 
18.37 
(900,4,49,4) 
Rps4x - ribosomal 
protein s4, x-linked 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 
Rps18 - ribosomal 
protein s18 
Eef2 - eukaryotic 
translation elongation 
factor 2 
Component      
GO term Description P-value FDR q-value 
Enrichment (N, 
B, n, b)  Genes  
GO:0005840 ribosome 2.58E-7 2.2E-4 11.69 (900,11,49,7) 
 
Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 







3.92E-7 1.67E-4 18.37 (900,5,49,5) 
 
Rps4x - ribosomal 
protein s4, x-linked 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 






3.92E-7 1.11E-4 18.37 (900,5,49,5) 
 
Rps4x - ribosomal 
protein s4, x-linked 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
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protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 




Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 
GO:0044445 cytosolic part 2.46E-5 4.19E-3 8.48 (900,13,49,6) 
 
Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Rps18 - ribosomal 
protein s18 
 
Gene Ontology (GO) terms enriched fpr the top 50 gene loadings for MOFA factor 2, using 
965 highly variable genes as a background: 
Process      


















Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
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Tet1 - tet methylcytosine 
dioxygenase 1 
Jarid2 - jumonji, at rich 
interactive domain 2 
Hist1h1b - histone cluster 1, h1b 













Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Tet1 - tet methylcytosine 
dioxygenase 1 
Jarid2 - jumonji, at rich 
interactive domain 2 
Hist1h1b - histone cluster 1, h1b 
Top2a - topoisomerase (dna) ii 
alpha 














Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Tet1 - tet methylcytosine 
dioxygenase 1 
Jarid2 - jumonji, at rich 
interactive domain 2 
Hist1h1b - histone cluster 1, h1b 






Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Comt - catechol-o-
methyltransferase 
Wtap - wilms' tumour 1-
associating protein 
Rbm15 - rna binding motif 
protein 15 













Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
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Tet1 - tet methylcytosine 
dioxygenase 1 
Hist1h1b - histone cluster 1, h1b 
Rbm15 - rna binding motif 
protein 15 














Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Tet1 - tet methylcytosine 
dioxygenase 1 
Jarid2 - jumonji, at rich 
interactive domain 2 
Hist1h1b - histone cluster 1, h1b 
Top2a - topoisomerase (dna) ii 
alpha 













Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Jarid2 - jumonji, at rich 
interactive domain 2 
Tet1 - tet methylcytosine 
dioxygenase 1 
Hist1h1b - histone cluster 1, h1b 













Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Wtap - wilms' tumour 1-
associating protein 
Rbm15 - rna binding motif 
protein 15 
Meg3 - maternally expressed 3 














Jarid2 - jumonji, at rich 
interactive domain 2 
Tet1 - tet methylcytosine 
dioxygenase 1 














Hist1h1e - histone cluster 1, h1e 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Hist1h1b - histone cluster 1, h1b 















Hist1h1e - histone cluster 1, h1e 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Tet1 - tet methylcytosine 
dioxygenase 1 
Hist1h1b - histone cluster 1, h1b 














Dnmt3b - dna methyltransferase 
3b 
Jarid2 - jumonji, at rich 
interactive domain 2 














Dnmt3b - dna methyltransferase 
3b 
Tet1 - tet methylcytosine 
dioxygenase 1 
Jarid2 - jumonji, at rich 
interactive domain 2 














Dnmt3b - dna methyltransferase 
3b 
Jarid2 - jumonji, at rich 
interactive domain 2 
Tet1 - tet methylcytosine 
dioxygenase 1 
Rif1 - rap1 interacting factor 1 
homolog (yeast) 














Hist1h1e - histone cluster 1, h1e 
Tet1 - tet methylcytosine 
dioxygenase 1 












Hist1h1e - histone cluster 1, h1e 
Tet1 - tet methylcytosine 
dioxygenase 1 













Hist1h1e - histone cluster 1, h1e 
Tet1 - tet methylcytosine 
dioxygenase 1 
Hist1h1b - histone cluster 1, h1b 








Dnmt3b - dna methyltransferase 
3b 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Tet1 - tet methylcytosine 
dioxygenase 1 
Meg3 - maternally expressed 3 
Function      





(N, B, n, b)  Genes  









Sall4 - sal-like 4 (drosophila) 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Nip7 - nuclear import 7 homolog 
(s. cerevisiae) 
Myef2 - myelin basic protein 
expression factor 2, repressor 
Skil - ski-like 
Ncoa3 - nuclear receptor 
coactivator 3 
Dnajc21 - dnaj (hsp40) homolog, 
subfamily c, member 21 
Jarid2 - jumonji, at rich 
interactive domain 2 
Rrn3 - rrn3 rna polymerase i 




Tet1 - tet methylcytosine 
dioxygenase 1 
Rbm15 - rna binding motif 
protein 15 
L1td1 - line-1 type transposase 
domain containing 1 
Tcf15 - transcription factor 15 
Cbx3 - chromobox 3 
Zfp428 - zinc finger protein 428 
Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Hist1h1b - histone cluster 1, h1b 
Snrpn - small nuclear 
ribonucleoprotein n 














Sall4 - sal-like 4 (drosophila) 
Pfas - 
phosphoribosylformylglycinamid
ine synthase (fgar 
amidotransferase) 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Nip7 - nuclear import 7 homolog 
(s. cerevisiae) 
Skil - ski-like 
Plk4 - polo-like kinase 4 
Myef2 - myelin basic protein 
expression factor 2, repressor 
Ncoa3 - nuclear receptor 
coactivator 3 
Dnajc21 - dnaj (hsp40) homolog, 
subfamily c, member 21 
Rrn3 - rrn3 rna polymerase i 
transcription factor homolog 
(yeast) 
Jarid2 - jumonji, at rich 
interactive domain 2 
Tet1 - tet methylcytosine 
dioxygenase 1 
Rbm15 - rna binding motif 
protein 15 
L1td1 - line-1 type transposase 
domain containing 1 
Tcf15 - transcription factor 15 
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Actb - actin, beta 
Cbx3 - chromobox 3 
Zfp428 - zinc finger protein 428 
Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Hist1h1b - histone cluster 1, h1b 
Snrpn - small nuclear 
ribonucleoprotein n 














Sall4 - sal-like 4 (drosophila) 
Pfas - 
phosphoribosylformylglycinamid
ine synthase (fgar 
amidotransferase) 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Nip7 - nuclear import 7 homolog 
(s. cerevisiae) 
Skil - ski-like 
Plk4 - polo-like kinase 4 
Myef2 - myelin basic protein 
expression factor 2, repressor 
Ncoa3 - nuclear receptor 
coactivator 3 
Dnajc21 - dnaj (hsp40) homolog, 
subfamily c, member 21 
Jarid2 - jumonji, at rich 
interactive domain 2 
Rrn3 - rrn3 rna polymerase i 
transcription factor homolog 
(yeast) 
Tet1 - tet methylcytosine 
dioxygenase 1 
Rbm15 - rna binding motif 
protein 15 
L1td1 - line-1 type transposase 
domain containing 1 
Tcf15 - transcription factor 15 
Actb - actin, beta 
Cbx3 - chromobox 3 
Zfp428 - zinc finger protein 428 




Hist1h1e - histone cluster 1, h1e 
Hist1h1b - histone cluster 1, h1b 
Snrpn - small nuclear 
ribonucleoprotein n 
Top2a - topoisomerase (dna) ii 
alpha 
Component      





(N, B, n, b)  Genes  







Sall4 - sal-like 4 (drosophila) 
Parp1 - poly (adp-ribose) 
polymerase family, member 1 
Nip7 - nuclear import 7 homolog 
(s. cerevisiae) 
Plk4 - polo-like kinase 4 
Myef2 - myelin basic protein 
expression factor 2, repressor 
Skil - ski-like 
Ncoa3 - nuclear receptor 
coactivator 3 
Fam60a - family with sequence 
similarity 60, member a 
Jarid2 - jumonji, at rich 
interactive domain 2 
Rrn3 - rrn3 rna polymerase i 
transcription factor homolog 
(yeast) 
Rbm15 - rna binding motif 
protein 15 
Tcf15 - transcription factor 15 
Actb - actin, beta 
Cbx3 - chromobox 3 
Dnmt3b - dna methyltransferase 
3b 
Hist1h1e - histone cluster 1, h1e 
Wtap - wilms' tumour 1-
associating protein 
Hist1h1b - histone cluster 1, h1b 
Snrpn - small nuclear 
ribonucleoprotein n 
Malat1 - metastasis associated 
lung adenocarcinoma transcript 1 
(non-coding rna) 
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Top2a - topoisomerase (dna) ii 
alpha 
Rif1 - rap1 interacting factor 1 
homolog (yeast) 
 
Gene Ontology (GO) terms enriched fpr the top 50 gene loadings for MOFA factor 3, using 
965 highly variable genes as a background: 
Process: None     
Function: None     
Component:      
GO term Description P-value FDR q-value 
Enrichment (N, 






04 4.47E-01 9.09 (901,9,44,4) 
 
Zscan4c - zinc finger 
and scan domain 
containing 4c 






Zscan4d - zinc finger 
and scan domain 
containing 4d 
Zscan4f - zinc finger 
and scan domain 
containing 4f 
 
Gene Ontology (GO) terms enriched for the top 50 gene loadings for MOFA factor 4, using 
965 highly variable genes as a background: 
Process      
GO term Description P-value FDR q-value 
Enrichment (N, 













Hspb1 - heat shock 
protein 1 
Parp1 - poly (adp-
ribose) polymerase 


















Klf4 - kruppel-like 
factor 4 (gut) 
Klf2 - kruppel-like 
factor 2 (lung) 












Klf4 - kruppel-like 
factor 4 (gut) 
Enah - enabled 
homolog (drosophila) 
Zfp42 - zinc finger 
protein 42 
Mkrn1 - makorin, ring 
finger protein, 1 
Kdm5b - lysine (k)-
specific demethylase 
5b 
Spp1 - secreted 
phosphoprotein 1 
Mtf2 - metal response 
element binding 












Klf4 - kruppel-like 
factor 4 (gut) 
Enah - enabled 
homolog (drosophila) 
Zfp42 - zinc finger 
protein 42 
Mkrn1 - makorin, ring 
finger protein, 1 
Kdm5b - lysine (k)-
specific demethylase 
5b 
Spp1 - secreted 
phosphoprotein 1 
Mtf2 - metal response 
element binding 










Klf4 - kruppel-like 
factor 4 (gut) 




Cdc5l - cell division 
cycle 5-like (s. 
pombe) 
Zfp57 - zinc finger 
protein 57 
Parp1 - poly (adp-
ribose) polymerase 





Tet1 - tet 
methylcytosine 
dioxygenase 1 
Nr0b1 - nuclear 
receptor subfamily 0, 
group b, member 1 
Rpp25 - ribonuclease 
p/mrp 25 subunit 
Chchd10 - coiled-coil-
helix-coiled-coil-helix 
domain containing 10 
Tcea3 - transcription 
elongation factor a 
(sii), 3 
H2afx - h2a histone 
family, member x 
Spp1 - secreted 
phosphoprotein 1 
Upp1 - uridine 
phosphorylase 1 
Dhx16 - deah (asp-
glu-ala-his) box 
polypeptide 16 
Morc1 - microrchidia 
1 






Klf4 - kruppel-like 
factor 4 (gut) 
Cdc5l - cell division 
cycle 5-like (s. 
pombe) 
Hspb1 - heat shock 
protein 1 
Sox2 - sry-box 
containing gene 2 
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Parp1 - poly (adp-
ribose) polymerase 
family, member 1 
Stmn2 - stathmin-like 
2 






Zfp57 - zinc finger 
protein 57 
Parp1 - poly (adp-
ribose) polymerase 
family, member 1 
Tet1 - tet 
methylcytosine 
dioxygenase 1 
Morc1 - microrchidia 
1 
Function      
GO term Description P-value FDR q-value 
Enrichment (N, 
B, n, b)  Genes  






Klf4 - kruppel-like 
factor 4 (gut) 
Cdc5l - cell division 
cycle 5-like (s. 
pombe) 
Zfp42 - zinc finger 
protein 42 
Klf2 - kruppel-like 
factor 2 (lung) 
Zfp57 - zinc finger 
protein 57 
Parp1 - poly (adp-
ribose) polymerase 
family, member 1 
Kdm5b - lysine (k)-
specific demethylase 
5b 
Tet1 - tet 
methylcytosine 
dioxygenase 1 
Mtf2 - metal response 
element binding 
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Nr0b1 - nuclear 
receptor subfamily 0, 
group b, member 1 
Rpp25 - ribonuclease 
p/mrp 25 subunit 
Tcea3 - transcription 
elongation factor a 
(sii), 3 
H2afx - h2a histone 
family, member x 
Sox2 - sry-box 
containing gene 2 
Eif2s2 - eukaryotic 
translation initiation 
factor 2, subunit 2 
(beta) 
Dhx16 - deah (asp-
glu-ala-his) box 
polypeptide 16 
Sod2 - superoxide 
dismutase 2, 
mitochondrial 
Component None     
 
Gene Ontology (GO) terms enriched for the top 50 gene loadings for MOFA factor 5, using 
965 highly variable genes as a background: 
Process      
GO term Description P-value FDR q-value 
Enrichment (N, 













inhibitor 1a (p21) 
Foxo3 - forkhead box 
o3 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 




Phlda3 - pleckstrin 
homology-like 












Btg2 - b cell 




inhibitor 1a (p21) 
Foxo3 - forkhead box 
o3 
Bbc3 - bcl2 binding 
component 3 





Mdm2 - transformed 
mouse 3t3 cell double 
minute 2 
Ccng1 - cyclin g1 
Marf1 - meiosis arrest 
female 1 
Phlda3 - pleckstrin 
homology-like 
domain, family a, 
member 3 















inhibitor 1a (p21) 
Bbc3 - bcl2 binding 
component 3 
Rps27l - ribosomal 
protein s27-like 
Perp - perp, tp53 
apoptosis effector 
Phlda3 - pleckstrin 
homology-like 
domain, family a, 
member 3 




Rps4x - ribosomal 
protein s4, x-linked 
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Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 











Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
















inhibitor 1a (p21) 
Foxo3 - forkhead box 
o3 
Rps27l - ribosomal 
protein s27-like 
Mdm2 - transformed 


















inhibitor 1a (p21) 
Rps27l - ribosomal 
protein s27-like 
Bbc3 - bcl2 binding 
component 3 
Phlda3 - pleckstrin 
homology-like 












inhibitor 1a (p21) 




Rps27l - ribosomal 
protein s27-like 
Mdm2 - transformed 











Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 










Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
Component      
GO term Description P-value FDR q-value 
Enrichment (N, 










Rps4x - ribosomal 
protein s4, x-linked 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 











Rps4x - ribosomal 
protein s4, x-linked 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
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Rps19 - ribosomal 
protein s19 






Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 




Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 




Rps4x - ribosomal 
protein s4, x-linked 
Rpl22l1 - ribosomal 
protein l22 like 1 
Rps27l - ribosomal 
protein s27-like 
Rps23 - ribosomal 
protein s23 
Rps19 - ribosomal 
protein s19 
 
Appendix I Gene names of ZGA signature list 
The following list contains the gene names of the ZGA signature list used in chapter 5. The list 
was obtained after merging the gene names in Table S1 from Eckersley-Maslin et al. 2016, 
Table S8 from Hendrickson et al. 2017 and Table S1 from Y. Li et al. 2018. 
0610005C13Rik, 0610009B14Rik, 0610031J06Rik, 0610040J01Rik, 1110005A03Rik, 
1110006O24Rik, 1110017F19Rik, 1110018J18Rik, 1110021L09Rik, 1110032F04Rik, 
1110038B12Rik, 1190002H23Rik, 1300014I06Rik, 1500010J02Rik, 1500012F01Rik, 
1600002K03Rik, 1600010M07Rik, 1600012H06Rik, 1600015I10Rik, 1600020E01Rik, 
1600025M17Rik, 1700001G17Rik, 1700007K13Rik, 1700009P17Rik, 1700010D01Rik, 
1700012B15Rik, 1700013H16Rik, 1700016D06Rik, 1700019B21Rik, 1700019E08Rik, 
1700019N12Rik, 1700024F13Rik, 1700025E21Rik, 1700029I01Rik, 1700034F02Rik, 
1700034H15Rik, 1700048O20Rik, 1700060J05Rik, 1700069L16Rik, 1700080O16Rik, 
1700084E18Rik, 1700086L19Rik, 1700086O06Rik, 1700093K21Rik, 1700096K18Rik, 
1700112E06Rik, 1700123O20Rik, 1810019D21Rik, 1810026B05Rik, 1810032O08Rik, 
1810035L17Rik, 1810044D09Rik, 1810062G17Rik, 2010001M09Rik, 2010204K13Rik, 
2010317E24Rik, 2010320M18Rik, 2210016L21Rik, 2210404O07Rik, 2210414B05Rik, 
2310003L22Rik, 2310011J03Rik, 2310040G24Rik, 2310045N01Rik, 2310047M10Rik, 
2410002F23Rik, 2410004N09Rik, 2410016O06Rik, 2410075B13Rik, 2510002D24Rik, 
2610005L07Rik, 2610019E17Rik, 2610027L16Rik, 2610028H24Rik, 2610206C17Rik, 
2610306M01Rik, 2610318N02Rik, 2700023E23Rik, 2700038G22Rik, 2700078E11Rik, 
2810004N23Rik, 2810006K23Rik, 2810008D09Rik, 2810021B07Rik, 2810029C07Rik, 
2810055F11Rik, 2810405K02Rik, 2810417H13Rik, 2810429I04Rik, 2810459M11Rik, 
2900002K06Rik, 2900079G21Rik, 3010003L10Rik, 3110056K07Rik, 3830408C21Rik, 
4632427E13Rik, 4732471D19Rik, 4831440E17Rik, 4921517L17Rik, 4921531C22Rik, 
4930413G21Rik, 4930427A07Rik, 4930447C04Rik, 4930455C21Rik, 4930465K10Rik, 
4930479M11Rik, 4930483J18Rik, 4930515G01Rik, 4930528A17Rik, 4930547E08Rik, 
4930558C23Rik, 4930578G10Rik, 4930578I07Rik, 4930579G24Rik, 4930583H14Rik, 
4932411N23Rik, 4933404O12Rik, 4933406J08Rik, 4933408N05Rik, 4933411G11Rik, 
4933430I17Rik, 4933430M04Rik, 4933440M02Rik, 5330411J11Rik, 5330426P16Rik, 
5430402O13Rik, 5430416N02Rik, 5730408K05Rik, 5730419I09Rik, 5730455P16Rik, 
5730508B09Rik, 5730590G19Rik, 5830403L16Rik, 5830433M19Rik, 6030408B16Rik, 
6230400D17Rik, 6230427J02Rik, 6430573F11Rik, 9130008F23Rik, 9330020H09Rik, 
9330133O14Rik, 9330159M07Rik, 9430008C03Rik, 9430015G10Rik, 9430016H08Rik, 
9430021M05Rik, 9430060I03Rik, 9530077C05Rik, A130040M12Rik, A2m, A330049M08Rik, 
A430035B10Rik, A430084P05Rik, A430089I19Rik, A530032D15Rik, A530040E14Rik, 
A630001G21Rik, A630066F11Rik, A630072M18Rik, A730018C14Rik, A730037C10Rik, 
A730085A09Rik, AA467197, Aacs, Abcb10, Abcb5, Abcc8, Abhd14b, Abhd3, Ablim1, Abo, Abpg, 
AC079644.1, AC079644.2, AC079644.3, AC091683.1, AC091683.2, AC121866.1, AC121888.1, 
AC122464.1, AC122464.2, AC124724.1, AC127274.2, AC127374.1, AC130840.1, AC132362.1, 
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AC134841.1, AC140240.1, AC140409.1, AC153539.1, AC153998.1, AC156643.1, AC158600.1, 
AC158600.2, AC158600.3, AC158600.4, AC158600.6, AC164627.1, AC165327.2, AC211878.1, 
AC231112.1, AC231112.2, AC238940.1, AC238940.3, AC239617.1, AC239678.2, AC240744.3, 
Acaa1a, Acad8, Acap3, Acn9, Acot1, Acrbp, Acrv1, Acss3, Actr2, Actr5, Adad1, Adam2, Adamts1, 
Adamts5, Adck4, Adcy2, Adh7, Adi1, Adm, Adnp, Adora2b, Adrb3, Adrbk1, AF067061, AF067063, 
Aff1, Aga, Agmat, Agpat9, Agrp, Agtrap, Ahnak, Ahnak2, AI427809, AI462493, AI464131, 
AI838599, Ajap1, Ak4, Akr1b7, Aldh18a1, Aldh1l1, Alg5, Alkbh4, Aloxe3, Alppl2, Amd2, Amhr2, 
Amica1, Ankdd1b, Ankrd17, Ankrd22, Ankrd35, Ankrd50, Ankrd54, Ankrd9, Antxr1, Ap2a2, Ap4m1, 
Apoa2, Apoc2, Apod, Apol7b, Apom, Aqp11, Aqp3, Aqr, Arap2, Arf2, Arfgap2, Arfip2, Arfrp1, Arg1, 
Arg2, Arhgap29, Arhgap36, Arhgap8, Arhgdib, Arhgdig, Arhgef26, Arid3c, Arid5a, Arid5b, Arih2, 
Arl13b, Arl14, Arl15, Arl16, Arl5c, Arnt, Arrdc3, Arrdc4, Arx, Ascl1, Ascl2, Asl, Asns, Ate1, Atf2, 
Atf3, Atf5, Atg4d, Atg9a, Atp5s, Atp6v1e1, Atp6v1g3, Atp8b1, Atxn7l3, AU019990, AU022252, 
AU041133, Auts2, Avpi1, AW822073, Axin2, AY761184, B020004C17Rik, B020004J07Rik, 
B020031M17Rik, B3gnt4, B3gntl1, B4galnt2, B4galt1, B4galt6, B930059L03Rik, Baat1, Bag3, 
Bambi, Bambips1, BB287469, "BB287469, Gm4027", BC002230, BC003965, BC016495, BC017647, 
BC025920, BC027231, BC028528, BC033916, BC037704, BC046404, BC048355, BC048507, 
BC049715, BC049762, BC057022, BC061212, BC080695, BC147527, Bcdin3d, Bcl2l14, Bcor, 
Bcorl1, Bcs1l, Bdh1, Bdnf, Bend3, Bend6, Best2, Bex1, Bex2, Bex6, Bhlhb9, Bicc1, Bid, Blnk, Blvrb, 
Bmp2, Bmyc, Bnc2, Bnip3, Bola2, Boll, Bop1, Brd2, Bre, Bri3bp, Bst1, Btbd19, Btg1, Btg2, Bud13, 
C030034I22Rik, C130026I21Rik, C130060C02Rik, C130074G19Rik, C1d, C1ql1, C1qtnf4, 
C230096C10Rik, C2cd2l, C2cd4b, C630043F03Rik, C86695, Cab39, Cacna1h, Cacna1s, Calcoco2, 
Cald1, Calml4, Cand1, Cap1, Capn5, Capsl, Car6, Caskin2, Catsperg1, Cbx7, Ccdc106, Ccdc110, 
Ccdc116, Ccdc125, Ccdc126, Ccdc134, Ccdc137, Ccdc160, Ccdc50, Ccdc60, Ccdc64b, Ccdc66, 
Ccdc83, Ccdc85b, Cchcr1, Ccl3, Ccng2, Ccnjl, Ccno, Ccrn4l, Ccs, Cct8l1, Cd200r2, Cd24a, Cd52, 
Cd63, Cd97, Cda, Cdan1, Cdc42ep3, Cdc42ep4, Cdk4, Cdk5r1, Cdk5rap3, Cdkn2aip, Cdkn3, Cdrt4, 
Cdsn, Cdyl2, Ceacam1, Ceacam19, Cebpa, Celf4, Cep57l1, Cep97, Cetn1, Chchd4, Chchd5, Chek2, 
Chga, Chit1, Chkb, Chrac1, Chrm3, Chrna10, Chrna5, Chrna9, Chst7, Chtf18, Chtf8, Churc1, Cirbp, 
Cited1, Cited4, Clcn5, Cldn18, Cldn3, Cldn5, Cldn6, Clec10a, Clic1, Clip2, Clk1, Clk3, Cln8, Clp1, 
Clu, Cml1, Cml2, Cmtm2a, Cndp2, Cnn2, Cnnm2, Cnnm3, Cnpy1, Cnpy3, Cntnap3, Cobl, Coch, 
Col12a1, Col13a1, Col28a1, Col4a1, Col4a2, Colq, Commd7, Coq4, Cotl1, Cox19, Cox8c, Cpb2, Cpe, 
Cpeb2, Cpt1a, Crabp1, Crebl2, Creld1, Crip1, Crtap, Crx, Crxos1, Csmd1, Csrnp1, Csrnp3, Cst6, Cst7, 
Cst9, Cstb, CT025616.1, CT030687.1, CT485612.1, CT485612.2, CT954323.2, Ctf2, Ctla2b, Ctr9, 
Ctrb1, Ctsa, Ctsc, Ctsl, Ctss, Ctsz, Ctu1, Cuedc2, Cwc22, Cwc25, Cxadr, Cxcl10, Cxcl11, Cxcl16, 
Cyba, Cyp2b23, Cyp2c44, Cyp2c67, Cyp2s1, "Cypt1, Cypt8", Cypt12, Cypt2ps, Cypt3, "Cypt4, 
Cypt9", Cypt7, D17Ertd648e, D1Pas1, D4Wsu53e, D5Ertd605e, D7Ertd143e, Dact3, Dapl1, Dars2, 
Dazl, Dbc1, Dbndd2, Dbnl, Dbp, Dbr1, Dbx1, Dcbld1, Dcc, Dcdc5, Dclre1c, Dcp2, Ddhd1, Ddit4, 
Ddit4l, Ddr2, Ddx26b, Ddx31, Ddx39, Ddx43, Decr2, Dedd2, Def8, Defb13, Defb23, Defb25, 
Dennd4c, Depdc1b, Depdc5, Depdc7, Dexi, Dgkk, Dhcr24, Dhcr7, Dhdds, Dhh, Dhrs7b, Dhtkd1, 
Dido1, Dkkl1, Dlgap2, Dlgap3, Dlx2, Dmrt1, Dnahc7b, Dnajb14, Dnajb3, Dnajb9, Dnajc12, Dnajc28, 
Dnajc6, Dnlz, Dnpep, Doc2a, Dock9, Dohh, Dolpp1, Dpagt1, Dpep1, Dpf3, Dph2, Dpp7, Dppa2, 
Dppa3, Dppa5a, Dpys, Dpysl3, Dpysl5, Drd3, Drr1, Dsg1b, Dst, Dub1, Dub1a, Dub2a, Dub3, Duox2, 
Duoxa2, Dusp1, Dusp28, Dusp4, Dux, Dyrk3, Dyrk4, Dzip1, E130309D02Rik, E2f7, Ears2, Ebf3, 
Ecel1, Echdc2, Echdc3, Ecm2, Ecsit, Efcab4b, Egflam, Egr1, Eid2, Eif2s3y, Eif4ebp3, Eif5a2, Elovl4, 
Elovl6, Emp3, Endod1, Enpp3, Entpd7, Epha10, Ephb1, Epm2a, Epm2aip1, Ercc4, Ero1l, Errfi1, 
Esp24, Esrrb, Esrrg, Esyt3, Etfdh, Etohd2, Etv3, Etv5, Exoc7, Exoc8, Exog, Exosc6, F11r, Fabp9, Fadd, 
Fah, Fahd1, Fam102b, Fam105a, Fam109a, Fam124a, Fam134a, Fam13c, Fam150a, Fam151a, 
Fam158a, Fam171b, Fam173b, Fam176a, Fam181b, Fam190a, Fam195b, Fam203a, Fam20b, Fam33a, 
Fam43b, Fam53c, Fam57b, Fam73a, Fam76a, Fam81a, Fam84a, Fam84b, Fam89b, Fan1, Fancf, Fat3, 
Fblim1, Fbll1, Fbxl15, Fbxo15, Fbxo31, Fbxo34, Fbxo6, Fbxw9, Fcgbp, Fcgr2b, Fcgrt, Fdxr, Fgf1, 
Fgf4, Filip1l, Fkbp11, Fkbp1b, Flrt2, Flt4, Flywch2, Folr1, Folr2, Fos, Foxi3, Foxo6, Foxp1, Foxred1, 
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Frat2, Frrs1, Fscn1, Fstl4, Fthl17, Fundc1, Fv1, Fxyd6, Fzd4, Fzd5, Fzd7, Fzd9, G2e3, Gabarap, Gabpa, 
Gabra1, Gadd45g, Gal, Gal3st2, Galns, Galnt3, Galt, Gan, Gata1, Gba2, Gcdh, Gcnt1, Gcnt2, Gdap10, 
Gdpd4, Gfra3, Ggn, Gja1, Gjb3, Gla, Glipr2, Glod5, Glrx, Glrx2, Glrx3, Glt25d1, Glud1, Glul, 
Gm10188, Gm10264, Gm10354, Gm10394, Gm10424, Gm10505, Gm10553, Gm10639, Gm10668, 
Gm10696, Gm10718, Gm10800, Gm10801, Gm11052, Gm11232, Gm11236, Gm11237, Gm11238, 
Gm11239, Gm11487, Gm11517, Gm11544, Gm11564, Gm11602, Gm11640, Gm11756, Gm11757, 
Gm11974, Gm12088, Gm12114, Gm12531, Gm12702, Gm12714, Gm12724, Gm12730, Gm12789, 
Gm12790, Gm12794, Gm12800, Gm12823, Gm12824, Gm12953, Gm13040, Gm13043, Gm13057, 
Gm13078, Gm13083, Gm13101, Gm13109, Gm13119, Gm13128, Gm13139, Gm13335, Gm13498, 
Gm13693, Gm13694, Gm13695, Gm13696, Gm13698, Gm13718, Gm13871, Gm13962, Gm13964, 
Gm14322, Gm14325, Gm14326, Gm14393, Gm14403, Gm14634, Gm14742, Gm14798, Gm14929, 
Gm15023, Gm1527, Gm15421, Gm15455, Gm15787, Gm16008, Gm16023, Gm16028, Gm16062, 
Gm16119, Gm16211, Gm16239, Gm16243, Gm16381, Gm16429, Gm16513, Gm16517, Gm17019, 
Gm17026, Gm17611, Gm1995, Gm2016, Gm20199, Gm2022, Gm2027, Gm2042, Gm20431, 
Gm20440, Gm2046, Gm20580, Gm20625, Gm20631, Gm20634, Gm2075, Gm281, Gm2a, Gm3139, 
Gm3258, Gm4027, Gm428, Gm4301, Gm4302, Gm4303, Gm4305, Gm4307, Gm4312, Gm4340, 
Gm44, Gm4532, Gm4778, Gm4782, Gm4827, Gm4858, Gm4971, Gm498, Gm4981, Gm4984, 
Gm5077, Gm5127, Gm5148, Gm5286, Gm5577, Gm5590, Gm5612, Gm5635, Gm5647, Gm5662, 
Gm5698, Gm5699, Gm5773, Gm581, Gm6086, Gm6189, Gm6351, Gm6432, Gm6468, Gm6502, 
Gm6507, Gm6509, Gm6568, Gm6654, Gm6763, Gm6880, Gm6890, Gm6902, Gm7102, Gm749, 
Gm7647, Gm7682, Gm773, Gm7942, Gm7982, Gm8038, Gm8094, Gm8104, Gm8300, Gm8766, 
Gm8994, Gm9, Gm9116, Gm9125, Gm973, Gm9895, Gm9958, Gmeb2, Gmpr2, Gna15, Gnat1, Gnaz, 
Gnb4, Gnl1, Gnl3l, Golga1, Gorasp1, Gpa33, Gpatch3, Gpbp1l1, Gpc5, Gpkow, Gpr126, Gpr137c, 
Gpr161, Gpr182, Gpr19, Gpr50, Gpr63, Gpr75, Gpr83, Gprc5c, Gpx7, Grb7, Gria1, Grifin, Grik3, 
Grk4, Grk6, Grp, Grwd1, Gsta4, Gstm1, Gstm6, Gsto1, Gt(ROSA)26Sor, Gtf2b, Gtf2i, Gtf3c4, Gtf3c5, 
Gtpbp3, Gtsf1l, Guca1a, Gulo, Gusb, H1f0, H2Bl, H2D1, H2DMa, H2M10.4, "H2Q7, H2Q9", H2Q8, 
"H2T22, H2T9", H2T9, H2afx, H47, Hadha, Hars2, Hbaa2, Hcrt, Hdc, Hddc3, Hdhd3, Herpud1, Hes1, 
Hesx1, Hexa, Hexb, Hexdc, Hexim1, Hinfp, Hip1, Hipk1, Hist1h1a, Hist1h1c, Hist1h2aa, Hist1h2ab, 
Hist1h2ac, Hist1h2ad, Hist1h2ag, Hist1h2ah, Hist1h2bh, Hist1h2bj, Hist1h2bk, Hist1h2bl, Hist1h2bp, 
Hist1h3c, Hist1h3d, Hist1h3e, Hist1h3g, Hist1h3h, Hist1h4b, Hist1h4f, Hist1h4i, Hist1h4j, Hist1h4n, 
Hist2h3c2, Hist3h2ba, Hlx, Hmgb4, Hmgcl, Hmgn3, Hmx1, Hoxa1, Hoxa9, Hoxb2, Hoxd10, Hoxd11, 
Hoxd13, Hpdl, Hrh2, Hs6st2, Hsd17b10, Hsd17b14, Hspa1a, Hspa1b, Hspa1l, Hspa2, Hspa8, Hspb3, 
Hspb8, Hspbp1, Htra1, I0C0044D17Rik, Iah1, Iars, Id1, Id3, Id4, Idh2, Idh3b, Ier2, Ier3, Ier3ip1, Ier5, 
Iffo1, Ifi35, Ifitm1, Ifitm3, Ifltd1, Ifng, Igf2bp1, Igfbp2, Igfbp3, Ighe, Igtp, Ikbip, Ikzf5, Il12rb2, 
Il18rap, Il2rg, Il6ra, Il6st, Impa1, Impdh1, Ing4, Inpp4b, Inpp5j, Insl6, Insrr, Ints7, Ipo4, Iqcf1, Iqch, 
Iqub, Irak2, Irak3, Irf2bp1, Irf3, Irf7, Irf9, Irgq, Irx1, Irx2, Irx4, Isca2, Isg15, Isg20, Isg20l2, Itfg2, 
Itgae, Itpkc, Jam2, Jmjd4, Jmjd8, Jmy, Jub, Jun, Junb, Kank4, Kat2b, Katnb1, Kbtbd10, Kbtbd2, Kcna1, 
Kcna3, Kcne1, Kcnj13, Kcnk6, Kcnn2, Kdelc2, Kdm4c, Kdm5a, Kif14, Kif18b, Kifc2, Kirrel, Klb, 
Klf3, Klf5, Klf9, Klhl13, Klhl7, Klrg2, Kpna1, Kpna4, Kri1, Krt18, Krt28, Krtap413, L1td1, L2hgdh, 
Laptm5, Lass5, Lass6, Lat2, Lck, Lctl, Ldhc, Lefty2, Lemd3, Leng8, Lgals1, Lgals12, Lgals2, Lgals4, 
Lgals9, Lhfpl1, Lias, Limch1, Lime1, Limk1, Lin7a, Lin7b, Lmbr1l, Lmo4, Lmx1a, Lnp, 
LOC100503496, Lonp2, Lonrf3, Loxl1, Lpar6, Lpcat3, Lpcat4, Lphn2, Lphn3, Lrig1, Lrp12, Lrrc2, 
Lrrc38, Lrrc3b, Lrrn4, Lst1, Lta, Lxn, Ly6g5b, Lyrm1, Lyrm2, Lyrm5, Macrod1, Mad2l1bp, Mafb, 
Mafk, Magel2, Mak16, Malt1, Man1b1, Man2a2, Man2b1, Maneal, Map2k3, Map3k3, Mapkapk2, 
March1, March3, Marcksl1, Mars2, Marveld1, Maz, Mb, Mbd4, Mbd5, Mbd6, Mbnl3, Mccc2, Mcm6, 
Mcm9, Mctp2, Mcts2, Mdn1, Mdp1, Mecom, Med26, Med29, Mef2a, Mef2d, Meg3, Meox2, Mep1b, 
Mesdc2, Mest, Mettl13, Mettl2, Mfap4, Mfap5, Mfsd12, Mfsd5, Mfsd7b, Mfsd7c, Mga, Mgat2, Mgll, 
Micall1, Micu1, Mir17hg, Mlh1, Mlh3, Mlxip, Mmp19, Mmrn2, Mn1, Mob3a, Mob3b, Mob3c, Morc1, 
Mpdu1, Mpp1, Mppe1, Mpv17, Mreg, Mrgprb1, Mrgprx2, Mrm1, Mrpl17, Mrpl33, Mrps34, Msra, 
Msx1, Mt1, Mt2, Mt3, Mta2, Mtap6, Mtap7d3, Mtch2, Mterfd3, Mthfr, Mtrf1l, Mtss1, Mttp, Muc13, 
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Mum1l1, Mvd, Mvk, Myadml2, Myc, Mycs, Myg1, Myl3, Mylpf, Myo1e, Myof, N4bp3, N6amt2, 
Naalad2, Nanog, Nanos3, Nanp, Narfl, Ncbp1, Ncf1, Ndrg1, Ndufaf1, Ndufaf3, Ndufb7, Ndufc1, 
Nedd4, Nedd4l, Nefl, Nek10, Neto2, Neu4, Neurl2, Neurog2, Nfam1, Nfat5, Nfatc3, Ngfrap1, Nid1, 
Nid2, Ninj2, Nipsnap1, Nkapl, Nkx25, Nlrp4f, Nme4, Nmnat2, Nop16, Nop2, Npc1l1, Npl, Nr2c2, 
Nrarp, Nrip1, Nrip3, Nrp, Nrxn3, Nsmaf, Nt5dc2, Nudt16l1, Nudt22, Nup62cl, Nupr1, Nxf2, Oaz3, 
Obox1, Obox2, Obox3, Obox6, Olfm3, Olfr118, Olfr119, Olfr120, Olfr1277, Olfr161, Olfr18, Olfr214, 
Olfr293, Olfr328, Olfr376, Olfr450, Olfr697, Olfr699, Olfr787, Olfr788, Olfr815, Olfr847, Olfr881, 
Oog4, Oraov1, Ormdl3, Os9, Osbpl6, Osgep, Osgin2, Osm, Osr2, Otud6a, Otx1, Ovol1, Ovol2, Oxsr1, 
P2ry1, P4ha2, Paip2b, Pank3, Papolb, Papolg, Parp10, Pax9, Pcdh10, Pcdh17, Pcdh8, Pcdhgb7, Pcf11, 
Pclo, Pcyt2, Pdcd1, Pde3b, Pde6a, Pde9a, Pdgfrl, Pdk3, Pdk4, Pdlim3, Pdp2, Pdxk, Pemt, Per1, Pgap1, 
Pgk2, Pgm3, Phc2, Phf11, Phf16, Phf17, Phf21b, Phldb2, Pi4k2b, Pias3, Pif1, Pigl, Pigo, Pin1, Pisdps1, 
Pitpnb, Pitpnc1, Piwil2, Pla2g16, Pla2g1b, Plcb1, Plcd4, Plcl1, Pld4, Plekhf1, Plekhm1, Plekho2, Plk2, 
Plk3, Plod3, Plp2, Plxdc2, Pmaip1, Pmm2, Pmpca, Pnp, Pnp2, Polg2, Polh, Polq, Polr2a, Pomc, 
Popdc3, Porcn, Pou2f3, Pou3f1, Pou6f2, Ppat, Ppcs, Ppig, Ppil1, Ppp1r12c, Ppp1r15a, Ppp1r2ps7, 
Ppp1r27, Ppp1r8, Ppp2cb, Ppp2r3a, Pramef6, Pramef8, Pramel1, Pramel3, Pramel4, Pramel5, Pramel6, 
Pramel7, Prdm15, Prdm9, Prdx4, Prex2, Prkch, Prkcz, Prkg1, Prmt10, Prmt6, Prnp, Prps1, Prr14, 
Prr15l, Prr19, Prrg2, Prss23, Prss8, Prtg, Prtn3, Psat1, Psmb10, Psmd13, Psme1, Psmg2, Ptch1, Ptpmt1, 
Ptpn18, Ptpn4, Ptprg, Ptrf, Ptrh1, Pura, Purb, Purg, Pusl1, Pygb, Pygm, Qpctl, Qrsl1, Qtrt1, Rab11fip4, 
Rab19, Rab20, Rab24, Rab30, Rab34, Rab39, Rab40c, Rab42ps, Rab43, Rab4b, Rab7l1, Rabep2, 
Rabepk, Rad9, Rad9b, Radil, Ramp1, Ranbp6, Rapgef2, Rarg, Rasd1, Rasgef1c, Rasl11a, Rasl29, 
Rbm10, Rbm15, Rbm41, Rbms3, Rbmx, Rbp7, Rc3h2, Rccd1, Rcn3, Rdh1, Rdh16, Rdh9, Rdm1, 
Recql4, Reep6, Renbp, Rfc5, Rfpl4b, Rfx4, Rg9mtd2, Rgl2, Rgn, Rgs11, Rgs16, Rgs2, Rhbdl2, Rhox5, 
Ric3, Rilpl2, Rimbp2, Rimklb, Ripk4, Rln1, Rnase4, Rnaseh2a, Rnf103, Rnf113a1, Rnf121, Rnf128, 
Rnf19b, Rnmtl1, Rnpc3, Robo1, Rpgrip1, Rpia, Rpl10l, Rpl39l, Rpp25, Rpp40, Rprd1b, Rps26, Rps27, 
Rpusd1, Rpusd2, Rrp9, Rrs1, Rsph1, Rtn2, Rundc1, Rusc1, Rxra, Rxrg, Sall4, Sat2, Satb2, Scamp1, 
Sccpdh, Scd1, Scd2, Scg5, Sco1, Sco2, Sdr39u1, Sdr9c7, Sec1, Sec61a2, Sel1l2, Sephs2, Sept1, Sept11, 
Sept2, Sept6, Sept9, Sepx1, Serpinb1c, Serpinf1, Sertad1, Sesn1, Sfta2, Sfxn2, Sfxn4, Sgk3, Sh2d3c, 
Sh3bp4, Sh3kbp1, Shb, Shroom1, Siah2, Sik1, Six1, Six4, Skil, Slc10a3, Slc14a2, Slc16a3, Slc16a6, 
Slc1a4, Slc1a5, Slc20a1, Slc22a20, Slc22a28, Slc25a14, Slc25a43, Slc26a1, Slc27a2, Slc27a5, 
Slc29a2, Slc2a1, Slc2a8, Slc30a2, Slc34a2, Slc35e2, Slc35e3, Slc38a2, Slc38a4, Slc39a1, Slc39a14, 
Slc39a4, Slc4a4, Slc4a5, Slc52a2, Slc5a4b, Slc5a6, Slc6a6, Slc6a8, Slc7a3, Slc7a9, Slc9a9, Slfn10ps, 
Smad7, Smg5, Smpd3, Smtn, Smyd5, Snai1, Snai2, Snai3, Snhg11, Snhg12, Snhg3, Snhg4, Snhg7, 
Snhg8, Snrnp35, Snrpc, Snta1, Snw1, Snx8, Socs2, Socs3, Sord, Sowaha, Sowahc, Sox10, Sox11, Sox2, 
Sox3, Sox30, Sox8, Sp110, Sp140, Sp4, Sp6, Spag9, Spdya, Specc1, Speer4c, Speer4d, Speer4e, 
Speer7ps1, Speer8ps1, Spesp1, Spic, Spin2, Spns1, Spock3, Spp1, Sprr2d, Sprr2e, Spry2, Spryd4, 
Spty2d1, Spz1, Srd5a1, Srgap3, Srl, Stac2, Stag3, Stard6, Steap1, Stim1, Stk16, Stk17b, Stk19, Stk38, 
Stmn3, Ston2, Stox1, Sult2b1, Sult5a1, Sun1, Surf2, Sva, Sycp1ps1, Syde2, Syne2, Syngr1, Synm, 
Synpo2, Sytl2, Tacc3, Tacr3, Taf1d, Tagln, Tagln2, Tapbp, Tatdn3, Tbc1d12, Tbl1x, Tbl2, Tbl3, Tbrg3, 
Tbrg4, Tbx1, Tbx20, Tbx3, Tbxa2r, Tceal8, Tchh, Tcirg1, Tcstv1, Tcstv3, Tdh, Tdpoz1, Tdpoz2, 
Tdpoz3, Tdpoz4, Tdpoz5, Tef, Tekt2, Terc, Tex101, Tex13, Tex19.1, Tfap2a, Tfcp2, Tfcp2l1, Tfpi2, 
Tfrc, Thbs1, Thnsl2, Thsd7b, Thy1, Ticam2, Tie1, Timd2, Timm22, Tktl1, Tle3, Tlk2, Tm4sf1, Tmco2, 
Tmed6, Tmeff1, Tmem101, Tmem106a, Tmem119, Tmem126b, Tmem129, Tmem146, Tmem167, 
Tmem167b, Tmem177, Tmem189, Tmem191c, Tmem20, Tmem208, Tmem215, Tmem229b, 
Tmem35, Tmem37, Tmem39a, Tmem56, Tmem79, Tmem92, Tmppe, Tmsb15b1, Tmsb15b2, 
Tmsb15l, Tmx1, Tmx2, Tnfaip6, Tnfaip8l2, Tnfrsf13b, Tnfrsf17, Tnip2, Tnnc2, Tob1, Toe1, Tomm5, 
Tor1b, Tor3a, Tpo, Traf2, Trak2, Trap1a, Trh, Trib3, Trim25, Trim32, Trim43a, Trim43b, Trim43c, 
Trim52, Trim8, Triml2, Trmt1, Trmt61a, Trmt61b, Trp53bp2, Trub2, Tsc22d3, Tsen2, Tsen54, Tsga8, 
Tspan1, Tspan4, Tspan6, Tssk6, Tsx, Ttc30b, Ttc39d, Ttll12, Tuba1a, Tubb2b, Txnip, Uap1, Uap1l1, 
Ubap1, Ubc, Ube2o, Ube2t, Ube2w, Ubtd2, Ubtfl1, Ubxn2a, Ugt1a1, Uhrf1bp1, Uhrf2, Uimc1, 
Unc119b, Upk1a, Upk3a, Uqcrc1, Ush1g, Uspps, Usp17l5, Usp25, Usp26, Usp50, Usp9y, Utf1, 
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Utp14b, Utp23, Uty, Vcam1, Vcan, Vegfa, Vgll1, Vhl, Vim, Vmn1r227, Vmn1r53, Vmn1r88, Vmn2r1, 
Vmn2r94, Vps33a, Vps39, Wbscr27, Wdr16, Wdr18, Wdr27, Wdr4, Wdr45, Wdr62, Wdr77, Wdtc1, 
Whsc2, Wipf2, Wnt5a, Wrap53, Wt1, Wwtr1, Xab2, Xaf1, Xkr9, Xlr, Xpnpep1, Xpot, Xylb, Yars, 
Ydjc, Yeats2, Yif1a, Yod1, Zbed6, Zbtb17, Zbtb5, Zbtb7a, Zbtb8a, Zc3h10, Zc3h12a, Zc3h7a, Zc3hc1, 
Zcchc11, Zcchc12, Zcchc13, Zcchc17, Zcchc24, Zfand2a, Zfp1, Zfp119b, Zfp142, Zfp184, Zfp187, 
Zfp217, Zfp239, Zfp280c, Zfp292, Zfp296, Zfp30, Zfp317, Zfp335, Zfp352, Zfp353, Zfp367, Zfp382, 
Zfp386, Zfp42, Zfp446, Zfp51, Zfp516, Zfp53, Zfp54, Zfp560, Zfp566, Zfp57, Zfp572, Zfp574, 
Zfp593, Zfp599, Zfp608, Zfp622, Zfp623, Zfp637, Zfp647, Zfp689, Zfp704, Zfp706, Zfp707, Zfp719, 
Zfp771, Zfp775, Zfp800, Zfp808, Zfp809, Zfp810, Zfp825, Zfp867, Zfp871, Zfp874b, Zfp882, Zfp941, 
Zfp948, Zfpm2, Zfx, Zfy1, Zfy2, Zfyve26, Zgpat, Zic3, Zkscan1, Zmiz1, Zmym2, Znhit2, Znhit3, 






Appendix J Validation of additional screen 
candidates  
During initial analysis of the CRISPRa scRNA-seq screen dataset, before developing the 
MOFA model in collaboration with Danila Bredikin and Oliver Stegle (EMBL, Heidelberg, 
see Table of Acknowledgement of Assistance), I identified potential hits by differential gene 
expression analysis of effective sgRNAs. Briefly, using an FDR thereshold of <10%, I called 
differentially expressed genes (DEG) and, subsequently, calculated the fraction of upregulated 
ZGA genes considering those previously reported in published literature (Eckersley-Maslin et 
al. 2016; Hendrickson et al. 2017; Y. Li et al. 2018) (Appendix I). As shown in the following 
table, 29 sgRNAs were ranked for differentially upregulating at least one ZGA gene, and some 
of them, in addition to Dppa2, Smarca5, and Patz1, were validated by CRISPRa and cDNA 
overexpression, as described in Figure 5.17. Dppa4 was included as an additional positive 
control (Eckersley-Maslin et al. 2019, De Iaco et al. 2019) and Plac8 and Preb were included 
as negative controls for inducing target gene activation but not upregulating ZGA genes 
(Appendix C), similar to the Carhsp1 control used in chapter 5. The results of these validations 
are presented here. However, the low number of differentially expressed genes captured 
suggested this approach was less than ideal to call screen hits and, therefore, most of these 
candidates were not analysed further. Instead, MOFA was developed to overcome the 
sensitivity limitations of scRNA-seq data and identify screen hits that induced a ZGA signature, 




























323 Dppa2 52 28 12 11 0.392857143 
353 Smarca5 111 54 19 15 0.277777778 
160 Hmgb2 22 15 4 3 0.2 
152 Ezh2 72 60 11 11 0.183333333 
379 Dppa3 296 147 26 21 0.142857143 
270 Smarce1 20 14 2 2 0.142857143 
150 E2f5 282 133 35 16 0.120300752 
103 Patz1 246 123 20 14 0.113821138 
153 Gata3 87 73 8 8 0.109589041 
455 Zscan29 62 46 8 5 0.108695652 
163 Smad1 61 47 7 5 0.106382979 
74 Sirt1 23 20 2 2 0.1 
211 Uhrf1 11 11 1 1 0.090909091 
396 Chd3 32 25 3 2 0.08 
242 Pou5f1 734 461 60 36 0.078091106 
333 Ep400 51 41 7 3 0.073170732 
170 Ncoa3 39 28 5 2 0.071428571 
391 Lin28a 92 79 6 5 0.063291139 
69 Max 18 16 1 1 0.0625 
224 Smarca2 88 65 8 4 0.061538462 
241 Pou5f1 1000 723 76 44 0.060857538 
350 Jmjd6 24 17 1 1 0.058823529 
288 Carhsp1 83 52 11 3 0.057692308 
190 Dnajc2 36 18 4 1 0.055555556 
124 Hmgb3 24 19 2 1 0.052631579 
305 Atad2 38 24 1 1 0.041666667 
374 Ybx3 33 28 2 1 0.035714286 
392 Lin28a 101 86 4 2 0.023255814 




Heatmaps of ZGA-like gene expression after CRISPRa and cDNA overexpression of different 
screen candidates, analysed by bulk RNA-sequencing 
Heatmaps showing transcript normalised expression, scaled per transcript, of the MERVL/ZSCAN4-
driven network described in Eckersley-Maslin et al. 2016, in bulk RNA-sequencing libraries after 
CRISPRa (top panel) and cDNA overexpression (bottom panel) of the indicated genes. Controls are 
two different non-targeting sgRNAs (NT1 and NT2) for CRISPRa and GFP only overexpression for 


















































































































































































Western-blots of DPPA2, ZSCAN4, OCT4 and NANOG in Dppa2 knock-out mESCs 
Western-blots showing DPPA2 (top left panel), ZSCAN4 (top right panel), OCT4 (bottom left panel) 
and NANOG (bottom right panel) protein levels in clonal wild-type and Dppa2 knock-out mESCs. 
HSP90 antibody was used as a loading control. 

 
 
